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ABSTRACT
The y-aminobutyric acid (GABA) neurotransmitter transporter GAT-1 plays a key 
role in regulating the amount of free, intercellular GAB A present in the central nervous 
system. Developmental studies show phenotypic changes in GABA transporters from 
prenatal to adult stages suggesting that this molecule influences development of the 
central nervous system. Thus, the GABA transporter appears to be a good candidate for 
assessing the developmental role of the GABAergic system. The purpose of this research 
is to advance the long-term goal of understanding the molecular regulation of GAT-1 
expression in Xenopus laevis and consequently the role of GAT-1 in neural development. 
Four study objectives were completed.
First, automated sequencing of the Xenopus laevis GAT-1 clone, named xGAT-1, 
was performed to complete and verify the manual sequencing results. The final cDNA 
clone of xGAT-1 comprises 2,451 nucleotide base pairs and encodes a 599 amino acid 
polypeptide. The putative xGAT-1 clone shows 87-88% identity with mammalian GAT- 
1 and lower (82%) percent identity with ray GAT-1.
Second, automated sequencing of the Xenopus laevis genomic fragment, named 
xgGAT-1, was performed. Based on sequence analysis, the xgGAT-1 fragment 
comprises 13,051 nucleotide base pairs. The fragment includes 1,130 nucleotides of 
cDNA from base 32-1161. It does not include the 5' end or promoter region required for 
future expression studies. The sequence shows the expected alignments across species 
between exons of GAT-1, but no alignment across introns. Unexpectedly, intron 
placement appears to be similar across species, suggesting a specific function for this 
gene organization.
Third, in situ hybridization results in normal embryos were examined. xGAT-1 is 
not present at detectable levels in Xenopus laevis embryos until post-neurulation, 
although our studies cannot rule out the possibility of low level occurrences in early 
development. Thus, the GABAergic system, and in particular the molecular components 
for GABA uptake, do not likely play a role in early patterning and inductive events. 
However, our results are consistent with a potential role for GABA in later events such as 
neural migration and synaptogenesis.
Fourth, in situ hybridization was performed on embryo explants including full 
neural plates and regional explants of the neural plate, both with and without mesoderm. 
Overall, the results demonstrate that all regions of the presumptive neural plate are 
independently capable of xGAT-1 transcription either prior to or at the initiation of 
neurulation. It appears that mesoderm is necessary to produce normal expression.
CHARACTERIZATION OF THE xGAT-1 GENE 
IN XENOPUS LAEVIS
2INTRODUCTION 
Statement of Problem
The development of the central nervous system (CNS) in vertebrates is an 
extremely complex process mediated by an intricate genetic cascade that must be 
regulated in a specific spatiotemporal pattern. There is growing evidence that 
neurotransmitters are among the molecules that play a key role in development. For 
example, several neurotransmitters, which primarily function in the adult CNS to 
facilitate synaptic transmission, are present before the formation of a functional synapse 
(Redbum and Rowe-Rendleman, 1996). Perturbation of neurotransmitter system 
components, for example by cocaine, alcohol, or pesticides, has been shown to produce 
developmental anomalies (Buznikov et al., 1999, Kentroti and Vemadakis, 1992, Levitt 
et al., 1997, Liu et al., 1997). Finally, neurotransmitter systems and their components 
have been shown to occur and operate differently in embryonic versus adult organisms 
(Cherubini et al., 1991). These observations suggest that neurotransmitter systems can 
play a role in early development that is separate and distinct from their role in synaptic 
transmission. However, this role is not well investigated.
Developmental biology is central to understanding the mechanisms influencing 
the regulation of an organism’s genes which, in turn, leads to our understanding of an 
organism’s susceptibility to disease and growth defects, and their capacity for repair and 
regeneration of internal biological systems. With the application of molecular biology to 
developmental studies, researchers have begun to work out the mechanisms of regional
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specification, cell differentiation, morphogenesis, and growth that together comprise 
development. Additionally, based on knowledge of neurotransmitter actions during 
development, it may become possible to therapeutically use agonists or antagonists to 
emulate embryonic neurotransmitter conditions in the adult to trigger cell proliferation or 
tissue repair, and to regulate programmed cell death in clinical situations involving 
trauma, degenerative diseases, or transplantation (Redbum and Rowe-Rendleman, 1996).
Studies have shown the neurotransmitter y-aminobutyric acid (GABA) and the 
GABAergic system to have a conserved and pervasive occurrence in invertebrates and 
vertebrates, making the molecules of this system an important set of markers in the study 
of comparative development and evolution (Roberts et al., 1958). As discussed in 
Chapter 2, previous studies have focused on the role of the GABAergic system in CNS 
development at the cellular level and a few studies have characterized the occurrence of 
GABAergic components in the early stages of CNS development. However, no study has 
examined the possible role of GABAergic components in the regional specification of 
CNS tissue or tried to determine if this neurotransmitter system contributes to the 
molecular mechanisms mediating the very early stages of development. The GABA 
neurotransmitter transporter plays a key role in regulating the amount of free, 
intercellular GABA present (Nelson, 1998) and developmental studies show phenotypic 
changes in GABA transporters from prenatal to adult stages suggesting that this molecule 
influences development of the CNS. Thus the GABA transporter appears to be a good 
candidate for assessing the developmental role of the GABAergic system.
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From a pharmacological perspective, using molecular biology to understand the 
structure and regulation of molecules associated with certain pathologies is also key to 
the creation of therapeutic drugs. In the extreme, the GABAergic system has proved vital 
to sustain the life of an organism because blockage of the enzyme glutamic acid 
decarboxylase (GAD) that is involved in the synthesis of GABA rapidly leads to 
convulsions and death (Barker et al, 1998). Abnormal GABAergic activity also has been 
implicated in neurological states such as epilepsy, anxiety, Parkinson’s disease, 
schizophrenia and brain inflammation (Mizuno et al, 1994, Volk et al, 2001) and in 
ethanol-induced liver disease (Gong et al., 1999, Lou et al., 1999). Abnormal expression 
of GABA transporters in particular may have protective role from excessive GABA 
inhibition during physiological and/or pathological events (Gadea and Lopez-Colome, 
2001). Ma et al. (2000) reported that GAT-1 overexpression causes focal damage of the 
spermatogenic epithelium accompanied by capillaries proliferation which may be 
implicated in the onset of testicular pathologies that cause male infertility.
Several pharmacological and biochemical studies have been performed to identify 
novel therapeutic agents. The use of appropriate agonists or antagonists for 
pharmacological inhibition of GABA transport increases GABAergic activity and has 
been found to be efficacious in the treatment of certain neuropsychiatric disorders, 
particularly epilepsy and anxiety (Akbar et al, 1998, Ueda and Willmore, 2000, Lam et 
al., 1993). Pharmacological inhibition in insects is also being studied to develop specific 
leads for insecticides (Gao et al., 1999).
As described above, study of the GABA transporter in vertebrates is important 
from both a developmental and pharmacological perspective. Only recently have
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molecular techniques been used to study neurotransmitter transporters. The first 
neurotransmitter transporter to be cloned, in 1990, was a GABA transporter (Guastella et 
al., 1990). For GABA transporters, the studies have focused primarily on validation of 
putative transporters by measurement of GABA uptake and differentiation of distinct 
GABA transporters with respect to pharmacology and cellular localization. Portions of 
the genomic sequence for a GABA transporter have been reported for only two 
organisms (human and mouse) and characterization of the regulatory elements is 
incomplete. No study has been reported that attempts to create a model system for 
transcriptional analysis of a GABA transporter gene.
Purpose of this Research
The purpose of this research is to advance the long-term goal of understanding the 
molecular regulation of GABA transporter (GAT-1) expression in Xenopus laevis and 
consequently the role of GAT-1 in neural development. There are four study objectives. 
The first objective is to determine the final cDNA sequence and structure of the xGAT-1 
in Xenopus laevis (GAT-1 homologue). The second objective is to sequence and 
characterize, to the extent possible, the single genomic fragment of the xGAT-1 gene 
obtained to date. The third objective is to elucidate the normal spaciotemporal expression 
pattern of xGAT-1 and the fourth objective is to analyze expression patterns of xGAT-1 
in manipulated Xenopus laevis embryos to assess the implications for cell-to-cell 
interactions.
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Previous Work in the Lab
To date, work by others in the lab has isolated the putative xGAT-1 cDNA and 
one fragment of a GABA transporter gene by the following approach. Degenerate 
Polymerase Chain Reaction (PCR) primers were designed based on published sequences 
for GABA transporters in mammals. The primers were used for application of PCR to 
genomic DNA from mouse (i.e., Peromyscus leucopus). The PCR product was an 
approximately 700 bp fragment with high homology to GABA transporter, GAT-1, in 
mammals (Hoke, 2000). The product was used as a probe to screen both a Xenopus 
laevis muscle genomic library (Clontech) and a Xenopus laevis tadpole brain library in 
XZAPII generously provided by Igor Dawid. The hybridizing fragment from the former 
(xGAT-1 genomic DNA clone) provided the experimental material used in this study to 
obtain partial sequence and characterization of the GAT-1 gene in Xenopus laevis. The 
hybridizing fragment from the latter (putative xGAT-1 cDNA) was used to sequence and 
characterize the xGAT-1 transcript.
Previous work also includes in situ hybridization on Xenopus laevis embryos over 
a time series from approximately stage 9 through stage 45 (all stages according to 
Nieuwkoop and Faber, 1967). The sections and whole mount embryos generated from 
that work were used to supplement the in situ hybridization experiments conducted for 
this study.
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CHAPTER 1 
LITERATURE REVIEW
The GABAergic System 
System Components
The principal components of the GABAergic system are: the neurotransmitter (y- 
aminobutyric acid, GABA); the enzyme necessary for its synthesis (glutamic acid 
decarboxylase, GAD); vesicular transporters that release GABA from the pre-synaptic 
cell to the synaptic cleft; membrane bound receptors in the post-synaptic cell that 
transduce the GABA signal; membrane bound transporters that clear free GABA from the 
synaptic cleft via uptake mechanisms and GABA a-oxoglutarate transaminase (GABA- 
T), a mitochondrial enzyme that degrades and inactivates the cleared GABA in the 
presynaptic cell. Together, in the adult, these components are responsible for the 
majority of inhibitory signals transmitted throughout the central nervous system (CNS).
GABA is ultimately derived from glucose metabolism when a-Ketoglutarate is 
transaminated to the amino acid glutamate by the enzyme GABA a-oxoglutarate 
transaminase (GABA-T). The enzyme, GAD, synthesizes GABA from glutamate but 
requires a cofactor, pyridoxal phosphate, which is derived from vitamin B6.
There are three types of post-synaptic receptors; GABAa and GABAC, which 
produce a fast synaptic inhibition and GABAb, which mediates slow, prolonged 
inhibitory signals and functions to modulate the release of neurotransmitters. GABAa 
and GABAc receptors are members of a superfamily of transmitter-gated ion channels.
In the adult, GABAa is the major receptor. GABAa receptors are hetero-oligomeric and, 
to date, 16 human GABAa receptor subunit cDNAs have been cloned including a l (6),
pi (4), yl (4), 5 and s. GABAa receptors form chloride channels that are activated by 
muscimol, competitively inhibited by the alkaloid bicuculline, noncompetitively inhibited 
by picrotoxin and modulated by steroids, barbiturates and benzodiazepines. In contrast, 
GABAc receptors form transmitter-gated C f channels made up of a single type of protein 
subunit (pi or p2). GABAc receptors are not sensitive to the above compounds but are 
selectively activated by the conformationally restricted analogues of GABA. Subunits a  
and p do not assemble with subunit p, thus GABAa and GABAc are distinct types or 
receptors (Chebib and Johnston, 1999).
GABAb receptors are seven transmembrane proteins that are coupled to G- 
proteins and activate second messenger systems and Ca2+ and K+ ion channels. GABAb 
receptors are bicuculline- and picrotoxin-insensitive, activated by baclofen and 
antagonized by 2-hydroxysaclofen. Like GABAa receptors, GABAb receptors are made 
up of a mixture of a combination of subunits (Behar et al., 1996, Chebib and Johnston,
1999).
Neurotransmitter Action in the Adult
GABA inhibits the ability of neurons to fire action potentials. When a 
propagating wave of depolarization reaches the axon terminal of the pre-synaptic cell, 
voltage-dependent calcium channels are opened. The resulting influx of calcium results 
in fusion of synaptic vesicles with the presynaptic plasma membrane, thereby leading to 
release of neurotransmitter. The presence of GAD determines if GABA is released. 
Unlike the transport of monoamines and acetylcholine, which rely almost entirely on pH 
gradients to drive active transport, the vesicular transport of amino acid transmitters such 
as GABA depends equally on electrical and pH gradients (Chaudhry et al., 1998).
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The released neurotransmitter diffuses across the synaptic cleft and binds to post- 
synaptic receptors, allowing ion transport which alters the electrical excitability of the 
post-synaptic neuron (Borden, 1996). The influx of Cf via GABAa and GABAc 
receptors mediate fast synaptic inhibition. GABAb receptors are G-protein coupled 
receptors that decrease cAMP levels and open K+ channels to produce slow, prolonged 
inhibitory signals and function only to modulate the release of neurotransmitter (Chebib 
and Johnston, 1999).
At the majority of synapses in the central nervous system, including those for the 
amino acid and monoamine transmitters, the released neurotransmitter is rapidly 
sequestered by high-affmity transporters (e.g., GAT-1) located on the pre-synaptic 
terminal and the surrounding astroglial cells (Mabjeesh et al., 1992, and Man-Kit Lam et 
al., 1993). The mechanisms were elucidated in pharmacological studies during the 1970s 
which identified ion-dependent transporters capable of bidirectional neurotransmitter 
transport (Iversen and Kelly, 1975; Martin, 1976; Snyder, 1970). After re-uptake of 
GABA into the pre-synaptic cell, the transmitter is partly inactivated enzymatically and 
partly stored in presynaptic vesicles for reuse. Enzymatic inactivation occurs after re­
uptake by transporters in glial cells (Soudijn and van Wijngaarden, 2000).
The GAT-1 uptake system is more extensive than the GABA synthesizing system 
and approximately 20% of GABA released into the synaptic cleft may be taken up into 
surrounding astrocytes (Schousboe, 2000). Astrocytes are thought to play an important 
role in modulating the paracrine spread of GABA, thereby assuring fidelity of synaptic 
transmission. Neurotransmitter transporters may also work in reverse and release 
neurotransmitter in a calcium-independent manner (Levi and Raiteri, 1993). This event is
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observed during ischemia or following seizures that produce alterations in the 
transmembrane sodium (or voltage) gradient (Borden, 1996). Thus, in addition to its role 
in terminating GABA action, GABA transporters maintain low intrasynaptic and 
extracellular neurotransmitter levels, thereby regulating synaptic efficacy, ensuring 
synaptic fidelity, and reducing the potential neurotoxicity of excessive excitatory 
neurotransmitters (Nelson, 1998). GABA transporters may also function in uptake 
processes not related to signal transduction including (1) detoxification, (2) protection 
from reactive substances, (3) nutrition, and (4) modulation of receptor activity (Jusky et 
al., 1994).
Neurons are generally specialized to release a single neurotransmitter. Thus, in 
the forebrain most inhibitory nerve endings are GABAergic. However, in the spinal cord 
and brainstem, nerve endings co-localize GABA and glycine and at many sites are more 
abundant than axon terminals rich in only one of the two inhibitory amino acids 
(Chaudhry et al., 1998). Jonas (1998) has demonstrated the co-release of GABA and 
glycine from single presynaptic terminals and, in fact, from the same vesicle. The co­
release generates a fast glycinergic component and a slow GABAergic component. The 
kinetic differences may be necessary for motor coordination which depends on precise 
timing.
Occurrence in Nature
GABA is the predominant inhibitory neurotransmitter in the vertebrate brain 
(reviewed in Liu et al., 1992, Borden et al., 1992 Guastella et al., and 1990, Nelson et al., 
1990). As many as one-third of the synapses in the human brain appear to use GABA as 
their neurotransmitter (Purves, 1997). Studies in the 1950s, summarized in Roberts et al.
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(1958), characterized GABA as a transmitter substance of inhibitory neurons and found 
GABA to occur in the nervous system of fish, amphibians, reptiles, birds, marsupials, and 
mammals. In addition to the widespread occurrence of GABAergic components in 
vertebrates, GABA and homologous GABA uptake systems are reported in 
nonvertebrates including insects and worms (Andre et al., 1993, Mbungo et al., 1995, 
Neckameyer and Cooper, 1998), single cell eukaryotes such as Saccharomyces cerevisiae 
(Grenson, 1992), eubacteria and archaebacteria such as Escherichia coli (Niegemann et 
al., 1993) and Symbiobacterium thermophilum (Nelson, 1998) and in plants (Barker et al., 
1998). These findings indicate that neurotransmitter transporters are involved in the 
development of early lifeforms. Studies by Guimbal et al. (1995) suggest that the 
specific isoforms for the GABA transporters arose before the divergence of vertebrates 
and invertebrates.
The GABA Transporter 
Characteristics o f Na+/CT transporters
The GABA transporter is part of a superfamily of sodium- and chloride- 
dependent neurotransmitter transporters whose other members include: biogenic 
monoamine transporters (dopamine, norepinephrine, serotonin), amino acid transporters, 
“orphan” transporters and the recently discovered bacterial transporters (Nelson, 1998). 
The requirement for a Na+ gradient is common to all families but they differ in their 
dependence on additional ions and have no significant sequence similarity (Guimbal et 
al., 1995). The precise physiological role of some transporters is complicated by 
substrate-specificity overlap; for example, some GABA transporters show some affinity
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for P-alanine and taurine. It is possible that some transporters have different 
physiological substrates and different functions in different cell types (Guimbal et al., 
1995).
Na+/C f transporters have a common membrane topology of 12 a-helical 
transmembrane (TM) domains consisting of about 20 predominantly hydrophobic amino 
acids each, but there are no apparent common motifs in all transporters with this 
topology. The absence of a cleavable N-terminal sequence suggests that the N-terminal 
part of the transporter is situated in the cytoplasmic face of the plasma membrane. The 
C-terminal sequence is also present inside the membrane (Nelson, 1998). The N- and C- 
terminal domains contain potential phosphorylation sites.
Na+/Cl' transporters are also distinguished by a conserved amino acid sequence 
that includes the residue WRFPXXXYXNGGGAF and the genes have an intron within 
the coding sequence of the three glycine residues. The position of this intron is 
conserved not only in the vertebrate genes, but also in the genes encoding Na+/Cl" 
transporters in insects (Nelson, 1998). Most transporters are constructed from about 600 
amino acids and have a large extracellular loop between TM3 and TM4 with potential 
sites for N-glycosylation (Soudijn and van Wijngaarden, 2000). The only conserved 
charged amino acid is an arginine residue in the middle of transmembrane helix 1 (Jusky 
et al., 1994).
GABA transporter isoforms and nomenclature
The first evidence for the occurrence of different forms of GABA transporter was 
compiled in the 1970s from a series of investigations by Krogsgaard-Larson and 
colleagues (reviewed in Krogsgaard-Larson et al., 1987). Studies through the 1980s
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described the electrogenic aspects of GABA transporters and provided further evidence 
for variation in sodium- and chloride-coupled GABA transport (e.g., Radian and Kanner, 
1983; Keynan and Kanner, 1988). These studies were based on measurements of ion 
fluxes across purified membranes.
The application of molecular techniques from 1990 to present day has greatly 
expanded the study of neurotransmitter transporters. To date, four distinct, high-affinity 
mammalian GABA transporter genes (cDNA sequences) have been cloned. Reviews by 
Borden (1996) and Palacin et al. (1998) resolve the nomenclature used in prior studies 
reporting novel mammalian GABA transporters as shown in Table 1. In addition to 
mammalian studies, investigators have cloned and characterized GABA transporters in 
Trichoplusia ni (Gao et al., 1999), Drosophila melanogaster (Neckameyer and Cooper, 
1998), Torpedo marmorata (Qian et al, 1998; Guimbal et al., 1995), Manduca sexta 
(Mbungu et al., 1995) and Saccharomyces cerevisiae (Grenson, 1992). The identification 
of multiple GABA transporter isoforms from Torpedo (Guimbal et al., 1995) indicates 
that GABA transporter isoforms are phylogenetically ancient and arose before the 
divergence of vertebrates.
The term isoform is used in the literature to distinguish GABA transporter 
proteins that are produced by the different transcripts. There is insufficient evidence to 
conclude that the isoforms arise from separate genes rather than by alternative splicing of 
a single gene, although the former appears to be the prevailing assumption. In their 
studies of GABA transporters in Drosophila melanogaster, Neckameyer and Cooper 
(1998) report that although the Drosophila cDNAs had distinct restriction enzyme 
patterns, they recognized the same locus in Drosophila genomic DNA lending support to
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TABLE 1
NOMENCLATURE FOR MAMMALIAN GABA TRANSPORTERS.
Transporter 
(Gene and 
Protein Name)*
Nomenclature in Literature
Mouse Rat Dog Human
GAT-1
GABAT 
(Liu et al., 1992)
GAT1 
(Liu et al., 1993)
GAT-1 
(Guastella et al., 
1990)
GAT-A 
(Clark et al, 1992)
GAT1 
(Nelson et al., 1990)
GAT-2 GAT3 (Liu et al., 1993)
GAT-2 
(Borden et al., 1992) - -
GAT-3
GAT4 
(Liu et al., 1993)
GAT-3 
(Borden et al., 1992)
GAT-B 
(Clark et al., 1992)
~ GAT-3 
(Borden et al, 1994)
BGT-1
GAT2
(Lopez-Corcuera et al., 1992)
GAT2 
(Liu et al., 1993)
'
BGT-1 
(Yamauchi et al., 
1992)
hS1a (brain) 
(Borden et al. 1995)
BGT-1 (kidney) 
(Rasola et al., 1995)
* Nomenclature used for this study.
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the alternative splicing hypothesis. Their work did not include complete sequencing of 
these presumptive GABA transporter cDNAs, so no comparison of exons could be made 
to verify their hypothesis.
GAT cDNA and Protein Structure
GAT-1 in rat, mouse and human are highly homologous (97%) proteins consisting 
of 599 amino acids with a molecular weight of 67 kilodaltons. GAT-2 and GAT-3 (rat) 
consists of 602 and 627 amino acids, respectively, with 67% homology (52% identical 
with GAT-1) (Soudijn and van Wijngaarden, 2000). Guastella, et al. (1990), who cloned 
the first GABA transporter (GAT-1 in rat) reported an open reading frame of 1797 
nucleotides, a 5' untranslated region of 149 nucleotides, and a 3' untranslated region of 
2108 nucleotides. He suggested that the region immediately surrounding the putative 
start codon, which contained purines at positions +4 and -3, represented a Kozak 
consensus sequence. Consistent with the mammalian GAT-1, the MasGAT transcript 
(cloned in Manduca sexta by Mbungu et al., 1995) shows with an open reading frame of 
1793 bp.
All of the GAT-1 cDNA transcripts cloned to date show conformity with the 
general characteristics of Na+/C f transporters including 12 V-helical transmembrane 
(TM) domains, N-termini and C-termini with potential protein kinase C sites located in 
the cytoplasm and a large extracellular loop between TM domains 3 and 4 with potential 
N-glycosylation sites. The most highly conserved regions of GAT-1 among species 
(>50% homology) are helix 1 together with the extracellular loop connecting it with helix 
2, and helix 5 together with a short intracellular loop connecting it with helix 4 and a 
larger extracellular loop connecting it with helix 6. The potentially glycosylated loop
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between TM helices 3 and 4 is not well conserved and even its size varies among 
different transporters. However, its first 30 amino acids are highly conserved and its 
strategic position in the transporters suggests possible involvement in substrate binding. 
The region stretching from helix 9 onwards is far less conserved than the segment 
containing the first 8 helices. The amino and carboxyl termini are the least conserved 
segments (Jusky et al., 1994, Kanner, 1994).
All splice donor and acceptor sequences contain the consensus splice signal GT at 
5' and AG at 3' of each intron (Lam et al., 1993). Based on their work in mouse, Liu et 
al. (1992) have observed that exon 1 is an untranslated mRNA sequence. Additionally, 
exon 2 contains the extension of this sequence, the initiator methionine and the N- 
terminal amino acid sequence including the first potential transmembrane helix. Exons 3, 
4, 6, 7, 8, 9 and 10 each contain a single potential transmembrane segment and exon 5 
contains a hydrophilic glycosylated loop between transmembrane segments 3 and 4.
Thus the structure of the gene is essentially a set of functional domains divided by 
introns. This arrangement is conducive to rapid evolution of the gene family by an “exon 
shuffling” mechanism.
Characteristics of GABA Transporter Isoforms 
Localization/Role
Before the availability of cloning techniques, the tissue distribution of GAT-1 was 
monitored by immunocytochemistry. Subsequently, transporter distribution was studied 
by Northern blot and in situ hybridization. Key distinguishing features of the four 
transporters studied in vertebrates are summarized in Table 2. The three transporters
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cloned in Drosophila melanogaster (Neckameyer and Cooper, 1998) are reported to share 
similar tissue distribution to the mammalian GAT-1, GAT-2 and GAT-3 transporters.
GAT-1 is present throughout the brain, mainly in neuropil but also in glial cells in 
the cerebral cortex, cerebellum, hippocampus, and retina (Muller cells). Muller cells, the 
principal retinal glia, span the entire neural retina between the external limiting 
membrane (ELM) and the internal limiting membrane (ILM). From this characteristic 
position, Muller cells take up GABA released by a variety of retinal neurons (Zhao et al.,
2000). Recent studies (Ping et al., 2001; Ma et al., 2000) have also identified GAT-1 in 
spleen and testis.
GAT-2 is the only high affinity GABA transporter expressed in peripheral tissues 
(i.e., liver and kidney) in addition to brain and retina. GAT-2 was first localized to cells 
of the leptomeninges, choroid plexus, and ependyma in the brain (Ikegaki et al., 1994, 
Durkin et al., 1995), and thus was assumed to have a non-neural function, possibly a 
nutritional role, but its presence in neuron and glial cells has subsequently been 
demonstrated (Gadea and Lopez-Colome, 2001). GAT-3 has strong expression in spinal 
cord, brainstem, thymus, and hypothalamus and weaker expression in areas where GAT-1 
is abundant. Current evidence suggests that GAT-3 is mainly a glial transporter. The 
pattern of early embryonic expression of GAT-1 and GAT-3 (discussed below) suggests 
they may also play a role in maturation of the adult GABA inhibitory system in the brain 
(Jursky and Nelson, 1996). BGT-1 (betaine-sensitive GABA transporter) is expressed as 
a lower affinity GABA transporter in brain, most probably with a role in glial transport. 
BGT-1 is expressed in the peripheral tissues medulla, liver and kidney.
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Collective evidence suggests that GAT-1 has a pre-synaptic role in GABAergic 
synapses but may also have a post-synaptic role and may regulate extracellular 
concentration of GABA in glial cells. For example, GAT-1 (or GAT-2) of Muller cells 
may protect the retinal synapses from inappropriate inhibition by excess GABA released 
during physiological and/or pathological events (Zhao et al., 2000). GAT-1 may 
influence both excitatory and inhibitory neurotransmission via substrate-independent leak 
currents carried by Li+ and K+ (blocked by the substrate and transport inhibitors) or by 
modulating the local and diffuse actions of GABA. Thus, reverse operation of GATs can 
result in the non-vesicular release of GABA by breakdown of the sodium/chloride/GABA 
gradient or by cell depolarization. Because carrier-mediated release of GABA does not 
rely on ATP but on ion gradients, it may modulate GABA concentration during periods 
of high energy utilization, such as burst firing or seizures. (Gadea and Lopez-Colome, 
2001, Minelli et al., 1995). Also, a role for the GAT transporter in intracellular signaling 
is suggested by its channel mode of action (Palacin et al., 1998). Because the GAT-1 
uptake system is more extensive than the GABA synthesizing system, and is expressed in 
glial cells on the cerebral and cerebellar cortex and spinal cord, it is posited to possibly 
contribute to the regulation of the cerebrospinal concentration of GABA. 
Substrates/Kinetics/Stoichiometry/Transport
The transporters of the GABA transporter family can be distinguished by 
substrate specificities and kinetics as shown on Table 2. GAT-1 has high affinity and 
specificity for GABA and no interaction with P-alanine. GAT-2 and GAT-3 also have 
high affinity for GABA, but lower specificity. These transporters also have high affinity 
for p-alanine. BGT-1 is a low affinity GABA transporter. The fact that a single clone of
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any of these members can express GABA uptake activity suggests that the GABA 
transporter functions as a single subunit or, less likely, as a multimer of identical subunits 
(Guastella, et al, 1990).
The Na+ electrochemical gradient is the driving force for GABA transport 
(Palacin et al., 1998). GABA transporters co-transport two Na+, one Cl', and one 
substrate molecule. The ions bind first and the conformational change induced by this 
binding enables the substrate binding. Following the transport step, the Na+ ions are 
released first, and then the substrate and Cl' are also released. The transporter is rendered 
competent for the next cycle by returning to the original conformation spontaneously, or 
through facilitation by K+ or H+ gradients, or by a membranes potential (Nelson, 1998). 
The two Na+ ions interact with the transporter even in the absence of GABA and Cl' is 
thought to facilitate the binding of Na+ (Mager et al., 1996). While sodium ions are 
required for transport, the dependence on chloride ions is less stringent. When Cl' is 
replaced by the Br anion, the transport of GABA by GAT-1 or BGT-1 is not affected 
whereas the transport is significantly reduced when N O 3,1 or F anions have been 
substituted for Cl (Soudijn and van Wijngaarden, 2000).
Despite the high sequence identity between the GABA and taurine transporters, 
the latter is not capable of GABA transport and GABA does not inhibit its taurine uptake 
activity (Nelson, 1998). This fact, plus the observation that the mechanisms for all 
GABA transport depend on previous binding of Na+ and Cl" suggest that conserved 
protein domains and the membrane placement of key amino acids are important in the 
interactions between the transporter and the permeant complex. Several amino acid
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residues that are critical for GABA transporter function have been identified by site- 
directed mutagenesis. These include:
• Arginine-69: Located in TM 1 helix, possibly involved in the binding of
chloride, conserved in all the transporters. (Kanner, 1994).
• Cysteine-74: Conserved in all the transporters.
• Glutamate-101: Located on the intracellular side of TM2. Critical for one
or more of the obligatory conformational changes during
the transport cycle; highly conserved in all the transporters. 
(Nelson, 1998, Soudijn and van Wijngaarden, 2000).
Located at the extracellular side of TM 1 helix, may be 
involved in the binding of Na+ and/or Cf, conserved in all 
the transporters. (Mager et al, 1996, Soudijn and van 
Wijngaarden, 2000).
Tryptophan-68:
Tryptophan-222: Located in TM 4 helix, possibly serves as a binding site for
the amino group of GABA (Kanner, 1994).
Tryptophan-230: Possibly involved in sorting of the transporter into the
plasma membrane (Jusky et al., 1994).
Tyrosine-140: Located in TM 3 helix, conserved in all the family 
members, including the bacterial transporters, critical for 
GABA recognition and transport by GAT-1 (Bismuth et al., 
1997), may be involved in the ligand binding of the amino 
group in GABA and other neurotransmitters (Bismuth et 
al., 1997).
The transporter may exist in two conformations. As long as GABA and the two 
co-substrates, sodium and chloride, are present, the transporter is protected against 
proteolysis. In the presence of all three substrates, the conformation is changed such that 
these sites become inaccessible to protease action (Kanner, 1994). Thus, charged amino 
acids in the membrane domain of the transporters that bind these substrates may be 
essential for their normal function.
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With respect to conserved protein domains, the importance of several structural 
features of the protein has been examined. Neither terminus of the GABA transporter 
appears to be needed for its transport function. Deletion of the N-terminal until 12 amino 
acids from the start of TM1 did not affect GABA transport at all. However, shortening of 
the N-terminal until 3 amino acids from TM1 proved to be detrimental for GABA 
transport. Deletion of more than half of the 42 amino acids from the end of the C- 
terminal of GAT-1 does not impair GABA transport (Soudijn and van Wijngaarden, 
2000). The protein domains might be relevant for other functions like regulation of the 
transport function or interaction with the cytoskelton (Kanner, 1994, Palacin et al., 1998).
Palacin et al., 1998, Kanner et al. (1994) and Tamura et al. (1995) examined the 
role of hydrophilic loops in the function of GABA transporters. They suggest that three 
external loops (Loops 4-6) might form a pocket on the transporters into which the 
substrates bind. Nelson (1998) notes that while amino acid sequences for the putative 
short external loops of GAT-2, GAT-3, and BGT-1 are nearly identical, they are 
significantly different from the sequences of GAT-1, possibly correlating to greater 
specificity for GABA by GAT-1. Soudijn and van Wijngaarden (2000) summarize 
additional findings which indicate that the external loops III-VI determine the kinetic 
characteristics of GABA uptake by GATs. Those results suggest that loop V is involved 
in the binding of substrates such as (3-alanine and thus may act as a selectivity filter.
In the adult, transporter-mediated nonvesicular GABA release (i.e., transport of 
GABA out of the pre-synaptic or glial cell via reversal of GABA transporters) can occur 
with depolarization under pathological conditions (periods of high energy utilization, 
such as burst firing or seizures). The findings reported from studies of the anticonvulsant
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vigabatrin by Wu et al. (2001) suggest that GABA transporters reverse more easily than 
previously recognized and are highly sensitive to changes in the [GABA] gradient and 
membrane potential. This study suggests that the stoichiometry is actually not fixed. The 
GABA transporter, which normally operates near its equilibrium, can be easily induced to 
reverse by an increase in cytosolic [GABA] or mild depolarization. Wu et al. (2001) 
posit that as cytosolic GABA increases sufficiently high, there may be significant 
“slippage” of the transporter, with uncoupled GABA efflux occurring without NaCl 
efflux. An alternative possibility is that GABA flux is coupled with Na+ and C f under 
physiological conditions but that Na+ is driven against its gradient when GABA efflux is 
induced by an increase in cytosolic [GABA].
Pharmacological Properties o f GABA Transporters
Examples of natural and synthetic inhibitors for each of the four GABA 
transporters are provided in Table 2. GABA transporters are studied as the potential 
targets of drugs for anti-convulsant activity. For example, Tiagabine, was introduced into 
the market as an anti epileptic in 1996, is selective for the GABA transporter. The 
compound does not inhibit dopamine or norepinephrine transporters. Some drugs exert 
anticonvulsant activity selectively by inhibiting glial but not neuronal GABA uptake 
(Gadea and Lopez-Colome, 2001). Selective block of glial GABA transport may be 
more effective than blocking neuronal transport because the former elevates GABA 
concentration in nerve terminal, whereas the selective blockage of the neuronal 
transporter may deplete the releasable neurotransmitter pool (Wood et al., 1980, 
Schousboe et al., 1983).
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GABA transporters in the insect CNS have also been the target of 
pharmacological studies motivated by interest in the development of rapidly-acting 
neuroactive agents to control agriculturally-important insects. The Trichoplusia ni 
transporter (TmGAT) presents a unique pharmacology distinguishable from mammalian 
GAT-1 by the inability of cyclic GABA analogues, such as nipecotic acid and its 
derivatives, to inhibit GABA uptake by the insect protein (Gao et al., 1999).
Regulation of GABA Transporters
Little is known about regulation of GABA transporters but several studies, taken 
together, suggest that transporter activity can be tightly, rapidly, and differentially 
regulated at the regional, cellular, and subcellular levels via both pre-and post- 
translational mechanisms. Previous work, discussed below, has examined the role of 
intracellular signaling pathways, extracellular GABA concentration, and hormones.
Intracellular signaling effects include regulatory roles for protein kinase C (PKC), 
protein kinase A (PKA), and direct tyrosine phosphorylation. These second messenger 
pathways exert their effects, at least in part, by transporter trafficking into and out of the 
synaptic plasma membrane causing a redistribution of the transporter protein at the cell 
surface (Law et al., 2000). All transporters contain consensus sites for phosphorylation 
within the intracellular domain of the molecule, and phosphorylation has been shown to 
modulate the function of these transporters. However, the effects of cell signaling 
systems are transporter-specific. For example, the Vmax for GABA transport (inXenopus 
oocytes) is increased by activation of PKC signaling pathways, but the Vmax for transport 
of both DA and serotonin is decreased. Thus, phosphorylation of PKC-consensus sites in
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different regions of the intracellular domain can have very different effects on transporter 
function (Figlewicz, 1999).
Both protein kinase C (Corey et al, 1994, Osawa et al, 1994) and protein kinase A 
(Tian et al, 1994, Gomeza et al., 1994) have been shown to regulate GAT-1-mediated 
GABA transport. Treatment of cultured neurons with cAMP analogues, which 
presumably activates PKA, has been shown to result in a decrease in GAT-1 mRNA 
(Gomeza et al., 1994). GAT-1 activity is also downregulated by PKC activation (Sato et 
al., 1995). The PKC pathway appears to regulate the interaction between GAT-1 and 
syntaxin 1A in neurons endogenously expressing these two proteins and Muncl8, a 
substrate for PKC phosphorylation (Beckman et al, 1998). Syntaxin 1A is a plasma 
membrane component of the SNARE complex which is involved in vesicle membrane 
fusion, thus GABA transporter function could be regulated by components of the vesicle 
docking and fusion machinery. Work by Horton and Quick (2001) suggests that syntaxin 
1A mediates the redistribution of GAT-1 on a time scale important for the rapid 
regulation of extracellular GABA levels. It appears that several portions of the syntaxin 
1A molecule are required for the trafficking of GAT-1, suggesting that the trafficking of 
GAT-1 will be subject to regulatory control by many molecules known to interact with 
various domains of syntaxin 1A.
Although the mechanism has not been revealed, inhibitors of tyrosine kinases 
have been shown to decrease GABA uptake while inhibitors of tyrosine phosphatases 
have been shown to increase GABA uptake. The decrease in uptake seen with tyrosine 
kinase inhibitors is correlated with a decrease in tyrosine phosphorylation of GAT-1 
resulting in a redistribution of the transporter from the cell surface to intracellular
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locations (Law et al., 2000). Law et al. (2000) also notes that PKC activation effects 
were additive to the effects of tyrosine kinase inhibitors suggesting that multiple 
signaling pathways control transporter redistribution. Together, the above studies support 
the hypothesis that transporter expression and function is controlled by the interplay of
9 4 -multiple cell signaling cascades. Given the importance of Ca , in all cell signaling 
pathways, it is not surprising that studies also indicate that the GABA transporter is
9  4-regulated by low Ca concentration (pM) (Goncalves et al., 1997)
The extracellular signal that activates intracellular signaling cascades is not 
known but studies by Bernstein and Quick (1999) have reported that extracellular GABA 
regulates GAT-1 by increasing transporter expression in the plasma membrane.
Bernstein and Quick (1999) posit a feedback mechanism in which transporter function is 
modulated by extracellular GABA concentration. They observe that functional 
modulation of GABA transport is correlated with the number of active surface 
transporters. They show that transporter surface expression increases with extracellular 
GABA concentration on a time scale of minutes and is due to a net change in the rate of 
transporter internalization. One possible mechanism suggested is that substrate transport 
alters the interaction of GABA transporters with SNARE proteins that otherwise would 
act to sequester the transporter in a non-functional state.
The possible role of hormones in regulating the GABA transporter is suggested by 
evidence that insulin and adrenal and gonadal steroid hormones may regulate the 
synthesis and activity of the transporters (Figlewicz, 1999). A series of experiments, 
conducted by Herbison et al. (1995), examined the effects of ovariectomy on cellular 
GAT-1 mRNA content. A 25% decrease in GAT-1 mRNA expression was detected
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within the medial preoptic area (MPOA) and estrogen replacement for 7 days replaced 
GAT-1 mRNA content of MPOA cells to level observed in intact rats. Herbison et al.
(1995) concluded that the presence of a putative estrogen response element in the GAT-1 
gene and the effects demonstrated in their work on GAT-1 mRNA content and GAT-1 
activity indicate that estrogen may influence GAT-1 gene transcription to alter GABA 
transporter function within the MPOA.
Genomic Structure and Regulatory Elements of GABA Transporters 
GAT Gene Structure
The whole GAT-1 GABA transporter gene has been cloned only in mouse and 
human. Liu et al. (1992) reported cloning and sequencing the genomic and cDNA clones 
of the mouse GABA transporter GABATMG (GenBank accession No. M92377). Their 
analysis indicates that the genomic clone contains 12 introns of various sizes including 
one intron prior to the initiating methionine. The second intron comes immediately after 
a sequence of amino acids that is highly conserved among neurotransmitter transporters. 
The introns are located in hydrophilic amino acid sequences in the coding sequence while 
each transmembrane helix of the protein is contained in a single, separate exon.
When compared to the genomic sequences of five other neurotransmitter 
transporter clones (in mouse), they found that the position of the first intron with respect 
to the coding sequence starts at an identical position in the DNA and amino acid 
sequences of these clones. This same result occurred when GABATMG was compared 
to a homologous Drosophila sequence retrieved from GenBank. The authors posit that
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the location of the first intron in the most conserved region of the gene suggests that it 
has a specific function in expression of the transporter genes.
In 1997, Fei et al. reported cloning the GAT-1 protein (designated as 
MGABAT-G) in mouse. The 39 kb insert contained the whole coding region of GAT-1 
and 5'-proximal sequence. The 5' proximal region and intron 1 were sequenced and 
analyzed. Comparison with the GAT-1 gene in human showed low homology in these 
regions except for some short conserved sequences. It was found that the gene could be 
transcribed from multiple starting points (-1077, -1057 and -1054). No TATA box and 
CCAAT site were apparent in the typical location (25-30 bp upstream of transcription 
start), but there were two short GC-rich regions before the transcription site (TATA-box- 
less genes may use GC-rich or AT-rich region as their promoter [Teijiro et al., 1994]). 
Within the first intron, a TATA box sequence starting from -398, CCAAT sites at -423 
and two potential transcription starting sites at -372 and -366, several SP1 sites and 
cAMP-responsive elements (CREs) upstream of the TATA box were identified.
Together, these elements may form a potential promoter regulated by cAMP. The 
transcript from this promoter still codes the entire GAT-1 protein.
In recent work by Ping et al. (2001), GAT-1 transcriptional starting sites in 
neonatal mouse cerebral cortex and intestine, adult mouse brain and adults rat testis were 
determined from genomic fragments obtained by 5' rapid amplification of cDNA end 
(RACE). Transcription start sites in neonatal mouse cerebral cortex and adult mouse 
brain are the same (inside of exon 1), 12 base pairs downstream of published mouse 
GAT-1 cDNA sequence. In Day 3 mouse intestine, the GAT-1 transcription start site is 
in intron 1, 1628 bp upstream of exon 2. Intron 1 is 2783 bp in size with typical splice
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site coding of gt (5' splice donor) and ag (3' splice acceptor). In rat testis, the transcript of 
GAT-1 has an additional untranslated exon 5' of the transcription start site. The 12 
nucleotides at the 5' prime terminal of the published mouse GAT-1 cDNA sequence were 
not found in the 1121 bp fragment obtained from rat genomic DNA.
In 1993, Lam et al. screened a human lymphocyte genomic library with a cDNA 
encoding the human GAT-1 GABA transporter (pGAT-1). A positive clone (pHGAT) 
harboring the whole gene (35 kb) was obtained utilizing the genomic "walking" 
technique. Consistent with the general structure of GABA transporters, the gene encodes 
a 12 transmembrane transporter protein with each of the transmembrane domains 
encoded by separate exons (intron-exon boundaries always occur in hydrophilic loops).
In contrast to the mouse gene, which contains 12 introns, the human genomic clone 
contains 15 introns, including two introns prior to the initiator methionine in exon 3 (note 
that Cai et al, 1998, reports a 37 bp sequence in the 5' flanking region that is conserved 
between human and mouse GAT-1 genes). With the exception of some intron 
sequences, Lam et al. (1993) reports the full sequence of the human GABA transporter 
gene including a potential promoter region. The study does not analyze structural 
features of the upstream regulatory region. In 1995, Huang et al. conducted in situ 
hybridization mapping with the GAT-1 gene cloned by Lam et al. (1993) and named 
GABATHG in this study. They reported that the GABATHG locus is at chromosome 
3p24-p25.
In 1995, Takenaka et al. reported cloning the BGT-1 gene in canines. The 28 kb 
gene consists of 18 exons. Although BGT-1 is not expressed in brain, it is interesting that 
this genomic analysis showed that the BGT-1 gene has three alternative promoters
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producing three different 5' end motifs with alternative splicing yielding at least eight 
kinds of mRNA. Alternative splicing was also posited as the mechanism to generate 
multiple transcripts from a single gene in Drosophila (Neckameyer and Cooper, 1998). 
Gene Regulation
The complex role of neurotransmitter transporters is a function of their 
distribution in tissue which is regulated by their gene expression in the nervous system.
So the study of their gene expression regulation is important in understanding their 
functions in the nervous system. Aside from describing potential cis-acting regulatory 
elements of GABA transporter genes, little work has been done to understand gene 
regulation. Two similar studies reported by the same group (Fei et al., 1997 and Cai et 
al., 1998) describe gel-shift assays conducted to study interactions of the mouse GABA 
transporter gene (GAT-1) with nuclear proteins of various tissues.
Those studies identified nuclear protein factors from non-nervous tissues that 
specifically recognized the conserved 37 bp sequence in the 5' flanking region of GAT-1 
genes. Similar nuclear protein factors were also found to exist in rat, rabbit and pig. 
Because these protein factors were absent in nuclear extract from the brain, where GAT-1 
is specially expressed, these factors may play a negative role (i.e., acting on a silencer 
sequence) in the regulation of GAT-1 gene expression in liver and kidney. Conversely, 
the authors report that a different region can be bound specifically by nuclear proteins 
from brain, liver, and kidney, but at least one of these factors from brain was not present 
in those from liver and kidney. Thus, nuclear proteins from brain may bind to this region 
to play a positive role (i.e., acting on an enhancer sequence) in the regulation of the gene 
expression.
31
Somewhat relatedly, Andre et al. (1993) reported studies in S. cervisiae that 
focused on the UGA4 GABA transporter gene which shows limited homology to 
mammalian transporters. The study reports that the induction of UGA4 requires the 
integrity of two proteins (i.e., inducer-specific factor UGA3 and pleiotropic factor 
UGA35/DURL/DAL81) at the 5' flanking region and that in the absence of the 
pleiotropic repressor (UGA43/DAL80), UGA4 is constitutively expressed at high levels. 
In two other separate studies, both UGA3 and UGA35 were found to have sequence 
similarities to other regulatory fungal proteins involved in DNA binding and 
transcriptional activation (Andre, 1990, and Coomaert et al., 1991, respectively).
Nervous System Development in Xenopus laevis 
General Development
A  summary o f embryonic development in Xenopus is provided in Slack (2001). 
Based on the numerical stage series of Nieuwkoop and Faber (1967), the initial stages of 
Xenopus development up to the general body plan are completed by stage 20, 
approximately 24 hour after fertilization (24°C). These stages comprise cleavage, 
gastrulation, and neurulation. Maturation of the unfertilized egg produces an animal- 
vegetal polarity. The sperm enters the animal hemisphere at fertilization stimulating a 
reorganization of egg contents by cortical rotation (approximately 30°). Internally, a 
dorsal determinant is moved from the vegetal pole to the dorsal side, leading to 
demarcation of future dorsal tissues opposite the site of sperm entry and establishment of 
the dorsal-ventral (D-V) axis.
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The first three cleavages separate the prospective dorsal and ventral halves and 
then the animal and vegetal halves. As cleavage proceeds, the blastocoel, a cavity in the 
center of the animal hemisphere, forms. After 12 divisions (over 4000 cells), the mid- 
blastula transition (MBT) occurs and transcription by the zygotic genome begins. With 
the initiation of zygotic transcription, it is possible to characterize cell fates by in situ 
hybridization for specific transcription factors that are required to activate tissue-specific 
genes. For example, transcription factor genes including siamois, goosecoid, not and • 
liml characterize the dorsal sector forming the organizer region (i.e., Spemann’s 
organizer).
Gastrulation establishes the three-layer structure o f an animal body comprising 
inner endoderm, the middle mesoderm and the outer ectoderm through a series of 
morphogenic movements. As described in Slack (2001) these movements include:
• Spreading: The animal hemisphere covers the whole embryo surface.
• Invagination: A pigmented depression in the dorsal vegetal quadrant
develops into the dorsal lip of the blastopore through which 
tissue invaginates. The blastopore is first elongated, but 
eventually the blastopore forms a complete circle with the 
ventral part forming the ventral lip. Invagination of the 
marginal zone is more extensive on the dorsal side relative 
to the ventral side. The cavity formed by invagination, the 
archenteron, expands and the blastocoel contracts. As a 
result of invagination, the yolky vegetal tissues become a 
mass of endoderm is inside the blastocoel.
Involution: During invagination, the prospective mesoderm separates
from the endoderm and involutes to form a separate layer 
between the endoderm and the ectoderm.
Elongation: The process of cellular intercalation (convergent extension)
in all three germ layers allows the elongation of the dorsal 
axial mesoderm in the anterioposterior (A-P) direction, thus 
lengthening the body.
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Expansion: The ventrolateral mesoderm expands toward the dorsal
midline, thus widening the body.
At the end of gastrulation (about stage 12/13), the embryo has rotated and the dorsal side
is uppermost. The A-P axis is identified by the residual blastopore which marks the
posterior region.
During neurulation, cellular intercalation continues to drive elongation with the 
whole trunk and tail region derived from the posterior sector of the neurula. By tailbud 
stage (about stage 30), all the major body parts are in place. Structurally, the nervous 
system develops from the dorsal ectoderm. The neural plate develops into the neural tube 
by stage 21 through the successive rise and convergence of neural folds. A layer of 
ectoderm originating beyond the folds covers the neural tube and becomes the epidermis. 
Tissue from the folds lying dorsal of the neural tube below the epidermis forms the neural 
crest. The neural crest forms several tissue types including most of the skeletal tissues of 
the skull and the dorsal root ganglia, sympathetic ganglia and parasympathetic ganglia of 
the trunk. The anterior portion of the neural tube forms three vesicles in the head that 
develop into the forebrain, midbrain and hindbrain. The posterior portion of the neural 
tube is long, narrow and gives rise to the portion of the nervous system posterior to the 
mid brain. Local thickening of the epidermis forms the nasal, lens and otic placodes from 
which the axons of the olfactory nerves, eye lens and ears originate, respectively. The 
eyes develop as outgrowths of the optic lobes in the forebrain. In general, all parts of the 
brain are developed by stage 53 with subsequent development consisting mainly of 
growth and additional cytological differentiation.
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Modem fate maps published by Dale and Slack, (1987) and Slack and Tannahill 
(1992) depict in a prospective way both the morphogenetic movements and the fates in 
terms of cell differentiation for each region of an embryo over the course of normal 
development. Regions destined for neural, muscle and endoderm fates can be discerned. 
Additionally, the notochord and adjacent somites are known to arise in normal 
development from the dorsal marginal zone (i.e., the organizer). However, the high 
degree of cellular intercalation which provides the driving force for the extreme A-P 
extension produces extensive cellular mixing and means that there cannot be a detailed 
mosaic of regions committed to particular A-P levels on a pregastrulation fate map.
The Use o f  Explants
Experimentation on explanted tissue (explants) is particularly useful in studies of 
signaling molecules and signaling mechanisms. In general, explants are tissue samples, 
removed from a developing embryo at a specified stage, that represent part or all of a 
specified presumptive structure (e.g., neural plate). Explants are cultured separately and 
assayed for the gene of interest typically using in situ hybridization or RT-PCR methods.
Keller explants are tissue samples of dorsal mesoderm and ectoderm, removed by 
microsurgery before mesodermal involution and therefore prior to any vertical 
interactions. They are cultured flat throughout gastrulation and neurulation. Extensive 
experiments have shown that vertical interactions do not occur in these explants, thus, 
they are useful to test the activity of planar signals. Examples include the Doniach 
(1992) work described above and work by Saha et al. (1997) that used Keller explants to 
show that direct mesodermal contact is both necessary and sufficient for the initial 
induction of xHB9 in the motor neuron region.
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Another type of experiment involves the activity of vertical signals by comparison 
of isolated germ layer explants with explants of multiple germ layers in their naturally 
apposed state. For example, Horb and Slack (2001) isolated endoderm from neurula and 
tail bud stages to show it remains fully viable but will not express markers of regional 
specification or differentiation. When mesoderm was present, regional markers were 
expressed indicating that vertical signals were necessary to correctly pattern the embryo.
A third type of experiment involves recombination of explant tissues to assess 
multiple molecular signals or the change in molecular signaling across different regions 
of the same tissue. For example, Ang et al. (1994) used explant recombination assays, to 
demonstrate in mouse that expression of the Engrailed (En) genes, En-1 and En-2, in the 
future midbrain and anterior hindbrain regions required a positive inductive signal from 
underlying anterior mesendoderm in the headfold stage embryo and a negative signal 
from the later-forming posterior mesendoderm was required to represses Otx2 expression 
in the posterior part of the embryo.
Neural Induction and Patterning
During gastrulation the neural plate is induced from ectoderm under the influence 
of Spemann’s organizer by the secretion of factors that inhibit the action of bone 
morphogenetic proteins (BMPs). BMP-4, a TGF-® family molecule is a strong 
ventralizing factor of mesoderm and is expressed widely in frog gastrulae, except for the 
organizer and dorsal animal cap regions where the neural plate forms. Noggin (Smith 
and Harland, 1992, Lamb et al., 1993), chordin (Sasai et al., 1994, 1995), and follistatin 
(Hemmati-Brivanlou et al., 1994) induce neural tissues. Additionally, these secretory 
proteins function by binding to, and inhibiting, ventral BMPs, in particular BMP-4.
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Thus, neural induction is the dorsalization of ectoderm, in which low levels of BMP-
signaling result in CNS formation. High levels of BMP-signaling ventralize the ectoderm 
%
and epidermis is formed. Neural induction also involves modifiers of neural patterning 
such as Xotch, dorsalinl, hedgehog (Kessler and Melton, 1994).
The organizer not only induces neural tissues, but patterns them. Extensive D/V 
patterning is evident in the developing neural plate suggesting that D/V patterning and 
neural induction share common molecular mechanisms. The notochord is a major 
derivative of Spemann’s organizer and has a central role in establishment of D-V polarity 
of the vertebrate neural tube through secretory proteins such as Sonic hedgehog (Saha et 
al., 1997, Sasai and DeRoberts, 1997). The notochord controls the generation of ventral 
cell types and is the source of two inductive signals in the midline neural late cells: a 
local signal that induces floor plate differentiation and a long range signal that induces 
motor neurons (Tanabe and Jessell, 1996).
The A-P pattern also develops during gastrulation although it is initiated 
somewhat later than D-V patterning. Two routes for inductive signaling have been 
proposed: appositional (vertical) induction in which involuting chordamesoderm 
(presumptive notochord) may vertically signal overlying ectoderm and tangential (planar 
or horizontal) induction in which mesodermal organizer signals travel horizontally within 
the plane of the ectoderm (Papalopulu and Kintner, 1992, Kessler and Melton, 1994,
Sasai and DeRoberts, 1997).
Using Keller explants, some studies have shown that planar signals are necessary 
and sufficient for expression of position-specific neural markers in their correct A-P order 
(Doniach, 1992; Kessler and Melton, 1994; Ruiz I Altaba, 1994). Doniach proposed six
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possible mechanisms for planar induction of the A-P axis: (1) inducer-formed 
concentration gradient with high levels inducing a posterior pattern and low levels 
inducing an anterior pattern; (2) a prepattem laid out in the ectoderm before induction for 
which the inducer is permissive; (3) an ectodermal competence model in which the 
inducer spreads laterally through the neuroectoderm at a certain velocity and the 
ectodermal competence changes with time, producing a series of different responses; (4) 
a timing gradient in which the duration of planar contact determines the A-P pattern; (5) a 
phase-shift model in which two signals propagate at different velocities through the 
ectoderm and the time interval between receipt of the signals at each location determines 
the A-P specification; and (6) self organization as the result of cell-cell interactions 
within the ectoderm after it has received signals from the mesoderm that specify polarity 
and stimulate general neural development.
There is also evidence that vertical signals can induce A-P pattern. Nieuwkoop 
and his colleagues favor a two-step process consisting of (1) an initial activation which 
without further stimulus will lead to forebrain and later transformation and (2) a 
transformation step in which further stimulus induces more posterior structures. Three 
candidate molecules for posterior specification are retinoic acid and the secreted protein 
factors, FGFs and Wnts. Nieuwkoop and Koster (1995) have argued that in Xenopus, 
planar induction can account for the transformation signal, but not for the initial neural 
induction, thus planar signals are not sufficient to direct the formation of the neural plate 
to correct A-P specification.
In the pre-molecular model (Slack and Tannahill, 1992), the Xenopus organizer 
initially has a posterior specification. It is formed at the blastula stage in response to a
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DV signal from the dorsovegetal blastomeres. The first cohorts of cells to involute 
acquire an extreme anterior specification, and progressively later cohorts acquire 
progressively less anterior codings. The surrounding ectoderm begins to become 
regionalized in response to signals emitted from the endo-mesodermal axis. The neural 
plate is formed and regionalized according to the A-P codings of the underlying 
mesoderm. Further pattern complexity arises through a gradient-like signal emitted from 
the posterior and transmitted in the plane of the neural plate.
Neuron Phenotype and Growth
The neural plate is built of undifferentiated, mitotically active cells. The progeny 
of most of these cells become postmitotic and differentiate into neurons and glia 
(Hartenstein, 1989). Three rows of neurons form at this stage: a row of motomeurons is 
formed next to the floor plate, intemeurons appear in the intermediate region, and large 
Rohon-Beard neurons are bom in the neural crest and flanking ectoderm of the spinal 
cord region (Sasai and DeRoberts, 1997). During later embryonic stages (25-35/36), the 
first neurons withdraw from the apical (now ependymal) surface and differentiate. They 
are the primary sensory neurons and primary motomeurons. Roberts and Clarke (1982) 
described nine differentiated spinal cord neuron classes. These include the Rohon-Beard 
cells and extramedullary cells which are both primary sensory neurons, one class of 
motomeurons that innervate the segmental myotomes, two classes of intemeurons with 
ipsilateral axons, and a previously undescribed class of ciliated ependymal cells with 
axons projecting ipsilaterally to the brain.
Neurons and glia which have withdrawn from the mitotic cycle form a 
differentiated circuit which controls early larval behavior. Over the larval period, the
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remaining, still undifferentiated, proliferating precursors produce the majority of cells 
found in the adult CNS. The axons of CNS neurons grow out and innervate their targets 
through several mechanisms that control the specificity of connections. At the tip of each 
developing axon is a growth cone possessing filopodia (elongating and retracting 
microfilament probes) that locally receive, process and react to information from their 
environment thus functioning to aid in the navigational and pathfmding roles. Only the 
pioneering growth cones, which first establish a path to the appropriate target, possess 
multiple filopodia. One way by which filopodia can be regulated is through the second 
messenger calcium (i.e., an increase in Ca+ can cause filopodial elongation). Membrane 
constituents (membrane proteins) present in filopodial membrane include 
neurotransmitter receptors, integrins, and molecules involved in maintaining calcium 
homeostasis (Rehder and Kater, 1996). The calcium level within filopodia also can be 
altered by contacts with defined ligands. Upon arrival at the growth cone proper, the 
signal, either in the form of an activated enzyme or another intermediate, likely activates 
specific targets.
Development o f  GABAergic Neurons
The GABAergic phenotype comprises several separate components, including 
the biosynthetic enzyme glutamic acid decarboxylase (GAD), the degradative enzyme 
GABA transaminase (GABA-T), and the high affinity GABA uptake system (i.e., GABA 
transporter). In rat, development of enzymatic activity lags far behind the uptake of 
GABA, which may indicate that GABA neurons are less metabolically active prior to 
birth than postnatally.
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The GABA system has been found to differentiate very early relative to other 
transmitter-identified neurons (Lauder et al., 1986). At stages 35/36 in Xenopus laevis, 
Barale et al. (1996) observed GABA-positive neurons throughout the proencephalon 
forming two main bilateral clusters within the lateral walls of the forebrain that ran 
caudally toward the hindbrain. Roberts et al. (1987) observed GABA-positive neurons in 
the hindbrain and the midbrain by stage 25.
Several studies indicate that the capability for GABA accumulation develops 
before phenotype maturation. Holyfield et al. (1979) showed that neuronal uptake of 
GABA precedes GABA synthesis in horizontal cells of the retina of Xenopus. Lam et al. 
(1980) demonstrated a mechanism for GABA uptake by neurons in the rabbit retina 
before they contain appreciable levels of GABA and GAD. Lamborghini and lies (1985) 
found intemeurons in the Xenopus embryo spinal cord that originated at the end of 
gastmlation and developed GABA uptake systems at the early tailbud stage (stage 24).
Maturation of the GABAergic phenotype appears to proceed in at least two steps. 
Experiments have shown that a GABA high-affmity uptake system develops when cells 
are dissociated and grown in culture, thus indicating that the early developmental 
program of these neurons, does not require cell-cell interaction. Kentroti and Vemadakis 
(1992) found that neuronal phenotypes inhabit specific CNS areas from early primordial 
stages of development and suggest that these GABAergic precursor neuroblasts 
differentiate at a later embryonic age and that specific regional factors may play a role in 
neuronal distribution and the rate of maturation. Other studies (Lamborghini and lies, 
1985) indicate that while calcium flux and neurotransmitter release are not necessary for
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the initial events in synapse formation, they may be involved in further maturation of 
synapses.
GABAergic signals at Cl" channels or involving Ca2+ fluctuations across the cell 
membrane could serve to differentiate embryonic CNS cells into those that persist as 
GABAergic neurons from those that cease being GABAergic. In electrogenic 
experiments by Barker et al. (1998), the Ca2+ responses to GABA disappeared during the 
same period as the polarity of the GABAergic potential response became hyperpolarizing 
with respect to the cell’s resting potential. Ganguly et al. (2001) report that the properties 
of depolarization-induced Ca influx can be altered by GABAergic activity. The level of 
depolarizing GABAergic activity determines the rate of transformation of neuronal 
GABAergic responses, thus, GABA acts as a self-limiting trophic factor during neural 
development.
Early in develop, transmitters function to a large extent in the absence of 
synapses. The specificity of neurotransmitter input may be influenced by the number, 
type and cellular distribution of receptors. For example, the interaction of GABA and 
GABAa receptors influences the development of the GABAergic phenotype. GABAa 
receptors on potential post-synaptic target cells develop in approximate spatiotemporal 
coincidence with GABAergic neurons and axons (Cobas et al., 1991, Schlumpf et al., 
1989), suggesting that GABA may modulate expression of these receptors. Alternatively, 
the presence of concentration gradients of neurotransmitter agents (i.e., GABA) may help 
define specific microenvironments and provide chemical cues for growth and 
differentiation within limited spatial domains (Redbum and Rowe-Rendleman, 1996). 
Gupta et al. (2000) suggest that other signals from the target neuron must be present
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because the same GABAergic axon can form distinct types of synapses onto different 
classes of target neurons. They propose that GABAergic neurons are able to detect 
functionally related neurons, even of different phenotypic classes.
The GABAergic System in Neural Development
While the following review focuses on neural development, it is worth noting that 
at least one study suggests a non-neural role for GABA transporters specifically in 
development. Jursky and Nelson (1999) report the presence, albeit in late embryonic 
development, of the GAT-2 (mouse homologue GAT3) transporter in hippocampal blood 
vessels. They posit that this transporter may have some nutritional or somatic function in 
these non-neural cells. Additionally, the presence of GAT-2 transporter in the border 
between epithelial cells in the mouse kidney may suggest its involvement in tight 
junction regulation.
GABA in Fetal Versus Adult Stages
There are several differences in the character and location of GABAergic 
components between adult and embryonic/neonatal organisms. Cherubini et al. (1991) 
cites four differences between adult and neonatal GABA electrogenic responses: (1) 
while GABA in the adult hyperpolarizes the neuronal membrane, in neonatal neurons, 
GABA is often depolarizing; (2) the effects of GABA are enhanced in neonatal neurons 
where GABA currents show little desensitization; (3) GABA currents in neonatal neurons 
are almost linearly related to membrane potential; and (4) GABA currents are potentiated 
by barbiturates but are insensitive to benzodiazapenes in neonatal neurons.
43
Several studies have demonstrated differences in the abundance of GABAergic 
components. In an early study, Roberts et al. (1958) compared the GABA content in 
extracts of brain obtained from a 16-day fetal mouse, one-day old mouse and adult mice, 
showing that GABA levels increased progressively with age only up to approximately 30 
days after birth. Liu et al. (1993) reported that mRNA for the mouse homologue of GAT- 
2 (GAT3) is more abundant in the neonatal than in the adult mouse brain. Blakely et al. 
(1991) showed in transport studies that the abundance of GABA uptake systems 
exceeded adult levels in the brainstem by postnatal day P10.
There are also differences in the expression patterns of GABAergic components 
between fetal and adults stages. For example, the mouse homologue of GAT-2 (GAT3) 
appears initially in somata and primary processes ofP7-21 astrocytes, and is later 
identified in distal processes in the adult (Yan and Ribak, 1998). Expression patterns of 
GAT-1 and GAT-2 mRNAs in immature granule cells were quite distinct from those in 
adulthood (Kawamoto et al., 2001). Huang and Moody (1998) observe that DA- and 
GABA-immunoreactive cells comprise completely separate populations in adult 
Xenopus, but in the early tadpole retina DA and GABA coexist in amacrine cells. 
GABAergic Components in General CNS Maturation
In addition to differences between fetal and adult expression patterns, there are 
several examples of transient and modulated expression of GABAergic components prior 
to adulthood, further suggesting a specific role during development. For example, Jursky 
and Nelson (1999) report that in the early developmental stages of rat, GAT-3 was 
localized to the meninges where two other GABA transporters, GAT-1 and GAT-4, were 
adjacently expressed. In later developmental stage, only GAT-3 remained in this area.
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Frahm and Draguhn (2001) report a significant reorganization of the GABAergic system 
in the rat hippocampus during the first weeks of postnatal development. In situ 
hybridization studies, staining GAD and GAT-1 mDNA, showed largely similar 
distribution and numbers of intemeurons expressing these transcripts, however, there 
were significant mismatches in certain subregions (e.g., stratum moleculare at P I6 and 
adult granule cell layer). These mismatches suggest a specific regional and growth 
pattern due to selective regulation of the two genes.
There also appears to be general coincidence between the appearance of 
GABAergic components and the start of various CNS developmental actions. Roberts et 
al. (1987) report that the first neurons showing GABA-like immunoreactivity in Xenopus 
CNS appeared in the hindbrain at stage 25, the time at which they initiate outgrowth of 
processes. This is also true for GABA in the cerebrospinal fluid contracting neurons. 
Transmitter synthesis therefore coincides with the start of morphological differentiation 
of processes. Barker et al. (1998) describe dramatic changes in GAD family transcript 
abundance during the embryonic and postnatal periods in mouse brain, rat spinal cord and 
rat hippocampus in which a perinatal decline in global GAD expression coincides with 
the end of neurogenesis. Das and Ray (1996) monitored the levels of the GABA 
synthesizing enzyme, GAD, and two GABA degrading enzymes, GABA-T and SSADH, 
during human pregnancy. They found maximal enzyme activities during the mid-period 
of the third trimester. They speculate that the progressive enhancement of activities of 
the three key enzymes up to the third trimester is perhaps due to a high GABA synthesis 
and reflects the utilization of GABA for brain growth as well as establishment of 
GABAergic system during fetal development.
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An Excitatory Role for GABA
In the normal adult, the GABA system transmits an inhibitory signal by 
hyperpolarizing the post-synaptic cell. However, an excitatory response by 
depolarization has been found to occur in primary neuronal cultures from the developing 
hypothalamus (Obrietan and van den Pol, 1995), hippocampus (Cherubini et al., 1990, 
Ben-Ari et al., 1997), neocortex (Fukuda et al., 1998), thalamus (Ikeda et al., 1997), 
cerebellum (Obata, 1997), and spinal cord (Rohrbough and Spitzer, 1996). In fact,
GABA acting on GABAa receptors provides most of the excitatory drive during the early 
prenatal period, while glutamatergic synapses, which produce the major excitatory 
responses in adults, are still quiescent (e.g., at birth, only GABAergic current can be 
detected in rats [Leinekugel et al., 1999]). The depolarization elevates intracellular 
calcium, thus influencing several aspects of neuronal development (described below).
Whether GABAergic transmission is excitatory or inhibitory is determined 
primarily by the electrochemical gradient for Cl", which depends on the intra- and 
extracellular concentrations of Cl". The Cl" gradient may be modulated directly by 
GABA interaction with Cl" transporters such as the GABAa receptors or KCC2 (a K+C1‘ 
co-transporter whose expression correlates with the developmental switch of GABAergic 
neurons to inhibitory) or indirectly by activation of GABAb receptors coupled to K+ 
channels). To the extent that GABAa receptors play a role, it is unclear whether the 
depolarization of the axon comes from receptors on the axons themselves or from the 
activation of glial receptors, resulting in a net outward movement of K+ from the glia, 
which in turn could depolarize the axons. The role of the multi-subunit GABAa receptor
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is not well understood, but it is known that changes in structure or assembly of different 
subunits may determine developmental modifications in function (Cherubini et al., 1991).
The depolarization state of a neuron or its axon affects calcium influx and thus is 
likely to have unique significance during development. Transporters may be crucial for 
releasing GABA during these early stages through the well known mechanism of 
calcium-independent release of GABA mediated by a reversal of the GABA transporter 
(Evans, et al., 1996). Apart from the effects on neuronal development, a few studies have 
shown a role for excitatory GABA responses in other developing systems. Perrot-Sinal et 
al. (2001) showed that GABA is excitatory during the sensitive period of steroid- 
mediated brain sexual differentiation (in rat) and that estradiol treatment maintained 
excitatory GABA. They suggest that estradiol may mediate sexual differentiation by 
enhancing GABA-induced increases in intracellular Ca2+.
Neurotrophic Capabilities
The neurotrophic effects of GABA, including the migration and motility of 
primary neurons, subsequent neurite outgrowth and neuronal survival have been 
demonstrated in several studies (Michler, 1990, Cherubini et al., 1991, Ma et al., 1992, 
Barbin et al., 1993, Wolff et al., 1993, Staley et al., 1995, Behar et al., 1995, Ikeda et al., 
1997, Obata, 1997). Early studies demonstrated that, in rat spinal cord, the early 
presence of GABA coincides with the period of axon outgrowth, and GABA or GABA 
uptake mechanisms are present in the axons of rats, rabbits, and fish during the time the 
axons are growing toward central targets. In chick tectal neurons and rat cortical neurons 
axon growth was stimulated by exogenous GABA. Lauder et al. (1986) observed that 
several populations of transmitter-identified neurons appear soon after GABAergic fibers
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pass through these regions and they posit that GABAergic neurons may exert trophic 
influences on later developing neuronal populations. They found that GAD 
immunoreactivity is present in growth cones of GABAergic neurons in the developing 
cerebellum. Thus, a trophic influence may be exerted by the spontaneous release of 
GABA from these growth cones.
In studies of neuronal migration during rat cortical development, Behar et al.
(1996) determined that GABA stimulated neuronal migration in vitro at embryonic stage 
E l5. From E l6 onward, two concentration ranges (fM and pM) induced motility. 
Femtomolar GABA primarily stimulated chemotaxis (migration along a chemical 
gradient) with neuronal cells in the germinal zones and along migration pathways 
expressing receptor subunit transcripts. Micromolar GABA predominantly initiated 
chemokinesis (increased random movement) through activation of fully formed GABAa 
receptors. Studies by Fueshko et al. (1998) of the migration of luteinizing hormone- 
releasing hormone (LHRH) neurons suggests that GABAergic activity in the nasal region 
acts as an embryonic “stop signal”, regulating LHRH cell entrance into the CNS. LHRH 
neuron migration is inhibited in the presence of GABA by activation of GABAa 
receptors on the embryonic LHRH neurons.
Much of the trophic effect of GABAergic neurons is associated with intracellular 
calcium concentration and associated phosphorylation activity. Intracellular calcium 
concentration correlates with growth cone motility and morphology, and calcium 
mediates protein phosphorylation in the growth cone (Sandell, 1998). Ikeda et al.
(1997) found that protein kinases play an important role in the trophic effect of GABA on 
embryonic striatal neurons. Two pathways for activation of tyrosine kinase include direct
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Ca2+-dependent activation and Ca2+-enhanced expression of neurotrophic factors (e.g., 
GABA) which in turn activate their receptors (e.g., GABAa receptor) associated with 
tyrosine kinases. Ikeda et al. (1997) report that expression of brain-derived neurotrophic 
factor (BDNF) is enhanced by GABAa receptor activation in immature rat hippocampal 
neurons.
Additional evidence of the influence of GABA receptors is provided in 
pharmacological experiments. Trophic effects of GABA are mimicked by GABAa 
receptor agonists and are blocked by GABAa receptor antagonists, suggesting that these 
effects are mediated via GABAa receptors. For example, in the presence of GABAa 
receptor antagonists (e.g., bicuculline), neurons display a reduction in the number of 
primary neurites and branching points (Barbin et al., 1993). Spontaneous depolarizing 
potentials mediated by GABA (probably released from growth cone axons) interaction 
with GABAa receptors may provide the calcium influx necessary for the morphological 
development of neurons at an early developmental stage when excitatory connections are 
poorly developed.
The termination of growth in proliferative zones also appears to be regulated in 
part by GABA levels. Barker et al. (1998) reported a decrease in proliferative activity in 
embryonic cortical explants coinciding with the progressive appearance of more 
widespread GABAergic cell bodies and processes, as well as GABAa receptors. 
Physiological levels of micromolar GABA accumulating in proliferative zones appear to 
signal an end to neurogenesis by activating GABAa receptor/Cl- channels with a 
resultant excess or self-limiting, intense entry of Ca2+ into cells.
Neuronal survival is, in general, enhanced by the various trophic effects of
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GABAergic neurons described above. More directly, Ikeda et al. (1997) showed that 
chronic exposure of dissociated cultures of striatal neurons to GABA resulted in a 
significant increase in the number of surviving neurons. Activation of GABAa receptors, 
not GABAb receptors, appeared to mediate this effect 
Neuronal Differentiation and Synapse Formation
Evidence that GABA and GABAa receptors are expressed in cells before they 
migrate to their final destination (Ma and Barker, 1995) suggest that GABAergic 
interaction may regulate neuronal differentiation as well as migration. As in migration, 
the complement of different receptor subunits as well as the distribution of receptors on 
neurons appears to be a key factor in differentiation.
After differentiation, the appearance of GABA transporters appears to be required 
for the onset of synaptogenesis in some regions (e.g., Rosina et al., 1999 studies of 
synaptogenesis in the basket intemeurons of Purkinje cells). In rabbit retina, GABA 
itself acts as a local guidance factor or trigger for synaptogenesis between GABAergic 
horizontal cells and target cone photoreceptors. In their study, Redbum and Rowe- 
Rendleman (1996) posit that GABA stimulation of intracellular calcium levels in 
growing tips of cone axons would cause growth cone collapse and trigger synaptogenesis 
upon encountering the neonatal outer plexiform layer.
GABAergic Components and Development o f the Eye
A  role for GABAergic components in development of the eye is evidenced by 
their early and transient expression in cells that express little or no GABA in the adult. 
Examples include GABA expression in the inner retina (Sandell, 1998), GAD67 and 
GABA levels in lens cells of rat (Barker et al., 1998) and GABAa receptors in the outer
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plexiform layer of the retina (Redbum and Rowe-Rendleman, 1996). A possible role in 
differentiation of neuronal phenotypes is suggested by the transient co-expression of DA 
and either GABA or 5-HT in amacrine cells as they migrate in establishment of local 
circuitry (Huang and Moody, 1998). Sandell (1998) describes dual mechanisms for 
GABA release, calcium-dependent vesicular release and calcium-independent release by 
reversal of GABA transporter. The latter serves to supply GABA prior to the 
establishment of vesicular synaptic transmission and thus may aid in the development of 
circuitry in the retinal inner plexiform layer and may also act on retinal ganglion cell 
axons as they form appropriate central connections.
Summary
GAT proteins have been characterized with respect to structure, pharmacology, 
localization and their role in the adult organism, but the timing of their expression during 
development has not been investigated at the protein level. That is, the timing of GAT-1 
mRNA expression is better characterized than timing in protein expression. Mechanisms 
for GABA transporter regulation have been identified at the regional level (e.g., steroid 
hormone regulation of gene transcription), the cellular level (e.g., extracellular GABA 
feedback), and the subcellular level (e.g., downregulation of GAT transport by 
intracellular signaling pathways involving PKA and PKC).
The GAT-1 gene in nervous system has been studied in only mouse and human.
In the 5’ proximal region and first intron region there is little homology between these 
two organisms except for some short conserved sequences (e.g., 37 bp intron sequence 
identified by Cai et al., 1998). In mouse, investigators have suggested that the promotor
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may be approximately 400 bp upstream of the transcription start site in a cAMP-regulated 
region containing a collection of cis-acting elements. Alternatively, the promotor may be 
a TATA-box-less GC-rich region close to the transcription start site. A comparative 
study suggested that the GAT-1 transcription start sites in adult and neonatal mouse brain 
are the same (inside exon 1), while the start site for intestinal mouse GAT-1 is in intron 1 
(between exons 1 and 2). Unlike the mouse GAT-1 gene, which contains 12 introns, the 
human, GAT-1 gene contains 15 introns including two introns prior to the transcription 
start site in exon 3. With the exception of a few gel-shift assays to study the role of 
nuclear proteins, no work has been done to assess the molecular regulation of GAT-1 
gene expression.
In studying development of the nervous system, two models for early A-P 
patterning of the embryo have emerged. Planar signals, alone, may induce expression of 
neural markers that specify the correct A-P pattern. Alternately, in a two-step process, a 
vertical signal may initiate neural induction followed by a transformation step, possibly 
by planar signals, that specifies the posterior structures.
Several lines of evidence point to a developmental role in neural systems for 
GABA and for components of the GABAergic system. These include differences 
between adult and embryonic GABA systems, correlation between the occurrence of 
GABAergic components and general CNS maturation, directly observable influences of 
the GABA and/or GABAergic components in neuronal development processes, and the 
transient occurrence of GABA and/or GABAergic components during development of 
specific sensory structures (e.g., the eye). Much of the literature reporting this evidence
52
is observational and, to date, there is little explanation about the molecular mechanisms 
directing the GABAergic components appearing in these processes.
Calcium has been shown to play a role in the maturation of synapses by regulating 
filopodia on pioneering growth cones of growing axons. Intracellular calcium increases 
have been attributed to depolarization by GABA acting on GABAa receptors. Reversal 
of GABA transport can occur in the adult under pathological conditions, suggesting that 
the stoichiometry is not fixed. GABA transporters are known to mediate calcium- 
independent release of GABA during development and transporter reversal may be the 
source of the GABA producing the excitatory response.
The earliest detection of GABA-positive neurons, by Roberts at al. (1987), is in the
t.
hindbrain and midbrain by Stage 25. The earliest detection of GABA uptake systems, by 
Lamborghini et al. (1985), is at Stage 24. Thus, GABA uptake appears to precede neuron 
phenotype maturation (i.e., GABA synthesis).
CHAPTER 2 
MATERIALS AND METHODS
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Isolation and Characterization of Genomic xGAT-1 
Isolation o f putative xGAT-1 genomic DNA
A phage plug for the putative xGAT-1 genomic DNA clone, previously generated 
in the lab (Hoke, 2000), was used as stock for the genomic DNA template used in this 
study. The genomic DNA was isolated from 300 pi of phage plug stock (approximately 
7xl07 phage particles) labeled “HA3 plaque pure genomic”. In a disposable glass tube, 
the phage stock was combined with 7 ml KW251 cells (approximately 1010 cells) that 
were prepared by first incubating 20 pi KW251 stock and 50 ml Luria Broth (LB) (1% 
Tryptone, 1% NaCl, 0.5% yeast extract, 7.5 pH) in a 37°C shaking incubator for at least 
18 hours. The cells were then pelleted in sterile oak ridge tubes by cold centrifuge at 
5000 rpm for 5 minutes. After decanting the supernatant, the cells were gently 
resuspended in 25 ml 0.1 M MgSCL and kept at 4°C until use. The glass tube was 
covered with parafilm and the bacteria/phage mixture was incubated in a 37°C shaking 
incubator for 20 minutes. The infected bacteria were added to a 1-L glass flask 
containing 440 ml NZCM media (0.1% Casitone, 0.1% Casamino acid, 0.5% NaCl, 0.2% 
anhydrous MgSCL) and incubated in a 37°C shaking incubator for approximately 10 
hours when the presence of suspended stringy material (bacterial debris) was sufficient 
to indicate completion of cell lysis. One ml chloroform was added to the culture and the 
flask was returned to the 37°C shaking incubator for 15 minutes. After incubation, 25.7 g 
NaCl (1M final concentration) and 44 g PEG (10% final concentration) were added to the
culture and the flask was shaken until the reagents dissolved completely. The flask was 
placed in a 4°C cold room overnight (approximately 13 hours).
After removal from the cold room, the contents of the flask were split between 
two centrifuge bottles and centrifuged in the HS-4 rotor at 7000 rpm for 20 minutes. The 
supernatant was gently decanted and discarded as bacterial waste. Each pellet was 
resuspended in 7 ml Solution A (0.5% Igepal, 3.6mM CaCl2, 30mM Tris pH 7.5, 5mM 
MgCl2, 125 mM KC1, 0.25% Deoxycholic acid, 6 mM P-mercaptoethanol). The 
resuspensions were transferred to two sterile Oak Ridge tubes. DNase I (25 pg/ml final 
concentration) and RNase A (60 pg/ml final concentration) were added to each tube to 
eliminate bacterial nucleic acids. The solutions were incubated at 37°C for 30 minutes. 
The solutions were extracted by adding an equal volume (7 ml) of Chloroform/Isoamyl 
alcohol (24:1) to each tube and shaking. The tubes were allowed to sit until two layers 
were formed and then the solutions were centrifuged in the HS-4 rotor at 3000 rpm for 10 
minutes. While solutions were centrifuged, glycerol gradients were prepared in two 
Beckman SW41 centrifuge tubes: 2 ml 40% glycerol in Solution B (0.5% Igepal, 30mM 
Tris pH 7.5, 125 mM KC1, 0.05mM EDTA, 6 mM p-mercaptoethanol), followed by the 
addition of 3.5 ml of 10% glycerol in Solution B by pipetting slowly down the side of the 
Beckman tube. Six ml of phage suspension (top layer of centrifuged solution) was 
layered on top of the glycerol gradient. The Beckman L8-70M ultrafuge was setup and 
the Beckman tubes, placed in ultrafuge jackets and caps, were weighed and volumes 
adjusted to balance. The gradients were ultrafuged at 35,000 rpm (20°C) for 1.4 hours. 
The supernatant was decanted off and the tubes were inverted on parafilm to dry the 
pellet. The dried pellet was resuspended in 2 ml storage medium. EDTA (20mM final
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concentration, SDS (0.5% final concentration) and proteinase K (final concentration 50 
pg/ml) were added and the solutions were incubated overnight (approximately 13 hours) 
in a 55°C water bath.
The solutions were transferred to sterile Oak Ridge tubes. An equal volume (2 
ml) of water-saturated phenol was added to each tube and the tubes were mixed by 
shaking and centrifuged in the HS-4 rotor at 10,000 rpm for 5 minutes. The aqueous 
(top) layer was removed to a sterile Oak Ridge tube using a Pasteur pipette. An equal 
volume Phenol/Chloroform (P/C) (49% Phenol, 49% Chloroform, 2% Isoamyl alcohol, 
saturated in Tris) was added and the tubes were mixed by shaking and centrifuged in the 
HS-4 rotor at 10,000 rpm for 8 minutes. The aqueous (top) layer was removed to a sterile 
Oak Ridge tube using a Pasteur pipette and an equal volume (2 ml) of 
Chloroform/Isoamyl alcohol (24:1) was added. Each solution was again mixed by 
shaking and centrifuged in the HS-4 rotor at 10,000 rpm for 8 minutes. The aqueous 
layer (containing the final phage DNA product) was transferred by Pasteur pipette to a 
sterile Corex tube and 1/10 volume 3M NaOAc and 3 volumes cold 100% ethanol were 
added to each tube and the tubes gently shaken to precipitate the DNA. A heat-sealed, 
sterile Pasteur pipette was swirled in the solution to spool the precipitated DNA and 
transfer it to a sterile microcentrifuge tube.
To salvage any DNA that was not spooled, the remaining solution in the Corex 
tube was centrifuged in the HS-4 rotor at 5,000 rpm for 10 minutes. After decanting the 
supernatant, the tube was inverted on parafilm to dry the pellet. The dried pellet was 
resuspended in 100 pi Tris-EDTA (TE) and the phage prep was stored at 4°C. The 
success of the phage prep was checked by electrophoresis of 5 ml of the phage prep
56
product on a 1.2% agarose minigel using a 15 pi aliquot of 1 Kb Plus DNA ladder 
(GibcoBRL) to provide a molecular weight standard.
Subcloning
Overview
The putative xGAT-1 genomic DNA cloned in lambda phage was digested with 
numerous restriction enzymes (Apa I, BamHI, Bgl II, Cla I, EcoRI, EcoRV, Hind III,
Kpn I, Psp Al, Pst I, Pvu II, Sac I, Sac II, Sal I, Sal 3A, Sma I, Xba I, Xho I, Xma I). 
Based on Southern Blot analysis, selected phage DNA fragments were subcloned into 
plasmid and sequenced. Preliminary sequence results confirmed that a single large 
fragment (~15 Kb), cut by Sac I, represented the entire clone (based also on the 
expectation that lambda phage will not accept an insert larger than 20 Kb). After cloning 
this fragment into plasmid, additional digests were performed to generate “Sac” 
subclones for sequencing.
Digestion o f Genomic DNA
Digest reactions were prepared by mixing 5 pi of genomic DNA with 12.5 sterile 
double distilled H2O, 2 pi 1 Ox enzyme-specific buffer, and 2-6 units restriction enzyme in 
an microcentrifuge tube. All restriction endonucleases and the restriction endonuclease 
buffers were obtained from Promega. The mixture was spun down and digested in a 
37°C heating block for 1.5-3 hours. After removing the tubes from the heating block, 6x 
glycerol-containing stop buffer was added to the reaction. The reactions were loaded into 
the wells of a 1.2% agarose mini-gel (30 ml TAE buffer, 0.36 g agarose, and 1.5 pi 
ethidium bromide, heated to boiling and then cooled in a plastic carrier that was placed in 
an electrophoresis apparatus). A 15 pi aliquot of 1 Kb Plus DNA ladder (GibcoBRL)
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that provided a molecular weight standard was also loaded into one of the wells. Bands 
were resolved by electrophoresis and visualized under UV light. The gel was 
photographed and a tracing was made on plastic film in preparation for Southern Blot 
analysis.
Probe Synthesis for Southern Blot
Due to the initial interest in isolating the promoter region of the putative xGAT-1 
genomic DNA, a probe comprising the 5' portion of the xGAT-1 cDNA, as well as a full 
xGAT-1 cDNA probe were synthesized for use in the Southern Blot analysis. The 
template for the full xGAT-1 cDNA was isolated previously in the lab (Hoke, 2000) and 
cloned into pBluescript SK+ (Stratagene). The template for the 5' portion was generated 
by PCR and ligated into pCRII (Invitrogen) (see PCR Protocol below). It comprised 
bases 5-104 of the xGAT-1 cDNA.
The insert, representing the template DNA for the probe, was excised by digestion 
and isolated with the GeneClean Kit (BIO 101) as follows. A 20 pi digest with 5 pi of 
the plasmid containing the template DNA was performed as described above (usually 
multiple digests were performed to produce more gene-cleaned product). The reaction 
was resolved by electrophoresis on a 1.2% agarose mini-gel using a 15 pi aliquot of 1 Kb 
Plus DNA ladder (GibcoBRL) to provide a molecular weight standard. The stained DNA 
bands were visualized under UV light and the band representing the insert DNA was 
carefully cut out of the gel using a razor blade. The excised band was placed in a sterile 
microcentrifuge tube and 400 pi Nal was added. The tube was floated in a 55°C water 
bath and periodically mixed until the agarose dissolved (2-5 minutes). The tube was 
removed from the water bath and 5 ml glassmilk (a proprietary silica matrix) was added.
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The solution was mixed and incubated at room temperature for 5 minutes, periodically 
remixing by finger flicking to keep the glassmilk suspended. The solution was 
centrifuged for 5 seconds at 14,000 rpm and the supernatant discarded. The pellet was 
washed with 500 pi of NEW solution (NaCl, Tris-HCl, EDTA, ethanol -  concentrations 
not specified by BIO 101), vortexed to resuspend the pellet, centrifuged for 5 seconds at 
14,000 rpm and the supernatant discarded. This wash step was repeated two more times 
and followed by a final centrifuge step to remove any residual liquid. The pellet was 
dried for 5 minutes in a SpeedVac® Plus (Savant) vacuum dryer and resuspended in 5 pi 
of sterile double distilled water, vortexing for 1 minute. The resuspension was heated for 
5 minutes in a 55°C water bath to elute the DNA and centrifuged at 14,000 rpm for 30 
seconds. The supernatant was transferred by Pasteur pipette to a sterile microcentrifuge 
tube. The elution step was repeated to produce a final gene-cleaned product of up to 10 
pi (depending on the efficiency of the transfer). To ensure no glassmilk remained, the 
final product was centrifuged for a final 30 seconds and the supernatant was transferred 
to the final sterile microcentrifuge tube. The gene-cleaned template was stored at 4°C 
until use.
The probes were synthesized by the random priming (Feinberg) method using the 
Prime-a-Gene Labeling® system (Promega). All work with radioactive reagents 
conformed to the College of William & Mary Radiation Program in compliance with 
regulations established by the Nuclear Regulatory Commission (NRC) under 10 CFR 
Parts 19, 20 and 30. Kit components were used to make two reaction mixes per probe 
with each reaction mix comprising lx  labeling buffer, 20 pM each unlabeled 
deoxyribonucleotide (adenine, guanine, thymidine), 400 pg/ml nuclease-free Bovine
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Serum Albumin and 50 pCi 32P-labeled deoxycytidine (NEN). Five ml of the gene- 
cleaned template DNA per reaction were boiled for 2 minutes in a sterile microcentrifuge 
tube, placed quickly on ice to minimize religation, and the reaction mix plus 5 units DNA 
Polymerase I, Large (Klenow) Fragment (Promega) were immediately added to the tube. 
The reaction was mixed by gentle finger-flicking and placed in a Nalgene storage box to 
incubate at room temperature for at least 4 hours.
To check the percentage incorporation after incubation, 1 pi of each reaction was 
spotted on each of two DE 81 2.4 cm filters (Whatman). The two filters were labeled 
“total” and “incorporated”. The “incorporated” filter was washed with two successive 
applications of 15 ml Na2HP04 and one application of 5 ml 70% ethanol under vacuum 
to remove unincorporated nucleotides. The “total” filter, representing total activity 
present in the mixture, remained untreated. The filters were placed in separate liquid 
scintillation vials and 3 ml ScintiSafe™ Econo I Liquid Scintillation Counter Cocktail 
(Fisher Scientific) were added to each. Disintigrations per minute (DPM) were counted 
on a Beckman LS 5000 CE Liquid Scintillation System. The “incorporated” DPM was 
divided by “total” DPM to determine the percent incorporation for each reaction.
If the percent incorporation was greater than 30%, probe synthesis continued with 
precipitation and elution of the probe reaction. The radiolabeled DNA was precipitated 
with the addition of 50 pi Tris-EDTA (TE), 200 mg salmon sperm DNA as a carrier, lA 
volume 7.5M ammonium acetate and, after mixing, 2 volumes cold 100% ethanol. The 
solution was inverted several times to mix and placed at -80°C for at least 45 minutes. 
After precipitation, the probe mix was centrifuged at 14,000 rpm at 4°C for 20 minutes. 
The supernatant was transferred to microcentrifuge tubes as a precaution against loss of
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the pellet and later disposed to radioactive waste. The pellet was transferred to a 50 ml 
centrifuge tube containing 15-40 ml (depending on the specific activity of the probe 
solution desired) of low stringency prehybridization solution (30% formamide, 1M NaCl, 
1% SDS, lOmM Tris-HCl [7.5 pH]). Approximately 300 pi of warm prehybridization 
solution was pipetted up and down to resuspend the pellet and then transfer the probe 
back to the centrifuge tube. This step was repeated until the counts in the original 
microcentrifuge tube containing the probe were close to background as measured by a 
Geiger-Muller Counter. The centrifuge tube was labeled radioactive and stored in a glass 
beaker at -20°C.
Southern Blot with Radioactive DNA Probe
Southern Blot analysis was performed on digest products of the phage genomic 
DNA to identify restriction enzymes that would produce the target genomic fragments for 
subcloning. Subsequently, Southern Blot analysis was performed on digested subclones 
to identify targets for sequencing. Probes comprising the 5' portion of the xGAT-1 
cDNA, as well as the full xGAT-1 cDNA were used for screening (see method for probe 
synthesis below). The gel was destained in a denaturant (1.5M N aC l, 0.5M NaOH) for 
30 minutes at room temperature on a Roto Mix type 50800 (Thermolyne). The gel was 
rinsed with double distilled H20, transferred to a neutralization solution (0.5 M 
ammonium acetate solution) and incubated for 30 minutes at room temperature on the 
Roto Mixer. The neutralizer was drained off and replaced with 2xSSC (0.15M NaCl,
0.015M Sodium Citrate) and incubation continued for 30 minutes on the Roto Mixer.
The gel was then set up to transfer the DNA to a transfer membrane (Magna 
Nylon Transfer Membrane or GeneScreen Plus® Hybridization Transfer Membrane) in
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the following manner. An electrophoresis box was used to support the blotting materials. 
Two to three strips of 3mm Chromotography Paper (Whatman) were laid with their ends 
in the wells of the box and the wells were filled with transfer buffer (2xSSC). The gel 
was placed on top of the 3mm paper, but not in contact with the buffer. The transfer 
membrane, three more sheets of 3mm paper, and stack of paper towels were all cut to the 
size of the gel to ensure no contact with the buffer and were placed, in that order, on top 
of the gel. The materials were weighted down and left overnight to allow the DNA to 
transfer to the membrane as the buffer was drawn up into the stack of paper towels.
After complete transfer, the DNA was covalently bonded to the membrane by 
cross-linking with 120 millijoules per cm2 in a FisherBiotech FB-UVXL-1000 
Microprocessor-Controlled UV Crosslinker. The membranes were stored in envelopes at 
room temperature.
Hybridization to yrobe
For prehybridization of a Southern blot membrane, a low stringency solution 
(30% formamide, 1M NaCl, 1% SDS, lOmM Tris-HCl [7.5 pH]) was boiled, poured over 
the membrane in a plastic container, covered, and incubated for 6-24 hours in a 42°C 
shaking water bath. After prehybridization, the fluid was replaced with a radioactive 
xGAT-1 probe solution that had been boiled at least 15 minutes. The membrane was 
incubated with probe for 12-24 hours in a 42°C shaking water bath. After hybridization, 
the probe was poured back into its tube and returned to storage. The membrane was then 
washed to remove unbound probe with a wash solution (2xSSC, 1% SDS). For the first 
wash, the membrane was incubated at room temperature for 10 minutes and then the 
wash solution was poured off to a P waste container. For the second wash, the
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membrane was incubated in a 42°C shaking water bath. The membrane was periodically 
monitored with a Geiger-Muller Counter until the count and distribution of radioactivity 
indicated that unbound probe had been transferred to the wash solution. The final wash 
solution was poured off to waste.
Visualization on film
To visualize the results of Southern blotting, the membrane was laid out in a film 
cassette for audioradiography. The membrane was placed on plastic-covered cardboard 
and wrapped in plastic film secured by tape. Radioactive ink was used to trace over 
markings made in pen around the membrane so the film and membrane could be aligned 
after development. The film cassette was assembled in the dark room. The cardboard 
piece with the membrane was overlain by a sheet of medical x-ray film, and an 
intensifying screen (FisherBiotech) was laid over the film. The cassette was closed and 
clamped between two particle boards. The cassette was stored in -80°C until 
development. Exposure times varied depending on the level of radioactivity (3-48 
hours).
In the dark room, the film was removed from the cassette and developed by 
immersion in GBX Developer/Replenisher fluid (Sigma) for 1 minute followed by a 
clean water rinse, followed by immersion in GBX Fixer/Replenisher fluid (Sigma) for 2 
minutes, followed by a final rinse and air drying. The developer and fixer were prepared 
according to the manufacturer’s protocol.
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Ligation into vBluescrint SK+
Based on hybridization results from Southern Blot analysis on the phage xGAT-1 
genomic DNA, fragments digested with selected restriction enzymes were ligated into 
pBluescript SK+ or pBluescript KS+ (Stratagene). Additionally, DNA fragments 
produced from digestion of the 20 Kb “Sac” clone were subcloned into pBluescript SK+ 
(Stratagene). The plasmid vector was linearized and digested (to produce compatible 
ends for ligation with the DNA segment to be cloned) in a 100 pi reaction containing 15- 
20 pi of pBluescript, 12-36 units of the restriction enzyme used to isolate the cloning 
fragment, and lx  appropriate buffer. If blunt ends were required, the vector was 
linearized with EcoRV. The reaction was incubated in a 37°C heating block for two 
hours. One unit of calf intestinal alkaline phosphatase (CIAP) was added to prevent 
religation of the vector and it was incubated for another 10 minutes in a 65°C heating 
block. The target DNA clone was digested in a 100 pi reaction containing 20-40 pi of 
DNA, 12-36 units of the appropriate restriction enzyme and lx  appropriate buffer. The 
reaction was incubated in a 37°C heating block for two hours. After incubation, an equal 
volume (100 pi) of Phenol/Chloroform (P/C) (50% Phenol, 48% Chloroform, 2%
Isoamyl alcohol, saturated in Tris) was added to the pBluescript and cloning DNA 
reactions and each reaction was mixed by brief vortexing and centrifuged at 14,000 rpm 
for five minutes. The nonaqueous (bottom) layer was removed to P/C waste using a 
Pasteur pipette. An equal volume (100 pi) of Chloroform/Isoamyl alcohol (24:1) was 
added and each reaction was again mixed by brief vortexing and centrifuged at 14,000 
rpm for five minutes. The aqueous layer (containing the DNA) was transferred by 
Pasteur pipette to a sterile microcentrifuge tube and the nonaqueous layer was poured off
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to P/C waste. The DNA was precipitated by adding 1/10 volume (10 pi) 3M sodium 
acetate and 3 volumes (300 pi) cold 100% ethanol to each tube, inverting to mix and 
placing the tubes at -80°C for at least 45 minutes. After precipitation, the tubes were 
centrifuged at 14,000 rpm in 4°C for 20 minutes. The supernatant was decanted and the 
pellet was rinsed with 150 pi 70% cold ethanol. The pellet was dried in a SpeedVac® 
Plus (Savant) vacuum dryer and resuspended in 10-20 pi of Tris-EDTA (TE).
Two microliters of the linearized vector and insert DNA were resolved by 
electrophoresis on a 1.2% agarose gel to check the success of the extraction. A 20 pi 
ligation reaction was prepared by combining 3 pi of the phosphatased pBluescript vector, 
8 pi of the target DNA insert, lx  ligation buffer (Promega) and 3 units T4 DNA ligase 
(Promega). The reaction was mixed by finger flicking, spun down and incubated at room 
temperature for 1 hour. The ligation reaction was then transferred to 14°C for 14-18 
hours. If not immediately transformed, the ligation reaction was stored at -20°C. 
Polymerase Chain Reaction (PCR)
Overview o f Experiments and Primer Design
Polymerase chain reaction (PCR) experiments were performed to generate and/or 
amplify cDNA and genomic DNA fragments for subcloning and subsequent sequencing. 
Three useful products were produced from this study. First, the putative xGAT-1 cDNA 
previously had been isolated and sequenced by manual sequencing methods (Hoke,
2000), however, ambiguities remained. PCR was used to amplify three overlapping 
segments that together comprised the entire xGAT-1 cDNA. Automated sequencing of 
these segments (described below) completely resolved the ambiguities and produced a 
final verified sequence. Second, interest in the promoter region of xGAT-1 focused
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initial experiments on characterization of the 5' region of the genomic clone. PCR, using 
5' xGAT-1 cDNA primers, was applied to generate a 5' cDNA fragment (cDNA bases 5- 
104). This fragment was subcloned and used to probe digests of the genomic clone in 
Southern Blot analyses. Third, the sequence of the 5' region of the genomic clone was 
obtained, in part, by PCR amplification using a xGAT-1 cDNA primer known to 
hybridize to the 5' region of the genomic clone and primers designed to hybridize the 
lambda arms close to the multiple cloning site in the EMBL3/SP6T7 vector. The 
sequences for primer pairs used in each of these experiments are provided in Table 3.
PCR Protocol
All PCR reactions were prepared using components from the GeneAmp® PCR 
Reagent Kit (Applied Biosystems) or the Promega PCR kit and AmpliTaq DNA 
Polymerase (Applied Biosystems). PCR reactions were prepared in 0.2 ml PCR strip 
tubes. For each 50 pi reaction, 0.5-10 pg DNA (depending on the template used) was 
combined with lOx PCR buffer(Applied Biosystems or Promega), 4 pi dNTP mix (lOmM 
each of dATP, dCTP, dGTP, and dTTP), and 2.5 pi of each primer. The reaction was 
mixed by finger flicking and the tubes were shaken down to collect the fluid at the 
bottom of the tube. The tubes were placed in a GeneAmp PCR System 9700 and the 
following cycling program was initiated: 5 minute hot start at 94°C; 40 cycles of melting 
(94°C for 1 minute), annealing (53°C for 2 minutes), and extension (72°C for 3 minutes); 
72°C for 7 minutes after final cycle; and 4°C storage. At the completion of the hot start, 
the cycling program was paused and 0.5 pi AmpliTaq DNA Polymerase (Applied
TABLE 3
PRIMERS USED FOR PCR EXPERIMENTS.
66
Experim ent Prim er ID
Direction 
in xGAT1 Sequence (5'-3’)
1.
Amplify xGAT1 cDNA 
segments for 
sequencing
GAB AT-10 Forward ATCCACAACTGCTG CATCTGG
GAB AT-17 Reverse GTGATCGCCAACGGCCATCGG
GABAT-8 Forward AATACGCACCAAACGACCGACGGA
GAB AT-19 Reverse AG G C CTGT AG AC C ATTTCT C A
GAB AT-18 Forward GAGTGCATCTCCATTTCTTGG
GABAT-20 Reverse T AT AT AC AT ATT ATTT AAATTT AACTT 
GAA
2.
Amplify 5’ fragment of 
xGAT 1 cDNA to probe 
genomic clone
GAB AT-10 Forward ATCCACAACT GCTGCAT CTGG
GABAT-11 Reverse GAAAGACCGCTTT CGCCAGGGT
3.
Amplify 5' region of 
genomic clone in 
EMBL3/SP6T7 vector 
to subclone and 
sequence
GABAT-20 Reverse T AT AT AC AT ATT ATTT AAATTT AACTT 
GAA
EMBL/SP6T7/L NA CTCGTGAAAGGTAGGCGGATCTGG
GTCG
EMBL/SP6T7/L NA CCGAGAATAACGAGTGGATCTGGGT
CG
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Biosystems) was added to each reaction. The solution was mixed by finger flicking and 
was shaken down. The tubes were returned to the thermocycler and the cycling program 
was restarted.
The products from primary PCR were analyzed by electrophoresis of 10 pi of 
product on a 1.2% agarose gel using a 1 Kb Plus DNA ladder (GibcoBRL) to provide a 
molecular weight standard and visualized under UV light.
Ligation into TA Vector
Amplified fragments were ligated into the pCR II using the TA Cloning Kit 
(Invitrogen). A 10 pi ligation reaction was prepared in a microcentrifuge tube by adding 
1 pi of secondary PCR product tolOx ligation buffer, 2 pi pCR II vector and 3 units T4 
DNA ligase. The reaction was mixed, spun down, and incubated at 14°C for 14-18 
hours. The ligation products were transformed into Topi OF’ supercompetent cells 
(Invitrogen) using the transformation protocol described below.
Deletion Experiment using Erase-a-Base® System (Promega)
Preparation o f Starting DNA
In addition to subcloning, fragments for sequencing the large 20Kb “Sac” clone 
were generated from an insert DNA deletion experiment using the Erase-a-Base® System 
(Promega). A double digest was performed with Apa I to produce linearized plasmid 
DNA with a 4-base 3’ overhang protecting the sequencing primer binding site and with 
Not I to leave a 5' overhang adjacent to the insert from which the deletion proceed. The 
digest began with a 200 pi reaction comprising lOx appropriate buffer (Buffer A), 10 pg 
genomic DNA, and 70 units Apa I restriction enzyme. The reaction was mixed, spun 
down and digested in a 37°C heating block for 1-2 hours. Not I restriction enzyme (224
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units) was added and because Not I activity requires a higher salt solution, lOx Buffer D 
was also added to adjust the reaction. The digest continued for another 2.5 hours.
The digest was extracted with an equal volume of P/C as described above and 
mixed by vortexing and centrifuged in at 14,000 rpm for 5 minutes. The nonaqueous 
(bottom) layer was removed to P/C waste using a Pasteur pipette. An equal volume of 
Chloroform/Isoamyl alcohol (24:1) was added and the microcentrifuge tube was again 
mixed by brief vortexing and centrifuged at 14,000 rpm for five minutes. The aqueous 
layer (containing the DNA) was transferred by Pasteur pipette to a sterile microcentrifuge 
tube and the nonaqueous layer was poured off to P/C waste. The DNA was precipitated 
by adding approximately 1/10 volume (27 pi) 3M NaOAc and 2 volumes (454 pi) cold 
100% ethanol, inverting to mix and placing the tube at -80°C for at least 30 minutes.
After precipitation, the tube was centrifuged at 14,000 rpm in 4°C for 20 minutes. The 
supernatant was decanted and the remaining pellet was rinsed with 1 ml 70% cold 
ethanol. The pellet was dried in a SpeedVac® Plus (Savant) vacuum dryer and 
resuspended in 12 pi of Tris-EDTA (TE).
Exonuclease III Deletion
The concentration of the linearized, double cut plasmid DNA was estimated by 
electrophoresis on a 2% minigel (30 ml TAE buffer, 0.6 g agarose, 1.5 pi ethidium 
bromide). A DNA mix for the selected number of timepoints (6-12 timepoints were used 
in these experiments) was prepared by adding lOx Exo III Buffer (660mM Tris-HCl pH 
8.0, 6.6mM MgCh) to 5 pg linearized plasmid DNA. The DNA mix was placed in a 
45°C water bath to reach digestion temperature. For each timepoint, 7.5 pi SI nuclease 
mix comprising 100 units/pl SI Nuclease and 7.4x SI Buffer (0.3M potassium acetate pH
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4.6, 2.25M NaCl, 16.9 mM Z11SO4, 45% glycerol) were added to a microcentrifuge tube 
and the timepoint tubes were set in ice. A zero time control tube was established by 
adding 2.5 pi DNA mix, but no Exo III. Two hundred units Exo III were added to the 
DNA mix and rapidly mixed by finger flicking. In predetermined intervals (depending 
on the desired amount of digestion between timepoints), 2.5 pi of the DNA/Exo III mix 
was added to the successive timepoint tubes pipetting briefly to mix.
After completing the DNA/Exo III addition to all timepoint tubes, the tubes were 
incubated at room temperature for 30 minutes. The reaction was stopped by adding 1 pi 
SI Nuclease Stop Buffer (0.3M Tris base, 0.05M EDTA) to each tube and heating the 
timepoint tubes in a 70°C water bath for 10 minutes. The tubes were briefly centrifuged 
to collect the liquid at the bottom of the tube. The digested DNA samples were 
precipitated with 0.3 volumes 7.5M ammonium acetate and 2 volumes cold 100% 
ethanol. After mixing, the timepoint tubes were placed in -20°C for at least 30 minutes. 
After precipitation, the tubes were centrifuged at 14,000 rpm for 5 minutes. The 
supernatant was decanted and the remaining pellet was rinsed with 500 pi 70% cold 
ethanol. The tubes were again centrifuged at 14,000 rpm for 5 minutes and the 
supernatant decanted. The pellet was dried in a SpeedVac® Plus (Savant) vacuum dryer 
and resuspended in 9 pi of Tris-EDTA (TE).
Ligation and Transformation
The timepoint tubes were placed in a 37°C water bath to prepare for religation 
using a Klenow mix comprising lx Klenow Buffer (20mM Tris-HCl pH 8.0, lOOmM 
MgCE), 2.5 units Klenow DNA Polymerase and a dNTP mix comprising 0.125mM each 
of dATP, dCTP, dGTP, and dTTP. One microliter Klenow mix was added to each tube
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and tubes were incubated in the 37°C water bath for 3 minutes. Following, 1 pi dNTP 
mix was added and the reaction was incubated for an additional 5 minutes. The reactions 
were transferred to a 65°C water bath for 10 minutes to heat inactivate the Klenow. The 
digested DNA fragments were re-ligated by the addition of 40 pi ligase mix (lOx Ligase 
Buffer, 5% PEG, lOOmM DTT, 3 units T4 DNA Ligase). The reactions were mixed, 
spun down, incubated at room temperature for 1 hour and then incubated at 14°C for 14- 
18 hours. The religation products were transformed into Topi OF’ supercomp etent cells 
(Invitrogen) using the transformation protocol described below.
Chromosome Walking Experiment with GenomeWalker™ Kit (Clontech)
A goal of the lab is to isolate the xGAT-1 promoter for subsequent study of the 
regulation of this gene. When it was determined that the putative xGAT-1 genomic 
clone, the subject of the research reported herein, did not contain the regions upstream of 
the cDNA, efforts were initiated to sequence a segment of the upstream portion outside 
the genomic clone to develop a probe for future library screening experiments. As part of 
this research, a chromosome walking experiment was conducted using the Universal 
GenomeWalker™ Kit (Clontech).
Construction o f GenomeWalkerLibraries
Adaptor-ligated, high-quality genomic DNA fragments (i.e., GenomeWalker 
libraries) provided the starting material for the experiment. Genomic DNA extracted 
from Xenopus laevis muscle was used. The size was checked by electrophoresis using a 
1 Kb Plus DNA ladder (GibcoBRL) to provide a molecular weight standard. The quality 
was checked against control human genomic DNA (provided in kit) by digestion of 5 pi 
DNA with 10 units Dra I in a 20 pi reaction. The digest was incubated in a 37°C heating
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block overnight. The reaction products were resolved by electrophoresis and visualized 
under UV light.
The GenomeWalker libraries were prepared from four blunt-end digestions of the 
Xenopus genomic DNA and one digestion of human genomic DNA with PVUII as a 
positive control. The four blunt-end cutters used were Dra I, EcoRV, PVU II, and Stu I. 
The five digests were set up in microcentrifuge tubes. A 100 p,l reaction was prepared 
using 25 Xenopus genomic DNA (2 mg/pl), lOx restriction enzyme buffer, and 40 
units restriction enzyme. The reactions were mixed and incubated in a 37°C heating 
block for two hours. The reactions were vortexed 5-10 seconds at low speed and returned 
to the 37°C heating block for incubation overnight (at least 16 hours). The reaction 
products were resolved by electrophoresis of 5 pi of product on a 0.5% agarose gel (30 
ml TAE buffer, 0.15 g agarose, 1.5 pi ethidium bromide) using a 1 Kb Plus DNA ladder 
(GibcoBRL) to provide a molecular weight standard and visualized under UV light.
To purify the genomic DNA, each digest was extracted with an equal volume of 
P/C as described previously, mixed by low-speed vortexing and centrifuged in at 14,000 
rpm for 5 minutes. After transferring the aqueous layer to a sterile microcentrifuge tube, 
an equal volume of chloroform was added and the microcentrifuge tube was again mixed 
by brief vortexing and centrifuged at 14,000 rpm for five minutes. The aqueous layer 
(containing the DNA) was transferred by Pasteur pipette to a sterile microcentrifuge tube. 
The DNA was precipitated by adding 1/10 volume 3M NaOAc, 2 volumes (454 pi) cold 
100% ethanol and 20 pg glycogen. The solution was vortexed at low-speed to mix and 
centrifuged at 14,000 rpm in for 10 minutes. The supernatant was decanted and 100 pi 
80% cold ethanol was added. The solution was centrifuged at 14,000 rpm for an
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additional 5 minutes. The supernatant was decanted and the pellet was dried in a 
SpeedVac® Plus (Savant) vacuum dryer. The pellet was resuspended in 20 pi of TE 
(lOmM Tris, O.lmM EDTA, pH7.5).
Each digest product was ligated to the GenomeWalker Adaptor, constructed to 
hybridize with the adaptor primer for subsequent PCR. For each ligation, 4 pi of the 
digested genomic DNA was added to lOx ligation buffer, 25uM GenomeWalker Adaptor 
and 3 units T4 DNA ligase. The ligation reactions were incubated at 16°C overnight. If 
PCR amplifications were not performed shortly after ligation, the ligation reaction was 
stopped by heat inactivation in a 70°C water bath for 5 minutes and the reactions stored 
at -20°C until use.
Primer Design for PCR Amplifications
Two PRC amplifications per library were performed using primer pairs consisting 
of one xGAT-1 specific primer and one adaptor-specific primer (AP1/AP2, provided in 
the kit). The primary PCR generated a template for a secondary “nested” PCR, thus the 
primary gene-specific primer was designed to hybridize to a region 3' of the secondary 
primer. The xGAT-1 primers were designed from the preliminary sequence in the 5' 
region of the putative xGAT-1 genomic clone used in this study and from the most 5' 
region of the cDNA that was upstream of the genomic clone.
Three experiments were conducted using the primers listed in Table 4. To test the 
method, the first experiment used primers designed from the preliminary genomic clone
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TABLE 4
PRIMERS DESIGNED TO TARGET TO xGAT-1 GENOMIC CLONE AND 
USED IN UNIVERSAL GENOME WALKER REACTION.
Experiment
Primer
ED Location Sequence (5'-3')
1.
Test GenomeWalker 
method
Gt-gw1 Bases 73-98 in xGAT1 
cDNA
CACCACT CT GCACCCTGGCGAAAGCG
Gt-gw2 Bases 108-133 in 
xGAT 1 cDNA
CCCTAGTTACGTAAGGAAGAGCCGCG
2a.
Generate fragments 5’ 
ofxGATI putative 
genomic clone
GT-gw3 Bases 931-966 from 5' 
end of genomic clone
AC AACTT CT ACT GAT ACTT C AG AACCCT 
CTCATCTC
GT-gw4 Bases 970-1006 from 5' 
end of genomic clone
CCT GTTT AT AGTT AT GTT CT CTT CTT GT 
CCTGAACTC
2b.
Generate fragments 5’ 
of xGAT-1 putative 
genomic clone
GT-gw5 Bases 299-336 from 5' 
end of genomic clone
CCCCCT CT GAAGCAAATTGGAGAGGCT 
TCAAATGGGG
GT-gw6 Bases 357-395 from 5' 
end of genomic clone
CAACT AGT GTT AGGCAGGTT AT ATACA 
GACCTAAAAGG
3.
Generate fragments 5' 
ofxGATI cDNA
GT-Ex1 Bases 1-28 in xGAT1 
cDNA (Upstream of 
genomic clone)
CCCAGAT CCACAACT GCTGCATCTGGG 
CG
Note: All primers are reverse.
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sequence that was over 1400 bases from the 5' end of the genomic clone, but was well 
defined. The method proved successful but the new fragments were too small to obtain 
new sequence. The second experiment used two sets of primer pairs; the first pair was 
located approximately 950 bases from the 5' end of the genomic clone and the second 
pair was located only 300 bases from the 5' end of the genomic clone. The primer for the 
third experiment was the 28-base sequence from the most 5' region of the cDNA that was 
upstream of the genomic clone. Due to the limited size of the sequence available for 
primer design this primer was used for both primary and secondary PCR amplifications. 
PCR Amylifications
Each PCR amplification consisted of eight primary and eight secondary reactions:
• Four experimental libraries
Two positive controls (PVU II-digested human genomic DNA generated 
as described above and Human GenomeWalker Library provided in the 
kit)
Two negative controls (xGAT-1 specific primer with no template and 
Positive Control Primer [PCP1/PCP2] provided in kit with no template).
For the primary PCR, 1 pi primary primer (either xGAT-1 primer or PCP1, as
appropriate) and 1 pi library (non-DEPC H2O used for negative controls) were added to
eight PCR strip tubes (0.2 ml). A master mix of sufficient volume for nine reactions (47
pl/reaction) was prepared from dNTP (lOmM each of dATP, dCTP, dGTP, and dTTP)
and kit components comprising lOx Tth PCR Reaction Buffer, 25 mM Mg(OAc)2, lOuM
A PI. The master mix was added to the tubes, the reaction was mixed by finger flicking
and the tubes were briefly spun in a microcentrifuge. The tubes were placed in a
GeneAmp PCR System 9700 and the following cycling program was initiated: 5 minute
hot start at 95 °C; 40 cycles of melting (94°C for 30 seconds), annealing (55°C for 2
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minutes), and extension (72°C for 3 minutes); 72°C for seven minutes after final cycle; 
and 4°C storage. At the completion of the hot start, the cycling program was paused and 
2.5 pi AmpliTaq DNA Polymerase (Applied Biosystems) was added to each reaction.
The solution was mixed by finger flicking, the tubes were returned to the thermocycler 
and the cycling program was restarted.
The products from primary PCR were analyzed by electrophoresis of 10 pi of 
product on a 1.5% agarose gel (30 ml TAE buffer, 0.45 g agarose, 1.5 pi ethidium 
bromide) using a 1 Kb Plus DNA ladder (GibcoBRL) to provide a molecular weight 
standard and visualized under UV light. A successful result included the presence of 
DNA bands, or at least smearing, in at least one of the experimental library products, one 
band only, representing primer, at the bottom of the negative control lanes, and a 1.5 Kb 
band or smearing in the positive control product from the Human GenomeWalker Library 
provided in the kit.
If a successful result was obtained from primary PCR amplification, another eight 
reactions were set up for secondary PCR using the same protocol described above with 
the following exceptions. The DNA template was provided from diluted libraries 
generated by mixing 1 pi of primary PCR product with 49 pi sterile, non-DEPC H2O. 
From this 50 pi mix, 1 pi was added to each PCR tube. Nested primer pairs were used 
for these reactions including the nested xGAT-1 specific primer for experimental 
libraries, PCP2 for the positive control and AP2 for the nested adaptor primer. The tubes 
were placed in a GeneAmp PCR System 9700 and the cycling program described above 
was repeated except that the annealing temperature was increased to 60°C. A hot start 
with 2.5 pi AmpliTaq DNA Polymerase (Applied Biosystems) was used as before.
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The products from secondary PCR were analyzed by electrophoresis of 10 pi of 
product on a 1.5% agarose gel as described above. A successful result included the 
presence of a single, clearly resolved DNA band in one or more of the experimental 
libraries that showed a positive DNA signal in the primary PCR result. Again, the 
controls were checked for the expected negative or positive result.
Ligation and Transformation o f PCR Products
The amplified DNA fragments representing potential xGAT-1 DNA upstream of 
the genomic clone, were ligated into the pCR II using the TA Cloning Kit (Invitrogen).
A 10 pi ligation reaction was prepared in a microcentrifuge tube by adding 1 pi of 
secondary PCR product tolOx ligation buffer, 2 pi pCR II vector and 3 units T4 DNA 
ligase. The reaction was mixed, spun down, and incubated at 14°C for 14-18 hours. The 
ligation products were transformed into Topi OF’ supercompetent cells (Invitrogen) using 
the transformation protocol described below.
Transformation
Once ligated into vector (either pBluescript SK+/KS+ or pCR II), all subcloned 
DNA plasmids were transformed into bacterial cells to provide a host organism for 
isolation of recombinant molecules and replication. Topi OF’ supercompetent cells 
(Invitrogen) were used for all transformations. Depending on the expected 
transformation efficiency, 20-50 pi of cells in a microcentrifuge tube were transformed 
by adding 2-10 pi of the ligation reaction and incubating the mixture on ice for 30 
minutes. The reaction was heat-shocked by floating the tubes a 42°C water bath for 30 
seconds and then incubated on ice for 2 minutes. SOC medium (100-250 pi) was added 
and the reaction was incubated for one hour at 37°C in a shaking incubator. Luria Broth
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(LB) agar plates, prepared with ampicillin (Amp), were pre-warmed in a 37°C incubator 
for at least 30 minutes (two plates per transformation). Using a bent Pasteur pipette, the 
plates were spread with 40 pi IPTG (isopropyl- p-D-thiogalactopyranoside) and 40 pi X- 
gal (5-bromo-4-chloro-3-indolyl- (3-D-galactopyranoside) for blue-white screening to 
identify plasmids containing an insert (i.e., the white colonies have no expressed p- 
galactosidase which yields a blue product in the presence of X-gal and hence are likely to 
contain the inserted fragment). The plates were returned to the 37°C incubator for at least 
30 minutes to allow absorption of the IPTG and X-gal. When incubation of the 
transformation reaction was complete, a bent Pasteur pipette was used to spread the 
reaction on the plates. A low density plate was prepared with approximately 10% of the 
reaction mix and a high density plate was prepared by spreading the remainder of the 
reaction mix. To ensure the small volume of reaction mix used for the low density plate 
was spread widely, approximately 130 pi LB-Amp was pipetted onto the plate to increase 
the liquid volume. The transformation plates were left upright at room temperature 
(partially covered) to allow absorption of the reaction mix. The plates were covered, 
inverted and incubated at 37°C for at least 18 hours. Plates were then moved to 4°C for 
at least three hours to allow proper color development before colony selection for 
plasmid DNA isolation.
Plasmid DNA Isolation
Plasmid DNA stocks for Southern blot digests and sequencing reactions were 
produced by growing up cultures derived from transformation plates or glycerol stocks of 
previous DNA preps and isolating the DNA plasmids using one of the three methods 
described below. In general, the “miniprep” method was used to produce stocks for
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digests and other screening procedures that did not have strict requirements for a high 
quality or high volume product. The “Wizard miniprep” method was used when low 
volume but high quality DNA was required (e.g., single sequencing reactions). The 
“midiprep” method was used to produce larger volumes of high quality DNA (e.g., for 
isolation of the 20Kb “Sac” clone used for the numerous IRDye terminator sequencing 
reactions).
Miniprep
Cultures from transformation products were prepared by excising an individual 
pure white colony, indicative of bacteria containing the cloned DNA insert, and placing it 
in a culture tube containing 3 ml Luria Broth with 50 pg/ml ampicillin. The colony was 
removed from the transformation plate with a Pasteur pipette taking care to prevent 
contact with any but the selected colony. The glass tubes were placed into a 37°C 
shaking incubator and the cultures were allowed to grow for 18-24 hours. Generally, 
glycerol stocks were made for each culture by combining 0.5 pi culture with 0.5 pi sterile 
glycerol in a sterile microcentrifuge tube and inverting to mix. Glycerol stocks were 
stored at -20°C. After incubation, 1.5 ml of each culture was transferred to sterile 
microcentrifuge tubes and centrifuged for 10 seconds at 14,000 to pellet the cells. The 
supernatant was poured off to bacterial waste and the pellet was resuspended in the 
residual liquid by vortexing for approximately 5 seconds. For each prep, 300 pi TENS 
solution (10 mM Tris pH 7.5, 1 mM EDTA, 0.1M NaOH, 0.5% SDS) was added and the 
mixture was vortexed for 5 seconds, followed by the addition of 150 pi 3M NaOAc (pH 
5.2). The tubes were centrifuged for 10 minutes at 14,000 rpm and the supernatant was 
transferred to sterile microcentrifuge tubes. Unboiled RNase A (20 pg/ml final
79
concentration) was added and the solution was incubated in a 37°C heating block for 30 
minutes. An equal volume (500 pi) of Phenol/Chloroform (P/C) (50% Phenol, 48% 
Chloroform, 2% Isoamyl alcohol, saturated in Tris) was added and the tubes were mixed 
by vortexing and centrifuged in at 14,000 rpm for 5 minutes. The nonaqueous (bottom) 
layer was removed to P/C waste using a Pasteur pipette. An equal volume (500 pi) of 
Chloroform/Isoamyl alcohol (24:1) was added and each tube was again mixed by brief 
vortexing and centrifuged at 14,000 rpm for five minutes. The aqueous layer (containing 
the DNA) was transferred by Pasteur pipette to a sterile microcentrifuge tube and the 
nonaqueous layer was poured off to P/C waste. The DNA was precipitated by adding 
approximately 2 volumes (900 pi) cold 100% ethanol to each tube, inverting to mix and 
placing the tubes at -80°C for at least 45 minutes. After precipitation, the tubes were 
centrifuged at 14,000 rpm in 4°C for 20 minutes. The supernatant was decanted and the 
remaining pellet was rinsed with 500 pi 70% cold ethanol. The pellet was dried in a 
SpeedVac® Plus (Savant) vacuum dryer and resuspended in 20 pi of Tris-EDTA (TE). 
Minipreps were stored at 4°C until use. The miniprep was analyzed by a 20 pi restriction 
digest (using 5 pi prep DNA) and mini-gel electrophoresis to check the success of the 
prep and to assess whether a DNA fragment of the correct length had been cloned. 
Miniyrey using Wizard® Plus Minipreps DNA Purification System (Promesa)
The starting culture for minipreps produced using the Wizard® Plus Minipreps 
DNA Purification System (Promega) was generated from single colonies picked from 
transformation plates as described above or from glycerol stocks. For the latter, an 
Erlenmeyer flask containing 50 ml Luria Broth with 50 pg/ml ampicillin was distributed 
to the desired number of culture tubes (3 ml/tube). Ten microliters of stock were added
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to each culture tube and the tubes were placed into a 37°C shaking incubator. The 
cultures were allowed to grow for 18-24 hours. Generally, glycerol stocks were made as 
described above and all remaining culture was used in the prep. For each prep, a sterile 
microcentrifuge tube was filled with culture and centrifuged at 14,000 rpm for 2 minutes. 
The supernatant was discarded and the step was repeated with any remaining culture to 
maximize the DNA concentration in the final product. After discarding the supernatant, 
the tube was inverted and blotted on a Kimwipe to remove as much culture medium as 
possible. Two hundred microliters of cell Resuspension Solution from the kit (50mM 
Tris-HCL pH 7.5, lOmM EDTA, 100 pg/ml RNase A) was added and pipetted up and 
down in the tube to resuspend the pellet. The tube was vortexed 3-5 seconds. Two 
hundred pi of Cell Lysis Solution (0.2M NaOH, 1% SDS) was added and the tube was 
inverted 4-5 times. Two hundred microliters of Neutralization Solution (1.32M 
potassium acetate pH 4.8) was added and the tube was inverted 4-5 times. The solution 
was centrifuged at 14,000 rpm for 5 minutes producing a cleared lysate. A vacuum 
manifold was setup to process the cleared lysate. For each miniprep, a Wizard®
Miniprep Column was prepared by attaching a Syringe Barrel to the Luer-Lok® 
extension of a Minicolumn. The tip of the Minicolumn/Syringe Barrel assembly was 
inserted into the Vac-Man® Jr. Vacuum Manifold which sealed a collection flask that 
was hook up to the laboratory vacuum pump system. All together the system allowed 
solutions placed in the Syringe Barrel to be pulled through the Minicolumn by the 
negative pressure created under vacuum. The vacuum pressure was regulated by 
stopcocks in the Vacuum Manifold. With the stopcocks closed, 1 ml of Wizard® 
Minipreps DNA Purification Resin (resuspended by shaking) was pipetted into the
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Syringe Barrel. The cleared lysate was poured on top of the resin and the stopcock was 
opened to apply a vacuum. The stopcock was closed immediately once the solution had 
passed completely through the column, leaving plasmid DNA bound to the resin. With 
the stopcock closed, 2 ml Column Wash Solution (80mM potassium acetate, 8.3mM Tris- 
HCL pH 7.5, 40mM EDTA, 55% ethanol) was added to the Syringe Barrel. The 
stopcock was open to reapply the vacuum and draw the solution through the resin. The 
vacuum was applied for an additional 30 seconds to dry the resin. The Syringe Barrel 
was discarded and the Minicolumn was placed in a 1.5 ml microcentrifuge tube and 
centrifuged at 14,000 rpm for 2 minutes to remove any residual wash. The Minicolumn 
was transferred to a sterile microcentrifuge tube and 30 pi of sterile, non-DEPC H2O 
(heated to 70°C when large fragments, such as the 20Kb “Sac” clone, were being 
isolated) was added to the Minicolumn for final elution of the plasmid DNA. After 1 -2 
minutes, the tube was centrifuged at 14,000 rpm for 60 seconds. The Minicolumn was 
discarded and the tube containing the plasmid DNA prep was stored at 4°C until use. 
Midiprep
The starting culture for midi-preps produced using the Quantum Prep™ Plasmid 
Midiprep Kit (BioRad) was generated by adding 10-30 pi of stock to an Erlenmeyer flask 
containing 50 ml Luria Broth with 50 pg/ml ampicillin. When plasmids with large 
inserts, such as the 20Kb “Sac” clone, were being isolated, three cultures were used for a 
single prep to maximize the DNA concentration in the final product. The flasks were 
placed into a 37°C shaking incubator and the cultures were allowed to grow for 18-24 
hours. For each prep, a sterile 50 ml Oak Ridge tube was filled with culture and 
centrifuged at 5,000 rpm for 5 minutes. The supernatant was discarded and the step was
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repeated until all culture had been processed. After discarding the final supernatant, 5 ml 
Quantum Prep Cell Resuspension Solution was added and the solution was vortexed to 
resuspend the pellet. Quantum Prep Cell Lysis Solution (5 ml) was added and the tube 
was inverted 8 times. Quantum Prep Neutralization Solution (5 ml) was added and the 
tube was inverted 8 times. The solution was centrifuged at 8,000 rpm for 10 minutes.
The supernatant was transferred to a sterile Oak Ridge tube and 1 ml Quantum Prep 
Matrix was added and mixed by swirling for 25 seconds. The solution was centrifuged at
8,000 rpm for 2 minutes. The supernatant was poured off to waste and 10 ml Quantum 
PrepWash Buffer (800mM NaCl, 40 mM Tris pH 7.5, 4mM EDTA, 50% ethanol) was 
added. The pellet was resuspended by shaking and the solution was centrifuged at 8,000 
rpm for 2 minutes. After discarding the supernatant, another 0.6 ml Quantum Prep Wash 
Buffer was added and the tube was gently swirled just to separate the pellet from the 
bottom of the tube. The pellet was transferred into a spin column by pouring and the spin 
column was placed inside a 2 ml collection tube. The spin column was capped (a hole 
was pre-punched in the cap to allow air displacement inside the collection tube) and the 
spin column/collection tube apparatus was centrifuged at 14,000 rpm for 30 seconds.
The supernatant was discarded and centrifuging was repeated with 0.5 ml wash buffer 
added to the spin column. After discarding the supernatant, the spin column/collection 
tube apparatus was centrifuged at 14,000 rpm for an additional 2 minutes to extract any 
residual wash buffer from the spin column. The spin column was transferred to a new 
collection tube and 200-300 pi sterile, non-DEPC H2O (heated to 70°C when large 
fragments, such as the 20Kb “Sac” clone, were being isolated) was added for final elution 
of the plasmid DNA. The spin column/collection tube apparatus was centrifuged at
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14,000 rpm for 1 minute. The spin column was discarded and the collection tube 
containing the midiprep plasmid DNA was stored at 4°C until use.
Automated Sequencing
All sequencing was based on the Sanger Method which uses four specific 
dideoxynucleotides (ddNTPs) to terminate enzymatically synthesized copies of a DNA 
template. A fluorescent dye label was incorporated in the sequencing reaction either with 
the primers (dye-primer protocol) or with the chain terminators (dye-terminator protocol). 
Preparin2  Sequence Reactions with Dve-Primer Protocol
For the cDNA subclones and genomic subclones that had sufficiently small 
inserts and/or'were cloned in vectors with universal primer sites, sequencing reactions 
were prepared using reagents from the Excel Kit (Epicentre) with one exception. In a 
few instances, Thermo Sequenase DNA Polymerase (Amersham) was substituted for 
Excel II DNA Polymerase. These reactions used a slightly different protocol for 
preparing the reaction solution as described below.
The procedure for making reactions using Excel II DNA Polymerase was as 
follows. Two microliters of each nucleotide termination mix (dNTPs plus either ddATP 
or ddTTP or ddGTP or ddCTP) were pipetted into separate 0.2 ml PCR strip tubes and 
these were kept at 4°C until the master mix was prepared. The master reaction mix was 
prepared by combining, for each 20 pi reaction, 200-400 fmol plasmid DNA (3-8 pi 
plasmid) with 3.5x Sequencing Buffer, 1.5 pmol forward primer (IRD700), 1,5 pmol 
reverse primer (IRD800), and 5 units Excel II DNA Polymerase. After the solution was 
mixed and spun down, 4 pi were pipetted into each of the four PCR tubes containing the 
a termination mix. The reactions were mixed by finger flicking, placed in a Gene Amp
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PCR System 9700 and the following cycling program was initiated: 2 minute hot start at 
92°C; 30 cycles of melting (92°C for 30 seconds), annealing (55°C for 30 seconds), and 
extension (70°C for 60 seconds); and 4°C storage. When PCR was completed, 3 pi 
Stop/Loading dye was added to each tube. •
The procedure for making reactions using Thermo Sequenase DNA Polymerase 
was as follows. Two microliters of each nucleotide termination mix were pipetted into 
separate 0.2 ml PCR strip tubes and these were kept at 4°C until the master mix was 
prepared. The master reaction mix was prepared by combining, for each 30 pi reaction, 
350-450 fmol plasmid DNA (10 pi plasmid) with 1.5 pmol forward primer (IRD700), 1.5 
pmol reverse primer (IRD800), and 32 units Thermo Sequenase DNA Polymerase. After 
the solution was mixed and spun down, 6 pi were pipetted into each of the four PCR 
tubes containing the a termination mix. The protocol continued as described above 
except when PCR was completed, 4 pi stop dye was added to each tube. All sequencing 
reactions were wrapped in foil and stored at -20°C until use.
Preparing Sequence Reactions with IR Dye Terminator Mix Sequencing Protocol
The IRDye Terminator Mix Sequencing Protocol (Dye-Terminator Protocol) (LI- 
Cor) was used to prepare sequence reactions for sequencing the putative xGAT-1 
genomic clone and specifically the large “Sac” fragment cut out of lambda phage and 
subcloned into pBluescript (representing the entire genomic clone). Initially, the primers 
designed for sequencing the xGAT-1 cDNA (Tables 5 and 6) were used to prepare 
sequencing reactions from the Dye-Terminator Protocol. Based on the novel sequences 
obtained from these results and from the results of sequencing Excel reactions, additional 
primers were designed. New sequence reactions were prepared using the new primers,
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TABLE 5
PRIMERS DESIGNED TO TARGET xGATl GENOMIC CLONE FOR USE 
IN IR-DYE TERMINATOR REACTION.
Primer ID
Direction  
in xG A T l 
clone
Source ID 
(Omiga file name 
and clone ID) Sequence (5'-3')
xgGAT1-1 Forward 071200 S03 700 
GT-Sac4-Xba1
CTT CTAAATT CT CAGCACCCT CTT C
xgGAT1-2 Forward 071200 S03 800 
GT-Sac4-Xba1
CCCT GTT GGCTTCTTT GTAAAGGGG
xgGAT1-3 Reverse 102900_S01_800 
xGATl primer 1
CAT CCCCACCAAGGTTTTT GGCTT G
xg GAT 1-4 Forward 080400_S06_800 
Sac4 Deletion TP3
GTGTTTAGCACCGTGGTCCTAGAGG
xgGAT1-51 Reverse 091400 S02 700 
GT-Sac4-Alu13
TGCTTAGTGCTCAGTTATCGTCGGC
xgGAT1-6 Forward 102900_S04_800 
xGATl primer 17
CCAATT GCAGCAGGGTTAT G GATAT G
xg GAT 1-7 Reverse 080900 S12 700 
GT-Sac4-Pst13
TT CAT CCCCCAGGGGTT CAG AT GGG
xgGAT1-81 Forward 082900_S02_700
GT-Sac4-Hae5
GTT AG G G AG C AC AAACT AG GT CAT GG
xgGAT1-91 Reverse 082600 S03 800 
GT-Sac4-Alu3
GCTTT ACT GT GGGCT GT G AAACCCC
xgGAT1-102 Reverse 082600 S10 700 
GT-Sac4-Hae4
CG GT ATT C G G C CTTTT AGT C CTT AC
xgGAT1-11 Reverse 082900 S03 800 
GT-Sac4-Hae2
CCAAACAAAAATCCATGACTGGACC
xgGAT1-12 Forward 091400 S01 800 
GT-Sac4-Alu9
GG AAGT AAC AG AGAG ACG CTT GGAG
xgGAT1-13 Reverse 080900 S10 800 
GT-Sac4-EcoR1-4
CAGAGCTTT CTGGATAACAGGTTT CC
xgGAT1-142 Reverse 082200 S03 800 
080800 Deletion TP3-1
CAACCTT G GCAG GT CT CAG AT GCT GG
xgGAT1-15 Forward 071200 S04 800 
GT-Sac4-Xba2
GCTGTTAAAAGTATTACGGGTGGGTGCC
xgGAT1-16 Forward 122900_S02_800 
xgGAT1-5
GTT GGAGTGCTCCCT GGGACAATAC
xgGAT1-17 Reverse 082600 S04 800 
GT-Sac4-Alu4
GATT C ACCCCT CTT GCTTT GTT CTCC
xgGAT1-18 Reverse 122900 S12 800 
xg GAT 1-7
GCCCAG GCG AT GAT AAC AAT GT AG
xgGAT1-191 Forward 082600 S01 800 
GT-Sac4-Alu1
GCACCGTGGTCCTAGAGGAACGTTG
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Primer ID
Direction  
in xG A Tl 
clone
Source ID 
(Om iga file name 
and clone ID) Sequence (5'-3')
xg GAT 1-20 Forward 080900 S04 700 
GT-Eco6
CATGGTCCATT CACTTCCCATACCC
xgGAT1-211 Reverse 082600 S02 800 
GT-Sac4-Alu2
CCCGGC AGTT C ACT C ATT ACCTTT CC
xgGAT1-222 Forward 010101 S02 800 
xgGATMO
GT CAACAT GAGGAACCCAAGGAACGC
xg GAT 1-23 Reverse 010101 S03 800 
xgGAT1-12
GCATCCTCCACCATGTGTAATCAAGG
xgGAT1-24 Forward 102900 S07 800 
GABATr 9
GGCTATTCCAATTTCCTGCCCATCTG
xg GAT 1-25 Reverse 080900_S10_700 
GT-Sac4-EcoR1 -4
CCCAGAGCAGAT GGCAACATCTT CAGG
xg GAT 1-26 Forward 082900 S04 700 
GT-Sac4-Alu5
GCCCCCAACTAACCAACCAACTAGGG
xgGAT1-272 Forward 010101 S02 800 
xgGAT1-10
CTT AACCTT G GC AAGCT CAG AG AT G
xg GAT 1-28 Forward 080900 S05 700 
GT-Pst5
GT CCAGT GGTAT CATTGGGAGATGG
xg G AT 1-29 Reverse 080900 S05 700 
GT-PST5
CCATCTCCCAATGATACCACTGGAC
xg GAT 1-30 Forward 122900 S07 800 
xgGAT1-13
GATTGCCGTTGGGGATCACCCTGGCC
xg GAT 1-31 Reverse 122900 S07 800 
xgGAT1-13
GGCCAGGGTGATCCCCAACGGCAATC
xg GAT 1-32 Forward CDNA1000 CT C AGCG ACAT AT CCCTAC AT CAT GC
xgGAT1-33 Reverse 022001 S05 800 
xgGAT1-25
GGCCCAAAAC AT AAG AGAAGAAGAT CT GAG
1 Sequence used to design primer was not included in xGAT-1 fragment contig (resulting sequence was included).
2 Sequence produced by primer was not included in xGAT-1 fragment contig (no alignment).
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TABLE 6
PRIMERS DESIGNED TO TARGET TO xGAT-1 (CDNA) AND 
USED IN IR-DYE TERMINATOR REACTION.
Prim er ID
Direction in 
xG A Tl
Bases of xG A Tl 
cDNA (1-2450) Sequence (5'-3')
GABAT-12 Forward 147-169 GT GGACT GGT GCT GAAAT CT C
GABAT-22 Reverse 293-312 CT G AACCTT CACCACCAAGG
GABAT-3 Forward 580-598 GTTGGACTCGCT GCT GCCCTT
GABAT-4 Reverse 1178-1198 TGCT GCACGAGTT GATGCAGC
GABAT-6 Reverse 1870-1893 G GT CGT AT G AGTT GT AGG CG C
GABAT-7 Forward 1273-1294 GTAGCTGCCTCAGGTCCTGGG
GABAT-81 Forward 793-816 AATACGCACCAAACGACCGACGGA
GABAT-92'3 Reverse 1042-1065 CAGCCAGACCTCTGAATCCGAGAG
GABAT-101 Forward 37035 AT C CACAACT GCTG CATCTG G
GABAT-112 Reverse 85-104 GAAAGACCGCTTT CGCCAGGGT
GABAT-12 Forward 1208-1227 CTG GTTT AGTAAT CTT CT CT
GABAT-13 Reverse 1980-2000 C ACT GG AACAAAACTCGGAAC
GABAT-14 Forward 1381-1398 TTGGGAATT GACAGCCAGT
GABAT-171 2 Reverse 837-857 GT GAT CGCCAACGGCCATCGG
GABAT-181 Forward 1598-1618 G AGT G CAT CT C C ATTT CTT G G
GABAT-191 Reverse 1648-1668 AGGCCT GT AG ACCATTT CT C A
GABAT-201 Reverse 2372-2403 T AT AT AC AT ATT ATTT AAATTT AACTT G AA
1 Primer used to resolve final cDNA sequence.
2 Primer used in IRDye terminator reactions for sequencing.
3 Primer GABAT-9 is split by an intron in the xgGATI genomic fragment.
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and the new sequencing results were analyzed with previous results to identify 
contiguous sequences that were used to design primers for the next round of sequencing. 
This iterative approach continued to extend and refine the genomic clone sequence.
The sequencing reactions prepared by the Dye-Terminator Protocol use Ll-Cor 
IRDye Termination mixes and reagents from the Thermosequenase kit (USB 78500 kit). 
For each reaction, 2 pi each of Acyclo A, T, G, and C termination mixes were pipetted 
into separate 0.2 ml PCR strip tubes and these were kept at 4°C until the master mix was 
prepared. The master reaction mix was prepared by combining, for each 27 pi reaction, 
350-500 fmol plasmid DNA (8-16 pi “Sac” plasmid) with 20x Reaction Buffer (260mM 
Tris-HCl pH 9.5, 65mM MgCb), 3 pmol xGAT-1 specific primer, and 4 units Thermo 
Sequenase™. After the solution was mixed and spun down, 6.5 pi were pipetted into 
each of the four PCR tubes containing a termination mix. The reactions were mixed by 
finger flicking, then shaken down, then placed in a GeneAmp PCR System 9700 and the 
following cycling program was initiated: 2 minute hot start at 95 °C; 30 cycles of melting 
(95°C for 30 seconds), annealing (50°C for 30 seconds), and extension (72°C for 45 
seconds); 72°C for 5 minutes after final cycle; and 4°C storage.
After PCR, the DNA was precipitated by transferring each PCR product to a 
separate microcentrifuge tube containing 11.5 pi sterile double-distilled H2O and 8 pi 3M 
NaOAc. After mixing, 80 pi cold 100% ethanol was added. The tubes were inverted 
several times to mix and placed in -80°C for at least 30 minutes. After precipitation, the 
tubes were centrifuged at 14,000 rpm in 4°C for 15 minutes. The supernatant was 
decanted and the remaining pellet was rinsed with 200 pi 70% cold ethanol. The pellet 
was thoroughly dried in a SpeedVac® Plus (Savant) vacuum dryer and resuspended in 4
pi IR2 Stop Solution by high-speed vortexing for 30 seconds. The solution was 
centrifuged briefly to collect the liquid at the bottom of the tube and then transferred by 
pipette to a 0.2 ml PCR strip tube. Sequencing reactions were stored at -20°C until use. 
Sequencing with the Global IR System
All DNA sequencing was performed on the Global IR2 System (Ll-Cor). 
Sequencing reactions were analyzed by polyacrylamide gel electrophoresis (PAGE) and 
the data were collected and processed using the software package e-Seq (Ll-Cor). A 4% 
acrylamide gel was prepared for 66 cm plates using the following method. After cleaning 
the plates with double distilled water and 100% isopropanol, the gel cassette apparatus 
was assembled with 0.25 mm spacers separating the plates. Binding silane (82.5 pi 
binding silane solution, 2.5 pi 10% acetic acid) was pipetted along the top inside of the 
notched front plate to silanize the plate behind the loading wells. The apparatus was set 
at an angle in a pouring jig to receive the gel solution.
Gel ingredients, 25.2 g 7M urea, 7.2 ml lOx TBE, and 4.8 ml Long Ranger 50% 
Gel Solution (FMC BioProducts) were combined in a 250 ml beaker and brought up to a 
final volume of 60 ml with sterile double distilled H20 . The solution was mixed on a 
stirring plate until completely dissolved. After adding 400 pi 10% APS (0.1 g 
ammonium persulfate in 1 ml sterile double distilled H20), the solution was drawn into a 
syringe and filtered through a Whatman GF/A filter into a clean 250 ml beaker. Forty 
microliters TEMED (N,N,N’,N’- tetramethylethylenediamine) (Fisher Biotech) was 
added to polymerize the filtered solution. The solution was swirled to mix, drawn into a 
plastic syringe and immediately (while still in a liquid state) injected into the gel cassette 
by plunging the syringe slowly as it was moved along the top of the notched front plate.
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Care was taken to pour the gel evenly and prevent bubbles. The gel solution filled the 
space between the plates by gravity flow and when the solution began to seep out of the 
bottom of the plates, the gel cassette was laid flat and the comb and casting plate were 
positioned according to Ll-Cor specifications. The gel was allowed to polymerize for at 
least 1.5 hours.
Once polymerized, the casting plate and comb were removed and the plates were 
cleaned with double distilled water and 100% isopropanol to remove all loose acrylamide 
from the loading reservoir and all acrylamide on the outside of the plates. The comb was 
inserted and positioned to rest on top of the gel. The top reservoir was installed and 
tightened down to ensure a good seal by the gasket. The gel cassette was positioned in 
the sequencer to sit in the bottom reservoir. The bottom and top reservoirs were filled to 
the appropriate level with 1 L of running buffer (lx  TBE). Generally, sequencing was 
initiated shortly after setting up the gel and at least within 24 hours of polymerization.
When ready to sequence, the circuit was connected and a 30-minute pre-run 
program (e-Seq) was initiated to calibrate focus and gain settings and set other system 
parameters. During the pre-run, sequence reactions were removed from -20°C storage 
and denatured in a thermal cycler (92°C for 2 minutes). Reactions were removed 
immediately after two minutes and placed on ice for quick cooling to reduce annealing.
A needle-syringe apparatus (Hamilton 1701 pipet) was used to draw up 1.5 pi of reaction 
and load this aliquot into the appropriate well of the comb. When all samples were 
loaded, the data collection program (e-Seq) was run and the run information was recorded 
in the laboratory sequencing notebook.
After completion of the sequencing run (18 hours), the gel cassette was
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disassembled and cleaned and the used buffer and gel were disposed to waste. The data 
file generated by the run was processed using e-Seq software, essentially according to the 
manufacturer’s instructions, to generate a quantitative peak profile and a text file of the 
nucleotide sequence for import into the sequence analysis program, Omiga™ 2.0. 
Sequence Analysis 
Homology Analysis o f Sequences
The decision to use sequence data from any given sample was based on the 
quality information provided in the e-Seq summary report. Average quality values, 
which reflected the number of ambiguities and the level of confidence in assignment of 
bases, range from 1-40. Sample data with an average quality value of 25 or greater 
were exported in Fasta format to the Omiga™ 2.0 software package (Omiga) from 
Oxford Molecular Ltd using the “Post Sequencing Wizard” function in e-Seq. A project 
file, set up in Omiga, was used to manage all sequencing information used in this study 
(e.g., sample data and primer sequences). After import into Omiga, all data files were 
screened to edit out vector sequences and were submitted for Blast search to delete any 
sequence file representing cloned vector.
The Omiga Cluster W Alignment function was used specifically for homology 
searches between xGAT-1 cDNA sequencing results to obtain a final sequence for this 
transcript. Omiga uses the Clustal W 1.6 algorithm, which is an upgrade of the Clustal V 
algorithm described in Higgins, Bleasby and Fuchs (1991). The Clustal W algorithm 
comprises three steps: (1) calculation of a pairwise similarity score, representing the 
distance between the pair; (2) formation of a dendrogram by clustering sequences based 
on their overall similarity; and (3) assembly of a multiple sequence alignment starting
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with similar sequences and working out toward least similar sequences based on the 
dendrogram. Detailed explanation of the algorithm is provided in the Omiga Reference 
Guide provided with the software package.
Generation o f  Genomic Sequence from Contiguous Fragments
Data files processed in Omiga, as described above, and representing sequencing 
on the xGAT-1 genomic clone, were used to assemble a contiguous fragment and 
generate a single consensus sequence for that genomic clone. The data files were 
converted to a compatible format and imported to the Wisconsin Package (Seqlab), 
Version 10.0 for UNIX, a product of Genetics Computer Group (Madison, Wisconsin). 
The fragment assembly function in Seqlab was used to align overlapping portions of 
sequence as new files from sequencing runs were generated, thereby creating “contigs” 
that grew in size and were reduced in number as the sequencing project progressed. The 
iterative analysis in Seqlab guided primer design and sequencing strategy.
The contigs generated in Seqlab were viewed using two post-processing routines. 
The BigPicture routine portrayed the contigs in a one-page graphical format, showing the 
position and orientation of each sequence comprising the contig. The PrettyOut routine 
printed out the actual base sequence of the contig including the consensus sequence and 
all sample sequences in correct position and orientation. The files produced by these 
routines are in text format and, thus, easily printed using standard word processing 
software.
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Embryologic Analysis of xGAT-1
In situ hybridization (ISH) experiments, performed previously in the laboratory 
using the entire antisense transcript of the putative xGAT-1 cDNA, generated stained 
Xenopus laevis embryos from stage 20 (Mid-Blastula Transition, start of transcription) 
through stage 45. Selected embryos from all stages were embedded in paraffin, sectioned 
onto slides and analyzed for the location and timing of xGAT-1 expression.
Embedding Whole Embryos
Embryos to be embedded in paraffin were transferred to 5 ml screw cap glass 
vials (Fisher Scientific) and dehydrated by a series of washes: 10 minutes in lx  
phosphate-buffered saline (PBS); 15 minutes in 75% PBS/25% ethanol; 15 minutes in 
50% PBS/50% ethanol; 15 minutes in 25% PBS/75% ethanol; and 15 minutes in 100% 
ethanol. The vials were rocked on a nutator for the duration of each wash. Under a 
laboratory hood, the wash was replaced with 50% ethanol/50% xylene (Fisher Scientific) 
and the embryos incubated for 15 minutes at room temperature. The vials were 
periodically inverted to mix. This wash was replaced with 100% xylene and the embryos 
incubated for another 15 minutes at room temperature with periodic mixing.
Embryos were aliquotted to plastic embedding molds (10-15 per mold). The 
residual xylene was removed with a transfer pipette and the embryos were washed in 
50% xylene/50% paraffin for 15 minutes at 60°C (to keep wash from solidifying). This 
wash was removed and replaced with melted paraffin. After 1-2 hours at 60°C, the 
paraffin was poured out and replaced with new melted paraffin. After another 1-2 hours 
at 60°C, this step was repeated with new melted paraffin. After the final paraffin 
application, individual embryos were embedded (1/mold) by transferring the embryo to a
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new mold containing fresh melted paraffin and orienting it head down by the use of a 
dissecting probe. Molds were solidified and stored at room temperature until sectioning. 
Sectioning Whole Embryos
Prior to sectioning, slides were prepared by cleaning with mild soap and water. 
When dry, a thin coat of Meyer’s egg albumin fixative (liquid extracted from beaten 
Meyer’s albumin with an equal volume of glycerin and formalin [1:100]) was applied to 
the slide and dried by heating on a hot plate for 25 seconds (removed from hot plate as 
soon as a visible vapor appeared). Slides were sequentially numbered labeled with the 
stage of the embryo, the date of sectioning, and the gene of interest.
The block of paraffin containing the embryo to be sectioned was removed from 
the plastic mold and the bottom (tail side of the embryo) was shaved to create a flat 
surface for mounting on a wooden sectioning block. The bottom of the paraffin block 
was slightly melted to fuse it to the textured wooden surface of the sectioning block. The 
paraffin block was trimmed on each side with a razor to create a protruding square or 
rectangle of wax that contained the embryo. The protrusion was shaped so sectioning 
cuts would slice horizontally through the embryo at a 90° angle to the anterior-posterior 
(A-P) axis. The sectioning block was positioned in a microtome (American Optical 
Company “820") set to slice 12 pm thick sections. The microtome produced ribbons of 
sections that were placed horizontally across the slides with the most anterior sections 
positioned in the upper left comer, then proceeding across and down so the most 
posterior section was located in the lower right comer of the slide. After positioning the 
ribbons of sections, water was pipetted onto the slide, seeping under the sections and 
allowing the sections to expand to their tme size. The slides were placed on a slide
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warmer and dried at approximately 50°C for at least 6 hours. When slides were dry, they 
were loaded into a glass slide carrier and dipped into xylene until the paraffin dissolved 
(1-5 minutes). The excess xylene was drained off and the slides were laid out on paper 
towels. Before the slides dried, several drops of permount (Fisher Scientific) were 
pipetted onto the slide and a cover slip was dropped on top. The cover slip was tapped to 
remove bubbles and excess permount was wipe away. The slides were left on clean 
paper towels to dry at least 24 hours before viewing.
Histological Analysis
Histological sections prepared for this study (representing 18 embryos) and 
selected histological sections of other xGAT-1 stained embryos prepared previously in 
the lab were viewed under microscope. All slides were examined for quality features 
including (1) the level of background staining, (2) the presence of particulate matter, 
bubbles or other features external to the embryo, (3) the structural integrity of the section 
and (4) any distortion due to uneven thickness or cuts made at a diagonal to the A-P axis. 
In the context of the quality assessment, sections were examined to identify positive 
signals representing xGAT-1 expression. The location in the embryo and the intensity of 
the verified signals were noted, as was the micrometer position of the embryo on the 
slide. Sections representing several stages from stage 20 to stage 45 were photographed 
using an Olympus Automatic Photomicrographic System.
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Cell-Cell Interactions
Animals
Sexually mature albino Xenopus laevis frogs were purchased from Xenopus I 
(Ann Arbor, Michigan) and housed in continuous flow tanks with water temperature 
maintained at 12-20°C. Frogs were primed for mating by subcutaneous injection into the 
dorsal lymph sac of human chorionic gonadotropin (Novarel™) (400 units for males and 
600 units for females) and placed together for at least 12 hours in an enclosed basket 
submerged in water, leaving an approximate 2-inch air space. Fertilized eggs were 
collected in a glass dish placed under the basket for a period up to 24 hours after pairing. 
The surfaces, tank, and basket used for mating were cleaned with alcohol and rinsed with 
water before and after use.
Processing Embryos
Protective jelly coats were removed from the eggs by swirling them gently in a 
beaker containing 2% L-cysteine (Sigma) and 0.18M NaOH at room temperature for 5 
minutes. The embryos were successively transferred, using transfer pipettes with tips cut 
off, to three beakers containing: %100 distilled H2O; 50% distilled H2O and 50% O.lx 
Normal Amphibian Medium (NAM) (lOOmM NaCl, 2mM KC1, ImM Ca(NOs)2, ImM 
MgSC>4); and 100% O.lx NAM, respectively. In each beaker, the embryos were swirled 
gently for 5 minutes to rinse. After dejellying, the embryos were distributed to glass 
culture dishes containing O.lx NAM with 50 pg/ml gentamycin sulfate and viewed under 
a dissecting microscope. Any unfertilized, necrotic or deformed embryos were discarded. 
Prior to final fixing for in situ hybridization experiments, embryonic material was stored 
at 14-16°C and NAM was changed out regularly.
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When the embryos reached stage 10-11 (all stages according to Nieuwkoop and 
Faber, 1967), the vitelline membranes were removed to ensure penetration of in situ 
hybridization reagents. Under a dissecting microscope, the embryo was positioned and 
held in place using #5 forceps and the membrane was pinched on the ventral side 
(between blastopore and animal cap) with #55 forceps. The vitelline membrane was 
peeled off and the embryo was embedded in clay, dorsal side up, with the anterior 
(animal cap) region at the top, thus exposing the presumptive neural plate for 
microsurgery. Embryos were dissected at stage 1VA in Ficoll solution (75% NAM, 5% 
Ficoll [Sigma]). Glass operating needles were formed from lmm-diameter capillary 
tubes using a needle puller (Narishige Model PB-7). Full neural plates with and without 
mesoderm were dissected. Additionally, regional neural explants, with and without 
mesoderm, were obtained by slicing the full neural plate into three sections: anterior 
(closest to animal cap); middle; and posterior (closest to blastopore). Explants were 
grouped according to type in separate glass culture dishes and maintained in 0.75 NAM 
with 50 pg/ml gentamycin sulfate. A group of whole embryo control siblings 
(maintained in O.lx NAM with 50 jug/ml gentamycin sulfate) was kept in the same 
environment as the explants throughout the dissection process.
Explants and control siblings were allowed to develop to stage 34-36 (based on 
inspection of control siblings) and then fixed for in situ hybridization. The embryonic 
material to be fixed was transferred to a 5 ml screw cap glass vial (Fisher Scientific) and 
the vial was filled with sterile double distilled H2O. After 5 minutes, the water was 
removed and replaced with fresh MEMFA solution (lx  MEMFA [0.1M MOPS, 2mM 
EGTA, ImM Mg2S04, 4% formaldehyde], 3.7% formaldehyde), completely filling the
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vial. The vial was rocked for 1-2 hours on a nutator. The MEMFA solution was 
removed and replaced with 100% ethanol to rinse for 5 minutes. After rinsing, the 
solution was replaced with fresh 100% ethanol and the vials were stored in -20°C until 
use.
In Situ Hybridization o f  Explants
In situ hybridization was used to batch stain whole embryos and embryo explants 
(full neural plates and regional explants of the neural plate). The stain, created by an 
antibody-mediated color reaction, localized the expression of xGAT-1 in the embryo.
The antisense xGAT-1 probe used in the procedure was synthesized by others in the lab 
by standard RNA synthesis on linearized plasmid xGAT-1 cDNA. The synthesis 
incorporated an antibody-labeled ribonucleotide (digoxigenin-11-uridine-5'-triphosphate) 
(Boehringer Mannheim).
In situ hybridization was performed on whole embryos, full neural plates with 
mesoderm, full neural plates without mesoderm, regional explants of the neural plate with 
mesoderm and regional explants of the neural plate without mesoderm. Whole embryos 
were siblings to the explants and were used as a check on staging. Additionally, controls 
for each type of experimental material were processed simultaneously in separate vials 
and probed with antisense OTX.
Selected embryos and explants were transfered, using transfer or Pasteur pipettes, 
to 5 ml screw cap glass vials (Fisher Scientific) and the vials were set on a nutator.
While rocking continuously on the nutator, the embryos and explants were rehydrated 
with successive 5 minute washes in: 100% ethanol; 75% ethanol; 50% ethanol; 25% 
ethanol and 75% PTw (lxPBS, 0.1% Tween-20); and four washes in 100% PTw. They
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were then incubated at room temperature for 30 minutes in 10 mg/ml proteinase K 
(Promega) to permeabilize the tissue and increase sensitivity. Embryos and explants 
were washed two times for 5 minutes each (with nutating) in 0.1 triethanolamine 
(Sigma), followed by two additions of 12.5 pi acetic anhydride with 5 minutes nutating 
after each addition. Embryos and explants were washed two times for 5 minutes each 
(with nutating) in 100% PTw and then refixed for 20 minutes with 4% paraformaldehyde 
(4 ml PTw, 1 ml 20% paraformaldehyde neutralized with NaOH and heated at 65°C and 
shaken until clear). Refixing was followed by five 5 minute washes (with nutating) in 
100% PTw. After the final wash, all but about 1 ml of PTw was removed and 250 pi 
hybridization buffer (50% formamide, 5x SSC, 1 pg/ml Torula RNA, 100 pg/ml heparin, 
lx Denhardt’s [composed of 2% BSA, 2% Polyvinyl pyrrolidone and 2% Ficoll 400]) 
were added. After the embryos and explants settled, the buffer was removed and an 
additional 500 pi hybridization buffer was added. The sample vials were placed in a 
60°C shaking water bath for 10 minutes. The hybridization buffer was replaced by 
another 500 pi of buffer and the embryos and explants were prehybridized for at least 6 
hours. The hybridization buffer was replaced with 0.25-0.3 ml probe solution (enough to 
cover experimental material) and incubated at 60°C in a shaking water bath overnight.
After hybridization, the probe was removed to sterile microcentrifuge tubes and 
stored at -20°C for reuse up to three times. Embryos and explants were washed in 2x 
SSC for 20 minutes in a 60°C shaking water bath for three successive washes. They were 
then washed in 2x SSC with 20 pg/ml RNase A and 10 units/ml RNase T for 30 minutes 
in a 37°C shaking water bath. Embryos and explants were washed twice for 10 minutes 
in 2x SSC at room temperature, twice for 30 minutes in 0.2x SSC at 60°C and twice for
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15 minutes in Maleic Acid Buffer (100 mM maleic acid, 150 mM NaCl pH 7.5) at room 
temperature.
For the antibody incubation step, the final MAB wash was replaced by MAB with
2% Boehringer Mannheim Blocking Reagent (BMB) and pre-incubated 1 hour at room
temperature. This solution was replaced with MAB containing 2% BMB and 20% heat-
♦
treated lamb serum (GibcoBRL) and the embryos and explants were pre-incubated 1 hour 
at room temperature. This solution was replaced with MAB containing 2% BMB and 
20% heat-treated lamb serum and V2OOO dilution of anti-digoxigenin Fab fragments 
coupled to alkaline phosphatase (AP) (Boehringer Mannheim); The embryos and explants 
were incubated overnight at 4°C (with nutating).
To remove excess antibody, the embryos and explants were washed five times 
with MAB (1 hour per wash) at room temperature (with nutating). For the color reaction, 
the embryos and explants were washed twice for 5 minutes at room temperature in AP 
Buffer (lOOmM Tris pH 9.5, 50 mM MgCl2, 100 mM NaCl, 0.1% Tween-20, 5 mM 
Levamisol). The second wash was replaced with AP Buffer containing 4.5 pi Nitro blue 
tetrazolium (75 mg/ml NBT in 70% dimethyl formamide) and 3.5 pi 5-bromo-4-chloro- 
3-indolyl-phosphate (50 mg/ml BCEP in 100% dimethyl formamide) per milliliter buffer. 
The color reaction was incubated at room temperature until the signal and background 
staining were satisfactory under a dissecting microscope. The reaction was stopped by 
replacing the AP Buffer solution with MEMFA (0.1M MOPS, 2 mM EGTA, 1 mM 
Mg2S04, 4% formaldehyde) which stabilizes the stain.
In one of the three experiments conducted for this study, unidentified debris was 
noted in the sample vials after the addition of the first MAB solution containing lamb
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serum. During the color reaction, the color agent appeared to precipitate out of solution 
and stain the debris. The debris was removed from the reaction, using a glass needle to 
remove any debris that was adhering to the experimental material. The AP Buffer 
containing NBT and BCIP was then replaced with fresh solution and the color reaction 
was allowed to proceed.
Samples were stored in 4°C until preparation for viewing/photodocumentation as 
follows. Each group of stained embryos or explants was transferred to a depression slide 
(concavity slide accommodating about 0.5 ml liquid). MEMFA was removed by transfer 
or Pasteur pipette and replaced with phosphate-buffered saline (PBS). After 1 minute, 
PBS was replaced by methanol for 10 minutes to dehydrate. Methanol was removed and 
Benzyl benzoate/Benzyl alcohol (2:1 ratio) was added. After analysis with a dissecting 
microscope, individual explants and groupings were selected and photographed using an 
Olympus Automatic Photomicrographic System.
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CHAPTER 3
RESULTS PART I: CHARACTERIZATION OF xGAT-1 
cDNA Sequencing
Automated sequencing of the Xenopus laevis GAT-1 clone, named xGAT-1, was 
performed to complete and verify the manual sequencing results reported in previous 
work (Hoke, 2000). Based on the preliminary sequence, three primer pairs were designed 
to produce three PCR products (each representing approximately one-third of the cDNA) 
that would overlap and that, together, would create one contig representing the entire 
xGAT-1 clone. These fragments were subcloned and completely sequenced in addition 
to sequencing the full cDNA clone, which produced putative sequence for the 5' and 3' 
ends of the clone. The final cDNA sequence (Figure 1) was based on alignment of six to 
eleven high quality sequences (forward and reverse) produced for each one-third of the 
cDNA. A description of all sequence reactions is provided in Appendix A l.
The final cDNA clone of xGAT-1 comprises 2,451 nucleotide base pairs. The 3' 
end includes a 15-nucleotide poly-A tail, representing the site of post-transcriptional 
cleavage of the polymerase II transcription enzyme. Cleavage of this enzyme is typically 
signaled by a poly-adenylation signal sequence (AAUAAA) that occurs 15-30 
nucleotides upstream of the cleavage site. The xGAT-1 cDNA clone features a putative 
poly-adenylation signal 14 bp upstream of the poly-A tail, however, the signal sequence 
(AATAA in xGAT-1) is missing the final adenosine.
Translation of the cDNA sequence, using the OMIGA translation function, was 
performed for all three potential open reading frames (ORF). The two ORFs initiating on
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1 CCCAGATCCACAACTGCTGCATCTGGCGCAGATCAACATTTAACCTTATAAGCAAGCTCTGACCATCATATTCAC  
76  CACTCTGCACCCTGGCGAAAGCGTCTTTCTAACCCTAGTTACGTAAGGAAGAGCCGCGAAGTGCTGTCCACGTGG  
1 5 1  ACTGGTGCTGAAATCTCTCGTCCGGCTGCCAGGCACTGCCATTCCAAACCAAGAGACATGGCAACAAATGGAACT
M A T N G T
2 2 6 AAAGTGGCTGATGGGCAAATTTCCACAGAACTTAGTGAGGCCCCCATTATTAATGACAAGCCAAAAACCTTGGTG
K V A D G Q I  S T E L S E A P I  I N D K P K T L V
3 01  GTGAAGGTTCAGAAGAAGAAAACAGAAGATATGGAAAGAGATACCTGGAAAGGGAGGTTTGACTTCCTTATGTCC
V K V Q K K K T E D M E R D T W K G R F D F L  M S
3 76 TGTGTTGGTTACGCCATTGGACTGGGAAATGTGTGGAGATTCCCCTATCTCTGCGGCAAGAATGGAGGAGGGGCT
C ' v  G Y A I  G L G N V W R F P Y L C G K N G G G A
4 51  TTTCTCATTCCCTATTTCCTTACGCTCATTTTCGCTGGGGTTCCTCTCTTTCTGTTGGAGTGCTCCCTGGGACAA
F L  X . P Y F ' L T L  I  >  A G V P '  E F  L L E C S L G Q
52 6 TACACTTCCATTGGAGGCCTTGGAGTATGGAAACTTGCTCCCATGTTTAAAGGTGTTGGACTCGCTGCTGCCATC  
Y T S  I G G L G V W K L A P M F K G V G L A A A I  
6 01  CTTTCCTTTTGGCTAAATATCTACTACATTGTTATCATCGCCTGGGCTATATATTACCTCTTCAGTTCCTTCACC  
L S F W E N t  Y Y I V I I A W A I Y Y L  P S S P T  
6 7 6 ACTACCCTCCCTTGGAAAAACTGTGACAACTATTGGAATACTGAACGTTGCTTCTCCAACTACAGTATCCCCAAC  
T T L P W K N C D N Y W N T E R  C F  S N Y  S I  P N
7 5 1  ACCACCAATATGACGAGTGCCGTTTTGGAATTTTGGGAGCGCAATATGCACCAAATGACTGACGGACTGGAAAAA 
T T N M T S A V L E F W E R N M H Q M T D G L E K  
8 2 6 CCAGGGCAGATCCGATGGCCGTTGGCGATCACACTGGCAATTGCGTGGGTTTTGGTCTATTTCTGCATCTGGAAA
p g  q  i  r  w p
9 0 1  GGAGTCGGCTGGACAGGAAAGGTGGTCTACTTCTCAGCGACATATCCCTACATCATGCTGGTCATCTTGTTCTTC  
G V G W T G K V  
97 6 AGAGGAGTGACCTTGCCGGGAGCCTTGGATGGGATTTTGTTTTATATAACTCCTAAATTCAGCAAGCTCTCGGAT
l i l M l l i i l l l l M i B i H i S i D  g i l f y i t p k f s k l s d
10  51 TCAGAGGTCTGGCTGGACGCTGCCACTCAGATCTTCTTTTCTTATGGTTTGGGACTTGGCTCCTTAATTGCTTTG  
S E V W L D A A T Q I  F F S ' Y  G ' L  G L G S E X A : ■ E
1 1 2 6  GGAAGCTACAATCGATTCCACAACAATGTTTACAGGGATTCTATCATTGTCTGCTGCATCAACTCGTGCACAAGC  
| | 1 | S  Y N R F H N N V Y R D S  I  I V C C I N S C  | | | 1 1  
12 01 ATGTTTGCTGGTTTAGTAATCTTCTCTATTGTTGGCTTCATGGCCCATGTCACCAAGAGACCTATAGAACAAGTA  
M T ‘ “A " G L V  I  ■ F  S I V G F M ' A  H V T K R  P I  E Q V
12 76 GCTGCCTCAGGTCCTGGGTTGGCGTTTTTAGCTTATTCTGAAGCGGTGACGCAACTGCCCATATCTCCGTTGTGG
• A A S G P G L A F L A Y S E A V T Q L P I  | l | | l | | | j | | | | |
13 51 TCGGTGCTTTTCTTTTCTATGTTGCTGATGCTTGGGATTGACAGCCAGTTTTGTACAGTTGAAGGCTTTATTACA
S V L F  F  S M L E M L G I  D S Q F C T V E G F I  T
14 26 GCTCTGGTGGATGAATTTCCAAAGTTGTTGCGCACACGGAGAGAAATTTTCATTGCAGTTGTTTGTGTTGTTTCT
A L V D E F P K L L R T R R E I . F  I A V V C V V S
15 01 TACTTGGTGGGACTGTCCAACATAACCCAGGGTGGAATTTATGTATTCAAACTGTTTGACTACTACTCGGCCAGT
Y L V G L S N I T Q G G I Y V F K L F D Y Y S  1 H | |
15 76 GGAATGAGTCTCTTGTTTCTGGTCTTCTTTGAGTGCATCTCCATTTCTTGGTGTTACGGCGTTAACAGATTCTAC
G M S E E F E V F F E C X S X  S ' W " C  Y G V N R F Y
16 51 GATAATATTGAGGAAATGGTCGGCTACAGGCCTTGTCTCTGGTGGAAACTCTGTTGGACTTTTTTCACCCCCATC
d n  i  e e m v g y r p c l w w k e ' c w t 'f ' f ' t ' p  i
1 7 2 6  ATCGTAGCAGGAGTCTTCCTTTTCAGTGCTATTCAGATGACTCCTCTGACTATGGGCAGCTACGTTTTCCCATCT 
l ^ ^ g g f l g g S B i Q  M T P L T M G S Y V F P S  
18 01 TGGGGGCAAGGAGTCGGCTGGTTCATGGCTTTGTCATCCATGGTGTTAATTCCAGGTTACATGGTTTATTTGTTT
w g  q
18 76 CTGTCTCTTAAAGGCTCATTAAAACAGCGCCTACAACTCATGATACGACCAACCGATGAAGTCGTCTGCTCTGAA
L S L K G S L K Q R L Q L M I R P T D E V V C S E
19 51 AATGGCCCAGAACAACTGTCCCAGAGCAACTCCGCAAACAAGGAAGCTTATATATAAAAATGTTCCGAGTTTTGT
N G P E Q L S Q S N S A N K E A Y I  *
2 02 6 TCCAGTGATGCAGTTGTGAAGATATTCTGAAATCATAACGGTTGACATGACCACCAATTTACATCTGGAATAAAG  
2 1 0 1  AATTTACCTACCTCCACTGTCAAAAAGGGGACCATCCAAACAAAGAGCACAAAGAAAAAAAAAATCTTGGGTTAT 
2 1 7 6  TTTCTTAATATTTTCTTGGGTCACCATGGCAAAATGGTATCAGCAGGTGGTTTAGACTGTTAACGTTTTTAATCT  
2 2 51 TTTCTGCGGGAGTGACATTTGTAAACTGTTTGCGTTTTTAAACCTATACTTGGCATGAAGATGTGAGGTTCTGAG  
2 3 26 TCTAATTTGTATCCACGTAACCAGCTCCCCAAAACAACATATACGTAGAATCTTGTTTTTAGTCAATATTTGTGA  
24 01  TTTTCAAGTTAAATTTAAATAATATGTATATATATTAAAAAAAAAAAAAAA
Figure 1. Nucleotide sequence and deduced amino acid sequence of Xenopus laevis 
GAT-1 cDNA. The ATG start codon, polyadenylation signal and poly-A 
tail are underlined; * represents a stop codon. The twelve putative 
transmembrane regions are shaded.
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the second and third nucleotides of the cDNA were eliminated as viable translations 
because stop codons occurred to close to potential start codons (ATG). The selected 
ORF contains a 207 nucleotide 5' untranslated region (UTR) followed by an ATG start 
codon (encoding the translation initiator methionine) and encodes a 599 amino acid 
polypeptide. Base pairs 2005-2007 encode a stop codon (TAA) and signal the beginning 
of the 3' UTR, which extends for 447 base pairs. The ATG codon at nucleotides 208-210 
is embedded in a Kozak-like sequence (GACATGG) with guanine in the +4 position and 
a purine in the -3 position, further supporting its characterization as an initiator 
methionine.
The typical structure of GAT-1 proteins includes 12 transmembrane segments.
An hydropathy analysis of the putative xGAT-1 polypeptide was performed using the 
program TMpred, maintained by the Swiss Institute of Bioinfomatics (available at 
www.ch.embnet.org). The program predicts membrane-spanning regions of an amino 
acid sequence and their orientations. The algorithm is based on statistical analysis of a 
database of naturally-occurring transmembrane proteins as described in Hofmann and 
Stoffel (1993). TMpred results predicted two possible models. The highest scoring 
model was also consistent with the known structure of GAT-1 proteins where the C- and 
N-termini are located in the cytoplasm. This model, shown in Figure 2, predicts a 
12-transmembrane protein. The putative transmembrane segments are highlighted in 
Figure 1.
In Figure 3, the translated portion of the cDNA sequence for the putative xGAT-1 
is compared to equivalent amino acid sequences from GAT-1 cDNA reported in other 
organisms. Alignments are made to human rat, mouse, and ray GAT-1 sequences that
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T M p r e d  o u t p u t  f o r  xGAT 1
i -  >o
o -  > i
2000
1 0 0 0
- 1 0 0 0
3 0 0 0
- 4 0 0 0
-5 0 0 0
6 0 0 0
0 2 0 0 3 0 0 4 0 0 5 0 0 6 0 0
Figure 2. TMpred model results predicting a twelve transmembrane structure for 
xGAT-1.
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1 X . L . MATNGTKVADGQISTELSEAPIINDKPKTLWKVQKKKTEDMERDTWKGRFDFLMSCVSY
Human -----S----------- V ---VA--------------- AADLPD------------------
Rat  DNS----------- V ---VAS-------------- AGDLPD------------------
Mouse  DNS----------- V---VAS-------------- AGDLPD------------------
Ray -----A-TP HD - - VS------------ TRKIP*--EK-G- - Y  L -----
61 X . L A IG L G N V W R F P YIjC G K N G G G A F L IP Y F L T L IF A G V P L F L L E C S IjG Q YTS IGGLGVWKLAP
Human ------------------------------------------------------------------- ^        —   — — —     —            _ _   _ _     _       _ _ _ _   -
Mouse -------------------------------------------------------------- NW--
Ray ----------------------------- M------M-I------------- V ----I-R---
121 X.L MFKGVGLAAAILSFWLWJrY’JVXIAWaTyyinFSfiF'rrTLPWKNCDNYWNTERCFSNYSIP
Human ---------- V ---------------S------YN--------- Q -- P---D---- MV
Rat ---------- V ---------------S------ YN-------- -Q-- P---D --------LV
Mouse -----AV V -------------- S------ YN----------Q ---P---D ------- LV
Ray ---------- V --------- V-----------YN---SE---QS-G-S---D ------- MT
181 X.L. NTTNMTSAVLEFWERNMHQMTDGLEKPGQIRWPLAI T L A  JAWVLVYFCJWKGVGWTGKVV
Human --------- V --------------- D-------------------1-------------------
Rat --------- V --------------- D---------------------------------------
Mouse --------- V --------------- D------ *C------------------------------
Ray -S--LS-PIV--------- L  DQ-----A ----------------------- S------
241 X.L. Y F S A T Y P Y IM L V IL F F R G V T L P G A L D G 1L F YIT P KF S KL S D S E VWLD AAT Q IF F S Y G L G L
Human ------------ 1------------- KE-------- N-R-------------------------
Rat ------------1--------------KE-------- N-R-------------------------
Mouse ------------1------------- KE-------- N-R------- IF---------------
Ray ----1------ LT------------RE-------- D-RR------------------------
3 01 X.L. G S L IA L G SYNRFHNNVYRDS11VCCINS C T S M F A G L V IF S IV G F M A H V T K R PIEQVAASG
Rat -----------s--------------------------- F----------------S-AD-----
Mouse -----------S---------------------------F----------------S-AD-- 
Ray  V------ K-------------------T----- —  F-------------- N ---AD-----
3 61 X.L. PGLAFLAYSEAVTQLPISPLWSVLFFSMLLMLGIDSQFCTVEGFITALVDEFPKLLRTRR
Human -------- P-------------AI-----   Y-R-----
Rat ------ --P-------------AI--------------------------------Y-R----
Mouse -------- P-------------AI--------------------------------Y-R----
4 21 X.L. E IF IA W C W S Y L V G L S N IT Q G G IY V F K L F D Y Y S A S G M S L L F L V F F E C IS IS W C Y G V N R F
Human -L--A — II----1--------------------------------------V ---- F-----
Mouse -L--A — I-----1-----------------------------   V -F--
Ray -----M— I-----1--------- L ------------------------- TV-----------
4 81 X.L. YDNIEEMVGYRPCLWWKLCWTFFTPJJV’.AGVFZ.FSA.rQMTPLTMGSYVFPSWGQGVGWFAr
Human  Q  S I------S------------1---V-------- N  K------- L-
Rat  Q ----S-- 1------S----------------- V ------------- K--------L-
Mouse  C----S-- 1------S----------------- V ------------- K--------L-
Ray FV-IE HK--------- S------- G-----------K--K----I--K----------
541 X.L. A-LSSMVIiXPGYMVYIfFLSLKGSLKQRLQLMIRPTDEVVCSENGPEQLSQSNSANKEAYI
Human -------------A-M--A---------1-V-VQ-SEDT-RP----- HAQAGS-TS----
Rat -------------A-M— T---------- V- -Q-SEDI -RP-------PQAGS--S----
Mouse  ----------- A-M--T------   V--Q-SEDI-RP-------PQAGS--S----
Ray -----M------ G-M--TS -  ------ R- -TQ-NEDMK-R------ TECG-TPSD---M
Notes: 1. Amino acid sequence references: Human (Nelson et al., 1990); Rat (Clark, J.A. 1997 and
Guastella et al., 1990); Mouse (Liu et al., 1992); Ray (Swanson et al., 1994).
2. N = N-glycosylation site proposed by Bennett and Kanner, 1997.
3. represents identical amino acids, "*" represents spaces required for proper alignment.
4. Putative transmembrane segments in bold for X. laevis and shaded for other organisms.
Figure 3. Amino acid alignment of A. laevis GAT-1 cDNA with human GAT-1 
(Accession #P30531), rat GAT-1 (Accession #P23978), mouse GAT-1 
(Accession #P31648) and Pacific electric ray GAT-1 (Accession 
#151368).
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were obtained from GenBank (www.ncbi.nlm.nih.gov). The putative xGAT-1 clone 
shows 87-88% identity with mammalian GAT-1 and lower (82%) percent identity with 
ray GAT-1 (Table 7). Figure 3 also shows the distribution of transmembrane segments in 
the mammalian GAT-1 polypeptides reported by authors of the source references. The 
most significant difference in transmembrane placement between the GAT-1 
polypeptides occurs in rat GAT-1, which has been remodeled by Guastella’s co-workers 
(Bennett and Kanner, 1997) as twelve transmembrane segments plus an initial pore-loop 
structure.
Amino acid alignments of xGAT-1 with other cloned genes of GAB A transporter 
from mouse are shown in Figure 4. There is less than 50% identity between these genes 
and xGAT-1 (Table 7). By comparison, there is 64% identity between mouse GAT-2 and 
mouse GAT-3; 64% identity between mouse GAT-2 and mouse BGT-1; 61% identity 
between mouse GAT-3 and mouse BGT-1.
Genomic Clone Sequencing
Automated sequencing of the Xenopus laevis genomic fragment, named xgGAT- 
1, was performed to confirm its identity and to determine what portion of the gene was 
represented by this fragment. The fragment comprises the GT-Sac4 clone plus 244 bases 
of upstream sequence that were obtained using the genomic walking method. Through 
dye primer sequencing of subclones and dye terminator sequencing of the whole GT- 
Sac4 clone, 100 sequences of suitable quality were produced for analysis. A description 
of all sequence reactions is provided in Appendix A2 and the sequences used in the 
analysis are denoted.
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TABLE 7
PERCENT AMINO ACID IDENTITY BETWEEN X. LAEVIS GAT-1 
AND OTHER CLONED GAB A TRANSPORTERS.
Amino Acid Sequence % Identity Reference (Genebank Accession #)
Human GAT-1 87.6 Nelson et al., 1990 (# P30531)
Rat GAT-1 88.3 Guastella et al., 1990 and Clark, J.A., 1997 (# P23978)
Mouse GAT-1 87 Liu et al., 1992 (# P31648)
Ray GAT-1 82.1 Swanson et al., 1994 (# 151368)
Mouse GAT-2 (GAT3) 49.4 Liu et al., 1993 (# P31649)
Mouse GAT-3 (GAT4) 48.7 Liu et al., 1993 (# B44409)
Mouse BGT-1 (GAT2) 47.9 Liu et al., 1993 (# A43390)
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1. XGATl 
GAT-2 
GAT-3 
BGT-1
58. XGATl 
GAT-2 
GAT-3 
BGT-1
117. XGATl 
GAT-2 
GAT-3 
BGT-1
174. XGATl 
GAT-2 
GAT-3 
BGT-1
22 5. XGATl 
GAT-2 
GAT-3 
BGT-1
2 85. XGATl 
GAT-2 
GAT-3 
BGT-1
34 5. XGATl 
GAT-2 
GAT-3 
BGT-1
4 05. XGATl 
GAT-2 
GAT-3 
BGT-1
463. XGATl 
GAT-2 
GAT-3 
BGT-1
MATNGTK
MTAEQALPLG
VGYAIGLGNV
A- El-----
A- El-----
A-EI-----
KLAPMFKGVG
RIC-I-E-I-
RVC-L-E-I-
-IC-LLQ-I-
F**SNYSIPN 
-QKA-D-M*- 
-QKL-F-NYS 
-LNHSSARGV
VYFCIWKGVG
C--------K
C------ TK
C--------K
WLDAATQIFF
-M--G----
-V--G----
-M--G----
MAHVTKRPIE 
-SQEQGV--S 
--YEQGV--A 
-SQEQGI--S
ITALVDEFPK
V---- MY-R
V--V--MY-- 
V--SM-M--Q
LVFFECISIS 
VAI- -SLCVA
VAI VCIG
-SL--V-CIG
VADGQISTEL 
MENRA 
NGKAAEEARG 
M-RKVAVHE
WRFPYLCGKN
   Y- -
 Y- -
LA*AAILSFW
Y-SQM-V-L*
Y-TQV-EAH*
M-SW-E-Y*
TT***NMTSA 
V- SE*-A--P 
HVSLQ-A--P 
SSSE*-F--P
WTGKWYFSA
S------ T-
S----- VT-
S------ T-
SYGLGLGSLI
-FAIC--C-T
--AIC--C-T
-FAICQ-C-T
QVAASGPGLA
E--E-----
E--E-----
E--E-----
LLRT* *RREI
VF-KKN V
VF-RGY L
Q--KSG--DV
WCYGVNRFYD
-V--AG---
-V--S----
-V--AD---
SEAPIINDKP 
-GTTSNGET- 
--TLGGGGGG 
DGY-WSWV-
GGGAFLIPYF
 F--L
 ------ V
---- F---
LNIYYIVIIA
- -V VL-
- -V I -L-
-------------------- 1  - L -
VLEFWERNMH
-I---- RVL
-M---- RVL
-M RVL
TYPYIMLVIL 
-F--L V-
- F---- L- -
-F--L--I--
ALGSYNRFHN
----- KY--
----- NYN-
----- KY--
FLAYSEAVTQ
-I--PR--VM
-I--PK M
-I-FPK M
FIAWCWSY 
L-LI-S-I-F 
L-LALSII-- 
L-LAIS-LC-
NIEEMVGYRP
 D-I--K-
 D-I--R-
-V-D-I--R-
KTLWKVQKK 
VCPAMEKV*E 
AAGTREAR*D 
EEGEMMD--G
LTLIFAGVPL 
IF-FTC-I-V 
VFF-CC-I-V 
IFFFSC-I-V
WAIYYLFSSF
- -LF-----
 F--SNC-
- -LF-----
QMT* * * *DGL 
KL*S * * * -- I 
AI*S***--I 
GITSGIH-LG
FFRGVTLPGA
L I -------------
LI-------
L I -------------
NVYRDSIIVC
-C C-AL-
-C C-ML-
-C --AL-
LPISPLWSVL
- - F--- ACC
M-L AT-
M-L-Q--SC-
LVGLSNITQG 
FI--IML-E- 
FL--VML-E- 
-M--LLV-E-
CLWWKLCWTF
WPLI-Y--L-
LSLI-W--KV
WPLV-IS-L-
KTEDMERDTW 
EDGTL--EH- 
-AVH*--GH- 
-DQVKD-GQ-
FLLECSLGQY
-F--TA---
-F--TA---F 
-F--VA---
TTTLPWKNCD
- -D-- GS-S
- -E-- AT-G
-WE TT-T
EKPGQIRWPL 
QHL-SL--E- 
-HI-NL--E- 
****SL--E-
LDGILFYITP 
AQ--Q--LY- 
SE--K--LY- 
YQ--V--LK-
CINSCTSMFA
IL--S--FM-
-L--G--FV-
FL--A--FV-
FFSMLLMLGI 
- F - W L - L  
--M--IF--L 
--I F--L
GIYVFKLFDY
-M Q-----
-M-I-Q--GS 
-M-I-Q---
FTPIIVAGVF
 AVCLAT-
V--G-C--I- 
L--GLCLAT-
KGRFDFLMSC
NNKME-VL-V
NNKVE-VL-V
TNKME-VL-V
TSIGGLGVW*
-NQ--ITA-R
--E--ITC-R
S-Q-SVTA-R
NYWNTERC* *
HE N-VE
HE K-VE
-S HE-VD
AITLAIAWVL 
VLC-LL--II 
-LC-LAG-TI 
-LC-LL--II
KFSKLSDSEV
NITR-W-PQ-
DL-R PQ-
DLLR-K-PQ-
GLVIFSIVGF
-FA L- -
-FA VL--
- F-V L- -
DSQFCTVEGF
 VC--SL
 VC--SL
 VCM-CL
YSASGMSLLF
-AA C--
-AA C--
-AS--IC--
LFSAIQMTPL
 L-KY--
I-FLVKYK-- 
F--LSKY--
523. XGATl TMG*SYVFPS WGQGVGWFMA LS**SMVLIP GYMVYLFLSL KGSLKQRLQL MIRPTDEWC
GAT-2 -YNKK-TY-W --DAL--LL- --NC--IC-- AWSI-KLRT- --P-RE--RQ LVC-AEDLPQ
GAT-3 KYNNV-TY-A --Y-I--L-- --**--LC-- LWIFIKLWKT E-T-PEK-QK LTV-SADLKM
BGT-1 KYNNV-MY-S --YSI--LL- F-**--ACV- LFIIIT--KT Q--F-K--RR L-T-DPSLPQ
580 XGATl SENGPEQLSQ SNSANKEAYI
GAT-2 KNQPEPTAPA TPMTSLLRLT ELES
GAT-3 RGKLGASPRT VTVNDC--KV KGDGTISAIT EKETHF
BGT-1 PGRR-P-DGS -AQN*CSSSP AKQELI*AWE *KETHL
Note: represents identical amino acids, represents spaces required for proper alignment.
Figure 4. Amino acid alignment of X. laevis GAT-1 cDNA with GAT-2 (mouse
GAT3, Accession #P31649), GAT-3 (mouse GAT4, Accession #B44409) 
and BGT-1 (mouse GAT2, Accession #A43390).
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Based on a series of computer-generated alignments, seven contiguous sequences 
(contigs) were generated from the individual sequences. The seven contigs were 
subsequently aligned manually to produce a single contig representing the entire xgGAT- 
1 clone. Manual alignment enabled recognition of overlapping sequences that were not 
recognized by the software algorithm due to insufficient length of overlap or numerous 
ambiguities that commonly occur at the beginning and end of sequences. Appendix B1 
shows the compilation of sequences comprising the contig as well as segments of xGAT- 
1 cDNA (sequences labeled cDNAl through cDNA7) that align with the xgGAT-1 
fragment. These segments represent xGAT-1 exons comprising cDNA bases 32-1161.
As a visual reference to supplement Tables 5 and 6, dye terminator primer locations are 
denoted by underlining the section of the source sequence used to design the primer.
Appendix B1 presents the final preliminary consensus sequence (labeled 
CONSENSUS). The consensus sequence produced by computer analysis was reviewed 
manually and adjusted according to the following guidelines.
• The assigned base reflects the base identified in the majority of sequences.
• If a gap occurs in the majority of overlapping sequences, no base is assigned in 
the consensus sequence.
• If two or more bases are identified in overlapping sequences with no majority, the 
IUPAC character (lowercase) for that ambiguity is assigned.
• If the overlapping sequence aligns with a segment of xGAT-1 cDNA, the cDNA 
sequence is assigned unless an alternative base is identified in several overlapping 
sequences; then, that alternative base is assigned.
The overall positioning of individual sequences and interpretation of the consensus 
sequence is supported by several factors. First, there is a high confidence in alignments 
at the 5' and 3' ends of the final contig due to strong matches among multiple sequences.
I l l
For several individual sequences, the placement of at these ends is consistent with 
experimental design. For example, the Sac4 clones harbor the entire xgGAT-1 clone, 
thus Sac4 sequencing results should represent the 5' and 3' ends of the fragment. Clones 
derived from PCR on the EMBL arms and erase-a-base products also should produce 
sequences representing the 5' and/or 3' ends of the fragment. Second, cDNA segments at 
seven locations along the contig confirm the orientation and placement of several 
individual sequences. Third, correct position and orientation is indicated where IR Dye 
terminator sequences are in proximity to their primer sequence.
However, the consensus sequence is considered preliminary because there are significant 
alignment conflicts in two sections of the contig: (1) between cDNAl and cDNA2; and 
(2) between cDNA4 and cDNA5. Eighteen valid sequences could not be aligned within 
the logical framework produced by the other 82 sequences. The omitted sequences are 
listed in Table 8. Referring to Table 8, some of these sequences contain the primer 
sequence used to generate sequences that do appear in the final contig, thus, their general 
position is indicated. For example, GT-Sac4-Alul, GT-Sac4-Hae5, and GT-Sac4-Alul3 
sequences should fall between cDNAl and cDNA2 in some proximity to xgGATl-19, 
xgGATl-8 and xgGATl-5, respectively. Similarly, GT-Sac4-Alu2 and GT-Sac4-Alu3 
sequences should fall between cDNA4 and cDNA5 in some proximity to xgGATl-21 and 
xgGATl-9, respectively. There is, however, no significant alignment found and only 
partial alignments can be found anywhere in the final contig.
It is notable that the 18 sequences can be aligned to form two separate contigs and 
that some sequences (e.g., GT-Sac4-Alul4) can be partially aligned at multiple locations
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TABLE 8
SEQUENCES NOT INCLUDED IN CONSTRUCTING THE 
xgGAT-1 FRAGMENT CONTIG.
Omiga File Name Clone Name Comments
082600_S01_700 GT-Sac4-Alu1 -
082600_S01_800 GT-Sac4-Alu1 Source sequence for primer xgGAT1-19
082600_S02_800 GT-Sac4-Alu2 Source sequence for primer xgGAT1-21
082600_S03_800 GT-Sac4-Alu3 Source sequence for primer xgGAT1-9
082600_S07_800 GT-Sac4-Hae1 -
082900_S02_7 00 GT-Sac4-Hae5 Source sequence for primer xgGAT 1 -8
082900_S02_800 GT-Sac4-Hae5 -
091400_S02_700 GT-Sac4-Alu13 Source sequence for primer xgGAT1-5
091400_S02_800 GT-Sac4-Alu13 -
091400_S03_700 GT-Sac4-Alu14 -
091400_S02_800 GT-Sac4-Alu14 -
122900_S04_800 xgGAT1-10 --
010101_S02_800 xgGAT1-10 Source sequence for primers xgGAT1-22 and 
xgGAT 1-27
010101_S05_800 xgGAT1-10 -
011201_S02_800 xgGAT1-13 Aligns with xgGAT1-10 (may be mislabeled)
062301_S02_800 xgGAT1-27 -
070601_S05_800 xgGAT1-27 -
072101_S05_800 xgGAT 1 -22 -
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within the final contig. Blast searches of separate intron sequences from the final contig 
show sections aligning with well known repetitive elements (e.g., Xenopus laevis REM 
1). It is possible that repetitive elements occur within the introns of the gene that are 
affecting primer hybridization, thus producing sequences from unintended parts of the 
gene fragment. Additional sequencing with more specific primers will be required to 
resolve the conflict. Ultimately, the final genomic sequence will need to incorporate the 
18 sequences.
The final preliminary genomic sequence is compiled in Appendix B2, which also 
identifies exons, based on cDNA alignments, and intervening introns. Dye terminator 
primer locations that have been confirmed are denoted by underlining their position in the 
sequence and the primer name and orientation are labeled on the side. Based on this 
sequence analysis, the xgGAT-1 fragment comprises 13,051 nucleotide base pairs. The 
fragment includes 1,130 nucleotides of cDNA from base 32-1161.
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CHAPTER 4
RESULTS PART II: EMBRYOLOGICAL ANALYSIS 
In situ hybridization in Normal Embryos
In situ hybridization results in normal embryos were examined using whole mount 
and histological analysis. Staining provided a positive signal for the presence of xGAT-1 
cDNA. In all cases, signals were specific to the central nervous system. Hoke (2000) 
reported that control embryos showed no staining above background. Additionally, 
previous work demonstrated that only a weak, hindbrain signal was discernible prior to 
tailbud stage [25] and that the signal showed increasing intensity through pre-larva stage 
[40].
Analysis o f Whole Mounted Embryos
A staged series of experimental embryos, from tailbud stage [25] to early tadpole 
stage [35/36], is shown in Figure 5. At tailbud stage (Figure 5A), signal is visible in the 
midbrain only. By late tailbud stage [27], signal is apparent in all regions of the central 
nervous system including the forebrain, midbrain, hindbrain and the anterior portion of 
the developing spinal cord (Figure 5B). At later tailbud stages (Figure 5C, D, E, F, G, 
H), the signal continues to intensify and, by stage 32, signal extends the full length of the 
neural tube. Gaps in signal appear between the three regions of the brain (i.e., between 
the forebrain and midbrain and between the midbrain and hindbrain).
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Figure 5. In situ hybridization with antisense transcript of xGAT-1 cDNA shown in 
whole-mounted Xenopus laevis embryos. (A) Stage 25 tailbud (B) Stage 
27 tailbud ©) Stage 28 tailbud (D) Stage 29/30 late tailbud (E) Stage 32 
late tailbud (F) Stage 33/34 early tadpole (G) Stage 35/36 early tadpole 
(H) Stage 35/36 early tadpole. FB, forebrain; HB, hindbrain; MB, 
midbrain; SC, spinal cord.
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Histological Analysis
Approximatelyl5 embryos, prepared for histology from previous work in the lab, 
were analyzed to characterize the results of in situ hybridization experiments. This 
collection represented Xenopus developmental stages 20-45 (staging according to 
Nieuwkoop and Faber, 1967).
Additionally, 63 newly prepared slides comprising sections from 18 A. laevis embryos
were analyzed to characterize the results of in situ hybridization experiments. This
collection represented Xenopus developmental stages 20-45 including:
Stage 20-24 - 4 embryos 
Stage 25-29 - 4 embryos 
Stage 30-34 - 3 embryos 
Stage 35-39 - 4 embryos 
Stage 40-45 - 3 embryos
Histological sections presented in Figure 6 show representative in situ hybridization 
results over three stages (tailbud [25/26], hatching [33/34] and pre-larva [42]) and at 
levels of the midbrain, hindbrain and anterior spinal cord. Prior to pre-larva stage, all 
signal is localized to the neural tube. At tailbud (Figure 6A, B), a strong signal is seen at 
the midbrain and only a weak but definite signal occurs at the hindbrain; a result 
consistent with that observed in whole mounted embryos. Also similar to the whole 
mounted embryos, by late tailbud the signal occurs throughout the central nervous system 
(Figure 6C, D, E). By pre-larva stage, xGAT-1 signal is intense and present in a 
developing layer of the eye (Figure 6F). The duplicate stain presented as two bilateral 
foci in Figure 6G represents a single focal point of expression (presumed medio-dorsal, 
based on the more intensely stained foci) resulting from oblique sectioning.
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Figure 6. In situ hybridization with antisense transcript of xGAT-1 cDNA shown in 
horizontal sections of Xenopus laevis embryos. (A) Stage 25/26 midbrain 
(B) Stage 25/26 hindbrain (C) Stage 33/34 midbrain (D) Stage 33/34 
hindbrain (E) Stage 33/34 anterior spinal cord (F) Stage 42 midbrain (G) 
Stage 42 hindbrain (oblique cut). DF, dorsal fin; EY, eye; NT, neural 
tube; NO, notocord; OT, otic vesicle; SO, somite.
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The gaps appearing on either side o f the midbrain in the whole mounted embryos 
are also apparent in the histological sections. While signal appears ventral-medial in the 
midbrain sections (Figures 6A,C, F), signal in the hindbrain appears more dorsal (medio- 
ventral). Signal in the hindbrain is more punctate than in the midbrain or spine. Signal in 
the hindbrain is clearly post-mitotic and localized to the outer neural tube. In the 
midbrain, signal appears diffuse in the earlier tailbud stage, then in hatching stages is 
post-mitotic but still extends laterally along the left-right axis o f  the neural tube. In pre­
larva stage, the m idbrain shows an intense, post-mitotic signal, but weaker signal also 
extends laterally and into the dorsal region.
In situ hybridization in Explants
In situ hybridization was performed on embryo explants including full neural plates 
and regional explants o f the neural plate, both with and w ithout mesoderm. In situ 
hybridization was sim ultaneously perform ed on whole embryo siblings as a control. 
Staining provided a positive signal for the presence o f  xGAT-1 cDNA.
The results o f  in situ hybridization on neural explants are shown in Figure 7. All 
explants represent Xenopus laevis embryonic tissue that was removed at stage 1114, just 
after the initiation o f neurulation, and cultured until tailbud stage [33/34]. In presumptive 
neural plate tissue w ithout mesoderm (Figure 7A, B, C, D), signal is present in all 
dissections, but is more prominent and abundant in whole neural plates (Figure 7A). The 
signal is punctate (i.e., localized to small patches o f cells). In dissections o f the 
presumptive neural plate w ith mesoderm retained (Figure 7E, F, G, H), the signal is more 
intense than dissections without mesoderm and the staining is broader and more diffuse.
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Figure 7. In situ hybridization with antisense transcript o f xGAT-1 cDNA shown in 
explanted presum ptive neural tissue dissected from Xenopus laevis 
embryos. All explants are stage 33/34. (A-D) Cultured without 
mesoderm (E-H) Cultured with mesoderm. Arrows indicate regions o f 
xGAT-1 expression in explants.
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Of all the experimental tissues, the signal pattern in the full neural plate (Figure 7E) best 
reflects normal expression observed in normal embryos.
Signal in the neural plate tissue without mesoderm does not vary significantly 
between anterior, middle and posterior dissections. However, in presumptive neural plate 
tissue with mesoderm, the middle and posterior dissections have more intense signal than 
the anterior dissection. Overall, the results demonstrate that all regions of the 
presumptive neural plate are independently capable of xGAT-1 transcription either prior 
to or at the initiation of neurulation. However, the character o f the transcription product 
differs considerably among different explants suggesting a role for the factors of 
horizontal location and vertical interactions in the expression of xGAT-1 protein.
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CHAPTER 5
DISCUSSION PART I: Structure of xGAT-1 cDNA Clone 
and xgGAT-1 Genomic Fragment
Several lines of evidence indicate that the 2451 base pair cDNA clone that was 
isolated from Xenopus laevis tadpole brain library putatively encodes a 599 amino acid 
polypeptide that is the GABA transporter GAT-1 in A  laevis (i.e., xGAT-1). 
Characteristic ofN a+/Cl" transporters, xGAT-1 putatively has 12 transmembrane (TM) 
domains with N-terminal and C-terminal domains inside the cell membrane (i.e., 
cytoplasmic). Also, both N-terminal and C-terminal domains possess serine, tyrosine and 
threonine amino acids which are potential phosphorylaytion sites.
Other structural features common to Na+/Cf transporters and found in xGAT-1 
include:
• The conserved amino acid sequence WRFPxxxYxNGGGAF occurs in xGAT-1 at 
amino acid segment 68-82 with only one discrepancy (in xGAT-1, a glycine 
replaces the tyrosine in the conserved sequence).
• B ased on genomic sequencing, discussed below, the conserved intron position 
within the coding of the three glycines in the above conserved sequence is present 
in xGAT-1 occurring between amino acids 81 and 82.
• B ased on the location of putative transmembrane regions, xGAT-1 includes the 
characteristic large extracellular loop between TM3 and TM4 and this loop 
contains three potential glycosolation sites.
The putative xGAT-1 cDNA translates a polypeptide that contains, in correct 
position, the amino acid residues reported to be critical for GABA transporter function 
including arg-69, cys-64, glu-101, trp-68, trp-222 and trp-230. It appears that in xGAT-1 
the key amino acid tyr-140 occurs in an adjacent position (i.e., amino acid tyr-141). In 
Figure 8, the translated section of xGAT-1 cDNA is presented highlighting the putative
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transmembrane regions and denoting the intron locations (based on genomic sequencing 
discussed below). All putative amino acid transmembrane regions, occurring across the 
portion of the gene that was sequenced, fall within single exons (i.e., do not span multiple 
exons), which is characteristic of GAT-1.
Not unexpectedly, there is a decrease in percent identity between mammal GAT-1 
amino acid sequences and other types of vertebrates. That is, mouse, rat and human have 
greater percent identity to each other (97%) than any of them has to xGAT-1 (i.e., 87- 
88%). However, the percent identity is sufficiently high to distinguish this clone as 
GAT-1 rather than another of the GAT isoforms. The dendrogram in Figure 9 show an 
analysis of amino acid sequences from a variety of species and reflects the expected 
phylogenetic relationships. Xenopus laevis appears more closely related to the 
mammalian examples (mouse, rat, human) than to insects or lower vertebrates.
The GAT-1 genomic clone obtained from a Xenopus laevis muscle genomic library 
(Clontech) represents only a fragment of the xGAT-1 gene. Some extension of the 
genomic sequence (244 bases) in the 5' direction was accomplished by genomic walking 
techniques, however, there appear to be repetitive elements within the first intron that 
have caused additional extension experiments to fail.
Sequencing the genomic fragment has illuminated some of the structural features of 
the GAT-1 gene in Xenopus laevis, as illustrated in Figure 10. For example, the exon- 
intron junctions can be defined for over 60% of the cDNA coding region. The fragment 
contains exons 2 through 8 and introns 2 through 7 plus a portion of introns 1 and 8.
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ATGGCAACAAATGGAACTAAAGTGGCTGATGGGCAAATTTCCACAGAACTTAGTGAGGCCCCCATTATTAATGACAAGCCAAAAACCTTG
H A T N G T K V A D G Q I S T E L S E A P I I N D K P K T L
GTGGTGAAGGTTCAGAAGAAGAAAACAGAAGATATGGAAAGAGATACCTGGAAAGGGAGGTTTGACTTCCTTATGTCCTGTGTTGGTTAC
V V K V Q K K K T E D M E R D T W K G R F D
x2,m2j, |h3
GCCATTGGACTGGGAAATGTGTGGAGATTCCCCTATCTCTGCGGCAAGAATGGAGGAGGGGCTTTTCTCATTCCCTATTTCCTTACGCTC
A I  G L G N V W . R F P Y L C G K N G G G A F ' L ' I  P Y F ' L ' T  L
ATTTTCGCTGGGGTTCCTCTCTTTCTGTTGGAGTGCTCCCTGGGACAATACACTTCCATTGGAGGCCTTGGAGTATGGAAACTTGCTCCC
■ I ' F A G V P ' L F ' L L E C S L G Q Y T  S I G G L G V W K L A P
x 3 ,m3,h4|
ATGTTTAAAGGTGTTGGACTCGCTGCTGCCATCCTTTCCTTTTGGCTAAATATCTACTACATTGTTATCATCGCCTGGGCTATATATTAC
M F K G V G L A A A I L S
m4j, |x4,h5
CTCTTCAGTTCCTTCACCACTACCCTCCCTTGGAAAAACTGTGACAACTATTGGAATACTGAACGTTGCTTCTCCAACTACAGTATCCCC
i l i l l B l i l i l l l i l l l l l l l l  T T L P W K N C D N Y W N T E R C F S N Y S  I P
5 , m 5 , h 6 j
AACACCACCAATATGACGAGTGCCGTTTTGGAATTTTGGGAGCGCAATATGCACCAAATGACTGACGGACTGGAAAAACCAGGGCAGATC
N T T N M T S A V L E F W E R N M H Q M T D G L E K P G Q I
x6,m6,h7|
CGATGGCCGTTGGCGATCACACTGGCAATTGCGTGGGTTTTGGTCTATTTCTGCATCTGGAAAGGAGTCGGCTGGACAGGAAAGGTGGTC
R W P G V G W T G K V V
TACTTCTCAGCGACATATCCCTACATCATGCTGGTCATCTTGTTCTTCAGAGGAGTGACCTTGCCGGGAGCCTTGGATGGGATTTTGTTT
x7,h8j |m7
TATATAACTCCTAAATTCAGCAAGCTCTCGGATTCAGAGGTCTGGCTGGACGCTGCCACTCAGATCTTCTTTTCTTATGGTTTGGGACTT
Y I T P K F S K L S D S E V W L D A A T  B i | g | i ^ B l i * B g | | |E l B H f f l i i a f f l l E ®
x8 , m8,h9|
GGCTCCTTAATTGCTTTGGGAAGCTACAATCGATTCCACAACAATGTTTACAGGGATTCTATCATTGTCTGCTGCATCAACTCGTGCACA
Y N R F H N N V Y R D S I I V O C I N S C T
m9 ,hlO|
AGCATGTTTGCTGGTTTAGTAATCTTCTCTATTGTTGGCTTCATGGCCCATGTCACCAAGAGACCTATAGAACAAGTAGCTGCCTCAGGT
s m f a g l v j f s i v g f m a h v t k r p i  e q v a a s g
CCTGGGTTGGCGTTTTTAGCTTATTCTGAAGCGGTGACGCAACTGCCCATATCTCCGTTGTGGTCGGTGCTTTTCTTTTCTATGTTGCTG
P G L A F L A Y S E A V T Q L P I  l l l l B g l i i l l ga iM lll l lM ll l i i lS l i i l l lF l l l i lliPBil l i l l l lla
mlO, hll j
ATGCTTGGGATTGACAGCCAGTTTTGTACAGTTGAAGGCTTTATTACAGCTCTGGTGGATGAATTTCCAAAGTTGTTGCGCACACGGAGA
i l l l l l i i i i l l l i l l D  s q f c t v e g f i t a l v d e f p k l l r t r r
mil, hl2j,
GAAATTTTCATTGCAGTTGTTTGTGTTGTTTCTTACTTGGTGGGACTGTCCAACATAACCCAGGGTGGAATTTATGTATTCAAACTGTTT
E G G I Y V F K L F
hl3|
GACTACTACTCGGCCAGTGGAATGAGTCTCTTGTTTCTGGTCTTCTTTGAGTGCATCTCCATTTCTTGGTGTTACGGCGTTAACAGATTC
d  y y s  n  r  f
hl4 J,
TACGATAATATTGAGGAAATGGTCGGCTACAGGCCTTGTCTCTGGTGGAAACTCTGTTGGACTTTTTTCACCCCCATCATCGTAGCAGGA
y d n i e e m v g y r p c l w w k l c w t f f t p i i v a g
GTCTTCCTTTTCAGTGCTATTCAGATGACTCCTCTGACTATGGGCAGCTACGTTTTCCCATCTTGGGGGCAAGGAGTCGGCTGGTTCATG
m t p l t m g s y v f p s w g q  i l l l i l l l l i H l H l E l i
ml2,hl5|
GCTTTGTCATCCATGGTGTTAATTCCAGGTTACATGGTTTATTTGTTTCTGTCTCTTAAAGGCTCATTAAAACAGCGCCTACAACTCATG
s l k g s l k q r l q l m
ATACGACCAACCGATGAAGTCGTCTGCTCTGAAAATGGCCCAGAACAACTGTCCCAGAGCAACTCCGCAAACAAGGAAGCTTATATATAA
I r p t d e v v c s e n g p e q l s q s n s a n k e a y  i  *
Figure 8. Coding region of xGAT-1 cDNA showing putative transmembrane
regions. Consistent with known GAT-1 structure, transmembrane regions 
do not span multiple exons. Arrows ( j)  denote the position of introns 
sequenced from the xgGAT-1 genomic fragment and analogous introns 
from mouse and human genomic clones (x=xgGAT-l, m=mouse 
GABATMG, h=human GABATHG).
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Figure 9. Dendrogram analysis of phylogenetic relationships based on GAT-1
amino acid sequences (Amino acid sequences obtained from genebank).
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CCCAGATCCACAACTGCTGCATCTGGCGCAG.. . p a r t i a l l y  m is s in g  IN TR O N  
s e q u e n c e . . . .
. .xgGAT-1 genomic sequence. .
. . . .ACTATAGGGCACGCGTGGTCGACGGCCCGGGCTGGTCTGACACAAGGTCAgsCCATTCyGA
TTAGAAGrAAAGAGGwTCCrsCTAAATATTGGGAAGGGGTTTGTTACAGTGAGAGCTGTGAAkAT
GTGGAATTGTCTCCCTGAATCAGTGGTACAGGCTGATACATTAGATAGGTATAAGAAGGGGTTGG
ATGGTGTTTAGCAAGTGAGGGAATACAGGGATATGGGAGATAGCTCATAGTAC
GAGGATCCATGGACTGGTCCCATTGCCATTTTGGAGTCAGGAAGGAATGTTTTCCCCCTCTGAAG
CAAATTGGAGAGGCTTCAAATGGGGATTTTTGCCTTCCTCTGGATCAACTAGTAGTTAGGCAGGT
TATATACAGACCTAAAAGGTTGAACTTGAGGGGTATGTATCTTTTTTCAACCTAACTATGTTACT
TTGTTAAGAACATAAACCTGAGTCTTTCGGTAAAGAAGACTTTGAATCTAGCCATAAGTCTTCTA
TATATCAACTGAACTTCCCCTGCTTCTCTAAATTCCATTATTCCTACACAACTACTACATTCCTG
TACTCCATCCCCCCTCTGTACTTCTTCCTACTTCACGAACATTTTTCCTGAACTCCCCTTCCTCT
CTTACTTGGTTTGAACCATACACCCTCCTAATATTTTGATCTCTGTCCTCTCCTGTCTCTCCTAA
ACTCTAATTTCCCCTAATTCTAATGAAATTAAACCTCCCTGTTGTCTTAGTTTTCTTACCCCTCC
TTATTTCCTTACTCTACTGAACACTAGACTACCCGAACTGTAATTTTCTACTTCTCCAGAACCAT
AGCTTCTCCTACTTCTCATAGGATTTGTGTCTCTCCAATTACTTAGGGCTTTTTCCTCTCTTGCT
GTATCTGAACTTAAATTCTTACATCTTCTGCATTACAACTTCTACTGATACTTCAGAACCCTCTC
ATCTCTTACCTGTTTATAGTTATGTTCTCTTCTTGTCCTGAACTCTTTCCTTTACTACTGGTCAG
TACCTTCTTGCACCTCCTGCCTCCATTATATTATGTCTTCTTCTGCCTCTCTTGAACTCTATCTT
CTCTTACTTCTCTGTCATCTCCTATCTCTTTTGAACTATGTTCTCTTCTAAATTCTCAGCACCCT
CTTCTTCAACCTATATTAAAATCTGTCTTCTTCTGCCTTTGAACTGCTTGTTCCTACCTTTTATG
GGTTCTTTCCTTTCTCTCAACTTGTGAACTTGTCCTCTACTTCTTTCTTGTATTTGGACTTGTTA
AACCCTGTTCTCTCTTAGCTGTACTGAATGCTGCCATTTCCCACCCTCCTATTCAATTCCTATGT
TTTATGTATTCATAATTTGGGACTAAATAGTGTTTTCAACATTATGTCTTTCAGATCAACATTTA
ACCTTATAACCAAGCTCTGACCATCATATTCACCACTCTGCACCCTGGCGAAAGCGTCTTTCTAA
CCCTAGTTACGTAAGGAAGAGCCGCGAAGTGCTGTCCACGTGGACTGGTGCTGAAATCTCTCGTC
CGGCTGCCAGGCACTGCCATTCCAAACCAAGAGACATGGCAACAAATGGAACTAAAGTGGCTGAT
GGGCAAATTTCCACAGAACTTAGTGAGGCCCCCATTATTAATGACAAGCCAAAACCTTGGTGGTG
AAGGTTCAGAAGAAGAAAACAGAAGATATGGAAAGAGATACCTGGAAAGGGAGGTTTGACTTCCT
TATGTCCTGTGTTGGTTACGCCATTGGACTGGGAAATGTGTGGAGATTCCCCTATCTCTGCGGCA
AGAATGGAGGAGGT..3 3  8 9 b p  IN T R O N . . AGGGGCTTTTCTCATTCCCTATTTCCTTACGCT
CATTTTCGCTGGGGTTCCTCTCTTTCTGTTGGAGTGCTCCCTGGGACAATACACTTCCATTGGAG
GCCTTGGAGTATGGAAACTTGCTCCCATGTTTAAAGGT..1 2 5 2  b p  IN T R O N . . AGGTGTTGG
ACTCGCTGCTGCCATCCTTTCCTTTTGGCTAAATATCTACTACATTGTTATCATCGCCTGGGCTA
TA TA TTA C C TC TTC A G TTC C TTC A C C A C TG T..2 2  8 b p  IN T R O N . . AGACCCTCCCTTGGAAA
AACTGTGACAACTATTGGAATACTGAACGTTGCTTCTCCAACTACAGTATCCCCAACACCACCAA
TATGACGAGTGCCGTTTTGGAATTTTGGGAGT. . 1 2 6 6  b p  IN T R O N . . AGGCGCAATATGCAC
CAAATGACTGACGGACTGGAAAAACCAGGGCAGATCCGATGGCCGTTGGCGATCACACTGGCCAT
TGCGTGGGTTTTGGTCTATTTCTGCATCTGGAAAGGAGTCGGCTGGACAGGAAAGGT..3  2 7 9
b p  IN T R O N . . AGGT GGTCTACTTCTCAGCGACATATCCCTACATCATGCTGGTCATCTTGTTC
TTCAGAGGAGTGACCTTGCCGGGAGCCTTGGATGGGATTTTGTTTTATATAACTCCTAAATTCAG
CAAGCTCTCGGATTCAGAGGT..8 7  b p  IN T R O N . . AGGTCTGGCTGGACGCTGCCACTCAGAT
CTTCTTCTCTTATGGTTTGGGACTTGGCTCCTTAATTGCTTTGGGAAGCTACAATCGATTCCACA
A C A A TG TTTA CA G G C ..1 0 1 7 +  b p  IN T R O N .
cDNA (b p  1 - 3 1 )
5 1 e x t e n s io n  b y  
Genom e W a lk e r  
t e c h n iq u e
5 1 x g G A T l g e n o m ic  
c lo n e
cDNA (b p  3 2 - 4 4 4 )
cDNA (b p 4 4  5 - 5 7 7 )  
cDNA ( b p 5 7 8 - 6 7 8 )  
CDNA (b p  6 7 9 - 7 8 8 )  
cDNA ( b p 7 8 9 - 9 2 1 )
CDNA ( b p 9 2 2 - 1 0 5 6 )
cDNA (b p l0 5  7 - 1 1 6 1 )
3 '  x g G A T l g e n o m ic  
c lo n e
Figure 10. General structure of xgGAT-1 genomic clone including sequence of intron 
between exon 1 and exon 2 (ATG start codon is shaded).
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With one possible exception, the intron/exon junctions follow the normal GT/AG rule for 
splice site signal sequences, in which the first two bases of the intron (GT) and the last 
two bases of the intron (AG) are present in the 5'-3' direction of the coding strand. The 
exception occurs at the junction of exon 8 and intron 8. Because exon 9 is not present in 
the xgGAT-1 fragment, it is unclear whether exon 8 terminates at base 1153, which is 
followed by the normal splice sequence (GT) or whether the alignment with cDNA, 
which continues through base 1161, signals the termination of exon 8. In the latter case, 
the splice signal sequence would be GC. Notably, in reporting the mouse GAT-1 
genomic sequence, Liu et al. (1992) also noted one atypical splice site. It occurred in 
intron 7 where both GT and AG junction sequences were replaced by CT.
In the final preliminary consensus sequence there are single base differences 
between the genomic and cDNA sequences at 3 locations. In exon 2, there is the addition 
of a cytosine in the genomic sequence between cDNA bases 136 and 137 (base 1509 in 
the preliminary consensus sequence). This variance is not in the coding region of the 
gene. In exon 6, the adenine at cDNA base 864 is cytosine in the genomic sequence 
(base 8372 in the preliminary consensus sequence). This variance occurs in the third 
position of an alanine codon and does not change the amino acid coding. In exon 8, the 
thymine at cDNA base 1089 is cytosine in the genomic sequence (base 11963 in the 
preliminary consensus sequence). This variance occurs in the third position of a 
phenylalanine codon and does not change the amino acid coding. Thus, while the xGAT- 
1 gene may be subject to post-transcriptional modifications, evidence from the 5' half of 
the gene suggests that they do not affect protein structure.
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As described in the literature, the genomic structure of GAT-1 in different 
organisms may very significantly, even when there is a high percent identity. While the 
mouse GAT-1 gene has a total of 12 introns and 12 coding exons with translation 
initiating in exon 2, the human GAT-1 has a total of 15 introns and 14 coding exons with 
translation initiating in exon 3. The xGAT-1 cDNA, with 12 coding exons and an 
initiating codon in exon 2, appears to be more similar to mouse. A side-by-side 
comparison of Mus musculus and preliminary Xen op us laevis GAT-1 gene structure is 
provided in Table 9. Inside the coding region (after exon 2) exon sizes are fairly similar, 
however there is as much as an order of magnitude difference in size of analogous 
introns. In addition to structure, comparisons of xgGAT-1 preliminary sequence with 
mouse and human GAT-1 sequences were performed using BLAST utilities. The results 
show the expected alignments between exons, but no alignment across introns. Taken 
together, it appears that noncoding sequences from other organisms can provide little 
help in finalizing the xGAT-1 gene sequence.
Although intron size and sequence are not conserved across species, intron 
placement does appear to be similar. Figure 8 shows the translated section of xGAT-1 
cDNA denoting the location of introns sequenced for this study. The position of 
analogous introns from mouse and human GAT-1 genomic clones is also shown. At four 
of the seven exon/intron junctions sequenced within the coding region, analogous mouse 
and human GAT-1 introns are identically placed. Beyond the region sequenced for 
xgGAT-1, mouse and human junctions continue to be identical. Consistent with this 
study, Liu et al. (1992) reported that the position of the first intron in the coding region of 
several neurotransmitter transporters has been preserved in Drosophila and mice.
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TABLE 9
COMPARISON OF GAT-1 GENOMIC STRUCTURE IN MUS MUSCULUS 
(GABATMG) AND XENOPUS LAEVIS (PRELIMINARY xgGAT-1 SEQUENCE).
Elem ent Size GABATMG xgGAT-1
Exon 1 54 bp >31 bp
Intron 1 746 bp >1403 bp
Exon 2 326 bp 413 bp
Intron 2 300 bp 3389 bp
Exon 3 133 bp 133 bp
Intron 3 103 bp 1252 bp
Exon 4 96 bp 101 bp
Intron 4 1089 bp 228 bp
Exon 5 117 bp 110 bp
Intron 5 705 bp 1266 bp
Exon 6 131 bp 133 bp
Intron 6 2759 bp 3279 bp
Exon 7 144 bp 135bp
Intron 7 178 bp 87 bp
Exon 8 96 bp 105 bp
Intron 8 416 bp >1017 bp
Exon 9 127 bp
Intron 9 1351 bp
Exon 10 112 bp
Intron 10 198 bp
Exon 11 132 bp
Intron 11 1195 bp
Exon 12 372 bp
Intron 12 832 bp
Exon 13 2241 bp
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As discussed in Liu et al. (1992), the identical positioning of introns in related 
genes within a species is not unusual. It is unusual, however, to maintain intron position 
across species. Such an observation suggests a specific function for this gene 
organization. In particular, the preservation of the first intron position within the highly 
conserved region of the first coding exon of several neurotransmitter transporters (e.g., 
GABA, glycine, noradrenaline) supports a role in expression of these genes.
CHAPTER 6
DISCUSSION PART II: EXPRESSION OF XGAT-1
130
Normal xGAT-1 Expression
Few studies have been published on the expression of GABA transporter isoforms 
in the embryo and most do not examine developmental stages prior to the completion of 
neurulation. Examples include Perrone-Capano et al. (1994), who investigated post- 
neurulation GAT expression by RT-PCR and Jursky et al. (1994), who examined rats 
applying immunocytochemistry at E l7 and later. Lamborghini and lies (1985) observed 
GABA accumulation in vitro in cultured spinal neurons of Xenopus laevis at early tailbud 
(stage 24). Because the observed GABA uptake was Na+-dependent and sensitive to the 
known GAT inhibitor nipectotic acid, they concluded that uptake was most likely due to 
the activity of a Na+/Cl"-coupled GABA transporter. However, without the use of 
molecular markers, the presence of a functional GABA transporter can not be confirmed. 
Earlier experiments also used less reliable techniques (e.g., Evans et al., 1996, employed
35 S-based in situ hybridization which relies on audiogram interpretations that are more 
subjective than in situ hybridization). We consider our study to be more rigorous because 
the use of color reaction-based in situ hybridization techniques in this study allowed 
direct visualization of gene expression within the target tissue and the study examined 
early developmental stages including pre-neuralization.
Studies conducted in our lab demonstrate that xGAT-1 is first detected in the early 
tailbud embryo. These studies are the first to rule out the presence of a GABA 
transporter at high levels during early events (patterning, gastrulation, neurulation) in
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embryo development. In our study, using in situ hybridization, xGAT-1 expression was 
examined in X. laevis embryos from stages 20-45 by histological analysis of over 120 
anterior sections. Horizontal sections from the forebrain through anterior spinal cord 
were analyzed for the signal representing hybridized xGAT-1. No signal was observed 
prior to stage 25, thus earlier occurrences of xGAT-1 cannot be confirmed. However, 
cross-sections of embryos at stage 25 and later show staining patterns that are consistent 
with previous studies in this lab as well as patterns reported in the few studies by others 
(e.g., Roberts et al., 1987).
As in earlier GAT-1 studies (Jursky et al., 1994), xGAT-1 expression occurs along 
the full length of the neural tube but is restricted to the central nervous system of the 
developing and mature organism. The pattern of early expression of xGAT-1 in the 
midbrain, which shows a strong, diffuse ventral-medial signal developing into an intense 
post-mitotic signal by pre-larva stage, is consistent with reports that GABAergic 
components in mouse and rat brain are concentrated in the periventricular region (Ma and 
Barker, 1995 and Evans et al., 1996). Also, in Roberts et al. (1987), expression of GABA 
positive neurons was first observed in the midbrain with a weaker signal in the hindbrain 
at stage 25. The pre-larva stage xGAT-1 expression in the eye is consistent with the 
observation by Lam et al. (1980) that selective neurons in rabbit retina have a GABA 
uptake mechanism before significant levels of glutamic acid decarboxylase (GAD) and 
GABA occur.
Several studies indicate that the capability for GABA accumulation develops before 
phenotype maturation. Holyfield et al. (1979) showed that neuronal uptake of GABA 
precedes GABA synthesis in horizontal cells of the retina of Xenopus. Lam et al. (1980)
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demonstrated a mechanism for GABA uptake by neurons in the rabbit retina before they 
contain appreciable levels of GABA and GAD. The earliest detection of GABA-positive 
neurons, by Roberts at al. (1987), is in the hindbrain and midbrain by stage 25. The 
earliest detection of GABA uptake systems, by Lamborghini et al. (1985), is at stage 24. 
Thus, GABA uptake appears to precede neuronal phenotype maturation (i.e., GABA 
synthesis).
GAT-1 may act to regulate GABA concentration in the developing CNS (Jursky 
and Nelson, 1996, Sandell, 1998). Additionally, transmitter synthesis appears to coincide 
with the shift of morphological differentiation of neuronal processes. In this context, the 
results of this study show a pattern of xGAT-1 expression that roughly follows the 
appearance of GABAergic neurons as classified by Roberts et al. (1987). For example 
the reticulospinal neurons of the midbrain differentiate at stage 25, followed by ascending 
neurons in the hindbrain and spinal cord at stage 26, followed by optic tract neurons at 
stage 32.
Expression of GAT-1 in mammals is slightly later than the early tailbud expression 
of GAT-1 in A  laevis. RT-PCR results in mice, reported by Perrone-Capano et al.
(1994), showed first detection of GAT-1 mRNA at Embryonic Day 12, which is two days 
past tailbud (Lehman, 1983). Although the different sensitivities between in situ 
hybridization and the RT-PCR method may explain this discrepancy, the difference 
between developmental stages at which GAT-1 first appears may also be due to timing 
difference in GABAergic system development in different organisms.
The change in xGAT-1 expression, from diffuse to highly localized, in the 
developing X  laevis central nervous system suggests that xGAT-1 may be present in
133
specific populations of differentiating neurons. In the rat brain, early occurrence of 
GABA in the central nervous system corresponds with regions that subsequently 
differentiate into neurons of specific monoaminergic and peptidergic identity (Lauder et 
al., 1986). Highly localized expression of these GABAergic components in early 
development suggests that this system is positioned to affect the development of specific 
neuron populations. This possibility also extends from the evidence that supports a 
neurotrophic role for GABA (Wolff et al., 1993; Redbum and Rowe-Rendleman, 1996; 
Behar et al., 1996; Lauder, 1998).
Several lines of evidence point to a developmental role in neural systems for GABA 
and for components of the GABAergic system. However, much of the literature 
reporting this evidence is observational and, to date, there is little explanation about the 
molecular mechanisms directing the GABAergic components appearing in these 
processes. Also, studies investigating the presence of GABA, GABA receptors and the 
GABA synthesizing enzyme GAD in the embryo (e.g., Lauder et al., 1998; Roberts et al., 
1987; Cobas et al., 1991; and Ma and Barker, 1995) do not examine embryos for 
GABAergic markers in the earliest stages of development. Currently, no X. laevis GABA 
receptors have been cloned and while GAD has been cloned in X. laevis by our lab, no 
early developmental expression studies have been completed.
Our studies support a neurotrophic role for GABA. Neurons initiate their migration 
at stage 25 when they first begin to withdraw from the ependymal surface of the neural 
tube (Hartenstein, 1989). This coincides with the initial location and timing of xGAT- 
1 expression. The presence of xGAT-1 throughout the entire neural migratory process
134
suggests that the GABAergic system is functional during the period of neuronal 
migration and synaptogenesis.
Calcium has been shown to play a role in the maturation of synapses by regulating 
filopodia on pioneering growth cones of growing axons. GABA transporters are known 
to mediate calcium-independent release of GABA during development and transporter 
reversal may be the source of the GABA producing the excitatory response. This 
demonstrates a role in early development that differs from the role of GAT-1 in mature 
synapses.
In summary, GABA transporter xGAT-1 is not present at detectable levels in 
Xenopus laevis embryos until post-neurulation, although our studies cannot rule out the 
possibility of low level occurrences in early development. Thus, the GABAergic system, 
and in particular the molecular components for GABA uptake, do not likely play a role in 
patterning and inductive events such as gastrulation, neural induction and neurulation. 
However, our results indicate that expression of this GAT-1 GABA transporter isoform 
in X. laevis is consistent with a potential role for GABA in later events in neural 
development such as neural migration and synaptogenesis.
Cell-Cell Interactions
In situ hybridization experiments on whole and regional explants of the presumptive 
neural plate in developing Xenopus laevis embryos were designed to detect differences in 
xGAT-1 expression under various conditions of horizontal and vertical cell-cell 
interaction. Horizontal interactions are indicated by differences between whole and 
regional explants with mesoderm. Vertical interactions are indicated by comparison of
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explants with and without mesoderm. Of the various types of explant experiments 
described in Chapter 1, our work is most similar to the Horb and Slack (2001) 
experiments that investigated regional markers for endoderm development in Xenopus. 
However, to date, there have been no studies of this kind for any GAB Aergic components 
in any species.
The results of explant in situ hybridization, in which middle and posterior 
presumptive neural tissue (with mesoderm) shows more intense signal than anterior 
tissue, is consistent with the strong neural inducing capacity of the more posterior region 
as discussed in Kessler and Melton (1994) and Slack and Tannahill (1992). Vertical 
signaling appears to play an important role as well. The explant in situ hybridization 
experiment results suggest that mesoderm is necessary to produce normal expression, 
where a positive signal provided by the mesoderm overrides a negative signal provided 
by the ectoderm. The broad and diffuse stain produced in explanted neural tissue with 
mesoderm may also reflect a lack of suppression by planar signal that would be present in 
the whole embryo.
136
CHAPTER 7 
FUTURE DIRECTIONS
Several questions remain in regard to the structure of the GAT-1 gene and the role 
of GABA transporters in development. Most important to future studies of the xGAT-1 
protein is isolation of the promotor region of the gene. The genomic fragment described 
in this study did not contain the entire cDNA, and the 31 nucleotide portion of cDNA that 
remains 5' of the fragment has proved too small to be used in genome walking 
experiments.
The next experiments, currently underway in the lab, focus on obtaining a new 
fragment that includes the promotor region. One approach is to screen the existing 
Xenopus laevis library using the 244 bp fragment, isolated by genome walking 
techniques, to obtain the fragment adjacent to the partial xgGAT-1 clone studied in this 
project. A second approach is to use the 5' segment of xGAT-1 cDNA (first 100+ 
nucleotides) to screen a differently cut Xenopus laevis library in hopes of hybridizing a 
fragment that is 5' of the partial xgGAT-1 clone.
Once the promotor region is identified and sequenced, it will be possible to develop 
transgenic lines of Xenopus laevis and Xenopus tropicalis with GFP reporter constructs 
that contain the isolated xGAT-1 promoter and to examine regulation of the GABAergic 
system. The reporter construct would be used in a dual approach of plasmid injections 
and transgenesis to characterize the cis-acting (regulatory) sequence required for cell- 
specific expression and to assess spatial and temporal controls for expression.
To complete characterization of the xGAT-1 gene, the sequence of partial xgGAT-1
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clone needs to be resolved and the adjacent 3' prime fragment needs to be isolated and 
sequenced. A genome walking experiment at the 3' end of the partial xgGAT-1 clone 
could generate a fragment for fishing out the remainder of the gene from the existing 
Xenopus laevis library. To resolve the remaining sequence ambiguities in the partial 
xgGAT-1 clone, a new set of primers could be developed based on the cDNA segments, 
now that their composition and position in the clone are known with a high degree of 
confidence. Using the IR Dye method, sequences would be obtained from both 
directions of the cDNA segments. Using the iterative approach taken in this study, new 
primers would continue extending these sequences to create a full verification contig. 
Efforts to sequence the entire GAT-1 gene have been reported for only two other 
organisms (mouse and human) and the human gene (GABATHG) sequence is 
incomplete. Thus, completion of the xGAT-1 gene sequence would be a valuable 
addition for future comparative studies.
While transgenesis experiments await the completion of promotor isolation, other 
types of expression studies may help further delineate the timing and location of GAT-1 
appearance in the central nervous system. Fluorescent microscopy using a confocal or 
two-photon microscope would allow visualization on any plane or at any point, 
respectively, of fluorescent in situ hybridization (FISH) DNA or protein within a whole 
embryo. This type of microscopic analysis can also be performed on colocalization 
experiments. Such experiments simultaneously process specific markers of interest. For 
example, Taylor and Benes (1996) used trilocalization of GAD67, 5HT and TH-IR in the 
pyramidal and nonpyramidal cell bodies of rat medial prefrontal cortex to demonstrate 
that GABAergic intemeurons can be simultaneously regulated by more than one
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monoaminergic system. Colocalization studies on expression of the various GABAergic 
components in developing Xenopus could help formulate a more refined hypothesis for 
the potential function of the GABAergic system during development.
Evaluation of the expression of GAT and other components of the GABAergic 
system in early development (e.g., receptors, GAD) also is critical to understanding the 
role of GABA-mediated signaling for neural migration and synaptogenesis. The current 
evidence from in vitro experiments could be validated and extended through in vivo 
experiments that assess embryonic development when GABA-mediated signaling is 
eliminated. For example, a saturating concentration of mutant subunits of GABAa and 
GAB Ac receptors could be introduced by mRNA injection into the oocyte resulting in the 
formation of nonfunctional receptors. Alternately, translation of subunit mRNAs can be 
inhibited by injection of morpholino-type antisense oligonucleotides. The isolation of 
GABA receptor subunits in Xenopus laevis, a prerequisite for both approaches, is 
currently underway in our laboratory.
Explant experiments described in this study are an important step to understanding 
the signaling pathway through which GABA exerts its neurotrophic effects. Our 
laboratory is extending these studies by more discrete analysis of post-neurulation 
expression of GAT. The three neural plate regions (anterior, middle and posterior) 
examined in this work have been sectioned to better characterized the GAT signal in 
those tissues. Additionally, work is underway to repeat these experiments at later stages 
(i.e., stage 13 and 14) to determine when the patterning becomes fixed.
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While the results of this study suggest that the GABAergic system is not 
functionally capable of acting in preneurulation development, discerning the role of this 
system in later development of the central nervous system may be critical to 
understanding the role of this and other transmitters in neuron growth. Further study of 
the GABAergic system might contribute to understanding nervous system repair and 
neuron regeneration in the adult, currently a topic of great medical interest. Our study 
demonstrates that important structural features found in mammalian GAT-1 
neurotransmitter transporter are preserved in Xenopus laevis. Given the experimental 
advantages of this organism, investigators may want to consider & Xenopus model for 
future in vivo experimentation.
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APPENDIX A 
SEQUENCING LOGS
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Appendix A1 
Sequencing Log for cDNA Analysis of xGAT-1
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Clone Name Alias
Date of 
Prep
Sequence ID 
(Run date in bold) Comment
Expected 
Insert Size
5-26-1
(discarded)
- 05-26-00 06012000 S01 700 
06012000S 01  800
(5' cDNA) 
700-ambiguities 
800-no seq.
825 bp 
(p. 2-77)
5-26-5
(discarded)
— 05-26-00 06012000 S02 700 
06012 0 0 0 S 0 2 8 0 0
(5* cDNA) 
700-ambiguities 
800-no seq.
825 bp 
(p. 2-77)
6-1-3
(discarded)
5-26-9 06-01-00 06012000 S03 700 
06012000_S03_800
(mid cDNA) 
700-70 bp seq. 
800-280 bp seq.
825 bp
(p. 2-82)
6-1-4
(discarded)
5-26-6 06-01-00 06012000 S04 700 
06012000_S04_800
(mid cDNA) 
700-130bp seq. 
800-360 bp seq.
825 bp
(p. 2-82)
6-1-5
(discarded)
5-26-7 06-01-00 06012000 S05 700 
06012000_S05_800
(3' cDNA) 
700-70 bp seq. 
800-280 bp seq.
825 bp
(p. 2-82)
6-2-1 5-26-1
6-1-1
06-02-00 060800 S04 700 
*060800_S04_800
(5' cDNA)
Great reverse (800) 
sequence. Aligns to 
xGAT 1 (GABA primer 
T10-T17)
825 bp 
(p. 2-77)
6-2-5 5-29-7
6-1-5
06-02-00 *060800 S05 700 
060800_S05_800
(3' cDNA)
Good forward (700) 
sequence. Aligns to 
xGAT 1 (GABA primer 
T18-T20)
825 bp 
(p. 2-84)
6-15-1 cGT 8/19-1 06-19-00 *061900 S01 700 
061900_S01_800
(mid cDNA) 
Good forward 
sequence (700)
825 bp 
(p. 2-90)
6-15-6 cGT 8/19-2 06-19-00 *061900 S02 700 
061900_S02_800
(mid cDNA) 
Good forward 
sequence (700)
825 bp 
(p. 2-90)
6-15-12 cGT 18/20-1 06-19-00 *061900 S03 700 
061900_S03_800
(3' cDNA)
Good forward 
sequence (700)
825 bp 
(p. 2-90)
6-15-14 cGT 18/20-2 06-19-00 *061900 S04 700 
061900_S04_800
(3' cDNA)
Good forward 
sequence (700)
825 bp 
(p. 2-90)
cGT-8/19-1 6-15-1 06-22-00 *062200 S01 700 
*062200_S01_800
(mid cDNA)
Great reverse (800) 
sequence.
825 bp 
(p. 2-98)
cGT-8/19-2 6-15-6 06-22-00 *062200 S02 700 
*062200_S02_800
(mid cDNA)
Great forward (700) 
sequence.
825 bp 
(p. 2-98)
cGT-18/20-1 6-15-12 06-22-00 *062200 S03 700 
*062200_S03_800
(3' cDNA)
Great forward (700) 
and reverse (800) 
sequence.
825 bp 
(p. 2-98)
cGT-18/20-2 6-15-14 06-22-00 062200 S04 700 
062200_S04_800
(3' cDNA) 
700-83 bp seq. 
800-21 bp seq.
825 bp 
(p. 2-98)
6-2-1 5-26-1
6-1-1
06-02-00 080900 S13 700 
080900_S1 3 8 0 0
(5' cDNA) 825 bp 
(p.2-77)
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Clone Name Alias
Date of 
Prep
Sequence ID 
(Run date in bold) Comment
Expected 
Insert Size
6-2-1 5-26-1
6-1-1
06-02-00 082200 S07 700 
082200_S07_800
(5' cDNA)
Aligns to 5' xGAT1
825 bp 
(p. 2-84)
6-2-1 5-26-1
6-1-1
06-02-00 082600 S13 700 
082600_S13_800
(5’cDNA) 
Poor seq.
825 bp 
(p. 3-34)
6-2-1 5-26-1
6-1-1
06-02-00 082900 S01 700 
082900_S01_800
(51 cDNA) 
Poor seq.
825 bp 
(p. 3-34)
5-26-1A 08-31-00 *090500 S01 700 
*090500_S01_800
(full cDNA)
Good forward and 
reverse sequence 
700-aligns to 3’, 
800-aligns to 5’
2550 bp 
(p. 3-39)
5-26-1B 08-31-00 *090500 S02 700 
*090500_S02_800
(full cDNA)
Good forward and 
reverse sequence 
700-aligns to 3' 
800-aligns to 5'
2550 bp 
(p. 3-39)
5-26-1A 08-31-00 *090500 S03 700 
*090500_S03_800
(full cDNA)
Good forward and 
reverse sequence 
700-aligns to 3’ 
800-aligns to 5'
2550 bp 
(p. 3-39)
5-26-1B 08-31-00 *090500 S04 700 
*090500_S04_800
(full cDNA)
Good forward and 
reverse sequence 
700-aligns to 3' 
800-aligns to 5'
2550 bp 
(p. 3-39)
T10/17-1 — 09-12-00 *091400 S06 700 
*091400_S06_800
(5' cDNA)
Great 5' forward and 
reverse sequence
850 bp 
(p. 3-43)
T10/17-2 — 09-12-00 *091400 S07 700 
*091400_S07_800
(5' cDNA)
Great forward and 
reverse sequence
850 bp 
(p. 3-43)
T10/17-4 — 09-12-00 *091400 S08 700 
*091400_S08_800
(5' cDNA)
Great forward and 
reverse sequence
850 bp 
(p. 3-43)
All sequencing performed using Dye-Primer Protocol.
* Sequence reaction used to develop final cDNA sequence for xGAT1
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APPENDIX A2 
Sequencing Log for Genomic Analysis of xgGAT-1 Fragment
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IR Dye Primer Name 
(GT-Sac4 Clone used in 
all cases)
Sequence ID 
(Date in bold) Result
GAB A Tr-1* 102900_S01_800 Good seq., alignment with xGAT1
GABA Tr-2* 102900_S05_800 436 bp, ambiguities, no cDNA match
GABA Tr-2* 110200_S01_800 Fair seq., ambiguities, no cDNA match
GABA Tr-3 102900_S02_800 361 bp, ambiguities, no cDNA match
GABA Tr-3 110200_S02_800 Poor seq., not analyzed
GABA Tr-3* 110900_S05_800 Fair seq., ambiguities, no cDNA match
GABA Tr-4 110200_S05_800 Poor seq., not analyzed
GABA Tr-4 102900_S06_800 Poor seq., not analyzed
GABA Tr-4 010101_Samp05_800 Poor seq., not analyzed
GABA Tr-6 110900_S01_800 Poor seq., not analyzed
GABA Tr-6 010101_Samp06_800 Poor seq., not analyzed
GABA Tr-7 110200_S06_800 Poor seq., not analyzed
GABA Tr-7 010101_Samp07_800 Poor seq., not analyzed
GABA Tr-8 110900S02800 Poor seq., not analyzed
GABA Tr-9* 102900_S07_800 Good seq., alignment with xGAT 1
GABA Tr-10 110200S03800 Poor seq., not analyzed
GABA Tr-10 110900S06800 Poor seq., not analyzed
GABA Tr-11* 102900_S03_800 Fair seq., ambiguities, no cDNA match
GABA Tr-11 102900_S08_800 282 bp, ambiguities, no cDNA match
GABA Tr-12 110200_S07_800 Poor seq., not analyzed
GABA Tr-12 010101_Samp08_800 Poor seq., not analyzed
GABA Tr-13 110900_S03_800 Poor seq., not analyzed
GABA Tr-14* 110200_S08_800 Good seq., no cDNA match
GABA Tr-17* 102900S04800 Good seq., no cDNA match
GABA Tr-18 110900_S07_800 Poor seq., not analyzed
GABA Tr-19 110900_S08_800 Poor seq., not analyzed
GABA Tr-20 110900_S04_800 Poor seq., not analyzed
xgGAT1-1* 121800_S01_800 Good seq., alignment with cDNA
xgGAT1-1* 122900_S09_800 Good seq., alignment with cDNA
xgGAT1-2* 121800_S02_800 Good seq., no cDNA match
xg GAT 1-2 011201_Samp01_800 Poor seq., not analyzed
xgGAT1-3 122900_S01_800 358 bp, ambiguities, no cDNA match
xgGAT1-3 122900S10_800 Fair seq., 393 bp, no cDNA match
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IR Dye Primer Name 
(GT-Sac4 Clone used in 
all cases)
Sequence ID 
(Date in bold) Result
xg GAT 1-3* 010101_S01_800 Fair seq., 897 bp, no cDNA match
xgGAT1-3* 072101_S01_800 Good seq., 241 bp
xg GAT 1-4* 121800S03800 Fair seq., ambiguities, no cDNA match
xgGAT1-4* 072101_S02_800 Good seq., 852 bp
xg GAT 1-5* 122900_S02_800 Good seq., no cDNA match
xgGAT1-5 122900_S11800 Fair seq., 401 bp, alignment with cDNA
xgGAT1-5 011201_Samp02„800 Poor seq., not analyzed
xgGAT1-5* 080401 _S01_800 Fair seq., 758 bp
xgGAT1-6* 121800S04800 Good seq., alignment with cDNA
xgGAT1-6* 011201_S01_800 Good seq., 853 bp
xg GAT 1-7* 122900_S12800 Good seq., alignment with cDNA
xgGAT1-8* 121800S05800 Good seq., no cDNA match
xgGAT1-8 011201_Samp04_800 Poor seq., not analyzed
xgGAT1-9* 122900_S03_800 Good seq., no cDNA match
xgGAT1-10* 122900_S04_800 Good seq., no cDNA match
xgGAT1-10* 010101_S02_800 Good seq., 830 bp, no cDNA match
xgGAT1-10* 010101_S05_800 Good seq., 829 bp, no cDNA match
xgGAT1-10 011201_Samp05_800 Poor seq., not analyzed
xgGAT1-10* 080401_S02_800 Fair seq., 512 bp
xgGAT1-11* 122900_S05_800 Good seq., no cDNA match
xgGAT1-12* 122900S06800 Good seq., no cDNA match
xgGAT1-12* 010101S03800 Good seq., 853 bp, no cDNA match
xgGAT1-12 011201_Samp06_800 Poor seq., not analyzed
xgGAT1-13* 122900_S07_800 Good seq., alignment with cDNA
xgGAT1-13 011201_Samp07_800 Poor seq., not analyzed
xgGAT1-14 122900_S08_800 320 bp, ambiguities, no cDNA match
xgGAT1-14 010101_S04_800 943 bp, ambiguities, no cDNA match
xgGAT1-14 010101_S06_800 391 bp, ambiguities, not analyzed
xgGAT1-14 011201_Samp08_800 Poor seq., not analyzed
xgGAT1-15 013101_Samp01_800 Poor seq., not analyzed
xgGAT1-15* 080401 _S03_800 Good seq., 922 bp
xgGAT1-15 022001 _Samp03_800 Poor seq., not analyzed
xgGAT1-15 022701_S01_800 Fair seq., 462 bp
xgGAT1-15 031101_Samp01_800 Poor seq., not analyzed
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IR Dye Primer Name 
(GT-Sac4 Clone used in 
all cases)
Sequence ID 
(Date in bold) Result
xgGAT1-15* 042601 _S01_800 Good.seq., 593 bp
xgGAT1-15* 072101_S03_800 Good seq., 105 bp
xgGAT1-16 013101_Samp02_800 Poor seq., not analyzed
xgGAT1-16* 082201_S01_800 Good seq., 640 bp
xgGAT1-16 022001_Samp04_800 Poor seq., not analyzed
xgGAT1-16* 022701_S02_800 Good seq., 730 bp
xgGAT1-17 013101_Samp03_800 Poor seq., not analyzed
xgGAT1-17 022001_Samp05_800 Poor seq., not analyzed
xgGAT1-17 022701_Samp03_800 Poor seq., not analyzed
xgGAT1-17 031101_Samp02_800 Poor seq., not analyzed
xgGAT1-17* 042601 _S02_800 Good seq., 568 bp
xgGAT1-17* 070601 _S01_800 Good seq., 743 bp
xgGAT1-18 013101_Samp04_800 Poor seq., not analyzed
xgGAT1-18 022001_Samp06_800 Poor seq., not analyzed
xgGAT1-18* 022701_S03_800 Good seq., 446 bp
xgGAT1-19 013101_Samp05_800 Poor seq., not analyzed
xgGAT1-19 022001_Samp07_800 Poor seq., not analyzed
xgGAT1-19 022701_Samp05_800 Poor seq., not analyzed
xgGAT1-19 031101_S01_800 Fair seq., 432 bp
xgGAT1-19* 042601 _S03_800 Good seq., 517 bp
xgGAT1-19* 070601_S02_800 Good seq., 756 bp
xgGAT1-20 013101_Samp06_800 Poor seq., not analyzed
xg GAT 1-20* 022001 _S03_800 Good seq., 373 bp
xg GAT 1-20 031101_Samp04_800 Poor seq., not analyzed
xg GAT 1-20* 072101_S04_800 Good seq., 912 bp
xg GAT 1-21 013101_Samp07_800 Poor seq., not analyzed
xg GAT 1-21 022001_Samp09_800 Poor seq., not analyzed
xgGAT1-21 022701_Samp06_800 Poor seq., not analyzed
xgGAT1-21* 022701_S04_800 Good seq., 666 bp
xg GAT 1-22 013101_Samp08_800 Poor seq., not analyzed
xg GAT 1-22 022001_Samp10_800 Poor seq., not analyzed
xgGAT1-22 022701 _Samp08_800 Poor seq., not analyzed
xgGAT1-22 031101_Samp05_800 Poor seq., not analyzed
xg GAT 1-22* 072101_S05_800 Good seq., 801 bp
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IR Dye Primer Name 
(GT-Sac4 Clone used in 
all cases)
Sequence ID 
(Date in bold) Result
xg GAT 1-23* 013101_S01_800 Good seq., 543 bp
xg GAT 1-23* 022001 _S04_800 Good seq., 230 bp
xg GAT 1-23* 022701_S05_800 Good seq., 340 bp
xg GAT 1-2 3 031101_Samp06_800 Poor seq., not analyzed
xg GAT 1-24 013101_Samp10_800 Poor seq., not analyzed
xg GAT 1-24 022001 _Samp12_800 Poor seq., not analyzed
xg GAT 1-24 022701_Samp10_800 Poor seq., not analyzed
xg GAT 1-24 031101_Samp07_800 Poor seq., not analyzed
xgGAT1-24* 070601_S03_800 Good seq., 825 bp
xgGAT1-25 013101_Samp11_800 Poor seq., not analyzed
xg GAT 1-25* 022001_S05_800 Fair seq., 485 bp
xg GAT 1-25 031101 _Samp08_800 Poor seq., not analyzed
xg GAT 1-26* 062301 _S01_800 Good seq., 524 bp
xgGAT1-26* 070601 _S04_800 Fair seq., 443 bp
xg GAT 1-27* 062301 _S02_800 Good seq., 792 bp
*xg GAT 1-27 070601 _S05_800 Good seq., 532 bp
*xgGAT1-30 062301_S03_800 Good seq., 773 bp
*xgGAT1-30 070601 _S06_800 Good seq., 611 bp
*xg GAT 1-31 062301 _S04_800 Good seq., 737 bp
*xgGAT1-32 062301_S05_800 Good seq., 745 bp
*xg GAT 1-32 070601_S07_800 Good seq., 861 bp
*xgGAT1-33 070601_S08_800 Good seq., 775 bp
All sequencing performed using Dye-Terminator Protocol.
* Used to form xGAT-1 fragment contig.
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APPENDIX B 
SEQUENCING RESULTS FOR xgGAT-1
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APPENDIX B-l
COMPILATION OF xgGAT-1 GENOMIC FRAGMENT SEQUENCES USING 
SEQLAB (GELASSEMBLE PRETTYOUT UTILITY)
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GCG File ID 
(Sequence ID 
abbreviated)
Sequence Exported from OMIGA to Wisconsin Package 
(source sequences for primers are underlined)
gw 0 8 2 6 1 7  
gw 0 8 2 6 1 8  
gw 0 8 2 6 2  7 
gw 0 8 2 6 2  8 
CONSENSUS
ACTATAGGGCACGCGTGGTCGACGGCCCGGGCTGGTCTGACACAAGGTCA. CCCATTCCG 
ACTATAGGGCACGCGTGGTCGACGGCCCGGGCTGGTCTGACACAAGGTCA. CCCATTCCG 
ACTATAGGGCACGCGTGGTCGACGGCCCGGGCTGGTCTGACACAAGGTCAGGCCATTCTG 
ACTATAGGGCACGCGTGGTCGACGGCCCGGGCTGGTCTGACACAAGGTCAGGCCATTCTG 
ACTATAGGGCACGCGTGGTCGACGGCCCGGGCTGGTCTGACACAAGGTCAgsCCATTCyG
gw 0 8 2 6 1 7  
gw 0 8 2 6 1 8  
gw 0 8 2 6 2  7 
gw 0 8 2 6  2 8 
CONSENSUS
> ATTAGAAGGAAAGAGGTTCCGCCTAAATATTGGGAAGGGGTTTGTTACAGTGAGAGCTGT
< ATTAGAAGGAAAGAGGTTCCGCCTAAATATTGGGAAGGGGTTTGTTACAGTGAGAGCTGT
> ATTAGAAGAAAAGAGGATCCAGCTAAATATTGGGAAGGGGTTTGTTACAGTGAGAGCTGT
< ATTAGAAGAAAAGAGGATCCAGCTAAATATTGGGAAGGGGTTTGTTACAGTGAGAGCTGT
< ATTAGAAGrAAAGAGGwTCCrsCTAAATATTGGGAAGGGGTTTGTTACAGTGAGAGCTGT
gw 0 8 2 6 1 7  
gw 0 8 2 6 1 8  
g w 0 8 2 6  2 7 
gw 0 8 2 6  2 8 
CONSENSUS
GAAGATGTGGAATTGTCTCCCTGAATCAGTGGTACAGGCTGATACATTAGATAGGTATAA
GAAGATGTGGAATTGTCTCCCTGAATCAGTGGTACAGGCTGATACATTAGATAGGTATAA
GAATATGTGGAATTGTCTCCCTGAATCAGTGGTACAGGCTGATACATTAGATAGGTATAA
GAATATGTGGAATTGTCTCCCTGAATCAGTGGTACAGGCTGATACATTAGATAGGTATAA
GAAkATGTGGAATTGTCTCCCTGAATCAGTGGTACAGGCTGATACATTAGATAGGTATAA
 + + + + + +
gwO 8 2 6 1 7 > GAAGGGGTTGGATGGTGTTTAGCAAGTGAGGGAATACAGGGATATGGGAGATAGCTCATA
g w 0 8 2 6 1 8  < GAAGGGGTTGGATGGTGTTTAGCAAGTGAGGGAATACAGGGATATGGGAGATAGCTCATA
gwO 8 2 6 2 7 > GAAGGGGTTGGATGGTGTTTAGCAAGTGAGGGAATACAGGGATATGGGAGATAGCTCATA
gwO 8 2 6 2 8 < GAAGGGGTTGGATGGTGTTTAGCAAGTGAGGGAATACAGGGATATGGGAGATAGCTCATA
0 4 1 2 _ 4 _ 8 0 0  > TATAGGG. A
CONSENSUS < GAAGGGGTTGGATGGTGTTTAGCAAGTGAGGGAATACAGGGATATGGGAGATAGCTCATA
gw 0 8 2 6 1 7  
g w 0 8 2  6 1 8  
g w 0 8 2 6 2  7 
g w 0 8 2 6 2  8 
0 7 1 2 _ 7 _ 7 0 0  
0 4 1 2 _ 7 _ 8 0 0
0728_5_700 
0 4 1 2 _ 4 _ 8 0 0  
0 7 1 2 _ 1 _ 7 0 0  
0 8 0 4 _ 4 _ 7 0 0  
08°4_2_70° 
0 8 0 4 _ 3 _ 7 0 0  
08 2 2 _ 4 _ 7 0  0 
0 8 2 2 _ 5 _ 7 0 0  
0 8 0 4 _ 5 _ 7 0 0  
0 7 1 2 _ 2 _ 7 0 0  
°804_1_700 
0 7 1 2 _ 4 _ 7 0 0  
0 7 1 2 _ 3 _ 7 0 0  
CONSENSUS
GTACAAATTGATCCAG. GGACTGGTCCCATTGCCATTTTGGAGTCAGGAAGGAAT. TCTT 
GTACAAATTGATCCAG. GGACTGGTCCCATTGCCATTTTGGAGTCAGGAAGGAAT. TCTT 
GTACAAGTTGATTCAG. GGACTGGTCCCATTGCCATTTTGGAGTC. GGAAGG. A T . TTTT 
GTACAAGTTGATTCAG. GGACTGGTCCCATTGCCATTTTGGAGTC. GGAAGG. A T . TTTT 
GWG. . G A . Y CA T. G G . CTGGTCCCATTS. CATTTTGGAGTCAGGMDGGAATGTTTT 
ATCCA T. GGACTGGTCCCATTGCCATTTTGGWGTCAGGAAGGAATGTTTT 
. G A . YCA T. G G . CTGGY. CCATTGACATTTTGGAGTCAGGAAGGAATGTTTT 
. GATCCAT. GGACTGGTCCCATTGCCATTTTGGAGTCAGGAAGGAATGTTTT 
. GW. CCA T. GGWCTGGT. CCATHGCCATTYTGGAGTCAGGAAGGAATGTHTT 
. SA TC CA T. GGACTGGTCCCATTGCCATTTTGGAGTCAGGAAGGAATGTTTT 
. GMTCCAW. GGACTGGTCCCATTGCCATTTTGGAGTCAGGAAGGAATGTTTT 
. GW. C C A T. GGACTCGT. CCATTGCCATTTTGGAGTCAGGWAGGAATGTTTT 
. GATCCAT. GGACTGGTCCCATTGCCATTTTGGAGTCAGGAAGGAATGTTTT 
. GATCCAT. GGACTGGTCCCATTGCCATTTTGGAGTCAGGAAGGAATGTTTT 
. G A . . C A T . GGCCTGGT. CCATTG. CATTTTGGAGT. AGGAAGG. ATGTTTT 
. GATCCATGTGACTGGTCCCATTGCCATTTTGGAGTCAGGAAGGAATGTTTT 
. GATACMTCGGACTGGT. CCATTGCCATTTTGGAGT. AGGAAGGAATGTTTT 
GAG. . GATCCAT. GGACTGGT. CCATTGCCATTTTGGAGTCAGGAAGGAATGTTTT 
GAG. . GATCCAT. GGACTGGTCCCATTGCCATTTTGGAGTCAGGAAGGAATGTTTT 
GTACGAG. . GATCCAT. GGACTGGTCCCATTGCCATTTTGGAGTCAGGAAGGAATGTTTT
GAG . 
GCTCGAG. 
GAG. 
GTCGAG. 
GAG. 
GAG. 
GAG. 
GAG. 
TGAG . 
GAG. 
GAG.
gwO 82 6 1 7  > CCCCCTCTGAAGCAAATTGGAGAGGCTTCAAATGGGG
gw0 82 6 1 8  < CCCCCTCTGAAGCAAATTGGAGAGGCTTCAAATGGGG
gw0 82 62 7 > CCCCCTCTGAAGCAAATTGGAGAGGCTTCAAATGGGG
g w 0 8 2 6 2 8  < CCCCCTCTGAAGCAAATTGGAGAGGCTTCAAATGGGGAAGCCG
0 7 1 2 _ 7 _ 7 0 0  > - CCCCTCTGRAGCAAATTGGAGAGGCTTCAAATGGGGATTTTTGCCTTC. TCTGG AT. CA 
0 4 1 2 _ 7 _ 8 0 0  > CCCCCTCTGAAGCAAATTGGAGAGGCTTCAAATGGGGATTTTTG CCTTCCTCTGGAT. CA
07 2 8 _ 5 _ 7  00 > CCCCCTCTGAAGCAA . TTGGAGAGGCTTCAAATGGGGATTTTTGCCTTCCTCTGGAT. CA
0 4 1 2 _ 4 _ 8  0 0 > CCCCCTCTGAAGCAAATTGGAGAGGCTTCAAATGGGGATTTTTGCCTTCCTCTGGAT. CA 
0 7 1 2 _ 1 _ 7  0 0 > CCCCCTCTGAWGCAAATTGGWGAGGCTTCAWATGGGGATTTTTGCCTTCCTCTGGTT. CA 
0 8 0 4 _ 4 _ 7 0 0  > CCCCCTCTGAAGCAAATTGGAGAGGCTTCAAATGGGGATTTTTGCCTTCCTCTGGATACA
08  0 4 _ 2 _ 7  0 0 > CCCCCTCTGAAGCAAATTGGAGAGGCTTCAAATGGGGATTTTTGCCTTCCTCTGGAT. CA 
08 0 4 _ 3 _ 7  0 0 > CCCCCTCTGAAGCAAATTGGAGAGGCTTCAAATGGGGATTTTTGCCTTCCTCTGGAT. CA 
0 8 2 2  4 7 0 0  > CCCCCTCTGAAGCAAATTGGAGAGGCTTCAAATGGGGATTTTTGCCTTCCTCTGGAT. CA
Clone Name 
(placed at start 
 of sequence)
D L 3 -g w 6 - 2 
D L 3 -g w 6 - 2 
D L 3 -g w 6 - 6 
D L 3 -g w 6 -6
T 2 -E L
G T -S a c 4  
T 2 - 3 ' LD 
S a c 4 - X h o 2
G T - S a c 4 - E c o l  
S a c 4 - X h o 2  
G T -S a c 4  
S a c 4 - X b a 5  
0 8 0 8  D e l . T P 4 - 1  
0 8 0 8  D e l . T P 5 - 1  
S a c 4 - d e l . -T P 3  
G T - S a c 4 - E c o 2  
G T -S a c 4  
G T - S a c 4 - X b a 2  
G T - S a c 4 - X b a l
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0 8 2  2 _ 5 _ 7  0 0  > CCCCCTCTGAAGCAAATTGGAGAGGCTTCAAATGGGGATTTTTGCCTTCCTCTGGAT. CA 
0 8 0 4 _ 6 _ 7 0 0  > CCCCGTCTGAAGCAAATTGGAGAGGCTTCAAATGGGGATTTTTGCCTTCCTCTGGAT. CA
0 7 1 2 _ 2 _ 7 0 0  > CCCCCTCTGAAGCAAATTGGAGAGGCTTCAAATGGGGATTTTTGCCTTCCTCTGGAT. CA
0 8 0 4 _ 1 _ 7 0 0  > . CCCCTCTGAAGCAAATTGGAGAGGCTTCAAATGGGGATTTTTGCCTTCCTCTGGAT. CA
0 7 1 2 _ 4 _ 7 0 0  > CCCCCTCTGAAGCAAATTGGAGAGGCTTCAAATGGGGATTTTTGCCTTCCTCTGGAT. CA
0 7 1 2 _ 3 _ 7 0 0  > CCCCCTCTGAAGCAAATTGGAGAGGCTTCAAATGGGGATTTTTGCCTTCCTCTGGAT. CA
CONSENSUS < CCCCCTCTGAAGCAAATTGGAGAGGCTTCAAATGGGGATTTTTGCCTTCCTCTGGAT. CA
0 7 1 2 _ 7 _ 7 0 0
0412_7_80°
0728_5_700 
0 4 1 2 _ 4 _ 8 0 0  
0 7 1 2 _ 1 _ 7 0 0  
0 8 0 4 _ 4 _ 7 0 0  
0 8 0 4 _ 2 _ 7 ° 0  
0 8 0 4 _ 3_ 7 ° 0  
0 8 2 2 _ 4 _ 7 0 0  
0 8 2 2 _ 5 _ 7 0 0  
0 8 0 4 _ 6 _ 7 0 0  
0 7 1 2 _ 2 _ 7 0 0  
08 0 4 _ 1 _ 7  0 0 
0 7 1 2 _ 4 _ 7 0 0
0712_3_700
CONSENSUS
. ACTAGTAGTTA . GGCAGGTTATATACA . GACCTAAAAGGTTGAACTTGAGGGGTATGTA 
. ACTAGTAGTTA. GGCAGGTTATATACA. GACCTAAAAGGTTGAACTTGAGGGGTATGTA
. ACTAGTAGTTA. GGCAGGTTATATACA. GACCTAAAAGGTTGAACTTGAGGGGTATGTA 
. ACTAGTAGTTA . GGCAGGTTATATACA . GACCTAAAAGGTTGAACTTGAGGGGTATGTA 
. ACTAGTAGTTA . GGCAGGTTATATACA. GACCTAAWAGGTTGAWCTTGAGGGGTATGTA 
. ACTAGTAGTTA. GGCAGGTTATATACA. GACCTAAAAGGTTGAACTTGAGGGGTATGTA 
. ACTAGTAGTTA. GGCAGGTTATATACA. GACCTAAAAGGTTGAACTTGAGGGGTATGTA 
. ACTAGTAGTTA . GGCAGGTTATATACA . GACCTAAAAGGTTGAACTTGAGGGGTATGTA 
. ACTAGTAGTTA . GGCAGGTTATATACA . GACCTAAAAGGTTGAACTTGAGGGGTATGTA 
. ACTAGTAGTTA . GGCAGGTTATATACA. GACCTAAAAGGTTGAACTTGAGGGGTATGTA 
. ACTAGTAGTTA . GGCAGGTTATATACA. GACCTAAAAGGTTGAACTTGAGGGGTATGTA 
. ACTAGTAGTTA . GGCAGGTTATATACA. GACCTAAAAGGTTGAACTTGAGGGGTATGTA 
CACTAGTAGTTACGGCAGGTTATATACACGACCTAAAAGGTTGAACTTGAGGGGTATGTA 
. ACTAGTAGTTA. GGCAGGTTATATACA. GACCTAAAAGGTTGAACTTGAGGGGTATGTA 
. ACTAGTAGTTA. GGCAGGTTATATACA. GACCTAAAAGGTTGAACTTGAGGGGTATGTA 
. ACTAGTAGTTA. GGCAGGTTATATACA. GACCTAAAAGGTTGAACTTGAGGGGTATGTA
0 7 1 2 _ 7 _ 7 0 0  
0 4 1 2 _ 7_ 8  0 0
0728_5_700 
0 4 1 2 _ 4 _ 8  0 0 
0 7 1 2 _ 1 _ 7  00  
0 8 0 4 _ 4 _ 7 0 0
0804_2_700 
0 8 0 4 _ 3 _ 7 00  
0 8 2 2 _ 4 _ 7 0 0  
0 8 2 2 _ 5 _ 7 0 0  
0 8 0 4 _ 6 _ 7 00 
0 7 1 2 _ 2 _ 7 0 0  
0 8 0 4 _ 1_ 7 0 °  
0 7 1 2 _ 4 _ 7 0 0  
0 7 1 2 _ 3 _ 7  00  
CONSENSUS
TCTTTTTTCAACCTAACTATGTTACTTTGTTAAGAACATAAACCTGAG. TCTTTCGGTAA 
TCTTTTTTCAACCTAACTATGTTACTTTGTTAAGAACATAAACCTGAG. TCTTTCGGTAA 
TCTYTTTTCAACCTAACAATGTTACTTTGTTANGNACATAAACCTRAA. ASMVCCGGTAA 
TCTTTTTTCAACCTAACTATGTTACTTTGTTAAGAACATAAACCTGAG . TCTTTCGGTAA 
TCTTTTTTCAWCCTAACTATGTTACTTTGTTAAGAACATAAACCTGAG. TCTTTCGGTAA 
TCTTTTTTCAACCTAACTATGTTACTTTGTTAAGAACATAAACCTGAG. TCTTTCGGTAA 
TCTTTTTTCAACCTAACTATGTTACTTTGTTAAGAACATAAACCTGAG. TCTTTCGGTAA 
TCTTTTTTCAACCTAACTATGTTACTTTGTTAAGAACATAAACCTGAGBTCTTTCGGTAA 
TCTTTTTTCAACCTAACTATGTTACTTTGTTAAGAACATAAACCTGAG. TCTTTCGGTAA 
TCTTTTTTCAACCTAACTATGTTACTTTGTTAAGAACATAAACCTGAG. TCTTTCGGTAA 
TCTTTTTTCAACCTAACTATGTTACTTTGTTAAGAACATAAACCTGAG. TCTTTCGGTAA 
TCTTTTTTCAACCTAACTATGTTACTTTGTTAAGAACATAAACCTGAG. TCTTTCGGTAA 
TCTTTTTTCAACCTAACTATGTTACTTTGTTAAGAACATAAACCTGAG. TCTTTCGGTAA 
TCTTTTTTCAACCTAACTATGTTACTTTGTTAAGAACATAAACCTGAG. TCTTTCGGTAA 
TCTTTTTTCAACCTAACTATGTTACTTTGTTAAGAACATAAACCTGAG. TCTTTCGGTAA 
TCTTTTTTCAACCTAACTATGTTACTTTGTTAAGAACATAAACCTGAG. TCTTTCGGTAA
0 7 1 2 _ 7 _ 7 0 0
0 4 1 2 _ 7_ 8 0 0
0728_5_700 
0 4 1 2 _ 4 _ 8 0 0  
0 7 1 2 _ 1 _ 7 0 0  
0 8 0 4 _ 4 _ 7  00  
0 8 0 4 _ 2 _ 7 0 0  
0 8 0 4 _ 3 _ 7 00
0822_4_700
0 8 2 2 _ 5 _ 7 0 0
0 8 0 4 _ 6 _ 7 0 0
0 7 1 2 _ 2 _ 7 0 0
0 8 0 4 _ 1 _ 7 0 0
0 7 1 2 _ 4 _ 7 0 0
0 7 1 2 _ 3 _ 7 0 0
CONSENSUS
AGAAGACTTTGAATCTAGCCATAAGTCTTCTATATATCAACTGAACTTCCCCTGCTTCTC
AGAAGACTTTGAATCTAGCCATAAGTCTTCTATATATCAACTGAACTTCCCCTGCTTCTC
AGNAGACTTTGATTCTAGCCATAAGTCTTCTATATATCACCTGASCTTCCCCTGCTTCTC
AGAAGACTTTGAATCTAGCCATAAGTCTTCTATATATCAACTGAACTTCCCCTGCTTCTC
AGAWGACTTTTAWTCTAGCCATAAGTTTTCTATATWTYATCTGAWCTTCCCCTGCTTCTC
AGAAGACTTTGAATCTAGCCATAAGTCTTCTATATATCAACTGAACTTCCCCTGCTTCTC
AGAAGACTTTGAATCTAGCCATAAGTCTTCTATATATCAACTGAACTTCCCCTGCTTCTC
AGAAGACTTTGAATCTAGCCATAAGTCTTCTATATATCAACTGAACTTCCCCTGCTTCTC
AGAAGACTTTGAATCTAGCCATAAGTCTTCTATATATCAACTGAACTTCCCCTGCTTCTC
AGAAGACTTTGAATCTAGCCATAAGTCTTCTATATATCAACTGAACTTCCCCTGCTTCTC
AGAAGACTTTGAATCTAGCCATAAGTCTTCTATATATCAACTGAACTTCCCCTGCTTCTC
AGAAGACTTTGAATCTAGCCATAAGTCTTCTATATATCAACTGAACTTCCCCTGCTTCTC
AGAAGACTTTGAATCTAGCCATAAGTCTTCTATATATCAACTGAACTTCCCCTGCTTCTC
AGAAGACTTTGAATCTAGCCATAAGTCTTCTATATATCAACTGAACTTCCCCTGCTTCTC
AGAAGACTTTGAATCTAGCCATAAGTCTTCTATATATCAACTGAACTTCCCCTGCTTCTC
AGAAGACTTTGAATCTAGCCATAAGTCTTCTATATATCAACTGAACTTCCCCTGCTTCTC
0 7 1 2 _ 7 _ 7 0 0
°412_7_8°0
0 7 2 8 _ 5 _ 7 00
0 4 1 2 _ 4 _ 8 0 0
0 7 1 2 _ 1 _ 7 0 0
0 8 0 4 _ 4 _ 7 0 0
0804_2_700 
0 8 0 4  3 7 0 0
TAAATTCCATTATTCCTACACAACTACTACATTCCTGTACTCCATCCCCCCTCTGTACTT
TAAATTCCATTATTCCTACACAACTACTACATTCCTGTACTCCATCCCCCCTCTGTACTT
TAAATTCCATTATTCCTACACAACTACTACATTCCTGTACTCCATCCCCCCTCTGTACTT
TAAATTCCATTATTCCTACACAACTACTACATTCCTGTACTCCATCCCCCCTCTGTACTT
TAAWTTCCATTATTCCTACACAACTACTACATTCCTGTACTCCATCCCCCCTCTKTWCTT
TAAATTCCATTATTCCTACACAACTACTACATTCCTGTACTCCATCCCCCCTCTGTACTT
TAAATTCCATTATTCCTACACAACTACTACATTCCTGTACTCCATCCCCCCTCTGTACTT
TAAATTCCATTATTCCTACACAACTACTACATTCCTGTACTCCATCCCCCCTCTGTACTT
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0 82 2 _ 4 _ 7 0  0 > TAAATTCCATTATTCCTACACAACTACTACATTCCTGTACTCCATCCCCCCTCTGTACTT
0 82 2 _ 5 _ 7 0 0  > TAAATTCCATTATTCCTACACAACTACTACATTCCTGTACTCCATCCCCCCTCTGTACTT
0 8 0 4 _ 6 _ 7 0 0  > TAAATTCCATTATTCCTACACAACTACTACATTCCTGTACTCCATCCCCCCTCTGTACTT
0 7 1 2 _ 2 _ 7 0 0  > TAAATTCCATTATTCCTACACAACTACTACATTCCTGTACTCCATCCCCCCTCTGTACTT
0 8 0 4 _ 1 _ 7 ° 0  > TAAATTCCATTATTCCTACACAACTACTACATTCCTGTACTCCATCCCCCCTCTGTACTT
0 7 1 2 _ 4 _ 7 0  0 > TAAATTCCATTATTCCTACACAACTACTACATTCCTGTACTCCATCCCCCCTCTGTACTT
0 7 1 2 _ 3 _ 7 0 0  > TAAATTCCATTATTCCTACACAACTACTACATTCCTGTACTCCATCCCCCCTCTGTACTT
1 0 2 9 _ 3 _ 8 0 0  < TACTCMATMCCCMCTCTSTACTT GABA T r - 1 1
CONSENSUS < TAAATTCCATTATTCCTACACAACTACTACATTCCTGTACTCCATCCCCCCTCTGTACTT
 + + + + + +
0 7 1 2 _ 7 _ 7 0 0  > CTTCCTACTTCACGAACATTT. TTCCTGAACTCCCCTTCCTCTCTTACTTGGTTTGAACC
0 4 1 2 _ 7 _ 8 0 0  > CTTCCTACTTCACGAACATTT. TTCCTGAACTCCCCTTCCTCTCTTACTTGGTTTGAACC
0 7 2  8 _ 5 _ 7  0 0 > CTTCCTACTTCACGAACATTT. TTCCTGAACTCCCCTTCCTCTCTTACTTGGTTTGAACC
0 4 1 2 _ 4 _ 8 0  0 > CTTCCTACTTCACGAACATTT. TTCCTGAACTCCCCTTCCTCTCTTACTTGGTTTGAACC
0 7 1 2 _ 1 _ 7 0 0 > YTTCCTACTTCACGAACATTT. TTTCTGAACTCCCCTTCCTCTCTTACTTGGTTTGAWCC 
0 8 0 4 _ 4 _ 7 0 0  > CTTCCTACTTCACGAACATTT. TTCCTGAACTCCCCTTCCTCTCTTACTTGGTTTGAACC
0 8 0 4 _ 2 _ 7 0  0 > CTTCCTACTTCACGAACATTT. TTCCTGAACTCCCCTTCCTCTCTTACTTGGTTTGAACC
0 8 0 4 _ 3 _ 7 0  0 > CTTCCTACTTCACGAACATTT. TTCCTGAACTCCCCTTCCTCTCTTACTTGGTTTGAACC
0 8 2 2 _ 4 _ 7 0 0  > CTTCCTACTTCACGAACATTT. TTCCTGAACTCCCCTTCCTCTCTTACTTGGTTTGAACC
0 82 2 _ 5 _ 7 0 0  > CTTCCTACTTCACGAACATTT. TTCCTGAACTCCCCTTCCTCTCTTACTTGGTTTGAACC
0 8 0 4 _ 6 _ 7 0  0 > CTTCCTACTTCACGAACATTT. TTCCTGAACTCCCCTTCCTCTCTTACTTGGTTTGAACC
0 7 1 2 _ 2 _ 7 0 0  > CTTCCTACTTCACGAACATTT. TTCCTGAACTCCCCTTCCTCTCTTACTTGGTTTGAACC
0 8 0 4 _ ! _ 7 0 0  > CTTCCTACTTCACGAACATTT. TTCCTGAACTCCCCTTCCTCTCTTACTTGGTTTGAACC
0 7 1 2 _ 4 _ 7 0  0 > CTTCCTACTTCACGAACATTT. TTCCTGAACTCCCCTTCCTCTCTTACTTGGTTTGAACC 
0 7 1 2 _ 3 _ 7 0 0  > CTTCCTACTTCACGAACATTT. TTCCTGAACTCCCCTTCCTCTCTTACTTGGTTTGAACC
1 0 2  9 _ 3 _ 8  0 0 < CTTCCTCCTTCACGAACATTTCTTCCTGAACTCCCCTCCCTCTCTTMCTTGGTTTGADCC
CONSENSUS < CTTCCTACTTCACGAACATTT. TTCCTGAACTCCCCTTCCTCTCTTACTTGGTTTGAACC
0 7 1 2 _ 7 _ 7 0 0  
0 4 1 2 _ 7 _ 8 0 0  
0 72 8 _ 5 _ 7  0 0 
0 4 1 2 _ 4 _ 8 0 0  
0 7 1 2 _ 1 _ 7 0 0  
0 8 0 4 _ 4 _ 7 0 0  
0 8 0 4 _ 2 _ 7 0 0  
0804_3_70° 
0 8 2 2 _ 4 _ 7 0 0  
0 82 2 _ 5 _ 7  0 0 
0 8 0 4 _ 6 _ 7 0 0  
0 7 1 2 _ 2 _ 7 0 0  
0 8 0 4 _ 1 _ 7 0 0  
0 7 1 2 _ 4 _ 7  0 0 
0 7 1 2 _ 3 _ 7  0 0 
1 0 2 9 _ 3 _ 8 0 0  
CONSENSUS
ATACACCCTCCTAATATTTTKMHCTCTGTCCY. TCCTGTCTCTCCTAAACTCTAATTKCC 
ATACACCCTCCTAATATTTTGATCTCTGTCCTCTCCTGTCTCTCCTAAACTCTAATTTCC 
ATACACCCTCCTAATATTTTGAKCTCTGTCCTCTCCTGTCTCTCCTAAACTCTAATTTCC 
ATACACCCTCCTAATATTTTGATCTCTGTCCTCTCCTGTCTCTCCTAAACTCTAATTTCC 
ATACACCCTCCTAATATTTTTTTCTCTGTCCTCTCCTGTCTCTCCTAAACTCTAATTTCC 
ATACACCCTCCTAATATTTTGAHCTCTGTCCTCTCCTGTCTCTCCTAAACTCTAATTTCC 
ATACACCCTCCTAATATTTTSMHCTCTGTCCTCTCCTGTCTCTCCTAAACTCTAATTTCC 
ATACACCCTCCTAATATTTTRAWCTCTGTCCTCTCCTGTCTCTCCTAAACTCTAATTTCC 
ATACACCCTCCTAATATTTTSATCTCTGTCCTCTCCTGTCTCTCCTAAACTCTAATTTCC 
ATACACCCTCCTAATATTTTGATCTCTGTCCTCTCCTGTCTCTCCTAAACTCTAATTTCC 
ATACACCCTCCTAATATTTTGATCTCTGTCCTCTCCTGTCTCTCCTAAACTCTAATTTCC 
ATACACCCTCCTAATATTTTGATCTCTGTCCTCTCCTGTCTCTCCTAAACTCTAATTTCC 
ATACACCCTCCTAATATTTTGMTCTCTGTCCTCTCCTGTCTCTCCTAAACTCTAATTTCC 
ATACACCCTCCTAATATTTTGATCTCTGTCCTCTCCTGTCTCTCCTAAACTCTAATTTCC 
ATACACCCTCCTAATATTTTGATCTCTGTCCTCTCCTGTCTCTCCTAAACTCTAATTTCC 
ATACACCCTCCTAATATTTTGATCTCTGTCMTCYCCTGTCTCTCCTAAACTCTAATTTCC 
ATACACCCTCCTAATATTTTGATCTCTGTCCTCTCCTGTCTCTCCTAAACTCTAATTTCC
 + + . . .  + + + +
0 7 1 2 _ 7 _ 7 0 0  > CCTAATTCT. AATGAAATTAAACCTCCCTGTTGTCTTAGTTTTCTTACCC 
0 4 1 2 _ 7 _ 8 0 0 > CCTAATTCT. AATGAAATTAAACCTCCCTGTTGTCTTAGTTTTCTTACCCCTCCTTA. TT
0 72 8 _ 5 _ 7 0 0 > CCTAAMBCTTAATGAAATTAAACCTCCCTGTTGTCTTAGTTTTCTTACCCCTCCTTA. TT
0 4 1 2 _ 4 _ 8 0 0  > CCTAATTCT. AATGAAATTAAACCTCCCTGTTGTCTTAGTTTTCTTACCCCTCCTTA. TT
0 7 1 2 _ 1 _ 7  0 0 > CCTAATTCT. WATGATATTAAACCTCCCTGTTGTCTTAGTTTTCTTACCCCTCCTTA. TT 
0 8 0 4 _ 4 _ 7  0 0 > CCTAMCTCT. AATGAAATTAAACCTCCCTGTTGTCTTAGTTTTCTTACCCCTCCTTA. TT
0 8 0 4 _ 2 _ 7 0 0  > CCTAATTCT. AATGAAATTAAACCTCCCTGTTGTCTTAGTTTTCTTACCCCTCCTTA. TT
0 8 0 4 _ 3 _ 7 0 0  > CCTAATTCT. AATGAAATTAAACCTCCCTGTTGTCTTAGTTTTCTTACCCCTCCTTA. TT
0 8 2 2 _ 4 _ 7 0 0  > CCTAATTCT. AATGAAATTAAACCTCCCTGTTGTCTTAGTTTTCTTACCCCTCCTTA. TT 
0 82 2 _ 5 _ 7 0 0  > CCTAATTCT. AATGAAATTAAACCTCCCTGTTGTCTTAGTTTTCTTACCCCTCCTTA. TT 
0 8 0 4 _ 6 _ 7 0  0 > CCTAATTCT. AATGAAATTAAACCTCCCTGTTGTCTTAGTTTTCTTACCCCTCCTTA. TT 
0 7 1 2 _ 2 _ 7 0 0  > CCTAATTCT. AATGAAATTAAACCTCCCTGTTGTCTTAGTTTTCTTACCCCTCCTTA. TT 
0 8 0 4 _ 1 _ 7 0 0  > CCTAATTCT. AATGAAATTAAACCTCCCTGTTGTCTTAGTTTTCTTACCCCTCCTTA. TT 
0 7 1 2 _ 4 _ 7 0 0  > CCTAATTCT. AATGAAATTAAACCTCCCTGTTGTCTTAGTTTTCTTACCCCTCCTTA. TT 
0 7 1 2 _ 3 _ 7 0 0  > CCTAATTCT. AATGAAATTAAACCTCCCTGTTGTCTTAGTTTTCTTACCCCTCCTTA. TT 
1 0 2 9 _ 3 _ 8 0 0  < CCTAATCMT. AATGAAATTAAACCYCCCTGTTGTCTTAGTTTTCTTAACCCTMMTTA.TT 
0 1 0 1 _ 1 _ 8 0 0  < TCTGCCTTATKTTTT. G CTTTA T. . CTCCTCCTTWMTT
CONSENSUS < CCTAATTCT. AATGAAATTAAACCTCCCTGTTGTCTTAGTTTTCTTACCCCTCCTTA. TT
x g G A T l- 3
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 + + . . +. . .  + +..............
0 4 1 2 _ 7 _ 8 0 0  > T C C .T T A C .. T C TA C . TGAACAC. TAGACTACCC. GAACTGTAATT. . TTC TA C TTC T.
0 7 2 8 _ 5 _ 7 0 0  > T C C •T T A C . . T C TA C . TGAACAC. TAGACTACCC. GAACTGTAATT. . TTC TA C TTC T.
0 4 1 2 _ 4 _ 8  0 0 > T C C . T T A C . . T C TA C . TGAACAC. TAGACTACCC. GAACTGTAATT. . TTC TA C TTC T.
0 7 1 2 _ 1 _ 7  0 0  > T C C . T T A C . . T C TA C . TGAACAC. TAGACTACCC. GAWCTGTAATT. . T TT TA C TT C T .
0 8 0 4 _ 4 _ 7 0 0  > T C C .T T A C .. T C TA C . TGAACAC. TAGACTACCC. GAACTGTAATT. .T TC TA C TTC T.
0 8 0 4 _ 2 _ 7 0 0  > T C C . T T A C . . T C TA C . TGAACAC. TAGACTACCC. GAACTGTAATT. . TTC TA C TTC T.
0 8 0 4 _ 3 _ 7 00  > T C C . T T A C . . T C TA C . TGAACAC. TAGACTACCC. GAACTGTAATT. . TTC TA C TTC T. 
0 8 2 2 _ 4 _ 7 0 0  > T C C .T T A C .. T C TA C . TGAACAC. TAGACTACCC. GAACTGTAATT. . Y TCTA CTTCT.
0 8 2 2 _ 5 _ 7  0 0  > T C C . T T A C . . T C TA C . TGAACAC. TAGACTACCC. GAACTGTAATT. . TTC TA C TTC T.
0 8 0 4 _ 6 _ 7 0 0  > T C C . T T A C . . T C TA C . TGAACAC. TAGACTACCC. GAACTGTAATT. . TTC TA C TTC T. 
0 7 1 2 _ 2 _ 7 0 0  > T C C .T T A C .. T C TA C . TGAACAC. TAGACTACCC. GAACTGTAATT. .T TC TA C TTC T.
0 8 0 4 _ 1 _ 7 0 0  > T C C .T T A C .. T C TA C . TGAACAC. TAGACTACCC. GAACTGTAATT. .T TC TA C TTC T.
0 7 1 2 _ 4 _ 7 0 0  > T C C . T T A C . . T C TA C . TGAACAC. TAGACTACCC. GAACTGTAATT. . TTC TA C TTC T.
0 7 1 2 _ 3 _ 7 ° 0  > T C C . T T A C . . T C TA C . TGAACAC. TAGACTACCC. GAACTGTAATT. . TTC TA C TTC T.
1 0 2 9 _ 3 _ 8 0 0  < T C C .T T A C .. T C TA C . TGAAMAC. TAGACTACCC. GAACTGTAATT. . TTCYMCTTCT.
1 2 2 9 _ 1 _ 8 0 0  < C C T . . . . TGTAATTMTTTCTTCTTCTYC
0 1 0 1 _ 1 _ 8 0 0  < TCCCTTTCCTTCTACYTGAACYCCTAKSCTTCCCTGATCTGTWAWT. TTTCTACTTCCTC
CONSENSUS < T C C . T T A C . . T C TA C . TGAACAC. TAGACTACCC. GAACTGTAATT. . TTC TA C TTC T. .
 + + + + + +
0 4 1 2 _ 7_ 8 0 0  > CCAGAACC. ATAGCT
0 7 2 8 _ 5_ 7 0 0  > CCAGAACC.ATAGCTTC. TCCTA CT............ AAA
0 4 1 2 _ 4 _ 8 0 0  > CCAGAACC. ATAGCTTC. TCCTA CTTC. TCATAGGA. . TTTGTG
0 7 1 2 _ 1 _ 7 0 0  > CCAGAACC. ATAGCTTC. TCCTA CTTC. TCATAGGA. . TTTG TG TCT. CTCCAATTAC. T
0 8 0 4 _ 4 _ 7 0 0  > CCA G AACC.ATAGCTTC.TCCTACTTC.YCATAG GA.. TTTG TG TCT. CTCCAATTAC. T
0 8 0 4 _ 2 _ 7 0 0  > CC A G A A C C.A TA G CTTC.TCC TA C TTC.TCA TA G G A .. TTTG TG TCT. CTCCAATTAC. T
0 8 0 4 _ 3 _ 7 0 0  > CCAGAACC. ATAGCTTC. TCCTA CTTC. TCATAGGA. . TTTG TG TCT. CTCCAATTAC. T
0 8 2 2 _ 4 _ 7  00  > CCAGAACC. ATAGCTTC. TCCTA CTTC. TCATAGGA. . TTTG TG TCT. CTCCAATTAC. T
0 8 2 2 _ 5 _ 7 0 0  > CCAGAACC. ATAGCTTC. TCCTA CTTC. TCATAGGA. . TTTG TG TCT. CTCCAATTAC. T
0 8 0 4 _ 6 _ 7 0 0  > CCAGAACC. ATAGCTTC. TCCTA CTTC. TCATAGGA
0 7 1 2 _ 2 _ 7 0 0  > CCAGAACC. ATAGCTTC. TCCTA CTTC. TCATAGGA 
0 8 0 4 _ 1 _ 7 0 0  > CCAGAACC. ATAGCTTC. TCCTA CTTC. TCATAGGA 
0 7 1 2 _ 4 _ 7 0 0  > CCAGAACC. ATAGCTTC. TCCTA CTTC. TCATAGGA
0 7 1 2 _ 3 _ 7  0 0  > CCAGAACC. ATAGCTTC. TCCTA CTTC. TCATAGGA
1 0 2  9 _ 3 _ 8  0 0  < CCAGAACC. ATAGCTTC. TCCTMCTTC. TCATAGGA 
12  2 9 _ 1 _ 8  0 0  < CTAGATCCCATAGCTTC. TCCTTCTTCCTCATAGGA. TTTKGTGTCT. CTCCMAATTCCT 
0 1 0 1 _ 1 _ 8 0 0  < CCWKAACCCATATCTTCCTCCTTCTTCCYCATATGAATTTTKTKTCTYCTCCAATTVCCT 
CONSENSUS < C C A G A A C C.A TA G CTTC.TCC TA C TTC.TCA TA G G A .. TTTG TG TCT. CTCCAATTAC. T
. TTTG TG TCT. CTCCAATTAC. T 
. TTTG TG TCT. CTCCAATTAC. T 
. TTTG TG TCT. CTCCAATTAC. T 
TTTG TG TCT. CTCCAATTAC. T 
. TTTG TG TCT. CTCCAATTAC. T 
. TTTG TG TCT. CTCCAATTAC. T
0 7 1 2 _ 1 _ 7  0 0  > TAGGGCTTTTTC. CTCTCTTGCTGTATCTGAWCTT. AAATTC. TTA C A TC TT.
0 8 0 4 _ 4 _ 7 0 0  > TAGGGCTTTTTC.CTCTCTTGCTGTATCTGAACTT.AAATTC.TTACATCTT.
° 8 0 4 _ 2_ 7 0 0  > TAGGGCTTTTTC. CTCTCTTGCTGTATCTGAACTT. AAATTC. TTA C A TCTT.
0 8 0 4 _ 3 _ 7 0 0  > TAGGGCTTTTWC. CTCTCTTGCTGTATCTGAACTT. AAATTC. TTA CA TC TT.
0 8 2 2 _ 4 _ 7  00  > TAGGGCTTTTTC. CTCTCTTGCTGTATCTGAACTT. AAATTC. TTA CA TC TT.
0 8 2 2 _ 5 _ 7  00  > TAGGGCTTTTTC. CTCTCTTGCTGTATCTGAACTT. AAATTC. TTA CA TC TT.
0 8 0 4 _ 6 _ 7 0 0 > TAGGGCTTTTTC. CTCTCTTGCTGTATCTGAACTT. AAATTC. TTA C A TC TT.
0 7 1 2 _ 2 _ 7 0 0  > TAGGGCTTTTTC. CTCTCTTGCTGTATCTGAACTT. AAATTC. TTA C A TC TT.
0 8 0 4 _ 1_ 7 0 0  > TAGGGCTTTTTC. CTCTCTTGCTGTATCTGAACTT. AAATTC. TTA CA TC TT. 
0 7 1 2 _ 4 _ 7 0 0  > TAGGGCTTTTTC. CTCTCTTGCTGTATCTGAACTT. AAATTC. TTA CA TC TT. 
0 7 1 2 _ 3 _ 7 0 °  > TAGGGCTTTTTC. CTCTCTTGCTGTATCTGAACTT. AAATTC. TTA CA TC TT. 
1 0 2 9 _ 3 _ 8 0 0  < TAGGGCTTTTTC. CTCTCTTGCTGTATCTGAACTT. AAATTC. TTA C A TC TT.
1 2 2  9 _ 1 _ 8 0 0  < TAGGGCTTTTTC. CTCTCTTGCTGTATCTGAACWTTAA. T Y C . . TW CATCTT. C . TGCAT 
0 1 0 1 _ 1 _ 8 0 0  < TAKGGCTTTTTSTCTCTCTTKCTGTATCTKAACTTWAAATTCCTTACATCTTTCATGCAT 
CONSENSUS < TAGGGCTTTTTC. CTCTCTTGCTGTATCTGAACTT. AAATTC. TTA C A TCTT. C . TGCAT
TGCAT 
TGCAT 
TGCAT 
TGCAT 
TGCAT 
TGCAT 
C . TGCAT 
C . TGCAT 
C . TGCAT 
C . TGCAT 
C . TGCAT 
C . TGCMT
 + + + + + +
0 7 1 2 _ 1 _ 7 0 0  > TACAACT. T C T . ACTGATAC■TTCAGAACCCT. CTCATCTC■TTAC C TG ■TTTA TA G . TT
0 8 0 4 _ 4 _ 7 0 0  > TACAACT. T C T . ACTGATAC. TTCAGAACCCT. CTCATCTC. TTA C CTG . TTTA TA G . TT 
0 8 0 4 _ 2 _ 7 0 0  > TACAACT. T C T . ACTGATAC. TTCAGAACCCT. CTCATCTC. TTA C CTG . TTTA TA G . TT 
0 8 0 4 _ 3 _ 7 0 0  > TACAACT. T C T . ACTGATAC. TTCAGAACCCT. CTCATCTC. TYACCTG. TTTATAG. TT 
0 8 2 2 _ 4 _ 7  0 0  > TACAACT. T C T . ACTGATAC. TTCAGAACCCT. CTCATCTC. TTA C CTG . TTTATAG. TT
0 8 2 2 _ 5 _ 7 0 0  > TACAACT. T C T . ACTGATAC. TTCAGAACCCT. CTCATCTC. TTA C CTG . TTTATAG. TT 
0 8 0 4 _ 6 _ 7 0 0  > TACAACT. T C T . ACTGATAC. TTCAGAACCCT. CTCATCTC. TTA C CTG . TTTATAG. TT 
0 7 1 2 _ 2 _ 7  0 0  > TACAACT. T C T . ACTGATAC. TTCAGAACCCT. CTCATCTC. TTA C CTG . TTTATAG. TT 
0 8 0 4 _ 1 _ 7 0 0  > TACAACT. T C T . ACTGATAC. TTCAGAACCCT. CTCATCTC. TTA C CTG . TTTA TA G . TT
0 7 1 2 _ 4 _ 7  0 0  > TACAACT. T C T . ACTGATAC. TTCAGAACCCT. CTCATCTC. TTA C CTG . TTTA TA G . TT
0 7 1 2 _ 3 _ 7  0 0  > TACAACT. T C T . ACTGATAC. TTCAGAACCCT. CTCATCTC. TTA C CTG . TTTA TA G . TT 
1 0 2  9 _ 3 _ 8  0 0  < TACAACT. T C T . CCTGATCC. TTCAGAACCCT. CTCATCTC. TTA CCTG . TTYATAG. TT 
1 2 2 9  1 8 0 0  < TACAACT. T C T . MCTGATACTTTCAGAACCCT. CTCATCTC. TTMCCTG. TTTATAG. TT
x g G A T l-3
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0 1 0 1 _ 1 _ 8 0 0  < TACACCTCTCTTACTGATWCCTTCAGAACWCTHCTCATCTCCTTACCTGYTTTATAGMTT
0 4 1 2 _ 7 _ 7 0 0  < TTA C CTG . TTTA TA G . TT
0 4 1 2 _ 4 _ 7 0 0  < CTTA CCTG. TTTA TA G . TT
CONSENSUS < TACAACT. T C T . ACTGATAC. TTCAGAACCCT. CTCATCTC. TTA C CTG . TTTA TA G . TT
 + + + + + +
0 7 1 2 _ 1 _ 7  0 0  > A T G T T . C T C T T . CTTG TCC■TGAACTC. T TB C C T T . TACTACTGG. TCAGTACCT 
0 8 0 4 _ 4 _ 7 0 0  > A T G T T . C T C T T . CTTG TCC. TGAACTC. T T T C C T T . TACTACTGG. TCAGTACCTT. CTT
0 8 0 4 _ 2 _ 7  0 0  > A T G T T . C T C T T . CTTG TCC. TGAACTC. T T T C C T T . TACTACTGG. TCAGTACCTT. CTT
0 8 0 4 _ 3 _ 7  0 0  > ATGTW. C T C T T . CTTG TCC. TGAACTC. T T T C C T T . TACTACTGG. TCAGTACCTT. CTT
0 8 2 2 _ 4 _ 7 0 0  > A T G T T . C T C T T . CTTG TCC. TGAACTC. T T T C C T T . TACTACTGG. TCAGTACCTT. CTT
0 8 2 2 _ 5 _ 7 0 0  > A T G T T . C T C T T . CTTG TCC. TGAACTC. T T T C C T T . TACTACTGG. TCAGTACCTT. CTT
0 8 0 4 _ 6 _ 7  0 0  > A T G T T . C T C T T . CTTG TCC. TGAACTC. T T T C C T T . TACTACTGG. TCAGTACCTT. CTT
0 7 1 2 _ 2 _ 7  0 0  > A T G T T . C T C T T . CTTG TCC. TGAACTC. T T T C C T T . TACTACTGG. TCAGTACCTT. CTT
0 8 0 4 _ 1 _ 7 0 0  > A T G T T . C T C T T . CTTG TCC. TGAACTC. T T T C C T T . TACTACTGG. TCAGTACCTT. CTT
0 7 1 2 _ 4 _ 7 0 0  > A T G T T . C T C T T . CTTG TCC. TGAACTC. T T T C C T T . TACTACTGG. TCAGTACCTT. CTT
0 7 1 2 _ 3 _ 7  0 0 > A T G T T . C T C T T . CTTG TCC. TGAACTC. T T T C C T T . TACTACTGG. TCAGTACCTT. CTT
1 0 2  9 _ 3 _ 8  0 0 < AWGTW. C T C T T . CTTG TCC. CGAGCTC. TTTCCTTCTACTACTGG. TCAGTACCTT. CTK 
1 2  2 9 _ 1 _ 8  0 0  < A T G T T . C T C T T . CTTG TCC. TGACCTCTTTTCCTTT. ACTACTGG. TCAGTGCCTT. CTT 
0 1 0 1 _ 1 _ 8 0 0  < ATGTTTCTCTTTCTTGTCCCTGAMCTCYTTTCCTTTTACTACTGGGTCAGTRCCTKKCTT
0 4 1 2 _ 7 _ 7 0 0  < A T G T T . C T C T T . C TTG TCC. TGAACTC. T T T C C T T T . ACTACTGG. TCAGTACCTT. CTT 
0 4 1 2 _ 4 _ 7  0 0  < A T G T T . C T C T T . C TTG TCC. TGAACTC. T T T C C T T T . ACTACTGG. TCAGTACCTT. CTT
CONSENSUS < A T G T T . C T C T T . C TTG TCC. TGAACTC. T T T C C T T . TACTACTGG. TCAGTACCTT. CTT
0 8 0 4 _ 4 _ 7  0 0 
0 8 04_2_7 0 0 
0 8 0 4 _ 3 _ 7  0 0 
0 8 2 2 _ 4 _ 7 0 0  
0 8 2 2 _ 5 _ 7 0 0  
0 8 0 4 _ 6 _ 7  0 0 
0 7 1 2 _ 2 _ 7 0 0  
0 8 0 4 _ 1 _ 7  0 0 
0 7 1 2 _ 4 _ 7 0 0  
0712_3_700 
1029_3_800 
1 2 2 9 _ 1 _ 8 0 0  
0 1 0 1 _ 1 _ 8 0 0
0412_7_700
0 4 1 2 _ 4 _ 7 0 0
CONSENSUS
T . GCAAM. CCCYTCTGCCTCCATTATATTATGT. CT
. KGCCAA. MCCTCCTGCCTCCATTATATTATGT. C T T . CTTCTGCCTCTCT 
. GGCWAM. CCCTCCTGCCTCCATTATATTATGT. C T T . CTTCTGCCTYTCTTG 
. . G C . . . . ACCTCCTGCCTCCATTATATTATGT. C T T . CTTCTGCCTCTCTTGAACTCT 
. . G C . . . . ACCTCCTGCCTCCATTATATTATST. C T T . CTTCTGCCTCTCTTGAACTCTA 
. . GCMAMCCCCTCCTGCCTCCATTATATTATGT. C T T . CTTCTGCCTCTCTTGAACTCTA
.G C . . ACCTCCTGCCTCCATTATATTATGT. C T T . CTTCTGCCTCTCTTGAACTCTA
TGGCMAA. MCCTCCTGCCTCCATTATATTATGT. C T T . CTTCTGCCTCTCTTGAACTCTA 
. . G C . . . . ACCTCCTGCCTCCATTATATTATGT. C T T . CTTCTGCCTCTCTTGAACTCTA 
. . G C . . . . ACCTCCTGCCTCCATTATATTATGT. C T T . CTTCTGCCTCTCTTGAACTCTA 
T . G C . . . . GCCTCCTGCCTCCMTTATATTATGT. C T T . CTTCTGCCTCTCTTGARCTCTA 
. . G C . . . . ACCTCCTGCCTCCATTATATTATGT. C T T . CTTCTKYCTCTCTTGAACTCTA 
. . G C . . . . ACCTCCTKCCTCCATTATATTATGTTCTTTCTTCTKCCTCTCTTGAACTCTA 
. . G C . . . . ACCTCCTGCCTCCATTATATTATGT. C T T . CTTCTGCCTCTCTTGAACTCTA 
. . G C . . . . ACCTCCTGCCTCCATTATATTATGT. C T T - CTTCTGCCTCTCTTGAACTCTA 
. . G C . . . .ACCTCCTGCCTCCATTATATTATGT.CTT.CTTCTGCCTCTCTTGAACTCTA
.   + . .   + + + +
0 8 2 2 _ 5 _ 7 0 0  > TCT
0 8 0 4 _ 6 _ 7  0 0 > TCTTCTCTTACTTCTCTGTCATCTCCTATCTCTTTTGAACT. ATGTTCTC
0 7 1 2 _ 2 _ 7 0 0 > TCTTCTCTTACTTCTCTGTCATCTCCTATCTCTTTTGAACT. A TG TTCTCTCCT. AAATT
0 8 0 4 _ 1 _ 7 0 0  > TCTTCTCTTACTTCTCTGTCATCTCCTATCTCTTTTGAACT. A TG TTCTCTTCT. AAATT
0 7 1 2 _ 4 _ 7  0 0 > TCTTCTCTTACTTCTCTGTCATCTCCTATCTCTTTTGAACT. A TG TTCTCTTCT. AAATT 
0 7 1 2 _ 3 _ 7 0 0  > TCTTCTCTTACTTCTCTGTCATCTCCTATCTCTTTTGAACT. A TG TTCTCTTCT. AAATT 
1 0 2  9 _ 3 _ 8 0 0 < WCTTCTCTTGCTTMTCTGTCATCTCMTATMTCTTTTGAACT. ATGYTCTCTTCT. AAATC
12 2 9 _ 1 _ 8 0 0  < TCTTCTCTTWCTTCTCTGTCATCTCCTATCTCTTTTGAACTYATGTTCTCTTCTTAAATT 
0 1 0 1 _ 1 _ 8 0 0 < TCTTCTCTTACTTCTCTGTCATCTCCTATCTCTTTTGAACT. A TG TTC TC TTCT. AAATT 
0 4 1 2 _ 7_ 7 ° 0  < TCTTCTCTTACTTCTCTGTCATCTCCTATCTCTTTTGAACT. A TG TTCTCTTCT. AAATT 
0 4 1 2 _ 4 _ 7 0 0  < TCTTCTCTTACTTCTCTGTCATCTCCTATCTCTTTTGAACT. A TG TTCTCTTCT. AAATT
0 8 2 2 _ 4 _ 8 0 0  < T . ATGTYCTCTTCT. AAATT
T P 4 - 1
CONSENSUS < TCTTCTCTTACTTCTCTGTCATCTCCTATCTCTTTTGAACT.ATGTTCTCTTCT.AAATT
0 8 0 4 _ 1 _ 7 0 °
0 7 1 2 _ 4 _ 7 ° 0
0712_3_700
1 0 2 9 _ 3 _ 8 0 0
1 2 2 9 _ 1 _ 8 0 0
0 1 0 1 _ 1 _ 8 0 0
0412_7_700 
0 4 1 2 _ 4 _ 7  0 0 
1 2 1 8 _ 1 _ 8 0 0  
0 8 0 4 _ 6 _ 8 0 0 
0 8 2 2 _ 4 _ 8 0 0  
CONSENSUS
. C . T . CAG
. C . T . CAGCACCCTCTTCT. TCAACCTATATTAAAATCTGT 
. C . T . CAGCACCCTCTTCT. TCAACCTATATTAAAATCTGT
. M . T . CAGAACCCTMTTCTCTCAAMMTATATTAAAATCTGTCTT. CTTCTGACTTTGARA 
TCATMCAGCACCCTCTTCT. TCAACCTATATTAAAATCTGTCTT. CTTCTGCCTTTGA. A 
. C . T . CAGCACCCTCTTCT. TCAMCCTATATTAAAATCTGTCTTTCTTCTGCCTTTGA. M 
. C . T . CAGCACCCTCTTCT. TCAACCTATATTAAAATCTGTCTT. CTTCTGCCTTTGA. A 
. C . T . CAGCACCCTCTTCT. TCAACCTATATTAAAATCTGTCTT. CTTCTGCCTTTGA. A
CTGGGGC. TTT G A . A 
C T . TCAACCTATATTAAAATCTGTCTT. CTTCTGCCTTTGA. A 
. C . T . CAGCACCCTCTYCT. TCAACCTATATRAAAATCTGTCTT. CTTCTGCCTTTGA. A 
. C . T . CAGCACCCTCTTCT. TCAACCTATATTAAAATCTGTCTT. CTTCTGCCTTTGA. A
T 2 - 3 1LD 
T 2 -E L
0 8 0 8 0 0  D e l .
x g G A T l-1  
S a c 4 - d e l - T P 3
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1 0 2  9 _ 3 _ 8 0  0 < CTGCTTGTTCCTACCTTTTATG GMG . TTATTTACTTTMTATMAACTTGTGAACTTGTCC
12  2 9 _ 1 _ 8 0 0 < CTGCTTGTTCCTACCTTTTATG. G . G . TTYTTTCCTTTCTCTCAACTTGTGAACTTGTCC
0 1 0 1 _ 1 _ 8  0 0 < CTGCTTG TTCCT. CCTTTTATG. G . G . TTCTTTCCTTTCTCTCCCCTTGTGCCCTTGTVC
1 0 2  9 _ 5 _ 8 0  0 < CTACCTTTTATGCGCGCTTCTTTCCTTTCTCTCAACTTGYGAACTTGTCC
0 4 1 2 _ 7 _ 7 0 0  < CTGCTTGTTCCTACCTTTTATG. G . G . TTCTTTCCTTTCTCTCAACTTGTGAACTTGTCC
0 4 1 2 _ 4 _ 7 0 0  < CTGCTTGTTCCTACCTTTTATG. G . G . TTCTTTCCTTTCTCTCAACTTGTGAACTTGTCC 
1 2 1 8 _ 1 _ 8 0 0  > CTGCTTGTTGGTACCTTTTATG. G . G . TTCTTTCCTTTCTCTCAACTTGTGAACTTGTCC 
1 2 2 9 _ 9 _ 8 0 0  > A T G . G . R . WTCTTTCCTTTCTCTCMACTTGTGAACTTGTCC
0 8 0 4 _ 6 _ 8  0 0 < CTGCTTGTTCCTACCTTTTATG. G . G . TTCTTTCCTTTCTCTCAACTTGTGAACTTGTCC 
0 8 2 2 _ 4 _ 8 0 0  < CTGCTTGTTCCTACMTDTTATG. G . G . TTCTTTCCTTTCTCTCAACTTGTGAACTTGTCC
CONSENSUS < CTGCTTGTTCCTACCTTTTATG. G . G . TTCTTTCCTTTCTCTCAACTTGTGAACTTGTCC
 + + + + + +
1 0 2 9 _ 3 _ 8 0 0  < YCW ACTTCTTTCTTG. T A . . . CTCWGACTTG. TTAAACMCWGTACACTCTTARCTG. TMC
1 2 2  9 _ 1 _ 8 0  0 < TCTCCTTC TTTC TTG . T A . . . T T . . GWCTTG. TTAACCCCTGTTCTCTCTTAGCTG. TYC
0 1 0 1 _ 1 _ 8 0  0 < TCTM CTTCTTTCTTG. T C . . . T T . . GCCTTG. TTAAACCCTGTTCTCTCTTAGCTG. TAM
1 0 2 9 _ 5 _ 8 0 0  < TCTA CTTCTTTCTTGCTA. . . . TTGCACTTGCTTAAACCCTGTTCTCTCTTAGCTGCTAC 
0 4 1 2 _ 7 _ 7 0  0 < TCTA CTTCTTTCTTG . T A . . . T T . . GACTTG. TTAAACCCTGTTCTCTCTTAGCTG. TAC
0 4 1 2 _ 4 _ 7 0 0  < TCTA CTTCTTTCTTG . T A . . . T T . . GACTTG. TTAAACCCTGTTCTCTCTTAGCTG. TAC
1 2 1 8 _ 1 _ 8  0 0 > TC TA CTTCTTTCTTG . T A . . . . T T G . A CTTG . TTAAACCCTGTTCTCTCTTAGCTG. TAC 
1 2 2 9 _ 9 _ 8 0 0  > TC TA CTTCTTTCTTG . T A . . . . T T G . A CTTG . TTAAACCCTGTTCTCTCTTAGCTG. TAC 
0 8 0 4 _ 6 _ 8 0 0  < TCTA CTTCTKTCTTG. TWAATTTTGRACTTG. TTAAACCCTGTTCTCTCTTAGCTG. TAC 
0 8 2 2 _ 4 _ 8 0 0  < TCTACKTCTGTCTTG. T A . . . . T T G . A CTTG . TTAAACCCTGTTCTCTCTTAGCTG. TAC
CONSENSUS < TCTA CTTCTTTCTTG . T A . . . TTTGGACTTG. TTAAACCCTGTTCTCTCTTAGCTG. TAC
 + + + + + +
1 0 2 9 _ 3 _ 8 0 0  < TAGAATGMWVMCATKTAGVMSCCTCCTATTCAATYC. TA TSA TTTTA TG . TA TTCA T. AT
1 2 2  9 _ 1 _ 8  0 0  < T . GAATGCTGCCATTTTCCTCCCTCCTATTCAATTCCTATG. T TT TA T G . TATTCATWAT
0 1 0 1 _ 1 _ 8 0 0  < T . GAATGCTGCCCTTTCCCCCCCTCCTMTTCMMTTCCTCTG. T T T T C T G . TMTTCMTMMT 
1 0 2 9 _ 5 _ 8 0 0  < TGCAATGCTGCCATTTCCCTCCCTCCTATTCAATTCCTATG. TTTTATGCTATTCATAAT
0 4 1 2 _ 7 _ 7 0 0  < T . GAATGCTGCCATTTCCCACCCTCCTATTCAATTCCTATG. T TT TA T G . TATTCATAAT
0 4 1 2 _ 4 _ 7 0 0 < T . GAATGCTGCCATTTCCCACCCTCCTATTCAATTCCTATG. T TT TA T G . TATTCATAAT
1 2 1 8 _ 1 _ 8 0 0 > T . GAATGCTGCCATTTCCCACCCTCCTATTCAATTCCTATG. T TT TA T G . TATTCATAAT 
1 2 2  9 _ 9 _ 8  0 0 > T . GAATGCTGCCATTTCCCACCCKCCTATTCAATKCCTATG. KTTKATG. TATKCAKAAK 
0 8 0 4 _ 6 _ 8 0  0 < T . GAATGCTGCCATTTCCCACCCTCCTATTCAATTCCTATG. T TT TA T G . TATTCATAAT 
0 8 2 2 _ 4 _ 8 0 0  < T . GAATGCTGCCATTTCCCACCCTCCTATTCAATTCCTATG. TK TTA TG . TATTCATAAT
CONSENSUS < T . GAATGCTGCCATTTCCCACCCTCCTATTCAATTCCTATG. T TT TA T G . TATTCATAAT
1 0 2  9 _ 3 _ 8 0  0 < T T . G G . G . CTAAAT. A G T . TTTTCM . C A TT. . ATGY. TTTCAGAT. C A . CA TTTA . .CAT
1 2 2 9 _ 1 _ 8 0 0 < TTT G G . GMCTAAATTAGTGTTTTCAACATTTAYTGTCTTTCAGATTCAACATTTACCCTT 
0 1 0 1 _ 1 _ 8 0  0 < T T . G G . GCCTCCCTC. GTGTTTTCCCCCTT. . CTGYYTTCC. GMTCCC. CMTTTMYCCTT 
1 0 2 9 _ 5 _ 8 0 0  < TTGCGCGHCTAAAT. AGTGTTTTCAACATT. . ATGTCTTTCAGCATCAACATTTAACCTT
0 4 1 2 _ 7 _ 7 0 0  < T T .G G .G A C T A A A T . AGTGTTTTCAACATT. . ATGTCTTTCAGAT. CAACATTTAACCTT
0 4 1 2 _ 4 _ 7 0 0  < T T . G G . GACTAAAT. AGTGTTTTCAACATT. . ATGTCTTTCAGAT. CAACATTTAACCTT
c d n a l  > A T . CAACATTTAACCTT
1 2 1 8 _ 1 _ 8 0 0  > T T . G G . GACTAAAT. AGTGTTTTCAACATT. . ATGTCTTTCAGAT. CAACATTTAACCTT 
1 2 2 9 _ 9 _ 8 0 0  > G G . G G . GACTAAAT. AGTGTTTTCAACAKK. . ATGKCTKKCAGAK. CAACATKKAACCKK 
0 8 0 4 _ 6 _ 8 0 0  < T T . G G . GACTAAAT. AGTGTTTTCAACATT. . ATGTCTTTCAGAT. CAACATTTAACCTT 
0 8 2 2 _ 4 _ 8 0 0  < T T . G G . GACTAAAT. AGTGTTTTCAACATT. . ATGTCTKTCAGAT. CAASATTTAACCTT 
CONSENSUS < T T . G G . GACTAAAT. AGTGTTTTCAACATT. . ATGTCTTTCAGAT. CAACATTTAACCTT
1 0 2 9 _ 3 _ 8 0 0
1 2 2 9 _ 1 _ 8 0 0
0 1 0 1 _ 1 _ 8 0 0
1 0 2 9 _ 5_ 8 0 0
0 4 1 2 _ 7 _ 7 0 0
0 4 1 2 _ 4 _ 7 0 0
c d n a l
1 2 1 8 _ 1 _ 8 0 0
1 2 2 9 _ 9 _ 8 0 0
0 8 0 4 _ 6 _ 8 0 0
0 8 2 2 _ 4 _ 8 0 0
CONSENSUS
GGGA. . CMAGCYA AACATAVG
TATWTCCAAGCTCTGACCATCATATTCACCACTCTTCACCCTGGCGAAAGCGTCGTTTCT 
. MTHTCCMMGCTCTGCCCCTCMTMTTCMCCMCTCTGCMCCCTGGCGAAAGCGTC. TTTCT 
. ATAACCAAGCTCTGMCCATCATATTCWCCACTCTKCACCCTKGSGAAAGCGTC. TTTCT 
. ATAACCAAGCTCTGACCATCATATTCACCACTCTGCACCCTGGCGAAAGCGTC. TTTCT 
. ATAACCAAGCTCTGACCATCATATTCACCACTCTGCACCCTGGCGAAAGCGTC. TTTCT 
. ATAAGCAAGCTCTGACCATCATATTCACCACTCTGCACCCTGGCGAAAGCGTC. TTTCT 
. ATAACCAAGCTCTGACCATCATATTCACCACTCTGCACCCTGGCGAAAGCGTC. TTTCT 
. AKAACCAAGCKCTGACCATCATATKCACCACTCTGCACCCTGGCGAAAG. G T C . TTTCT 
. ATAACCAAGCTCTGACCATCATATTCACCACTCTGCACCCTGGCGAAAGCGTC. TTTCT 
. ATAACCAAGCTCTGACCATCATATTCACCACTCTGCACCCTGGCGAAAGCGTC. TKTCT 
. ATAACCAAGCTCTGACCATCATATTCACCACTCTGCACCCTGGCGAAAGCGTC. TTTCT
GABA T r - 2
x g G A T l- 1
x G A T -1
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 + + + + + +
12  2 9 _ 1 _ 8 00  < AACCCTAKTT. CGTAAK. GAAGAGCMKAGAAGCTK. CTKYC. ACGTGGACKTGGTGCTGA
0 1 0 1 _ 1 _ 8 0 0  < AACTCTAGTTAYGTAAGTGAAGAGCAGAGAAGCTG. CTGTCCAYGTGGAC. TGGTGCTGA
1 0 2  9_ 5_ 8 00  < AACCCTAKTTACGTAAG. GAAGAGCCGCGAAKCTG. CTGTCCACGTGGAC. TGGTKCTGA
0 4 1 2 _ 7_ 7 00  < AACCCTAGTTACGTAAG. GAAGAGCCACGAAGCTG. CTGTCCACGTGGAC. TGGTGCTGA 
0 4 1 2 _ 4 _ 7 0 0  < AACCCTAGTTACGTAAG. GAAGAGCCGCGAAGCTG. CTGTCCACGTGGAC. TGGTGCTGA
c d n a l  > AACCCTAGTTACGTAAG . GAAGAGCCGCGAAG . TG . CTGTCCACGTGGAC . TGGTGCTGA
1 2 1 8 _ 1 _ 8 0 0  > AACCCTAGKTACGTAAG. GAAGAGCCGCGAAG. T G . CTGTCCACGTGGAC. TGGTGCTGA
12  2 9 _ 9 _ 8  00  > AACCCTAGTKACGTAAG. GAAGAGCCGCGAA. . TGNCTGTCCACGTGGAC. TGGTGCTGA
0 8 0 4 _ 6 _ 8  00  < AACCCTAGTTACGTAAG. GAAGAGCCGCGAAGCTG. CTGTCCACGTGGAC. TGGTGCTGA
0 8 2 2 _ 4 _ 8  00  < AACCCTAGTTACGTAAG. GAAGAGCCGCGAAGCTG. CTGTCCACGTGGAC. TGGTGCTGA 
CONSENSUS < AACCCTAGTTACGTAAG. GAAGAGCCGCGAAGCTG. CTGTCCACGTGGAC. TGGTGCTGA
1 2 2  9 _ 1 _ 8  0 0  < AATMA . CWWGTCMGKCTKCCATC . ACTTCYATTC . CAAAYYTTTATACAYTBCAMCAAA 
0 1 0 1 _ 1 _ 8  0 0  < AATCTGCTMGTCTGGMTGCCAGCCACTGCCATTCACAATCCAASARACATGGCAACAAAT
1 0 2  9 _ 5 _ 8  0 0 < AATCT . CTCKTCCKKCTTCCAKBCACTGCCATTC . CAAWCCAAGAGACATGGCRSSAAAT
0 4 1 2 _ 7 _ 7  0 0 < AATCT . CTCGTCCGGCTGCCAGGCACTGCCATTC . CAAACCAAGAGACATGGCAACAAAT
0 4 1 2 _ 4 _ 7 0 0  < AATCT . CTCGTCCGGCTGCCAGGCACTGCCATTC . CAAACCAAGAGACATGGCAACAAAT
c d n a l  > AATCT . CTCGTCCGGCTGCCAGGCACTGCCATTC . CAAACCAAGAGACATGGCAACAAAT
1 2 1 8 _ 1 _ 8  0 0  > AATCT . CTCGTCCGGCTGCCAGGCACT . CCATTC . CAAACCAAGAGACATGGCAACAAAT
1 2  2 9 _ 9 _ 8  0 0  > AATCT . CTCGTCCGGCTGCCAGGCACTGCCATTC . CAAACCAAGAGACATGGCAACAAAT
0 8 0 4 _ 6 _ 8  0 0  < AATCT . CTCGTCCGGCTGCCAGGCACTGCCATTC . CAAACCAAGAGACATGGCAACAAAT
0 8 2 2 _ 4 _ 8 0 0  < AATCT . CTCGTCCGGCTGCCAGGCACTGCCATTC . CAAACCAAGAGACATGGCAACAAAT
1 0 2 9 _ 1 _ 8 0 0  > TGN. . TGCKTTGCCM SC . . SGGGCCT . GCANMAA. T
CONSENSUS < AATCT . CTCGTCCGGCTGCCAGGCACTGCCATTC . CAAACCAAGAGACATGGCAACAAAT
GABA T r - 1
0 1 0 1 _ 1 _ 8 0 0  < GG
1 0 2 9 _ 5 _ 8 0 0  < GGARCTAAAGTGGCTGAKKK. . . AATCTCGTTTKTKCTTATTTT
0 4 1 2  7  7 0 0  < GGAACTAAAGTGGCWGATGGGCAAATTTCCACAGAACTTAGTGAGGCCCCCATTATTAAT
0 4 1 2 _ 4 _ 7 00  < GGAACTAAAGTGGCTGATGGGCAAATTTCCACAGAACTTAGTGAGGCCCCCATTATTAAT
c d n a l  > GGAACTAAAGTGGCTGATGGGCAAATTTCCACAGAACTTAGTGAGGCCCCCATTATTAAT
1 2 1 8 _ 1 _ 8  0 0 > GGAACTAAAGKGGCTGATGGGCAAATTTCCACAGAACTTAGKGAGGCCCCCATTATTAAT
1 2 2 9 _ 9 _ 8 0 0  > GGAACTAAAGTGGCTGATGGGCAAATTTCCACAGAACTTAGTGAGGCCCCCATTATTAAT
0 8 0 4 _ 6 _ 8  0 0 < GGAACTAAAGTGGCTGATGGGCAAATTTCCACAGAACTTAGTGAGGCCCCCATTATTAAT
0 8 2 2 _ 4 _ 8 0 0  < GGAACTAAAGTGGCTGATGGGCAAATTTCCACAGAACTTAGTGAGGCCCCCATTATTAAT 
1 0 2  9 _ 1 _ 8 0 0  > GGAS . . AAAG . GGC . KATGGA . AACMCTCCACAGAACT . AG . GAGGCCCC . AT . ANTAAT 
CONSENSUS < GGAACTAAAGTGGCTGATGGGCAAATTTCCACAGAACTTAGTGAGGCCCCCATTATTAAT
0 4 1 2 _ 7 _ 7 0 0  
0 4 1 2 _ 4 _ 7 0  0 
c d n a l  
1 2 1 8 _ 1 _ 8 0 0  
1 2 2 9 _ 9 _ 8 0 0  
0 8 0 4 _ 6 _ 8 0 0  
0 8 2 2 _ 4 _ 8 0 0  
1 0 2 9 _ 1 _ 8 0 0  
CONSENSUS
SACAAGCCAAAAACCTTGGTTGTCCCSCT. CAG 
GACAAGCCAAAAACCTTGGTGGTGAAGGTTCAG
GACAAGCCAAAAACCTTGGTGGTGAAGGTTCAGAA. GAAGAAAACAGAAGATATGGAAAG 
GACAAGCCAAAAACCTTGGTGGTGAAGGKTCAGAA. GAAGAAAACAGAAGATATGGAAAG 
GACAAGCCAAAAAMCTTGGTGGTGAAGGTTCAGAA. GAAGAAAACAGAAGATATGGAAAG 
GAC AAGC CAAAAAC CTTGGTGGTGAAGGTT C AGAA. GAAGAAAACAGAAGATATGGAAAG 
GACAAGCCAAAAACCTTGGTGGTGAAGGTTCAGAA. GAAGAAAACAGAAGATATGGAAAG 
TRCAAGCCAAAAACCTTGGTGGGGATGKTCAHGAAWGAWGAAACATGATGTAATGGAAYG 
GACAAGCCAAAAACCTTGGTGGTGAAGGTTCAGAA. GAAGAAAACAGAAGATATGGAAAG
............................+ ..............................+ .............................. + ............................ + ..............................4*............................... +
c d n a l  > AGATACCTGGAAAGGGAGGTTTGACTTCCTTATGTCCTGTGTTGGTTACGCCATTGGACT
1 2 1 8 _ 1 _ 8  0 0 > AGATACCTGGAAAGGGAGGTTTGACTTCCTTATGTCCTGTGTTGGKTACGCCATTGGACT 
1 2 2  9 _ 9 _ 8  0 0 > AGATACCTGGAAAGGGAGGTTTGACTTCCTTATGTCCTGTGTTGGTTACGCCATTGGACT 
0 8 0 4 _ 6 _ 8 0 0 < AGATACCTGGAAAGGGAGGTTTGACTKCCTTATGTCCTGTGTTGGTTACGCCATTGGACT 
0 82 2 _ 4 _ 8 0 0  < AGATACCTGGAAAGGGAGGTTTGACTTCCTTATGTCCTGTGTTGGTTACGCCATTGGACT 
1 0 2 9 _ 1_ 8 0 0  > T G . TACCTGGAA. GGGAGKTT. . ACTTCCTTATG. CCTGTGTTGG. TACACCATTGG. CT 
CONSENSUS < AGATACCTGGAAAGGGAGGTTTGACTTCCTTATGTCCTGTGTTGGTTACGCCATTGGACT
. * .....................+ ..............................+ ............................. + ............................. 4 - ..............................4 -............................... 4-
c d n a l  > GGGAAATGTGTGGAGATTCCCCTATCTCTGCGGCAAGAATGGAGGAG
1 2 1 8 _ 1 _ 8  0 0 > GGGAAATGTGTGGAGATTCCCCTATCTCTGCGGCAAGAATGGAGGAGGWAAGCTCTTCAT 
1 2 2  9 _ 9 _ 8  0 0 > GGGRAATGTGTGGAGATTCCCCTATCTCTGCGGCMAGAATGGAGGAGGTAAGCTCTTCAT 
0 8 ° 4 _ 6 _ 8 0 0  < GGGAAATGTGTGGAGATTCCCCTATCTCTGCGGCAAGAATGGAGGAGGTAAGCTCTTCAT 
0 8 2 2 _ 4 _ 8 0 0  < GGGAAATGTGTGGAGATTCCCCTATCTCTGCGGCAAGAATGGAGGAGGTAAGCTCTTCAT 
1 ° 2 9 _ 1 _ 8 0 0  > GGG. AATGTGTGGAGAT. CCCCTATCTCTGCGG. AAGAATGGAGGAGGTAAGCTCTTCAT 
CONSENSUS < GGGAAATGTGTGGAGATTCCCCTATCTCTGCGGCAAGAATGGAGGAGGTAAGCTCTTCAT
I l l
 +.............. +.............. +............... +.............+................+
1 2 1 8 _ 1 _ 8  0 0  > AGAAATTATATTTCCCATGATGCTTCAATTGCTACAATTTTTTTGTCTGAAATTTGTCAG
1 2 2  9 _ 9 _ 8  0 0  > AGAAATTATATTTCCCATGATGCTTCMATTGCTACMAWTTTTTTGTCTGAAATTTGTCAG
0 8 0 4 _ 6 _ 8 0 0  < AGAAATTATATTTCCCATGATGCTTCAATTGCTACAATTTTTTTGTCTGAAATTTGTCAG
0 8 2 2 _ 4 _ 8 0 0  < AGAAATTATATTTCCCATGATGCTTCAATTGCTACAATTTTTTTGTCTGAAATTTGTCAG
1 0 2 9 _ 1 _ 8 0 0  > AGAAATTATATTTCCCATGATGCTTCAATTGCTACAATTTTTTTGTCTGAAATTTGTCAG
0 8 2 2 _ 5 _ 8 0 0  < GAAATTTGT CAG
CONSENSUS < AGAAATTATATTTCCCATGATGCTTCAATTGCTACAATTTTTTTGTCTGAAATTTGTCAG
 +.............. +.............. +............... +.............+................+
1 2 1 8 _ 1 _ 8  0 0  > ATTTTATGGGG
12 2 9 _ 9 _ 8 0 0  > ATTTTATGGSGGTGKTTTTTATTTCTAAATTAGATTGKTTACACTCC
0 8 0 4 _ 6 _ 8 0 0 < ATTTTATGGTGTTGTTTTTTATTTCTAAATTAGATTGTTTACACTCCAAACTATTCACTC
0 8 2 2 ~ 4 _ 8  0 0  < ATTTTATGGTGTTGTTTTTTATTTCTAAATTAGATTGTTTACACKCCAAACTATTCACTC
1 0 2  9 _ 1 _ 8  0 0 > ATTTTATGGKGTTGTTTTTTATTTCTAAATTAGATTGTTTACACTCCAAACTATTCACTC
0 8 2 2 _ 5 _ 8  0 0 < ATTTTATGGTGTTGKGKKKTAKKTCTAAATTAGATTGTTTACACTCCAAACTATTCACTC
CONSENSUS < ATTTTATGGTGTTGTTTTTTATTTCTAAATTAGATTGTTTACACTCCAAACTATTCACTC
 +.............. +.............. +............... +.............+................+
0 8 0 4 _ 6 _ 8 0 0 < CACCATGTAAAATGTCATTCCAGAACCAACAAGTGTATTTAGTTGTAATATTGGTGTGTA
0 8 2 2 _ 4 _ 8  0 0 < CACCATGTAAAATGTCATTCCAGAACCAACAAGTGTATTTAGTTGTAATATTGGTGTGTA
1 0  2 9 _ 1 _ 8 0 0 > CACCATGTAAAATGTCATTCCAGAACCAACAAGTGTATTTAGTTGTAATATTGGTGTGTA
0 8 2 2 _ 5 _ 8  0 0 < CACCATGTAAAATGTCATTCCAGAACCAACAAGTGTATTTAGTTGTAATATTGGTGTGTA 
CONSENSUS < CACCATGTAAAATGTCATTCCAGAACCAACAAGTGTATTTAGTTGTAATATTGGTGTGTA
0 8 0 4 _ 6 _ 8  0 0 
0 8 2 2 _ 4 _ 8 0 0  
1 0 2 9 _ 1 _ 8 0 0  
0 8 2 2 _ 5 _ 8 0 0  
CONSENSUS
TCTATGTTGTGTTTAGCACCGTGGTCCTAGAGGAACG 
TCTATGTTGTGTTTAGCACCGTGGTCCTAGAGGAACG. . GGTA
TCTATGTTGTGTTTAGCACCGTGGKCCTAGAGGAACGTTG. TTTCGTTTCACTGTGTACT 
TCTATGTTGTGTTTAGCACCGTGGTCCTAGAGGAACGTTGTTTTCGTTTCACTGTGTACT 
TCTATGTTGTGTTTAGCACCGTGGTCCTAGAGGAACGTTGkTTTCGTTTCACTGTGTACT
 + + + + + +
1 0 2  9 _ 1 _ 8 0 0 > GTACAAACGTATATGGATGAAATGACAATAAACTCACTCTTGACTCTCTTGACTTGACTC
0 4 2 6 _ 3 _ 8 0 0  > TWKATTGACTKGAACA
1 2 1 8 _ 3 _ 8 0 0  > MAACTATATRGATGAAAWRACAATAAACTCACTCTTKACTCTCTTGACTTGACTC
0 8 2 2 _ 5 _ 8 0 0  < GTACAAACGTATATGGATGAAATGACAATAAACTCACTCTTGACTCTCTTGACTTGACTC 
0 7 0 6 _ 2 _ 8  0 0 > RAAMKAMBAAM. AAMACWAANTKACTC
CONSENSUS < GTACAAACGTATATGGATGAAATGACAATAAACTCACTCTTGACTCTCTTGACTTGACTC
1 0 2  9 _ 1 _ 8  0 0 
0 4 2 6 _ 3 _ 8 0 0  
1 2 1 8 _ 3 _ 8 0 0  
0 8 2 2 _ 5 _ 8 0 0  
0 7 0 6 _ 2 _ 8 0 0  
CONSENSUS
TTGACTAGGTACATC. TCAGCTCATTTTG. CCTGGTCATGTGATTTCAGAAAGAGCCAGC 
TTGACTMBBDAMATCATCAGCACATTTTGACATGGACATRAGATATCAGAAAGAG. CAGC 
TTGACTAGCYACATC. TCAGCTCATTTTG. CCTGGTCATGTGATTTCAGAAAGAGCCAGC 
TTGACTAGGTACATC. TCAGCTCATTTTG. CCTGGTCATGTGATTTCAGAAAGAGCCAGC 
. TGRSGASGNACATC. TCAGCTCATTTTG. CCTGGTCATGTGATTTCAGAAARAAACAAC 
TTGACTAGGTACATC. TCAGCTCATTTTG. CCTGGTCATGTGATTTCAGAAAGAGCCAGC
1 0 2 9 _ 1_ 8 ° 0  
0 4 2 6 _ 3 _ 8 0 0  
1 2 1 8 _ 3 _ 8  0 0 
0 8 2 2 _ 5 _ 8 0 0  
0 7 0 6 _ 2 _ 8 0 0  
CONSENSUS
ACTTTAGGATGGAACTGCTTTCTGGCAGGCTGTTGTTTCTCCTACTCAATGTAACTGAAC 
ACTTTAGGATGGAACTGCTTTCTGGCAGGCTGTTGTTTCTCCTACTCAATGTAACTGAAC 
ACTTTAGGATGGAACTGCTTTCTGGCAGGCTGTTGTTTCTCCTACTCAATGTAACTGAAC 
ACTTTAGGATGGAACTGCTTTCTGGCAGGCTGTTGTTTCTCCTACTCAATGTAACTGAAC 
ACTTTAGGATGGAACTGCTTTCTGGCAGGCTGTTGTTTCTCCTACTCAATG. AACTGAAC 
ACTTTAGGATGGAACTGCTTTCTGGCAGGCTGTTGTTTCTCCTACTCAATGtAACTGAAC
 + + + + + +
1 0 2  9 _ 1 _ 8 0 0 > GTGTGTCAGTGGGACCTGGATTTTTAATATTGAGTGCTGTTCTTAGATCTACCAGGCAGC 
04  2 6 _ 3 _ 8 0 0 > GTGTGTCAGTGGGACCTGGATTTTTAATATTGAGTGCTGTTCTTAGATCTACCAGGCAGC 
1 2 1 8 _ 3 _ 8 0 0 > GTGTGTCAGAGGGACCTGGATTTTTAATATTGAGTGCTGTTCTTAGATCTACCAGGCAGY 
0 8 2  2 _ 5 _ 8  0 0 < GTGTGTCAGTGGGACCTGGATTTTTAATATTGAGTGCTGTTCTTAGATCTACCAGGCAGC 
07  0 6 _ 2 _ 8  0 0 > GTGTGTCAGTGGGACCTGGATTTTTAATATTGAGTGCTGTTCTTAGATCTACCAGGCAGC 
CONSENSUS < GTGTGTCAGTGGGACCTGGATTTTTAATATTGAGTGCTGTTCTTAGATCTACCAGGCAGC
0 8 0 8  D e l . T P 5 - 1
x g G A T l-1 9
x g G A T l-4
x g G A T l-1 9
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1 0 2  9 _ 1 _ 8 0 0 > TGTTATCTTGTGTTAGGGAGCTGCTATCTGGKTACCTTCCCATTGTTCGGGTGKTAGGST
0 4 2  6 _ 3 _ 8 0 0  > t g t t a t c t t g t g t t a g g g a g c t g c t a t c t g g t t a c c t t c c c a t t g t t c g g t t g t t a g g c t  
1 2 1 8 _ 3 _ 8 0 0 > t k t t a t c t t g t g t t a g g g a g c t g c t a t c t g g y t a c c t t c c c a t t g t t c g g t t g t t a g g s t  
0 8 2 2 _ 5 _ 8  0 0 < t g t t a t c t t g t g t t a g g g a g c t g c t a t c t g g t t a c c t t c c c a t t g t t c g g t t g t t a g g c t  
0 7 0 6 _ 2 _ 8 0 0  > TGTTATCTTGTGTTAGRGAGCTGCTATCTGGTTACCTTCCCATTGTTCGGTTGTTAGGCT
CONSENSUS < TGTTATCTTGTGTTAGGGAGCTGCTATCTGGTTACCTTCCCATTGTTCGGTTGTTAGGCT
1 0  2 9 _ 1 _ 8  0 0 
0 4 2 6 _ 3 _ 8 0 0  
1 2 1 8 _ 3 _ 8  0 0 
0 8 2 2 _ 5 _ 8 0 0  
0 7 0 6 _ 2 _ 8 0 0  
CO NSENSUS
GCTGGGGGGGAAGGGAGGGGCTAATATCACTCTAACGTGSAGGACAGCAGAAAAGAGGGA
GCTGGGGGGGAAGGGAGGGGCTAATATCACTCTAACTTGCAGTACAGCAGTAAAGAGTGA
GCTGGGGGGGAAGGGAGGKKYTAATATCACTCKAACKKGCAGGACAGCAGGAAAGAGGGA
GCTGGGGGGGAAGGGAGGSGCTAATATCACTCTAACTTGCAGTACAGCAGTAAAGAGTGA
GCTGGGGGGGAAGGGAGGGGCTAATATCACTCTAACTTGCAGTACAGCAGTAAAGAGTGA
GCTGGGGGGGAAGGGAGGGGCTAATATCACTCTAACTTGCAGTACAGCAGTAAAGAGTGA
 + + + + + +
1 0  2 9 _ 1 _ 8  0 0 > CTGAA
0 4  2 6 _ 3 _ 8  0 0 > CTGAAGTTTATCAGAGCACAAGTCAATGKKKGKWACCTGGGAAACTGACAATATGTCTAG
1 2 1 8 _ 3_ 8 0 0  > CKGAAGTTTATCAGAGCACAAGGCAAKG. GGGGRACCKGGGAAACTGACAATATSCCTAS
08 2 2 _ 5 _ 8 0 0 < CTGAAGTTTATCAGAGCACAAGTCAATG. GGGGAACCTGGGAAACTGACAATATGTCTAG 
0 7  0 6 _ 2 _ 8 0 0 > CTGAAGTTTATCAGAGCACAAGTCAATG. GGGGAACCTGGGAAACTGACAATATGTCTAG
CONSENSUS < CTGAAGTTTATCAGAGCACAAGTCAATG. GGGGAACCTGGGAAACTGACAATATGTCTAG
0 4 2 6 _ 3 _ 8  0 0 > CCCCATATTTGTATTTGTATTAGTATTATTGTTTGYATCCAATTGGGTCATTAATGGGAC  
1 2 1 8 _ 3 _ 8 0 0 > CCCCATATTTGGAKGGGGAKGAGGAKKAKKGKKKGWATCCAAKKGGGKCAKKAAKGGCAC
0 8 2 2 _ 5 _ 8  0 0  < CCCCATATTTGTATTTGTATTAGTATTATTGTTTGTATCCAATTGGTTCATTAATGGCAC  
0 7 0 6 _ 2 _ 8 0 0 > CCCCATATTTGTATTTGTATTAGTATTATTGTTTGTATCCAATTGGTTCATTAATGGCAC
CCCCATATTTGTATTTGTATTAGTATTATTGTTTGTATCCAATTGGkTCATTAATGGCACCO NSENSUS
+ ,
0 4  2 6 _ 3 _ 8 0 0 > AAATAAATCAATGTATYTATYTTTGGCAAAATATGTMATGGATAGSGGTACTGGYTTAGT
1 2 1 8 _ 3 _ _ 8  0 0 > AAAKAAATCAATGKATCTATCTKKGCCAAAAKAKGCAAKGGAKAGGGCKACKGGGCKAGG 
0 8 2  2 _ 5 _ 8 0 0 < AAATAAATCAATGTATCTATCTTTGCCAAAATATGCAATGGATAGTGCTACTGGTCTAGT
0 7  0 6 _ 2 _ 8 0 0  > AAATAAATCAATGTATCTATCTTTGCCAAAATATGCAATGGATAGTGCTACTGGTCTAGT
CONSENSUS < AAATAAATCAATGTATCTATCTTTGCCAAAATATGCAATGGATAGTGCTACTGGTCTAGT
0 4 2 6 _ 3 _ 8 0 0
1 2 1 8 _ 3 _ 8 0 0
0 8 2 2 _ 5 _ 8 0 0
0 7 0 6 _ 2 _ 8 ° 0
CO NSENSUS
AAACCATMGSATGGTMGCATGT
AACCCATAGCAKGGGAGCATGBGGGGGRGCCAAGAAGGAGGGAAA
AACCCATAGCATGGTAGCATGTGTTTGTGCCAATAATGATGGAAATAGCTATAAAGCATG
AACCCATAGCATGGTAGCATGTGTTTGTGCCAATAATGATGGAAATAGCTATAAAGCATG
AACCCATAGCATGGTAGCATGTGTTTGTGCCAATAATGATGGAAATAGCTATAAAGCATG
 +.............. +............... +..............+...............+...............+
0 8 2 2 _ 5 _ 8 0 0 < AAGGTCATTTAATTAAACAGCAATTAAAGTCTAATATATCCTTCTAATCATGATATAGTT 
0 7 0 6 _ 2 _ 8  0 0 > AAGGTCATTTAATTAAACAGCAATTAAAGTCTAATATATCCTTCTAATCATGATATAGTT 
CONSENSUS < AAGGTCATTTAATTAAACAGCAATTAAAGTCTAATATATCCTTCTAATCATGATATAGTT
 +.............. +.............. + ..............+...............+...............+
08  2 2 _ 5 _ 8  0 0 < TTATAGGATCTCTCTGTACAGACTATGAGCAAACTTAGGGGACTGTT
0 7 0 6 _ 2 _ 8  0 0 > TTATAGGATCTCTCTGTACAGACTATGAGCAAACTTAGGGGACTGTTCCTGCTGAATTGT
0 7 1 2 _ 2 _ 8 0 0  < CTWTGAGCAARCTTAGGGGACTGTTCCTGCTGRATTGT G T - S a c 4 - E c o 2
CONSENSUS < TTATAGGATCTCTCTGTACAGACTATGAGCAAACTTAGGGGACTGTTCCTGCTGAATTGT
 +.............. +............... +..............+...............+...............+
0 7 0 6 _ 2 _ 8  0 0 > GCTTAGSACAGGGAATACCTATGCTGCCATAGKTTTATGGGATCTCTCTGKACAGACGAK 
0 7 1 2 _ 2 _ 8  0 0 < GCTTAGTACAGGGAATACCTATGCTGCCATAGTTTTATGGGATCTCTCTGTACAGACTAT 
CONSENSUS < GCTTAGtACAGGGAATACCTATGCTGCCATAGkTTTATGGGATCTCTCTGtACAGACkAt
0 7 0 6 _ 2 _ 8  0 0 
0 7 1 2 _ 2 _ 8 0 0  
CO NSENSUS
GAGTTWWTGKWTTTT
GAGCAAACTTARGGGACTGTTCCTGCTGAATTGTGCTTAGTACAGGGAATACCTATGCT
GAGywAAykTAtkkkACTGTTCCTGCTGAATTGTGCTTAGTACAGGGAATACCTATGCT
0 7 1 2 _ 2 _ 8 0 0
0 7 1 2 _ 1 _ 8 0 0
CO NSENSUS
GCCATAGTTTTATGGGATCTCYCTGTACAGACTATGAGCAAACTTAGGGGACTGTTCCTG
GCCATAGWAWTAWGGGATCTCTCTGTACAGACTATGAGCAAACTTAGGGGACTGTWCCTG
GCCATAGTwTTATGGGATCTCTCTGTACAGACTATGAGCAAACTTAGGGGACTGTTCCTG
G T - S a c 4 - E c o l
179
0 7 1 2 _ 2 _ 8 0 0
0 7 1 2 _ 1 _ 8 0 0
0 7;L 2 _ 4 _ 8 0 0
0 7 1 2 _ 3 _ 8 0 0
CONSENSUS
0 7 1 2 _ 2 _ 8 0 0
0 7 1 2 _ 1 _ 8 0 0
0 7 1 2 _ 4 _ 8 0 0
0 7 1 2 _ 3 _ 8 0 0
CONSENSUS
0712_2_800 
0 7 1 2 _ 1 _ 8 0 0  
0 7 1 2 _ 4 _ 8 0 0  
0 7 1 2 _ 3 _ 8  0 0 
CONSENSUS
0 7 1 2 _ 2 _ 8 0 0  
0 7 1 2 _ 1 _ 8 0 0  
0 7 1 2 _ 4 _ 8  00  
0 7 1 2 _ 3 _ 8 0 0  
CONSENSUS
0712_2_800 
0 7 1 2 _ 1 _ 8  00 
0 7 1 2 _ 4 _ 8 0 0  
0 7 1 2 _ 3 _ 8 0  0 
CONSENSUS
0 7 1 2 _ 2 _ 8 0 0
0 7 1 2 _ 1 _ 8 0 0
0 7 1 2 _ 4 _ 8 0 0
0 7 1 2 _ 3 _ 8 0 0
CONSENSUS
0 7 1 2 _ 2 _ 8 0 0
0 7 1 2 _ 1 _ 8 0 0
0712_4_800
0 7 1 2 _ 3 _ 8 0 0
CONSENSUS
0 7 1 2 _ 2 _ 8 Q 0
0 7 1 2 _ 1 _ 8 0 0
0 7 1 2 _ 4 _ 8 0 0
0 7 1 2 _ 3 _ 8 0 0
0 4 2 6 _ 2 _ 8 0 0
CONSENSUS
0 7 1 2 _ 2 _ 8 0 0  
0 7 1 2 _ 1 _ 8 0 0  
0 7 1 2 _ 4 _ 8 0 0  
0 7 1 2 _ 3 _ 8  0 0 
0 4 2 6 _ 2 _ 8 0 0  
CONSENSUS
..........................................4 - ............................................ + ............................................. 4- ...........................................+ ............................................ 4" ............................................... 4"
< CTGAATTGTGCTTAGTACAGGGAATACCTATGTACCATAGTTTTATGGGATCTCTCTGTA
< CTGAATTGWGCTTAGTACAGGGAATACCTATGTACCATAGTWTTATGGGATCTCTCTGTA
< A
< A
< CTGAATTGTGCTTAGTACAGGGAATACCTATGTACCATAGTTTTATGGGATCTCTCTGTA
 + + + + ... + +
< CAGACTATGA. GCAAACTTAGGGGACTGTTCCTGCTGAATTGTGCTTAGTACAGGGAATA
< CAGACTATGA. GCAAACTTAGGGGACTGTTCCTGCTGAATTGTGCTTAGTACAGGGAATA
< CAGACTATKAAGCAAACTTAGGGGACTGKTCCTGCTGRAATGTSCTTAGTACAGGGAATA
< CAGACTATGA. GCAAACTTAGGGGACTGTTCCTGCTGAATTGTGCTTAGTACAGGGAATA
< CAGACTATGA. GCAAACTTAGGGGACTGTTCCTGCTGAATTGTGCTTAGTACAGGGAATA
 + + + + + +
< CCTATGCTGTCATAGTTTTATGGGATCTCTCTGTACAGACTATGAGCAAACTTAGGGGCT
< CCTATGCTGTCATAGWATTATGGGATCTCTCTGTACAGACTATGAGMAAACTTAGGGGCT
< CCTATGCTGTCATAGTTTTATGGGATCYCTCTGTACAGACTATGAGCAAACTTAGGGGCT
< CCTATGCTGTCATAGTTTTATGGGATCTCTCTGTACAGACTATGAGCAAACTTAGGGGCT
< CCTATGCTGTCATAGTTTTATGGGATCTCTCTGTACAGACTATGAGCAAACTTAGGGGCT
 + + + + + +
< GTTCCTGCTGAATTGTGCTTAGTACAGGGAATACCTATGCTGCCATAGTTTTATGGGATC
< GTTCCTGCTGAATTGTGCTTAGTACAGGGAATACCTATGCTGCCATAGTATTATGGGATC
< GTTCCTGCTGAATTGTGCTTAGTACAGGGAATACCTATGCTGCCATAGTTTTATGGGATC
< GTTCCTGCTGAATTGTGCTTAGTACAGGGAATACCTATGCTGCCATAGTTTTATGGGATC
< GTTCCTGCTGAATTGTGCTTAGTACAGGGAATACCTATGCTGCCATAGTTTTATGGGATC
 + + + + + +
< TCWCTGTACAGACTATGAGCAAACTTAGGGACTGTTCCTGCTGAATTGTGCTTAGTACAG
< TCTCTGTACAGACTATGAGCAAACTTAGGGACTGTTCCTGCTGAATTGTGCTTAGTACAG
< TCTCTGTACAGACTATGAGCAAACTTAGGGACTGTTCCTGCTGAATTGTGCTTAGTACAG
< TCTCTGTACAGACTATGAGCAAACTTAGGGACTGTTCCTGCTGAATTGTGCTTAGTACAG
< TCTCTGTACAGACTATGAGCAAACTTAGGGACTGTTCCTGCTGAATTGTGCTTAGTACAG
 +...............+..............+............... +.............. +.............. +
•c GGAATACCTATGCTGCCATAGTTTTATGGGATCTCTCTGTACAGACTATGAGCAAACTTA
< GGAATACCTATGCTGCCATAGTATTATGGGATCTCTCTGTACAGACTATGAGCAAACTTA
< GGAATACCTATGCTGCCATAGTTTTATGGGATCTCTCTGTACAGACTATGAGCAAACTTA
< GGAATACCTATGCTGCCATAGTTTTATGGGATCTCTCTGTACAGACTATGAGCAAACTTA
< GGAATACCTATGCTGCCATAGTTTTATGGGATCTCTCTGTACAGACTATGAGCAAACTTA
 +...............+..............+............... +.............. +.............. +
< GGGGACTGTTCCTGCTGAATTGTGCTTAGTACAGGGAATACCTATGCTGCCATAGTTTTA
< GGGGACTGTTCCTGCTGAATTGTGCWTAGTACAGGGAATACCTATGCTGCCATAGTATTA
< GGGGACTGTTCCTGCTGAATTGTGCTTAGTACAGGGAATACCTATGCTGCCATAGTTTTA
< GGGGACTGTTCCTGCTGAATTGTGCTTAGTACAGGGAATACCTATGCTGCCATAGTTTTA
< GGGGACTGTTCCTGCTGAATTGTGCTTAGTACAGGGAATACCTATGCTGCCATAGTTTTA
..........................................4- ............................................ 4- . , ...................................4~ ............................................ 4- ........................................... 4- ............................................... 4-
< TGGGATCTCTCTGTACAGACTATGAGCAAACTTAGGGACTGTTCCTGCTGAATTGTGCTT
< TGGGATCTCTCTGTACAGACTATGAGCAAACTTAGGGACTGTTCCTGCTGAATTGTGCTT
< TGGGATCTCTCTGTACAGACTATGAGCAAACTTAGGGACTGTTCCTGCTGAATTGTGCTT
< TGGGATCTCTCTGTACAGACTATGAGCAAACTTAGGGACTGTTCCTGCTGAATTGTGCTT
< ACTATGASAAHCTTTAGSGACTGTGACTGCTGAATTGTSCTT
< TGGGATCTCTCTGTACAGACTATGAGCAAACTTAGGGACTGTTCCTGCTGAATTGTGCTT
 + + + + + .. . .+
< AGTACAGGGAATACCTATGTTGCCATAGTTTTATTATAGCTCTTTGTACAGACTACAGTA
< AGTACAGGGAATACCTATGTTGCCATAGWWATATTATAGCTCTTTGTACAGACTACAGTA
< AGTACAGGGAATACCTATGTTGCCATAGTTTTATTATAGCTCTTTGTACAGACTACAGTA
< AGTACAGGGAATACCTATGTTGCCATAGTTTTATTATAGCTCTTTGTACAGACTACAGTA
< AGTACARGGAATACCTATGTKCCCATAKTTTTATTATAGCKCTTTGTACAGCCTACAGTA
< AGTACAGGGAATACCTATGTTGCCATAGTTTTATTATAGCTCTTTGTACAGACTACAGTA
G T - S a c 4 - X b a 2  
G T - S a c 4 - X b a l
x g G A T l- 1 7
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0 7 1 2 _ 2 _ 8 0 °
0 7 1 2 _ 1 _ 8 0 0
0 7 1 2 _ 4 _ 8 0 0
0 7 1 2 _ 3 _ 8 0 °
0 4 2 6 _ 2 _ 8 0 0
CONSENSUS
0 7 1 2 _ 2 _ 8 0 0  
0 7 1 2 _ 1 _ 8 0 0  
0 7 1 2 _ 4 _ 8 0 0  
0 7 1 2 _ 3 _ 8  0 0 
0 4 2 6 _ 2 _ 8 0 0  
CONSENSUS
0 7 1 2 _ 2 _ 8 0 0
0 7 1 2 _ 1 _ 8 0 0
° 7 1 2 _ 4 _ 8 0 0
0712_3_800
0 4 2 S _ 2 _ 8 0 0
CONSENSUS
0 7 1 2 _ 4 _ 8 0 0
0 7 1 2 _ 3 _ 8 0 0
0 4 2 6 _ 2 _ 8 0 0
CONSENSUS
0712_4_800
0 7 1 2 _ 3 _ 8 0 0
0 4 2 6 _ 2 _ 8 0 0
CONSENSUS
0 7 1 2 _ 4 _ 8 0 0
0 7 1 2 _ 3 _ S 0 °
0 4 2 6 _ 2 _ 8 0 0
CONSENSUS
0 7 1 2 _ 4 _ 8 0 0
0 7 1 2 _ 3 _ 8 0 0
0 4 2 6 _ 2 _ 8 0 0
0 4 2 6 _ 1 _ 8
0 2 2  7 _ 1 _ 8
0 8 2 6 _ 4 _ 8 0 0
CONSENSUS
0 7 1 2 _ 4 _ 8 0 0
0 7 1 2 _ 3 _ 80 0
0 4 2 6 _ 2 _ 8 0 0
0 4 2 6 _ 1 _ 8 0 0
0 2 2 7 _ 1 _ 8 0 0
0826_4_800
1 2 1 8 _ 2 _ 8 0 0
CONSENSUS
1 2 1 8 _ 2 _ 8 0 0
0 4 2 6 _ 1 _ 8 0 0
0 2 2 7 _ 1 _ 8 0 0
0826_4_800
CONSENSUS
 +  +  +  +  +  +
< TATGTAAATGTAGGTAATGCTCTTTCTGAATTGTGCTTAATACAGAGTAATACTGTCCTG
< TATGWAAATGTAGGTAATGCTCTWTCTGAATTGTGCTTAATACAGAGTAATACTGTCCTG
< TATGTAAATGTAGGTAATGCTCTTTCTGAATTGTGCTTAATACAGAGTAATACTGTCCTG
< TATGTAAATGTAGGTAATGCTCTTTCTGAATTGTGCTTAATACAGAGTAATACTGTCCTG
< TATGTAAATGTAGGTAATGCYCTTTCTGAATTGTSCTTAATACAGAGTAATRCTGTCCTG
< TATGTAAATGTAGGTAATGCTCTTTCTGAATTGTGCTTAATACAGAGTAATACTGTCCTG
 + + + + + +
< GCATTGTTTTCTATAGGGTACTATGACCTCAGATGAGTGTTGTCTGCCCCTTATGAATAC
< GCATTGTTWTCTATAGGGTACTATGACCTCAGATGAGTGTTGTCTGCCCCTTATGAATAC
< GCATTGTTTTCTATAGGGTACTATGACCTCAGATGAGTGTTGTCTGCCCCTTATGAATAC
< GCATTGTTTTCTATAGGGTACTATGACCTCAGATGAGTGTTGTCTGCCCCTTATGAATAC
< SCATTGTTTTCTATAGGGTGCTATGCCCTCAGATGAGTGTTGTCTGCCCCTTATGAATAC
< GCATTGTTTTCTATAGGGTACTATGACCTCAGATGAGTGTTGTCTGCCCCTTATGAATAC
 + + + + + +
< AGTGCTGCTGAAGGCAACAC. TGTATTCATGAGTTGTGGGCAA. AGTCTTTCAGTCTAT
< AGTGCTGCTGAAGGCAACAC. TGTATTCATGAGTTGTGGGCAAGAGTCTTTCAGTCTAT
< AGTGCTGCTGAAGGCAACAC. TGTATTCATGAGTTGTGGGCAA. AGTCTTTCAGTCTATG
< AGTGCTGCTGAAGGCAACAC. TGTATTCATGAGTTGTGGGCAA. AGTCTTTCAGTCTATG
< AGTGCTSCTGAAGSCAMCCCCTSTATTCATGAGTTGTGGGCAA. AGTCTTTCAGTCTATG
< AGTGCTGCTGAAGGCAACAC. TGTATTCATGAGTTGTGGGCAA. AGTCTTTCAGTCTATG
 + + . + + + +
< AATTCATTTAGGGGGTGATTCTTGGTGGATTGTGCTTAGTACACAGGTAAACCAATGTTG
< AATTCATTTAGGGGGTGATTCTTGGTGGATTGTGCTTAGTACACAGGTAAACCAATGTTG
< AATTCATTTAGGGGGTGATTCTTGGTGGATTGTGCTTAGTACACAGGTAAACCAATGTTG
< AATTCATTTAGGGGGTGATTCTTGGTGGATTGTGCTTAGTACACAGGTAAACCAATGTTG
.......................................... -4- .............................................+ ............................................. + ...........................................+ .............................................+ ................................................4*
< GCATAGTTTTTGGTATCTCTCTTAACAGGTTATGACCAAACCTAGAAGATTATTGCTGTT
< GCATAGTTTTTGGTATCTCTCTTAACAGGTTATGACCAAACCTAGAAGATTATTGCTGTT
< GCATAGTTTTTGGTATCTCTCTTAACAGGTTATGACCAAACCTAGAAGATTATTGCTGTT
< GCATAGTTTTTGGTATCTCTCTTAACAGGTTATGACCAAACCTAGAAGATTATTGCTGTT
 + + + + + +
< AAAAGTATTACGGGTGGGTGCCTATGCTGGCATAGCGGCAGATACAATAAGCGGTGGGTT
< AAAAGTATTACGGGTGGGTGCCTATGCTGGCATAGCGGCAGATACAATAAGCGGTGGGTT
< AAAAGTATTACGGGTGGGTGCCTAT. C T G . CATAGCGGCAGATACAATAA. CGGTGGGTT
< AAAAGTATTACGGGTGGGTGCCTATGCTGGCATAGCGGCAGATACAATAAGCGGTGGGTT
 + + + + + +
< TCAATAAACATCTCCAATGAGTTCAATGTACATCTCACAGTCTGATAGATCACCCTGTTG
< TCAATAAACATCTCCAATGAGTTCAATGTACATCTCACAGTCTGATAGATCACCCTGTTG
< T . AATAA. CA TC TC . AATGAGTT. AATGT. C A TC T. ACAGTCTGAT. GATCMCC. TGTTG
> GTCACAG. ATRGG. GCCCA. CCTGTTG x g G A T l- 1 5
> GTGAGAGGGGGGWA. A T C . CCCTGTTG x g G A T l- 1 5
> CTCATTTTGCCTGGTCATGTGATTTC G T - S a c 4 - A lu 4
< TCAATAAACATCTCCAATGAGTTCAATGTACATCTCACAGTCTGATAGATCACCCTGTTG
 + + + + + +
< GCTTCTTTGTAA. AGGG. . GTTATAGT
< GCTTCTTTGTAA. AGGG. . GTTATAGT
< . CTTCTTTKTAAGAGGTATGTTCTAGAGRTTGAGTVSGNVTTAATTTCCCAMGCAHASN
> . VTTCTMTGTAA. AGAG. ATATAGMTCTAGAGGTGGATAATGGMACAGATACAGAT. AT
> . CTTCTTTGAAA. AGGGTATA. AGTTCAAGAAGTTGATAAATGAACANGTACAGATAAT
> AGAAAGAGCCAGCACTTTAGGATGGAACTGCTTTCTGGCAGGCTGTTGTTTCTCCTACT
> CGCTACAGAT. AT xgG A T 1 - 2
< GCTTCTTTGTAA. AGGG. . GTTATAGydAGAGGTTGATAATTGAACwGnTACAGATAAT
> TTGTCACC. AGAAARAA. AATAGAACCTAAAAMA. GAC
> TTGYCACC. AGAAAGAACAATAGAACCTAAAACA. G . C
> TTGTCACCAAGAAARAACAATAGAACCTAAAACACGCA
> CAATGTAACTGAACGTGTGTCAGTGGGACCTGGATTTT
> TTGTCACC. AGAAAGAACAATAGAACCTAAAACA. GhC
181
1 2 1 8 _ 2 _ 8  00  > AAATGA. GCCA. G TA . G CA . CTTG C. A TA . . AAARMTACAAGGAAGAACA. . AAGC. AAG
04  2 6 _ 1 _ 8  00  > AAATGA. GCCA. G T A . G CA . CTTG C. A TA . . GAAGCTAC. AGG. AGAACA. . AAGC. AAG
0 2 2 7 _ 1 _ 8 0 0  > AAATGANGCCACGTANGCACCTTGCAATAWGAAAGCTACMCGGANGAACAACAAGCAAAG
0 8 2 6 _ 4 _ 8 0 0  > TAATATTGAGTGCTGTTCTTAGATCTACCAGGCAGCTAC. AG G ■AGAACA. . AAGC■AAG 
CONSENSUS > AAATGA. GCCA. G T A . G CA . CTTG C. A T A . . rAAGCTACAAGGAAGAACA. . AAGC. AAG
 +.............. +.............. +...............+.............. +...............+
1 2 1 8 _ 2 _ 8  00  > A . . GGGGTG. A A T . CTTGTWACTATTTCATTATGAAAAATACACTGAAACTAAAAGATGC
04 2 6 _ 1 _ 8  00  > A . . GGGGTG. A A T . CTTGTTACTATTTCATTATGAAAAATACACTGAAACTAAAAGATGC
02 2 7 _ 1 _ 8  00  > AAGGGGGTGAAATCCTTGTTACYATTTCATTAT . AAAAATACACTGAAACTAAAAGATGC
0 8 2 6 _ 4 _ 8  00  > A . . GGGGTG. A A T . CTTGTTACTATTTCATTATGAAAAATACACTGAAACTAAAAGATGC
CONSENSUS > A . . GGGGTG. A A T . CTTGTTACTATTTCATTATGAAAAATACACTGAAACTAAAAGATGC
  +.............. +.............. +...............+.............. +...............+
1 2 1 8 _ 2 _ 8 0 0  > TGCAGAAGATATCTAAATTGTGCCTTTGATTGTAACTCGTTGGTGCCTGACTGGCATTGT
0 4 2 6 _ 1 _ 8  00  > TGCAGAAGATTTCTAAATTGTGCCTTTGATTGTAACTCGTTGGTGCCTGACTGGCATTGT
0 2 2  7 _ 1 _ 8 00  > TGCAGAAGATTTCTAAATTGTGCCTTTGATTGTAACTCSTTGGTGCCTGACTGGCATTGT
0 8 2 6 _ 4 _ 8  00  > TGCAGAAGATTTCTAAATTGTGCCTTTGATTGTAACTCGTTGGTGCCTGACTGGCATTGT
CONSENSUS > TGCAGAAGATTTCTAAATTGTGCCTTTGATTGTAACTCGTTGGTGCCTGACTGGCATTGT
 +.............. +.............. +...............+.............. +...............+
1 2 1 8 _ 2 _ 8 0 0  > GCTCTCCTACACCGGTTAGAACTTCTAGGTATTTCCAGTCTCTCATCACAC. AACCTTGA
0 4 2 6 _ 1 _ 8 0 0  > GCTCTCCTACACCGGTTAGAACTTCTAGGTATTTCCAGTCTCTCATCRCAC. AACCTTGA
0 2 2  7 _ 1 _ 8 00  > GCTCTCCTACMCCSGTTAGAACTTCTAGGTATTTCCMGTCTCTCMTCACACAAAMCTTGA
0 8 2 6 _ 4 _ 8 0 0  > GCTCTCCTACACCGGTTAGAACTTCTAGGTATTTCCAGTCTCTCATCACAC. AACCTTGA
CONSENSUS > GCTCTCCTACACCGGTTAGAACTTCTAGGTATTTCCAGTCTCTCATCACAC. AACCTTGA
1 2 1 8 _ 2 _ 8 0 0
0 4 2 6 _ 1 _ 8 0 0
0 2 2 7 _ 1 _ 8 0 0
0826_4_800
1 2 1 8 _ 5 _ 8 0 0
CONSENSUS
ATATATCGTGTTTCTGTATTAAGGCATCATCTTCCTTTCAGCTGCACATTCCTCCTTTTC
ATATATCGTGTTTCTGTATTAAGSCATCATCTTCCTTTCAGCTGCACATTCCTCCTTTTC
ATATATCSTGTTTCTGTATTAAARCATCATCTTCCTTTCMGCTGCMCATTCCYCCYTTTC
ATATATCGTGTTTCTGTATTAAGGCATCATCTTCCTTTCAGCTGTCTCAAAGCAGTTCCA
A C C . . CVAGCKGTCKCAAAG. AGTTCCA 
ATATATCGTGTTTCTGTATTAAGGCATCATCTTCCTTTCAGCTGCACATTCCTCCTTTTC
1 2 1 8 _ 2 _ 8 0 0
0 4 2 6 _ 1 _ 8 0 0
0 2 2 7 _ 1 _ 8 0 0
° 8 2 6 _ 4 _ 8 0 0
1 2 1 8 _ 5 _ 8 0 0
CONSENSUS
TTGGAATAAATCTGGAGATACTTAATATTCAGTTTATTTCCATCTCTAAGCGAAG. CCCT 
TTGGAATAAATCTGGAGATACTTAATATTCAGKTTATTTCCATCTCTAAGSAAAGCCCCT 
TTGGAATAAAW CTGGAGA
TCCTGAAGTGCTGGCTCCTACTCAAAGCCCAGAATTTCTAAATTGTCTCTCTGTGTTGCA 
TCCTGAAGTGCTGGCTCCTACTCAAAG. CCAGAATTTCTAAATTGTCTCTCTGTGTTGCA 
TTGGAATAAAtCTGGAGATACTyAATATTCAGwwTwTyTmmATykyywmkCTrwGTysCw
 +  + + + + +
1 2 1 8 _ 2 _ 8 0 0  > GCCGTTGCCTCAAGGGTTGGCTTCTAGGCTTCTAGKTAATGAGATAAAAAAAATAAGGAA 
0 4 2  6 _ 1 _ 8  00  > GCCGYTGCCTCAAGCGTTGGCTTCTAGGCTTCTAGCTAATGAGVTRAAAAAAATAAGGAA 
0 8 2 6 _ 4 _ 8 0 0  > CGGCTGGTGA. . CTTGTTGGGTTGCTAAG. WG
1 2 1 8 _ 5 _ 8  0 0 > CGGCTGGTGAAGCTCATTAAATCCCTGAGTTGAATCCGTTGGTTATTACATGAAAAAGTC 
CONSENSUS > GCCsTkGyswCAmkCGTTGGCTTCywGrsTTsTAGCTAATGAGwTwAAAAAAATAAGGAA
1 2 1 8 _ 2 _ 8 0 0
0 4 2 6 _ 1 _ 8 0 0
1 2 1 8 _ 5 _ 8 0 0
° 8 ° 9 _ 5 _ 8 0 0
0 8 ° 9 _ S _ 7 0 0
CONSENSUS
TGAGCCTCCAACTGAATCGTATCCGCTCCACTTACTGCCTTTGCCCATAATCTTTAAATT
TGAGSCTCCAACTGAATTGTATCTGCTCCACTTACYGCCTTTGKCCATAAK
AAATGTGGGAAAAACACACAACCCAGTCCTGTGCCTATTCTCTAGATCTCGCCGATATCA
GATATCA
GATATCA
TGAGsCTCCAACTGAAThGTATCCGCTCCACTTACTGCCTTTGnCCATAAkCyGATATCA
 + + + + + +
1 2 1 8 _ 2 _ 8  0 0 > TCTGCTAACTCTCAGACTTCATTATCAGCTCATGTTAAATCCAAGAGGTCAGKAGCCACC 
1 2 1 8 _ 5 _ 8 0 0 > GTTTTTCAGCTCAAAGWTTAGTGAGTAATAGTCCAGTGGTATCATTGGGAGATGGTAATA 
0 8 0 9 _ 5 _ 8 0 0 < GTTTTTCAGCTCAAAGTTTAGTGAGTAATAGTCMAGTGGTATCATTGGGAGATGGTAATA 
0 80 9 _ 5 _ 7 0  0 > GTTTTTCAGCTCAAAGTTTAGTGAGTAATAGTCCAGTGGTATCATTGGGAGATGGTAATA 
CONSENSUS > GTTTTTCAGCTCAAAGtTTAGTGAGTAATAGTCcAGTGGTATCATTGGGAGATGGTAATA
x g G A T l- 8
G T - P s t 5 
G T - P s t  5
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1 2 1 8 _ 2 _ 8  0 0 > CATAGCTTGAGGCACTTCATGGACAAGKCAAGGAATGAATATTTTACATGAGGAGGCTTC 
1 2 1 8 _ 5 _ 8 0 0 > GKC. CAGTGGTATCATTGGGAGATGGTAATAGTCCAGTGATATCATTGGGAGGTGGTAAT 
0 8 0 9 _ 5 _ 8 0  0 < GTCACAGTGGTATCATTGGGAGATGGTAATAGACCAGT 
0 80  9 _ 5 _ 7 0 0  > G T C . CAGTGGTATCATTGGGAGATGGTAATAGTCCAGT
CONSENSUS > G t C . CAGTGGTATCATTGGGAGATGGTAATAGTCCAGTrwwwTywwyrkGAGGwGGywwy
   +  + + + + +
1 2 1 8 _ 2 _ 8 0 0 > CTTGTAACCTTGTATAGAATCTTGACTCCCAGWAATGATTCAACCTTCTTCTTTCAAGKA 
1 2 1 8 _ 5 _ 8  0 0 > AGTCCAGCGGTATCATTGGGAGGWGGTAATAGTCCAGTGGTATCACTGGGAGGTGGTAAT
12 2 9 _ 2 _ 8  0 0 < GTGGTAAT
CONSENSUS > m kTsyA rC skT rT m w w krrkm kkdrsT m m yA G T m m w G w kkyA w C m yT skkm kG T G G T A A T
1 2 1 8 _ 2 _ 8  00  > ATTATGGCAAATCCGATGCAC
1 2 1 8 _ 5 _ 8 00  > AGTCCAGTGGTATCATTGAGAGGTGGTAATAGTCCAGTGATATCCCTGGGAGGTGGTAAT
1 2 2  9 _ 2 _ 8  0 0  < AGTCCAGTTGTATCATKGKGAGGTGATAATAGTCCAGTGTTATCRCTGGGAGGTGGTAAT
CONSENSUS > AGTCCAGTdGTATCATTGnGAGGTGrTAATAGTCCAGTGwTATCvCTGGGAGGTGGTAAT
 + .............................+ ..............................+ ............................ + ............................. + .............................. +
12  2 9 J 2 _ 8 0 0  < AGACCAG
1 2 1 8 _ 5 _ 8 0 0  > AGTCCAG
CONSENSUS > AgwCCAG
 + ..................................+ ...............................+ .................................+ .................................+ ..................................+
1 2 2  9 _ 2 _ 8 0 0  < TGGTATCATTGGAAGGTGGTAGTAGTCCAGTGGTATCATTGAGAGGTGGTAATAGTCCAG 
1 2 1 8 _ 5 _ 8 0  0 > TGGAATCATTGGGAGATGGTAATAGTCCAGTGGTATCATTGGGAGGTGGTAAT. . T . . .G
CONSENSUS > TGGwATCATTGGrAGrTGGTArTAGTCCAGTGGTATCATTGrGAGGTGGTAATagTccaG
 + .............................. + ............................+ ............................. + .+  . . . +
1 2 2 9 _ 2 _ 8 0 0  < TGGTATCATTGGGAGGTGGTAATAGTACAGTGGTATCACTGGGAGGTGGTAATAGT. . .G  
1 2 1 8 _ 5 _ 8 0 0  > TGGTATTATTGGGAGGTGGKAATAGTCCAGTTGTATCATTGGGAGGKGGTAATAGTCCAG
CONSENSUS > TGGTATyATTGGGAGGTGGtAATAGTmCAGTkGTATCAyTGGGAGGtGGTAATAGTccaG
 +...............+.......... + . . .............. +.............. +...............+
12 2 9 _ 2 _ 8  0 0 < GGG . . TCATTGGGAGGTACAGTGGAAGGGTACAAATTCATGCGA. T . . . ATTGCTGTMTA
1 2 1 8 _ 5 _ 8  0 0 > TGGTATGATTGGGAGGT. . . G . GTARKAGTCC. . TTTGGTATCACTGGGAGGGGGGAACA
CONSENSUS > k G G taT sA T T G G G A G G T acaG tG k A ag rG T m C aaw T T srT ry C A cT g g g A k k G sk G w A y A
  +...............+..............+...............+.............. +...............+
12 2 9 _ 2 _ 8  00 < TCTCGACGAGGCACCCTT. . AGTAATGACMCTTATGGGGTTAATCAAT. . . AAAGCATAC
1 2 1 8 _ 5 _ 8  00 > . G TCCA . TTGGKATCATTGGGGGGAGGA. . . . AWTGGGG. . AATCATTGGGAAGGGGTAA
CONSENSUS > t  sT C sA ck w G G c A y C m T T g g rG k rA k G A c. ctw A TG G G G 11A A TC A w TgggA A rG srTA m
 +.............. +.............. +.............. +.............. +...............+
1 2 2 9 _ 2 _ 8 0 0  < AAG. . TTGGGAAA. . ATGGCTGAAATATGACAATATCAGTGMCTTATCAAACGTTGCCTG 
1 2 1 8 _ 5 _ 8 0 0  > TAGGCCAGGGATATCATTG. . GGAGGGTG
CONSENSUS > wAGgcywGGGAwAtcATkGctGrArkrTGACAATATCAGTGmCTTATCAAACGTTGCCTG
 +...............+..............+.............. +.............. +...............+
1 2 2  9 _ 2 _ 8  0 0 < TCTATAAATGTTTWCTACCTCTGACCCATCTTCCTTGGTCCTAAATCCTCTCCTGGGAAA 
CONSENSUS > TCTATAAATGTTTwCTACCTCTGACCCATCTTCCTTGGTCCTAAATCCTCTCCTGGGAAA
 +...............+..............+.............. +.............. +...............+
1 2 2  9 _ 2 _ 8  0 0 < ATATTTCTGGAATTTATCAGCCGATTCTCCGACATCCCATCATTTGTGTATAAAGGCCAC 
CONSENSUS > ATATTTCTGGAATTTATCAGCCGATTCTCCGACATCCCATCATTTGTGTATAAAGGCCAC
+ + + + + +
12 2 9 _ 2 _ 8  0 0  < AGTGAACGATTTTATTGGCCCAAACGTACTGAATTTTATTGTTACTTTGTTTCTGTCCAG 
CONSENSUS > AGTGAACGATTTTATTGGCCCAAACGTACTGAATTTTATTGTTACTTTGTTTCTGTCCAG
 +...............+..............+.............. +.............. +...............+
c d n a 2  > GGGCTTTTCTCATTCCCTATTTCCTTACGCTCATTTTCG. CTGGGGTTCCTCTCTTTCTG
12  2 9 _ 2 _ 8 00  < GGGCTTTTCTCATTCCCTATTTCCTTACGCTCATTTTCGYCTGGGGTTCCTCTCTTTCTG 
CONSENSUS > GGGCTTTTCTCATTCCCTATTTCCTTACGCTCATTTTCG. CTGGGGTTCCTCTCTTTCTG
 + .............................. + ............................+ ............................. + ............................. + .............................. +
C d n a 2  > TTGGAGTGCTCCCTGGGACAATACACTTCCATTG. GAGGCCTTGGAGTATGGAAACTTGC
1 2 2  9 _ 2 _ 8  0 0 < TTGGAGTGCTCCCTGGGACAATACWCTTCCATTGTGAGTCCTTGGAGTATGGAACCTTGC 
CONSENSUS > TTGGAGTGCTCCCTGGGACAATACACTTCCATTG. GAGGCCTTGGAGTATGGAAACTTGC
x g G A T l- 5
X G A T -1
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 + + + + + +
c d n a 2  > TCCCATGTTTAAAG
12  2 9 _ 2 _ 8  0 0 < TCCCATGTTTAAAGGTACAGATATMACCACATTTTATTATACTCTGTGTTTCTCTGTGTT
0 2 2 7 _ 2 _ 8 0 0  > TAAAGGWACAGATTCAAMCACATWTTATCATACTCTGTWWWWMTCTGTGTT x g G A T l- 1 6
CONSENSUS > TCCCATGTTTAAAGGTACAGATATAACCACATTTTATTATACTCTGTGTTTCTCTGTGTT
 + + + + + +
1 2 2 9 _ 2 _ 8 0  0 < TTYCTAAMACCTTWCA. AATTMTTTATATGTCATTCACAGACAGTAAGKT. GWTGTTTWT
02  2 7 _ 2 _ 8  0 0  > TTCCTACACCCCTCCCCAATTCTTTCTCTGTCATTCACAGACAGTAAGGTCGATGGTTTC
0 8 2 2  0 1 _ 1  > CACCCCTCCCCAACACYCWCTCTGWCACWCACAGACAG. A A . GACGAH. GACWC x g G A T l- 1 6
CONSENSUS > TTCCTACACCCCTCCCCAATTCTTTCTCTGTCATTCACAGACAGTAAGGTCGATGGTTTC
 + + + + + +
1 2 2 9 _ 2 _ 8 0 0  < KTTCTGWGTTTTTWAT. ATAA
0 8 2 2  0 1 _ 1  > ATTGWCACWGA . GGAWG . WAAATATAAGGG . ATACATGAGGAG . TCCATTCCATATTAAA
0 2 2  7 _ 2 _ 8 0 0 > ATTGTCACTGAGGGTTGTTAAATATAAGGGTATACATGAGGAGKTCCATTCCATATTAAA
CONSENSUS > ATTGTCACTGAkGGATGwTAAATATAAGGGtATACATGAGGAG . TCCATTCCATATTAAA
 + ,
0 8 2 2 0 1 _ 1  > GKGCAAAGS
0 2 2 7 _ 2 _ 8 0 0  > GAG. MAAGC 
CONSENSUS > GaGcAAAGC
 + + + + + +
0 8 2 2 0 1 _ 1  > TGAAAGCGACGATAACTGAGCACTAAGCACCATTTATAAGGATATAGATTATAGGATATT
0 2 2  7 _ 2 _ 8  0 0 > TGAAAGCGACGATAACTGAGCACTAAGMACCATTTATAAGGATATAGGTTATAGGATATT
CONSENSUS > TGAAAGCGACGATAACTGAGCACTAAGCACCATTTATAAGGATATAGrTTATAGGATATT
 + + + + + +
0 8 2 2 0 1 _ 1  > CATGGCTCCTTYTATATTGTATGTACCCGGGGGTTCATTTAGGGGG. TTAACTTAATAGA
0 2 2  7 _ 2 _ 8 0 0  > CATGGCTCCTT. TATATTGTATGTACCCGGGGGKTCATTTAGGGGGKTTAACTTAATAGA
CONSENSUS > CATGGCTCCTT. TATATTGTATGTACC CGGGGGt TCATTTAGGGGG. TTAACTTAATAGA
 + + + + + +
0 8 2 2 0 1 _ 1  > CTATTGTATTTGTTCAACTCAACATTAACCATGTACACTGTGTAAGATGCACATAGGAGG
0 2 2  7 _ 2 _ 8  0 0 > CTATTGTATTTGTTCAACTCAA . ATTAACCATGTA . ACTGTGTAAGATGCACATA . GRGG
CONSENSUS > CTATTGTATTTGTTCAACTCAAcATTAACCATGTAcACTGTGTAAGATGCACATAgGaGG
 + .............................+ ............................. + ..............................+ ............................. + ..............................+
0 82 2 0 1 _ 1  > TAAATAGAGCATTAGTTATGGSGTATGTTATGCTACTCGTGTACTGTATCTTCCCTTTGG
0 2 2  7 _ 2 _ 8  0 0 > KAAATAGRGCATTAGKTATGG. GKATGTTATGCTACTC. TGTACTGTATCTTCCCTTTGG
CONSENSUS > tA AATAGaGCATTAGtTATGG. GtATGTTATGCTACTCgTGTACTGTATCTTCCCTTTGG
 + .............................+ ............................. + ..............................+ ............................. + ..............................+
0 8 2 2 0 1 _ 1  > ATACGTTTCATGAGCCTGAAAATACATTTTAGCCGTAACTAATGGTCAATATAAGCTGAA
0 2 2 7 _ 2 _ 8  0 0 > GTACGTTTCATGRGSCTGAAAATACATTTTAGSCGTAACTAATGGGCAATATAAGSTGGR
CONSENSUS > rTACGTTTCATGAGCCTGAAAATACATTTTAGCCGTAACTAATGGkCAATATAAGCTGrA
+  ,   +  +  +  + . . .  +
0 8 2 9  4 8 0 0 < CCACATATGACTTGTGCCCCCAACTAACCAACCAACTAGGGACGC G T -S a c 4
0 8 2 9  4 7 0 0 > CCACATATGACTTGTGCCCCCAACTAACCAACCAACTAGGGACGC G T -S a c 4
0 8 2 2 0 1 1 > GTGGAAAAGAAGYGGCCACATATGACTTGTGCCCCCAACTAACCAACCAACTAGGGACGS
0 2 2 7  2 8 0 0 > GGGGGAAAGRAGGGGSCMCATATGACTTGTGSCCCCMACTAACCCACCCACTAGGGGCGS
CONSENSUS > GkGGrAAAGAAGgGGCCACATATGACTTGTGCCCCCAACTAACCAACCAACTAGGGACGC
 +  +  +  +  +  +
0 8 2 6 _ 9 _ 7 0 0  > C C . G T - S a c 4 - H a e 3
0 8 2 6 _ 9 _ 8 0 0  < C C. G T - S a c 4 - H a e 3
0 8 2 6 _ 1 0 _ 8 0  > CCAAT. TCAGGTTAGSTAAGGACCTAAAAGGCCA G T - S a c 4 - H a e 4
0 8 2 6 _ 1 0 _ 7 0  < CCA . T . TCAG■TTAG . TAAGGAC. TAAAAGGCC■ G T - S a c 4 - H a e 4
0 8 2 9 _ 4 _ 8  0 0  < ACCGAATCCACTATTTGGGATTCGGCC. ATTTTCAGCGGGATTCGGATTCGG 
0 8 2 9 _ 4 _ 7  0 0  > ACCGAATCCACTATTTGGGATTCGGCC. ATTTTCAGCGGGATTCGGATTCGG 
08  2 2 0 1 _ 1  > ACCGAATCCACTATTTGGGATTCGGCCGAATCCCCGAATCCTTCGTGAAAGMTKCGGCC.
02  2 7 _ 2 _ 8  0 0  > ACCGRATCCACTATTTGGGGTTCSGCCGMATCCCCGVATCCTTCGTGRAAGGTTCGGGC.
CONSENSUS > ACCGAATCCACTATTTGGGATTCGGCCsAwTyTCAGvdTwTTCGGGAhCGrwwmGGCC .
 +  +  +  +  +  +
0 8 2  6 _ 9 _ 7  0 0  > G A . TACCGA . CCAAATCCGM . CCTTAATTTCGCATATGTAAATTAYGGG . KAGAAA . GGA 
0 8 2 6 _ 9 _ 8 0 0  < GAATACCGAACCAAATCCGAACCTTAATTT . GCATATGTAAATTAGGGG . TAGAAAAGRA 
0 8 2 6 _ 1 0 _ 8 0  > GAATACCGAACCAAATC. GAACCTTAATTT. . CATATGTAAATTAGGGGGTAGAAAAGGA 
0 8 2 6  1 0  7 0  < GAATACCGAACCAAATCCGAACCTTAATTT . GCATATGTAAATTAGGGG . TAGAAAAGGA
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0 8 2 2 0 1 _ 1
0 2 2 7 _ 2 _ 8 0 0
0 6 2 3 _ 1 _ 8 0 0
0 7 0 6 _ 4 _ 8 0 0
CONSENSUS
0 8 2 6 _ 9 _ 7 0 ° 
0 8 2 6 _ 9 _ 8  0 0 
0 8 2 6 _ 1 0 _ 8 0  
0 8 2 6 _ 1 0 _ 7 0  
0 8 2 2 0 1 _ 1  
0 2 2 7 _ 2 _ 8 0 0  
0 6 2 3 _ 1 _ 8 ° 0  
0 7 0 6 _ 4 _ 8 0 0  
CONSENSUS
0 8 2 6 _ 9 _ 7 0 0
0 B 2 6 _ 9 _ 8 0 0
0 8 2 6 _ 1 0 _ 8 0
0 8 2 6 _ 1 0 _ 7 0
0 2 2 7 _ 2 _ 8 0 0
0 6 2 3 _ 1 _ 8 0 0
0 7 0 6 _ 4 _ 8 0 0
CONSENSUS
0 8 2 6 _ 9 _ 7 0 0  
08 2 6 _ 9 _ 8  0 0 
0 8 2 6 _ 1 0 _ 8 0  
0 8 2 6 _ 1 0 _ 7 0  
0 9 1 4 _ 5 _ 7 0 0  
0 9 1 4 _ 5 _ 8 0 0  
0 2 2 7 _ 3 _ 8 0 0  
0 6 2 3 _ 1 _ 8 0 0  
0 7  0 6 _ 4 _ 8  00 
CONSENSUS
0 9 1 4 _ 5 _ 7 0 0
0 9 1 4 _ 5 _ 8 0 0
0 2 2 7 _ 3 _ 8 0 0
0 6 2 3 _ 1 _ 8 0 0
0 7 0 6 _ 4 _ 8 0 0
CONSENSUS
0 9 1 4 _ 5 _ 7 0 0
0 9 1 4 _ 5_ 8 ° 0
0 2 2 7 _ 3 _ 8 0 0
0 6 2 3 _ 1 _ 8 0 0
0 7 0 6 _ 4 _ 8 0 0
CONSENSUS
0 9 1 4 _ 5 _ 7 0 0  
0 9 1 4 _ 5 _ 8 0 0  
0 2 2 7 _ 3 _ 8 0 0  
0 6 2 3 _ 1 _ 8 0 0  
0 7 0 6 _ 4 _ 8 0 0  
CONSENSUS
0 9 1 4 _ 5 _ _ 7 0 0  
0 9 1 4 _ 5 _ 8 0 0  
0 2 2  7 _ 3 _ 8  0 0 
0 6 2 3 _ 1 _ 8 0 0  
0 7 0 6 _ 4 _ 8 0 0  
CONSENSUS
> GAATACCGAACCAAATCCGAASCTTAATYT . GCRTATGTAAATTAGGGGBAGG . AAAGGA
> GGATACCGGACCCAATCCGAACCTTAATTT. GCRTATGKAAATTAGGGGGAGGRAAAGGR
> GGA. GAAAATKA x g G A T l- 2 6
> GGACGAARATGA x g G A T l- 2 6
> GAATACCGAACCAAATCCGAACCTTAATTT. GCATATGTAAATTAGGGGGwAGAAAAGGA
 +  +  +  +  +  +
> AAA . . GTGGAAAAA . TCCTTCTTTTGTTGACGAAANGTCATGTGRTTTT . YCTACCCGCC
< AAAA . GTGGAAAAAATCCTTCTTTTGT . GACGAAAAGTCATGTGATTTT . CCTACCCGCC
> AAAA. GTGGAAAAAATCCTTCTTTTGT. GACGAAAAG. CATGTGATTTY. C . TACCCGCC
< AAAA. GTGGAAAAAATCCTTCTTTTGT. GACGAAAAGTCATGTGATTTT. CCTACCCGCC
> AAAA . GTGGWMAAAAKCCTTC. TTTAGCGASGAAAAGTCATGKGATHTK. C
> AAAAGGGGGARAAAATCCTTCTTTTGGGGCGGARAAGGCATGGGGTTTTACCTACCCGCC
> AAAAAGTGAAAAAAYTCCTTCTTTTGT. . A C . AAAAGGMATGTANTTTT. CCTACCCGCC
> AAAATGTGGRAAAA. TCCTTCTTTTGTGGCG. AAANG. CATGTAGTTTT. CCTASCCGCC
> AAAA. GTGGAAAAAATCCTTCTTTTGT. GACGAAAAGTCATGTGATTTT. CCTACCCGCC
 +  +  +  +  +  +
> C . CTAATTTACA. TATGCAAA. TTAGGATTCGGATT. C A . GTTCGGCCG. . . AATCCGAA
< CGCTAATTTACA. TATGCAAA. TTAGGATTCGGATT. C A . GTTCGGCCG. . . AATCCGAA
> C . CTAATTTACA. TATGCAAA. TTAGGATTCGGATT. C A . GTTCGGCCTTTTAGTCCTTA
< C . CTAATTTACA. TATGCAAA. TTAGGATTCGGATT. C A . GTTCGGCCTTTTAGTCCTTA
> C . CTMATTTACA. TATGSAAA
> C . CTAANKKACA. TANTGAAA. TTAAGATTCGGATTTCANGTTCGGCCATGGCA. CAATG
> C . CTARGTWGSAGTAGTGAAAATRGGGATTCKGAWTTCA. GTTCNGCCATGGCAGCAAWG
> C . CTAATTTACA. TATGCAAA. TTAGGATTCGGATT. C A . GTTCGGCCdTkkAATCCdwA
 +  +  +  +  +  +
TCCCGCTGAAAATGG 
TCCCGCTGRAAATGG 
, CTAACTG. . AATGG 
. CTAACTG. . AATGG
C C . AAGATTC. GGCCGAA. TC G T - S a c 4 - H a e l 1 
C C . AAGATTC. GGCCGAA. TC G T - S a c 4 - H a e l 1 
AAAA. GGGCCGAAC. . CCGGGCSGAAC. C x g G A T l- 1 8  
GATTTCATGCCGAAATCCGAATTCAGTGCTGAAAAWTGGCCGAAN. TCCTGGCCGAANTC 
GANTTCATGCCGAANTCCGAACTCASTGCTGAAAAATGGCCGAAN. TCCTGGCCGAAKTC 
kCyhdCTGGmAATGGTCCGAAyTCAGTGCTGAAAAATGGCCGAAsaTCCtGGCCGAAbTC
 + + + + + . . . .
CCGAACCGAA. TCCTGGA. TTCGGTGCATCCCTACAACCAACCAACGTGAAGW 
CCGAACCGAA. TCCTGGA. TTCGGTG CATCCMTACAACCAACCAACGTGAAGA 
CSGAMCSGAAC. CCKGGA. TTCGGTGCACCCCTACACCCACCCAACGTGAAGA 
CCGAACCGAANTCCTGGA. TTCGGTGCATCCCTACAACCAACCAACG. GAAGA 
CCGAACCGAANTCCTGGANTTCGGTGCATCCCTACAACCAACCAACGTGAAGA 
CCGAACCGAA. TCCTGGA. TTCGGTGCATCCCTACAACCAACCAACGTGAAGA
 +  +  +  +  +  +
< ACATATGGAAACAATACTATAATATATACATTAAATGGTCCTTTTGGGCAACTGCAGATG
> ACATATGGAAACAATACTATAATATATACATTAAATGGTCCTTTTGGGCAACTGCAGATG
< ACATATGGAAACAATCCTATAATATATACATWAAAKGGTCCTTTGGGGCACCTGCAGATG
> ACATATGGAAACAATACTATAATATATACATTAAATGTTCTTTTGGGCRAS. KGCAGATG
> ACATATGGAAACAATACTATAATATATACATTAAATGKTCTTTTGGG. R A C . TGCAGATG
> ACATATGGAAACAATACTATAATATATACATtAAATGGTCCTTTGGGGCAmcTGCAGATG
 +  +  +  +  +  +
< AAAGTTCTCCTCAATGTGCTTTGGGAAG. CCCCAGCTGCAAATCATAG. CAGCCCCCATG
> AAAGTWCTCCTCAATGTGCTTTGGGAAG. CCCCAGCTGCAAATCATAGGCAGCCCCCATG
< AAAGYCCCCCCCAATGYGCTTTGGGAAG. CCCCAGCTGCAAATCATAGGCAGCCCCCATG
> AAAGTTCTCCTCAATGTGCTTTGGGDAG. SCCCAGCTGCAAATYATAGGCAGCCCCCATG
> AAAGTTCTCCTCAATGTGCTTTGGGAAGBCCCCAGCTGCAWATTATAGTCAGCCCCCATG
> AAAGTTCTCCTCAATGTGCTTTGGGAAG. CCCCAGCTGCAAATCATAGGCAGCCCCCATG
 +  +  +  +  +  +
< TAGAGCAATCATATGG. . CCAAGG. . TGGGGGTTGCTGGCATTCCTGGGGGCCAGGATTC
> TAGAGCAATCATATGG. . CCAAGG. . TGGGGGTTGCTGGCATTCCTGGGGGCCAGGATTC
< TAGAGCAATCATAGGGCCCCCAGGAATGCCAGCAACCCCCA. . CCTKGG. . CCAGGCTTT
> TAGAGYAATCATATGGYCCCCAGGAATGCCAGCAACCCCCA. . CCTTGG. .CCAGGCTTT
> TAGAKTTATCAKAGGGTCYCCAGGAA. G
> TAGAGCAATCATATGG. C C C C A G G A A T G ssrG yw rC ys sC A t tCC TkG G ggC CA G G m TTy
185
0 9 1 4 _ 5 _ 7 0 0  < GG
0 9 1 4 _ 5 _ 8 0 0  > GG
0 2 2 7 _ 3 _ 8 0 0  < CTCCATATATCAATTCCTCTCCTTTCTCTTGAGTTTCTCCATGTCAAAACTGCACCCCAG 
0 6 2 3 _ 1 _ 8 0 0  > CTCCATATATCAATTCCTCTCCTTTCTCTTGAGTTTCTCCATGTCAAAACTGCASCSSAK
CONSENSUS > skCCATATATCAATTCCTCTCCTTTCTCTTGAGTTTCTCCATGTCAAAACTGCACCCCAG
1 2 2 9 _ 1 2 _ 8 0
0227_3_800
0 6 2 3 _ 1 _ 8 0 0
CONSENSUS
AATCMC CATTTAGTY C TY C . TTAT 
TCTCTAGTTGAGTCCAAGGCTTTATAAAGGGCAAGAAATCACCATTTAGTTCTTCATTAT 
GCTSTA
kCTCTAGTTGAGTCCAAGGCTTTATAAAGGGCAAGAAATCACCATTTAGTTCTtCaTTAT
1 2 2 9 _ 1 2 _ 8 0
0 2 2 7 _ 3 _ 8 0 0
CONSENSUS
c d n a 3
0 8 0 9 _ 1 1 _ 8  0 
0 8 0 9 _ 1 1 _ 7  0 
1 2 2 9 _ 1 2 _ 8 0  
0 2 2 7 _ 3 _ 8 0 0  
CONSENSUS
CAAGGGTTCCCCTTATTAGGTTTGAATGCAGATGTGGAATGTTCCTGCAGWCTGATAGGA
CAAGGGTTCACCTTATTAGGTTTGAATGCAGATGTGGAATWWWACTGCAGACTGATAGGA
CAAGGGTTCmCCTTATTAGGTTTGAATGCAGATGTGGAATgTTmCTGCAGACTGATAGGA
 +  +  +  +  +  +
GTGTTGGACTCGCTGCTGCCATCCTTTCCTTTTGGCTAA 
TGTTGGACTCGCTGCTGCCATCCTTTCCTTTTGGCTAA 
TGTTGGACTCGCTGCTGCCATCCTTTCCTTTTGGCTAA 
CGAGATCTCTTCTATCTGCAGGTGTTGGACTYGCTGCTGCCATCCTTTCCTTTTGGCTAA 
CGAKWYC. CTTCTATC
CGAGATCtCTTCTATCTGCAGGTGTTGGACTCGCTGCTGCCATCCTTTCCTTTTGGCTAA
 +  +  +  +  +  +
C d n a 3  > ATATCTACTACATTGTTATCATCGCCTGGGCTATATATTACCTCTTCAGTTCCTTCACCA
0 8 0 9 _ 1 1 _ 8 0 > ATATCTACTACATTGTTATCATCGCCTGGGCTATATATTACCTCTTCAGTTCCTTCACCA
0 80  9 _ 1 1 _ 7 0 < ATATCTACTACATTGTTATCATCGCCTGGGCTATATATTACCTCTTCAGTTCCTTCACCA
1 2 2  9 _ 1 2 _ 8  0 < ATATCTMCTACATTGTTATCATCGCCTGGGCTATATATTMCCTCTTCAGTTCCTTCMCCM 
CONSENSUS > ATATCTACTACATTGTTATCATCGCCTGGGCTATATATTACCTCTTCAGTTCCTTCACCA
. +  ,
c d n a 3
08 0 9 _ 1 1 _ 8  0 
08  0 9 _ 1 1 _ 7 0  
1 2 2  9 _ 1 2 _ 8 0  
CONSENSUS
> CT
CTGTGAGTAATAAGTCAAGTTCTTTCCATGTGTAATATTCTCTACTGTGTACAATAAACA
CTGTGAGTAATAAGTCAAGTTCTTTCCATGTGTAATATTCTCTACTGTGTACAATAAACA
CTGTGAGTAATAAGTCAAGTTCTTTCCATGTGTAATATTCTCTACTGTGTACAATAAACA
CTGTGAGTAATAAGTCAAGTTCTTTCCATGTGTAATATTCTCTACTGTGTACAATAAACA
 +  +  +  +  +  +
0 8 0 9 _ 1 1 _ 8 0  > TGTCCTAAGAAAGGCAGACCCACCCATATCTGTAACATCATTTTACATTTTTTATTAATT
08  0 9 _ 1 1 _ 7 0  < TGTCCTAAGAAAGGCAGACCCMCCCATATCTGTAACATCATTTTACATTTTTTATTAATT
12  2 9 _ 1 2 _ 8  0 < TGTCCTAAGAAAGGCAGACCCMCCCATATCTGTAACATCATTTTACATTTTTTATTAATT
CONSENSUS > TGTCCTAAGAAAGGCAGACCCACCCATATCTGTAACATCATTTTACATTTTTTATTAATT
0 8 0 9 _ 1 1 _ 8 0  
0 8 0 9 _ 1 1 _ 7 0  
1 2 2  9 _ 1 2 _ 8  0 
CONSENSUS
ATATTCTGAGATATGGGGTGGGGCAGTTTTTCATTTTGGCATAATCCAATGGCATTAGTT
ATATTCTGAGATATGGGGTGGGGCAGTTTTTCATTTTGGCATAATCCAATGGCATTAGTT
ATATTCTGAGATATGGGGTGGGGCAGTTTTTCATTTTGGCATAATCCAATGGCATTAGTT
ATATTCTGAGATATGGGGTGGGGCAGTTTTTCATTTTGGCATAATCCAATGGCATTAGTT
............................4 - ..............................4*............................. 4 - ............................. 4 - .................. . . . 4 " ............................... 4-
c d n a 4  > ACCCTCCCTT
0 2 2  0 _ 2 _ 7 0 0 > ATAAAAGGCTATTTTGCAGCAATAAATACATTTCTTTTCTGTTACAGACCCTCCCTT 
0 8 0 9 _ 1 1 _ 8 0 > GTGATAAAAGGCTATTTTGCAGCAATAAATACATTTCTTTTCTGTTACAGACCCTCCCTT 
0 80 9 _ 1 1 _ 7 0 < GTGATAAAAGGCTATTTTGCAGCAAWAAATACATTTCTTTTCTGTTACAGACCCTCCCTT 
1 2 2  9 _ 1 2 _ 8  0 < GTGATAAAAGGCTATTTTGCAGCAATAAATACATTTCTTTTCTGTTACAGACCCTCCCTT 
CONSENSUS > GTGATAAAAGGCTATTTTGCAGCAAtAAATACATTTCTTTTCTGTTACAGACCCTCCCTT
 +  +  +  +  +  +
c d n a 4  > GGAAAAACTGTGACAACTATTGGAATACTGAACGTTGCTTCTCCAACTACAGTATCCCCA
02 2 0 _ 2 _ 7  00  > GGAAAAACTGTGACAACTATTGGAATACTGAACGTTGCTTCTCCAACTACAGTATCCCCA 
08 0 9 _ 1 1 _ 8 0 > GGAAAAACTGTGACAACTATTGGAATACTGAACGTTGCTTCTCCAACTACAGTATCCCCA 
0 8 0 9 _ 1 1 _ 7 0  < GGAAAAACTGTGACAACTATTGGAATACTGAACGTTGCTTCTCCAACTACAGTATCCCCA 
1 2 2  9 _ 1 2 _ 8  0 < GGAAAAACTGTGACAMCTATTGGAATACTGAACGTTGCTTCTCCAMCTACAGTATCCCCA 
CONSENSUS > GGAAAAACTGTGACAACTATTGGAATACTGAACGTTGCTTCTCCAACTACAGTATCCCCA
x g G A T l- 7
x G A T -1
S a c 4 - P s t l l  
S a c 4 - P s t l l
x G A T -1
x g G A T -3 / 1 7 R T -1
186
c d n a 4  > ACACCACCAATATGACGAGTGCCGTTTTGGAATTTTGGGAG
0 2 2  0 _ 2 _ 7 0 0 > ACACCACCAATATGACGAGTGCCGTTTTGGAATTTTGGGAGTAAGTTTTTTTTTCCATTT
0 80 9 _ 1 1 _ 8 0 > ACACCACCAATATGACGAGTGCCGTTTTGGAATTTTGGGAGTAAGTTTTTTTTTCCATTT
0 8 0  9 _ 1 1 _ 7  0 < ACACCACCAATATGACGAGTGCCGTTTTGGAATTTTGGGAGTAAGTTTTTTTTTCCATTT
1 2 2  9 _ 1 2 _ 8 0  < ACACCACCAATATGACGAGTGCCGTTTTGGAATTTTGGGAGTAAGTTTTTTTTTCCATTT
CONSENSUS > ACACCACCAATATGACGAGTGCCGTTTTGGAATTTTGGGAGTAAGTTTTTTTTTCCATTT
 +  +  +  +  +  +
02 2 0 _ 2 _ 7 0 0 > GTGATTGTCACACTTATATGGCTAAAAGTATGTTCTTCTTATTGCTGGAATTGGCTATAC
0 8 0  9 _ 1 1 _ 8  0 > GTGATTGTCACACTTATATGGCTAAAAGTATGTTCTTCTTATTGCTGGAATTGGCTATAC
08 0 9 _ 1 1 _ 7 0 < GTGATTGTCACACTTATATGGCTAAAAGTATGTTCTTCTTATTGCTGGAATTGGCTATAC
1 2 2  9 _ 1 2 _ 8 0  < GTGATTGTCACACTTATATGGCTAAAAGTATGTTCTTCTTATTGCTGGAATTGGCTATAC
CONSENSUS > GTGATTGTCACACTTATATGGCTAAAAGTATGTTCTTCTTATTGCTGGAATTGGCTATAC
 +  +  +  +  +  +
0 2 2 0 _ 2 _ 7 0 0  > ATCATTGCCAACCCAAGTGCCACCACATCATCCAATGACATTCCTGACAATTCCTACTTC
08  0 9 _ 1 1 _ 8  0 > ATCATTGCCAACCCAAGTGCCACCACATCATCCAATGACATTCCTGACAATTCCTACTTC
08  0 9 _ 1 1 _ 7 0 < ATCATTGCCAACCCAAGTGCCACCACATCATCCAATGACATTCCTGACAATTCCTACTTC
12 2 9 _ 1 2 _ 8 0 < ATCATTGCCAACCCAAGTGCCACCACATCATCCAATGACATTCCTGACAATTCCTACTTC
CONSENSUS > ATCATTGCCAACCCAAGTGCCACCACATCATCCAATGACATTCCTGACAATTCCTACTTC
0 2 2 0 _ 2 _ 7 0 0  > CTACTTAATGGAACAGTTTGGGGGACCCTTTCCTGTTTCAGC. ACAATATTGCCCCCCCC
08  0 9 _ 1 1 _ 8  0 > CTACTTAATGGAACAGTTTGGGGGACCCTTTCCTGTTTCAGC.ACAATATTGCCCCCCCC
0 8 0 9 _ 1 1 _ 7 0  < CTACTTAATGGAACAGTTTGGGGGACCCTTTCCTGTTTCAGC. ACAATATTGCCCCCCCC
1 2 2 9 _ 1 2 _ 8 0  < CTACTTAATGGAACAGTTTGGGGG. CCCTTTCCTGTTTCAGCBMCAATATTS
CONSENSUS > CTACTTAATGGAACAGTTTGGGGGACCCTTTCCTGTTTCAGC. ACAATATTGCCCCCCCC
 +  +  +  +  +  +
1 2 2 9 _ 3 _ 8 0 0  < CATGCACAGAGCCAGGTCCCTACAGAATGGGTTTGCTGAGATGGGAAGACCCTGACTGC x g G A T l- 9 
02  2 0 _ 2 _ 7 00  > CCATGCACAGAGCCAGGTCCCTACAGAATGGGTTTGCTGAGATGGGAAGACCCTGACTGC
0 8 0 9 _ 1 1 _ 8  0 > CCATGCACAGAGCCAGGTCCCTACAGAATGGGTTTGCTGAGATGGGAAGACCCTGA
0 8 0 9 _ 1 1 _ 7 0  < CCATGCACAGAGCCAGGTCCCTACAGAATGGGTTTGCTGAGATGGGAAGACCCTGA 
CONSENSUS > CCATGCACAGAGCCAGGTCCCTACAGAATGGGTTTGCTGAGATGGGAAGACCCTGACTGC
 +  +  +  +  +  +
0 8 0 9 _ 1 2 _ 7 0  > AACCCATCTGAACCCCTGGGGGATGAATTGGAAACCCAACTGTGAGCCTGATCCCCAA S a c 4 - P s t l 3  
1 2  2 9 _ 3 _ 8  00 < AGAMCCCATCTGAACCCCTGGGGGATGAATTGGAAACCCAMCTGTGAGCCTGATCCCCAA
0 2 2 0 _ 2 _ 7 0 0  > AGAACCCATCTGAACCCCTGGGGGATGAATTGGAAACCCAACTGTGAGCCTGATCCCCAA
CONSENSUS > AGAACCCATCTGAACCCCTGGGGGATGAATTGGAAACCCAACTGTGAGCCTGATCCCCAA
0 8 0 9 _ 1 2 _ 7 0 > CATCAGTGTCCAACCTCAGTAATGCTCTTGTATCTGAATGGAAACAACTCCCAGCAACAA 
12  2 9 _ 3 _ 8 0 0 < CATCAGTGTCCAACCTCAGTAATGCTCTTGTATCTGAATGGAAACAACTCCCAGCAACAA 
0 2 2 0 _ 2 _ 7 0 0  > CATCAGTGTCCAACCTCAGTAATGCTCTTGTATCTGAATGGAAACAACTCCCAGCAACAA
CONSENSUS > CATCAGTGTCCAACCTCAGTAATGCTCTTGTATCTGAATGGAAACAACTCCCAGCAACAA
 +  +  +  +  +  +
0 8 0 9 _ 1 2 _ 7 0 > TGTTCCATCATGGAACCTTCAGAGAAGCACCGGAGCAGTTATAGCAGCAAAGAGGAGGGC 
1 2 2  9 _ 3 _ 8  0 0  < TGTTCCATCATGGAMCCTTCAGAGAAGCACCGGAGCAGTTATAGCAGCAAAGAGGAGGGC 
0 2 2 0 _ 2 _ 7  0 0 > TGTTCCATCATGGAACCTTCAGAGAAGCACCGGAGCAGTTATAGCAGCAAAGAGGAGGGC 
CONSENSUS > TGTTCCATCATGGAACCTTCAGAGAAGCACCGGAGCAGTTATAGCAGCAAAGAGGAGGGC
06 2 3 __ 4 _ 8 0  0 < GMCCCAAC x g G A T l- 3 1
0220_ _1 _ 7 0 ° < GCGACTGTGAGCCTGATCCCCAAC S a c 4 - 3 / l 7 R T
0220~_ 2 _ 8 0 0 < AATCCCTGTGGGATGAACTGGAACCSCGACTGTGAGCCTGATCCCCAAC x g G A T 3 -1 7 R T
1 0 2 9 ^_ 4 _ 8 0 0 < AAACCAACGGAAATCCCTGTGGGATGAACTGGAACCGCGACTGTGAGCCTGATCCCCAAC GABA T r  1 7
0 809~_ 1 2 _ 7  0 > AAACCAACGGAAATCCCTGTGGGATGAACTGGAACCGCGACTGTGAGCCTGATCCCCAAC
1 2 2  9__ 3 _ 8 0 0 < AAACCAACGGAAATCCCTGTGGGATGAACTGGAACCGCGACTGTGAGCCTGATCCCCAAC022o]_ 2 _ 7 0  0 > AAACCAACGGAAATCCCTGTGGGATGAACTGGAACCGCGACTGTGAGCCTGATCCCCAAC
CONSENSUS > AAACCAACGGAAATCCCTGTGGGATGAACTGGAACCGCGACTGTGAGCCTGATCCCCAAC
 +  +  + . .  +  +  +
0 6 2 3 _ 4 _ 8  0 0 < ATCAGKKTYTVTTCCTCACTCTTGKGGCKGAATGGAAGCAVCTCCCAGGRACAATGTYCC 
0 2 2  0 _ 1 _ 7 0  0 < ATCAGTGTCCAA. CCTCACTCTTGTGGCTGAATGGAAGCAACTCCCAGGAACAATGTTCC 
0 2 2  0 _ 2 _ 8  00  < ATCAGTGTCCAA. CCTCACTCTTGTGGCTGAATGGAAGCAACTCCCAGGAACAATGTTCC 
1 0 2 9 _ 4 _ 8 0 0  < ATCAGTGTCCAA. CCTCACTCTTGTGGCTGAATGGAAGCAACTCCCAGGAACAATGTTCC 
0 80  9 _ 1 2 _ 7 0 > ATCAGTGTCCAA. CCTCACTCTTGTGGCTGAATGGAAGCAACTCCCAGGAACAATGTTCC
187
1 2 2 9 _ 3 _ 8 0 0  < ATCAGTGTCCAA. CCTCACTCTTGTGGCTGAATGGAAGCAACTCCCAGGAACAATGTTCC 
0 2 2 0 _ 2 _ 7  0 0 > ATCAGTGTCCAA. CCTCACTCTTGTGGCTGAATGGAAGCAACTCCCAGGAACAATGTTCC 
CONSENSUS > ATCAGTGTCCAA. CCTCACTCTTGTGGCTGAATGGAAGCAACTCCCAGGAACAATGTTCC
0 6 2 3 _ 4 _ 8 0 0  
0 2 2  0 _ 1 _ 7 0  0 
0 2 2 0 _ 2 _ 8 0 0  
1 0 2  9 _ 4 _ 8 0 0  
0 8 0 9 _ 1 2 _ 7 0  
1 2 2 9 _ 3 _ 8 0 0  
02 2 0 _ 2 _ 7  00 
CONSENSUS
AACATGGAAACTTCAGAGAAGCACCAGGGCAGTTATAGCAGCAAGAGGAGGGCAAACCAA
AACATGGAAACTTCAGAGAAGCACCAGGGCAGTTATAGCAGCAAGAGGAGGGCAAACCAA
AACATGGAAACTTCAGAGAAGCACCAGGGCAGTTATAGCAGCAAGAGGAGGGCAAACCAA
AACATGGAAACTTCAGAGAAGCACCAGGGCAGTTATAGCAGCAAGAGGAGGGCAAACCAA
AACATGGAAACTTCAGAGAAGCACCAGGGCAGTTATAGCAGCAAGAGGAGGGCAAACCAA
AACATGGAAACTTCAGAGAAGCACCAGGGCAGTTATAGCAGCAAGAGGAGGGCAAACCAA
AACATGGAAACTTCAGAGAAGCACCAGGGCAGTTATAGCAGCAAGAGGAGGGCAAACCAA
AACATGGAAACTTCAGAGAAGCACCAGGGCAGTTATAGCAGCAAGAGGAGGGCAAACCAA
0 6 2 3 _ 4 _ 8 00
0 2 2 0 _ 1 _ 7 0 0
0 2 2 0 _ 2 _ 8 0 0
1 0 2 9 _ 4 _ 8 0 0
0 8 0 9 _ 1 2 _ 7 0
1 2 2 9 _ 3 _ 8 0 0
0 2 2 0 _ 2 _ 7 0 0
CONSENSUS
CTGAACTCCTGTGGGATAAACTGGAACCCCGMCTGTGATCCTGATTCCCAACATCAGTGC 
CTGAACCCCTGTGGGATAAACTGGAACCCCGACTGTGATCCTGATTCCCAACATCAGTGC 
CTGAACCCCTGTGGGATAAACTGGAACCCCGACTGTGATCCTGATTCCCAACATCAGTGC 
CTGAACCCCTGTGGGATAAACTGGAACCCCGACTGTGATCCTGATTCCCAACATCAGTGC 
CTGAACCCCTGTGGGATAAACTGGAACCCCGACTGTGATCCTGATTCCCAACATCAGTGC 
CTGAA. CCCTGTGGGATAAACTGGAACCCCGACTGTGATCCTGATTCCCAACATCAGTGC 
CTGAACCCCTGTGGGATAAACTGGAACCCCGACTGTGATCCTGATTCCCAACATCAGTGC 
CTGAACCCCTGTGGGATAAACTGGAACCCCGACTGTGATCCTGATTCCCAACATCAGTGC
 + .............................. + ............................+ ............................. + ............................. + .............................. +
0 2 2 7 _ 4 _ 8 0 0  < CCAMCYTTWCTCATKTTTTGTYTTAATGGAAGCAACTCCCAGCAACAATGTTCCAACATT x g G A T l- 2 1
0 6 2 3 _ 4_ 8 0 0  < CCAMCCCC. CTCATGTGTTGGCTTAATGGAAGCAMCTCCCAGCAACAATGTTCCAACATT
0 2 2 0 _ 1 _ 7 0 0  < CCAACCTCACTCATGTGTTGGCTTAATGGAAGCAACTCCCAGCAACAATGTTCCAACATT
02 2 0 _ 2 _ 8  0 0 < CCAACCTCACTCATGTGTTGGCTTAATGGAAGCAACTCCCAGCAACAATGTTCCAACATT
1 0 2 9 _ 4 _ 8  0 0 < CCAACCTCACTCATGTGTTGGCTTAATGGAAGCAACTCCCAGCAACAATGTTCCAACATT
08 0 9 _ 1 2 _ 7 0  > CCAACCTCACTCATGTGTTGGCTTAATGGAAGCAACTCCCAGCAACAATGTTCCAACATT
1 2 2  9 _ 3 _ 8  0 0  < CCAACCTCACTCATGTGTTGGCTTAATGGAAGCAACTCCCAGCAACAATGTTCCAACATT
0 2 2  0 _ 2 _ 7  0 0  > CCAACCTCACTCATGTGTTGGCTTAAT
CONSENSUS > CCAACCtCACTCATGTGTTGGCTTAATGGAAGCAACTCCCAGCAACAATGTTCCAACATT
 + .............................. + ............................+ ............................. + ............................. + .............................. +
0 2  2 7 _ 4 _ 8 00 < AAGTGGGATCCTYCCCAGAAGCACCGGGGCWTTTATAGCAGCAAAGGGGGGCAYCTTCAT
0 6 2 3 _ 4 _ 8 0 0  < AAGTGGGAMCCTTCCCAGAAGCMCCGGGGCAGTTATAGCAGCAAAGGGGGGCAACTTCAT
0 2 2  0 _ 1 _ 7  00  < AAGTGGGAACCTTCCCAGAAGCACCGGGGCAGTTATAGCAGCAAAGGGGGGCAACTTCAT 
0 2 2 0 _ 2 _ 8 0 0 < AAGTGGGAACCTTCCCAGAAGCACCGGGGCAGTTATAGCAGCAAAGGGGGGCAACTTCAT
1 0 2 9_ 4 _ 8 0 0  < AAGTGGGAACCTTCCCAGAAGCACCGGGGCAGTTATAGCAGCAAAGGGGGGCARCTTCAT 
0 8 0  9 _ 1 2 _ 7 0 > AAGTGGGAACCTTCCCAGAAGCACCGGGGCAGTTATAGCAGCAAAGGGGGGCAACTTCAT 
1 2 2 9 _ 3 _ 8 0 0  < AAGTGGGAACCTTCCCAGAAGCACCGGGGCAGTTATAGCAGCAAAGGGGGGCAACTTCAT 
CONSENSUS > AAGTGGGAACCTTCCCAGAAGCACCGGGGCAGTTATAGCAGCAAAGGGGGGCAACTTCAT
 + .......................... + ........................+ ......................... + ......................... + ..........................+
0 2 2  7 _ 4 _ 8  0 0 < ATTACCYTYTTGGTTTAGGAATGAGATTTKGGGAGGAAGGTGTTCYTATATTTTTGCCAT 
0 6 2  3 _ 4 _ 8  0 0  < ATTACCCCCTTGGGTTAGGAATGAGATGTTGGGAGGAAGGTGTTCCTATATTTTTGCMAW 
02 2 0 _ 1 _ 7 0 0 < ATTACCCCCTTGGGTTAGGAATGAGATGTTGGGAGGAAGGTGTTCCTATATTTTTGCCAT 
02 2 0 _ 2 _ 8  00  < ATTACCCCCTTGGGTTAGGAATGAGATGTTGGGAGGAAGGTGTTCCTATATTTTTGCCAT 
10  2 9 _ 4 _ 8  00  < ATTACCCCCTTGGGTTAGGAATGAGATGTTGGGAGGAAGGTGTTCCTATATTTTTGCCAT 
0 8 0 9 _ 1 2 _ 7 0 > ATTACCCCCTTGGGTTAGGAATGAGATGTTGGGAGGRAGGTGTTCCTATATTTTTGCCAT 
1 2 2 9 _ 3 _ 8 0 0  < A T TA . CCCCTTGGGTTAGGAATGAGATGTTGGGAGGAAGGTGTTCCTATATTTTTGCCAT 
CONSENSUS > ATTACCCCCTTGGGTTAGGAATGAGATGTTGGGAGGAAGGTGTTCCTATATTTTTGCCAT
 + .................................. + ...............................+ .................................+ .................................+ ................................. +
02  2 7 _ 4 _ 8  00 < ACTGTGTACAAGCATGGAAACATKGGCATGGGAAAAAATCAAKWTTAGAATGAGTTTAGG 
0 6 2 3 _ 4 _ 8 0 0  < ACTGTGTACAAGCATRGAAACATTGRCATGGGAAAAAATCAAGATTAGAATGAGTATAGG 
0 2 2 0 _ 1 _ 7 0 0  < ACTGTGTACAAGCATGGAAACATTGGCATGGGAAAAAATCAAGATTAGAATGAGT. TA G .
0 2 2  0 _ 2 _ 8  0 0 < ACTGTGTACAAGCATGGAAACATTGGCATGGGAAAAAATCAAGATTAGAATGAGT. T A G .
1 0 2  9 _ 4 _ 8 0 0  < ACTGTGTACAAGCATGGAAACATTGGCATGGGAAAAAATCAAGATTAGAATGAGT. TAGG 
0 80 9 _ 1 2 _ 7 0 > ACTGTGTACAAGCATGGAAACATTGGCATGGGAAAAAATCAAGATTAGAATGAGT. TAGG
1 2 2  9 _ 3 _ 8 0 0  < ACTGTGTACAAGCATGGAAACATTGGCATGGGAAAAAATCAAGATTAGAATGAGTGTAGG 
CONSENSUS > ACTGTGTACAAGCATGGAAACATTGGCATGGGAAAAAATCAAGATTAGAATGAGT . TAGG
 + + + + + +
O2 2  7 _ 4 _ 8  0 0 < CAAAGCCAACATCAGCAGCAGAGAAKTTCTGCA. TCACAAGAACCCTACAAAATATGGGA 
0 6 2  3 _ 4 _ 8  0 0 < CAAAGCCAACATCAGCAGCAGAGAAGTTCTGCAATCACAAGACMCCTACAAAATATGGGA 
0 2 2 0 _ 1 _ 7  0 0  < CAAAGCCAACATCAGCAGCAGAGAAGTTCTGCA. TCACAAGAACCCTACAAAATATGGGA 
02 2 0 _ 2 _ 8  0 0  < SAAAGCCAACATCAGCAGCAGAGAAGTTCTGCA. TCACAAGAACCCTACAAAATATGGGA 
1 0 2 9  4 8 0 0  < CAAAGCCAACATCAGCAGCAGAGAAGTTCTGCA. TCACAAGAACCCTACAAAATATGGGA
188
0 80 9 _ 1 2 _ 7  0 > . C AAAG C AA CAT C AG C AG C AG AG AAGT T C TG C A . TCACAAGAACCCTACAAAATATGGGA 
1 2 2  9 _ 3 _ 8  0 0 < . AAAG C C AAC AT C AG C AG C AG AG MMSTTCTGCA . TCACAAG . ACCCYCCAAAATATGGGA 
CONSENSUS > CAAAGCCAACATCAGCAGCAGAGAAGTTCTGCA . TCACAAGAACCCTACAAAATATGGGA
0 82 6 _ 3 _ 8  0 0 
0 2 2 7_ 4 _ 8 0 0  
0 6 2 3 _ 4 _ 8 0 0  
02  2 0 _ 1 _ 7  0 0 
0 2 2 0 _ 2 _ 8 0 0  
1 02 9 _ 4 _ 8  0 0 
0 80  9 _ 1 2 _ 7  0 
1 2 2  9 _ 3 _ 8  0 0 
CONSENSUS
CTGATGGGGTTTCACAGC G T - S a c 4 - A lu 3
AGG S GG AT ACG AAGG AT CGG . CAG . TGGGATATACAGTAAAGCTGATGGGGTTTCACAGC 
AGGCGGATACGAAGGATCGVACAGATRGGATATACARTAAAGCTGATGGG. TTTCACAGC 
AGGCGGATACGAAGGATCGG. CAG. TGGGATATACAGTAAAGCTGATGGGGTTTCACAGC 
AGGCGGATACGAAGGATCGG. CAG. TGGGATATACAGTAAAGCTGATGGGGTTTCACAGC 
AGGCGGATACGAAGGATCGG. CAG. TGGGATATACAGTAAAGCTGATGGG. TTTCACAGC 
AGGCGGATACGAAGGATCGG. CAG. TGGGATATACAGTAAAGCTGATGGGGTTTCACAGC 
A
AGGCGGATACGAAGGATCGG. CAG. TGGGATATACAGTAAAGCTGATGGGGTTTCACAGC
 +  +  +  +  +  +
0 8 2  6 _ 3 _ 8  0 0 < CCACAGTAAAGCAACACTGGGTCATGTTTAATCCAATTGCAGCAGGGTTATGGATATGAT 
0 2 2  7_ 4 _ 8 0 0  < CCACAGTAAAGCAACACTGGGTCATGTTTAATCCAATTGCAGCAGGKTTATGGATATGAT 
0 6 2 3 _ 4 _ 8 0 0 < CCACAGTAAAGCAACACTGGGTCATGTTTWATCCAATTGCAGCAGGGTTATGGATATGAT 
02  2 0 _ 1 _ 7 0 0 < CCACAGTAAAGCAACACTGGGTCATGTTTAATCCAATTGCAGCAGGGTTATGGATATGAT 
02 2 0 _ 2 _ 8 0 0  < CCACAGTAAAGCAACACTGGGTCATGTTTAATCCAATTGCAGCAGGGTTATGGATATGAT 
1 0 2  9 _ 4 _ 8  0 0 < CCACAGTAAAGCAACACTGGGTCATGTTTAATCCAATTGCAGCAGGGTTATGGATATGAT 
0 8 0 9 _ 1 2 _ 7  0 > CCACAGTAAAGCAACACTGGGTCATGTTTAATCCAATTGCAGCAGGGTTATGGATATGAT 
CONSENSUS > CCACAGTAAAGCAACACTGGGTCATGTTTAATCCAATTGCAGCAGGGTTATGGATATGAT
0826_3_800 
1 2 1 8 _ 4 _ 8 0 0  
0 2 2  7 _ 4 _ 8  00  
0 6 2 3 _ 4 _ 8 0 0  
02 2 0 _ 1 _ 7  0 0 
0 2 2 0 _ 2 _ 8 0 0  
1 0 2 9 _ 4 _ 8 0 0  
0 8 0 9 _ 1 2 _ 7 0  
CONSENSUS
ATATAGATATCAGTCTTTGAG...............................................................................................................
TTMMMATATCTAGAAAATATGTAGAAATAATATTTTTTG
ATATAGATATCAGTCTTTGAGCTTAAATATCTAGAAAATATGTAGAAATAATATTTTTTG
ATATAGATATCAGTCTTTGAGCTTAAATATCTAGAAAATATGTAGAAATAATATTTTTTG
ATATAGATATCAGTCTTTGAGCTTAAATATCTAGAAAATATGTAGAAATAATATTTTTTG
ATATAGATATCAGTCTTTGAGCTTAAATATCTAGAAAATATGTAGAAATAATATTTTTTG
ATATAGATATCAGTCTTTGAGCTTAAATATCTAGAAAATATGTAGAAATAATATTTTTTG
ATAWAGMTATCAGTCTTTGA
ATATAGATATCAGTCTTTGAGCTtAAATATCTAGAAAATATGTAGAAATAATATTTTTTG
x g G A T l- 6
08  2 6 _ 3 _ 8  00  
1 2 1 8 _ 4 _ 8 0 0  
0 2 2 7 _ 4 _ 8 0 0  
0 6 2 3 _ 4 _ 8 0 0  
02 2 0 _ 1 _ 7  0 0 
0 2 2 0 _ 2 _ 8 0 0  
1 0 2 9 _ 4 _ 8  00 
CONSENSUS
AAATATA. . AATTCTATGCKTTTTTTAATATTGMAMAAACGAAGAAAGAGCAATTGTATK 
AAATATA. . AATTCTATGCGTTTTTGAATATTGCACAAACGAAGAAAGAGCAATTGTATG 
AAATATA. . AATTCTATRCGTTTTTGAATATTGYACAAAMGAAGAAAGAGCAATTGTATG 
AAATATA. . AATTCTATGCGTTTTTGAATATTGCACAAACGAAGAAAGAGCAATTGTATG 
AAATATA. . AATTCTATGCGTTTTTGAATATTGCACAAACGAAGAAAGAGCAATTGTATG 
AAATATA. . AATTCTATGCGTTTTTGAATATTGCACAAACGAAGAAAGAGCAATTGTATG 
AAATATA. . AATTCTATGCGTTTTTGAATATTGCACAAACGAAGAAAGAGCAATTGTATG
 +  +  +  +  +
c d n a 5  > CGCAA
1 2 2 9 _ 7 _ 8 0 0  < TTTTRATACAACCYCTT. TGTATGAMAATCATTCAATTCCATCCCAGGCGCAA
0 8 2 6 _ 3 _ 8 00  < ..................................................... CTCTT . TGTATGACAATCATWCAATTCCATTCCAGGCGCAA
1 2 1 8 _ 4 _ 8  00  > TAGATTATTTTGATACAAGCTCTT . TGTATGACAATCATTCAATTCCATTCCAGG . SSAA 
02  2 7 _ 4 _ 8  00  < TAGATTATTTTGATACAAGCTCTT . TGTATGACAATCATTCAATTCCATTCCAGGCGCAA 
0 6 2 3 _ 4 _ 8 0 0  < TAGATTATTTTGA
0 2  2 0 _ 1 _ 7  00  < TAGATTATTTTGATACAAGCTCTT. TGTATGACAATCATTCAATTCCATTCCAGGCGCAA 
0 2  2 0 _ 2 _ 8  0 0 < TAGATTATTTTGATACAAGCTCTT. TGTATGACAATCATTCAATTCCGTTCCAGGCGCAA
1 0 2  9_ 4 _ 8 00  < TAGATTATTTTGATACAAGCTCTTGTGTATGACAATCATTCAATTMMATTCCAG. CGCAA 
CONSENSUS > TAGATTATTTTGATACAAGCTCTT. TGTATGACAATCATTCAATTCCATTCCAGGCGCAA
x G A T -1
x g G A T l- 1 3
c d n a 5
1 2 2 9 _ 7 _ 8 0 0  
0 8 2 6 _ 3 _ 8 0 0  
1 2 1 8 _ 4 _ 8 0 0  
0 2 2 7 _ 4 _ S 0 0  
0 2 2 0 _ 1 _ 7 0 0  
0 2  2 0 _ 2 _ 8  00  
1 0 2 9 _ 4 _ 8 0 0  
CONSENSUS
TATGCACCAAATGACTGACGGACTGGAAAAACCAGGGCAGATCCGATGGCCGTTGGCGAT 
TATSCCCCAAATGCCTGACGGCCTGGAAAACCCAGGGCAGATCCGATTGCCGTTGGGGAT 
TATGCACCAAATGACTGACGGACTGGAAAAACCAGGGMAGATCCGATGGCCGTTGGCGAT 
TATGCACCAAATGACTGACGGACTGGAAAAACCAGGGCAGATCCGATGGCCGTTGGCGAT 
TATGCACCAAATGACTGACGGACTGGAAAAACCAGGCCMGATCCGANTGC. GTTGGCGMY 
TATGCACCAAATGACTGACGGACTGGAAAAACCAGGGCAGATCCGATGGC. GTTGGCGAT 
TATGCACCAAATGACTGACGGACTGGAAAAACCAGGGCAGATCCGATGSC. GTTGGCGAT 
T A T . CYSSVAATG. CTGAMM. ACTGSCS
TATGCACCAAATGACTGACGGACTGGAAAAACCAGGGCAGATCCGATGGCCGTTGGCGAT
189
 + + + + + +
C d n a 5  > CACACTGGCAATTGCGTGGGTTTTGGTCTATTTCTGCATCTGGAAAGGAGTCGGCTGGAC
12  2 9 _ 7 _ 8  00  < CACCCTGGCCATTGCGTGGGTTTTGGTCTATTTCTSCATCTGGAAAGGAGTCGSCTGGMC
0 82 6 _ 3 _ 8 00  < CACACTGGCCATTGCGTGGGTTTTGGTCTATTTCTGCATCTGGAAAGGAGTCGGCTGGAC
1 2 1 8 _ 4 _ 8 00  > CACACTGGCCATTGCGTGGGTTTTGGTCTATTTCTGCATCTGGAAAGGAGGCGGCTGGAC
0 2 2 7_ 4 _ 8  00  < CCCMCTGSC. ATTS 
0 2 2 0 _ 1 _ 7 0 0  < CAC 
0 2 2 0 _ 2 _ 8 0 0  < CAC
CONSENSUS > CACACTGGCCATTGCGTGGGTTTTGGTCTATTTCTGCATCTGGAAAGGAGTCGGCTGGAC
 + + + + + +
0 6 2 3 _ 3 _ 8 0 0  > TTTTTWTANGRACTGNCNGGWTTTHYMMAAACCTTTATATAWKTTCTTTATTTG
c d n a 5  > AGGAAAGGT
12 2 9 _ 7 _ 8  00  < AGGAAAGGTAATGAGGACCTCCCGGGATATAG. AAAACCTTTATATAGTGTCTTTATTTG
0 8 2  6 _ 3 _ 8 00  < AGGAAAGGTAATGAGGAACTGCMGGGATATAGAAAAAMCTTTATATAGTGTCTTTATTTG 
1 2 1 8 _ 4 _ 8 00 > AGGAAAGGTAATGAGGAACTGCCGGGATATAGAAAAACCTTTATATAGTGTCTTTATTTG
CONSENSUS > AGGAAAGGTAATGAGGAACTGCCGGGATATAGAAAAACCTTTATATAGTGTCTTTATTTG
x g G A T l-3 0
 +  +  +  +  +  +
0 6 2 3 _ 3 _ 8  00  > CTTTTTTATAAATTCTACTTTTTCTTTACTGCCCTCTTTTCCGTCACTTTCATTATCACC 
1 2  2 9 _ 7 _ 8  00  < CTTTTTTATAATGTCTCCTTTTTCTTTACTGCCCTCTTTTCCGTCMCTTTCATTGTCMCC
0 8 2 6 _ 3 _ 8 0 0  < CTTTTTTATAATGTCTACTTTTTCTTTACTGCCCTCTTTTCCGTCACTTTCATTGTCACC
1 2 1 8 _ 4 _ 8 0 0  > CTTTTTTATAATGTCTACTTTTTCTTTACTGCCCTCTTTTCCGTCACTTTCATTGTCACC
CONSENSUS > CTTTTTTATAATGTCTACTTTTTCTTTACTGCCCTCTTTTCCGTCACTTTCATTGTCACC
+ .
0 6 2 3 _ 3 _ 8 0 0
1 2 2 9 _ 7 _ 8 0 0
0 8 2 6 _ 3 _ 8 0 0
1 2 1 8 _ 4 _ 8 0 0
CONSENSUS
TGCTGARTAGCTCCTTCCTCCCCCCACTCTCCAAGAACAATTTTTTCTTCCTCTCAGAAT
TGCTGAGTAGCTCCTTCCTCCCCCCYCTCTCCAAGTACAATTTTTTCTTCCTCTCAGAAT
TGCTGAGTAG
TGCTGAGTAGCTCCTTCCTCCCCCCACTCTCCAAGRACAATTTTTTCTTCCTCTCAGAAT
TGCTGAGTAGCTCCTTCCTCCCCCCGCTCTCCAAGwACAATTTTTTCTTCCTCTCAGAAT
 + + + + + +
08  0 9 _ 4 _ 8 00  > ACCACCACTCCT. CCTTTTTTTCTGTGCCATTCTCTCCTCTATACCCACCTCTACCCA
08  0 9 _ 4 _ 7 00  < ACCMCCACYCCT. CCTTTTTTTCTGTGCCATTCTCYCCTCTATWCCCMCCTCTACCCA 
0 6 2 3 _ 3_ 8 0 0  > TCACCACCACTCCT. CCTTTTTTTCTGTGCCATTCTCTCCTCTATACCCACCTCTACCCA
1 2 2 9 _ 7 _ 8 0 0  < TCACCACCACTCCT. CCTTTTTTTCTGTGCCATTCYCTCCTCTATACCCACCTCTACCCA
1 2 1 8 _ 4 _ 8 0 0  > TCACCACCACTCCTCCCTTTTTTTCTGTGCCATTCTCTCCTCTATACCCACCTCTACCCA 
CONSENSUS > TCACCACCACTCCT. CCTTTTTTTCTGTGCCATTCTCTCCTCTATACCCACCTCTACCCA
G T -E c o 6
G T -E c o 6
0 8  0 9 _ 4 _ 8 0 0  
0 8 0 9 _ 4 _ 7 0 0  
0 6 2 3 _ 3 _ 8 0 0  
1 2  2 9 _ 7 _ 8  0 0 
1 2 1 8 _ 4 _ 8 0 0  
CONSENSUS
TGCAACATTCTCTCCTCTATACCCACCTCTACCCATGCAACATTTTCTCCCCTTTCCCAA 
TGCAACATTCTCTCCTCTATMCCCACCTCTACCCATRAAACATTTTCTCCCCTTTCCCAA 
T G . AACATTCTCTCCTCTATACCCACCTCTACCCATGVAACATTTTCTCCCCTTTCCCAA 
TGCAACATTCTCTCCTCTATACCCACCTCTACCCATGCAACATTTTCTCCCCTTTCCCAA 
TGCAACATTCTCTCCTCTATACCCACCTCTACCCATGCAACATTTTCTCCCCTTTCCCAA 
TGCAACATTCTCTCCTCTATACCCACCTCTACCCATGCAACATTTTCTCCCCTTTCCCAA
 + + + + + +
0 8 0 9 _ 4 _ 8 0 0 > GAGTCATTTTCATTTTCCCAGTGTTTTATTCTTTTTTTGCCAGAGTAACCTTCACTTTTC
0 8 0 9 _ 4 _ 7 0 0  < GAGTCATTTTCATTTTCCCAGTGTTTTATTCTTTTTTTGCCAGAGTAACCTTCACTTTTC 
0 6 2 3 _ 3 _ 8  0 0 > GAGGCATTTTCATTTTCCCAGTGKTTTATKSTKTTTTTGCCAGAGTAACCTTCAMTTTTC 
12  2 9 _ 7 _ 8  0 0 < GAGTCATTTTCATTTTCCCAGTGTTTTATTCTTTTTTTGCCAGAGTAACCTTCACTTTTC 
1 2 1 8 _ 4 _ 8 0 0  > GAGTCATTTTCATTTTCCCAGCGTTTTATTCTTTTTTTGCCAGAGWAACCTTCACTTTTC 
CONSENSUS > GAGTCATTTTCATTTTCCCAGTGTTTTATTCTTTTTTTGCCAGAGTAACCTTCACTTTTC
 + + + + + +
0 8 0 9 _ 4 _ 8  0 0 > ATGGTCCATTCACTTCCCATACCCATTCAC. TATGTTCCCCTACTTTCTTTGCCCATTCT 
0 8 0 9 _ 4 _ 7 0 0  < ATGGTCCATTCACTTCCCATACCCATTCAC. TATGTTCCCCTACTTTCTTTGCCCATTCT 
0 6 2 3 _ 3 _ 8 0  0 > ATGGTCCATTCACTTCCCATACCCATTCACATATG. TCCCCTACTTTCTTTGCCCATTCT
1 2 2  9 _ 7 _ 8 0 0 < ATGGTCCATTCACTTCCCATACCCATTCAC. TATGTTCCCCTMCTTTCTTTGCCMATTCT 
1 2 1 8 _ 4 _ 8 0 0  > ATGGGCCATTCACTTCCCATACCCATTCAC. TATGTTCCCCTACTTTCTTTGCCCATTCT 
CONSENSUS > ATGGTCCATTCACTTCCCATACCCATTCAC. TATGTTCCCCTACTTTCTTTGCCCATTCT
190
 + + + + + +
°  7 2 1 _ 4 _ 8 0 0 > C . AGCCCATTGCTMAAAGTKGTGTAAATAACC. . CCAGATGTCTGTGC
0 2 2 0 _ 3 _ 8 0 0  > AATCCC. ATTNTCTTTTTAWTTATTATTAAATTAAMCATMANNATCTCTTTAC
0 80 9 _ 4 _ 8 0 0 > GACAGCCAGTCCC. ATTGTCTTTTTAGTTGTTGTTAAATTAAACATGAGGATGTCTGTGC 
0 80 9 _ 4 _ 7 0 0 < GACAGCCAGTCCC. ATTGTCTTTTTAGTTGTTGTTAAATTAAACATGAGGATGTCTGTGC
0 6 2  3 _ 3 _ 8 0 0 > GACAGCCAGTCCCGATTGTCTTTTTAGDTGTTGTTAAATTAAACATGAGGATGTCTGTGC
1 2 2  9 _ 7 _ 8  0 0 < GACAGCCAGTCCC. ATTGTCTTTTTAGTTGTTGTTAAATTAAACATGAGGATGTCTGTGC 
1 2 1 8 _ 4 _ 8  0 0 > GACAGCCAGKCCC. ATTGTCT
CONSENSUS > GACAGCCAGTCCC. ATTGTCTTTTTAGTTGTTGTTAAATTAAACATGAGGATGTCTGTGC
0 8 0  9 _ 1 0 _ 8  0 
0 7 2 1 _ 4 _ 8 0 0  
0 2 2 0 _ 3 _ 8 0 0  
0 8 0  9 _ 4 _ 8  00  
0 8 0 9 _ 4 _ 7 0 0  
0 6 2 3 _ 3 _ 8 0 0  
12  2 9 _ 7 _ 8  00  
CONSENSUS
CTGCTGTTAAG
CATCATATATAATATACTATATCAGTCACACATACAG. AAAAGGAATTCCTGCTGTTAAG 
CATCATATATAATATACTATATCATTCACACATACAG. AAAAGGAATTCCTKCTATTAAA 
CATCATATATAATATACTATATCAGTCACACATACAG. AAAAGGAATTC 
CATCATATATAATATACTATATCAGTCACACATACAG. AAAAGGAATTC 
CATCATATATAATATACTATATSAGKCACACATACAG. AAAAGGAATACCTGCTGKTAAG 
CATCATATATAATATTCTATATCAGTCACACATACWGBNVAAGGAATWCCTGCTGTTAAS 
CAT CATATATAATATACTATAT CAGT CACACATACAG. AAAAGGAATTCCTGCTGTTAAG
0 8 0 9 _ 1 0 _ 8 0  
0 7 2 1 _ 4 _ 8 0 0  
02 2 0 _ 3 _ 8  0 0 
0 6 2 3 _ 3_ 8 0 0  
1 2 2 9 _ 7 _ 8 0 0  
CONSENSUS
TAGCTGAACTGACTAAATCAATTCATTAATGCTAATACAGGTATGGGATCTGTTATTTGG 
TAGCTGAACTGACTAAATCAATTCATTAATGCTAATACAGGTATGGGATCTGTTATTTGG 
TAACTAAACTGACTAAATCAATTCATTAATDCTAATACAGGTATKKGATCTTTTATTTTG 
GAGSTGAACTGACTAAATCAATTCATTAATGCTAATACAGGKATGGGATCTGTTATTTGG 
HA S CTGAACTGACT
TAGCTGAACTGACTAAATCAATTCATTAATGCTAATACAGGTATGGGATCTGTTATTTGG
0 8 0 9 _ 1 0 _ 8 0  
0 7 2 1 _ 4 _ 8 ° 0 
02 2 0 _ 3 _ 8  00 
06 2 3 _ 3 _ 8  00  
CONSENSUS
AAACCTGTTATCCAGAAAGCTCTGAATATTGGAAAMGCAATCTCCCATAGAATCCATTAT
AAACCTGTTATCCAGAAAGCTCTGAATATTGGAAAAGCAATCTCCCATAGAATCCATTAT
AAACCTKTTATCCAAAAAGCTCTGAATATTTGAAAAGCAATCTCCCATAGAATCCATTAT
AAACCTGTTATCCRGAAAGSTCTGAATATTGGAAAAGGAATGTGSCATAGAATGSATTAT
AAACCTGTTATCCAGAAAGCTCTGAATATTGGAAAAGCAATCTCCCATAGAATCCATTAT
 + + + + + +
08 0 9 _ 1 0 _ 8 0 > GATAAAATAATCCACATTTTTAAACATTATTCCCTTTTTCT. GTGTA. ATAATAAAACAG
07  2 1 _ 4 _ 8  00  > GATAAAATAATCCACATTTTTAAACATTATTCCCTTTTTCT. GTGTA. ATAATAAAACAG
02 2 0 _ 3 _ 8  00  > KATAAAATAATSCACATTTTTAAACATGATTCCCTTTTTCTGGKGKAGAKAATAAAAGAG 
0 6 2 3 _ 3 _ 8  00  > GATAAAATAATGSAGATTTTKAAASATTATTSGSTTTTTGT . GKGKA . ATAATAAAASAG 
CONSENSUS > GATAAAATAATCCACATTTTTAAACATTATTCCCTTTTTCT. GTGTA. ATAATAAAACAG
0 8 0 9 _ 1 0 _ 8 0  
0 7 2 1 _ 4 _ 8  00 
0 2 2 0 _ 3 _ 8 0 0  
0 6 2 3 _ 3 _ 8 0 0  
CONSENSUS
TAGGCTGTACTTGA. TTCAAACCAAGATATAATTAATCCTTATTTTAAATAAAACCAGCC 
TAGG CTGTACTTGA. TTCAAACCAAGATATAATTAATCCTTATTTTAAATAAAACCAGCC 
GRGAGTGTASKTGAGTKCAAACCAAGATATAAKTAAKGGKTATKTKAAAKRAARGGRGGG 
TAGGGTGKASTTGA. TTSAAASSAAGATATAAKTAATSGTTATTTTAAATAAAASGAGGS 
TAGGsTGTACTTGA. TTCAAACCAAGATATAATTAATCsTTATTTTAAATAAAAC SAG S C
......................... +  + ..........................+ .........................+ ......................... - f ...........................+
08 0 9 _ 1 0 _ 8  0 > TAATGGGTTCATTTAATGTTTACATGTTTTTCTAGTAGACTTAAGGTATGAAGATCCAAA 
0 7 2 1 _ 4 _ 8 00  > TAATGGGTTCATTTAATGTTTACATGTTTTTCTAGTAGACTTAAGGTATGAAGATCCAAA 
02  2 0 _ 3 _ 8  00  > GAAGGGGGGGRGKGAAKKTGKA 
0 6 2 3 _ 3 _ 8 00  > TAATTG
CONSENSUS > TAATGGGTTCATTTAATGTTTACATGTTTTTCTAGTAGACTTAAGGTATGAAGATCCAAA
0 8 0 9 _ 1 0 _ 8 0  
0 7 2 1 _ 4 _ 8 0 0  
CONSENSUS
TTATAGAAAGATCCATTATTCGGAAAACCCGAGTCCCAAGCATTCTGGATAACAGGTCCC
TTATAGAAAGATCCATTATTCGGAAAACCCGAGTCCCAAGCATTCTGGATAACAGGTCCC
TTATAGAAAGATCCATTATTCGGAAAACCCGAGTCCCAAGCATTCTGGATAACAGGTCCC
 + + + + + +
0 8 0 9 _ 1 0 _ 8 0  > ATACCTGTATTGATATCCTCAGTTATGGGACACAGAACAGTGGATGAGCTGAACCAAAAC 
0 7 2 1 _ 4 _ 8 0 0  > ATACCTGTATTGATATCCTCAGTTATGGGACACAGAACAGTGGATGAGCTGAACCAAAAC 
CONSENSUS > ATACCTGTATTGATATCCTCAGTTATGGGACACAGAACAGTGGATGAGCTGAACCAAAAC
0 8 0 9 _ 1 0 _ 8 0  
0 7 2 1 _ 4 _ 8 0 0  
CONSENSUS
+,
a t a g c a a a g c c a t t t t a c c At t a t a a c t g t a t t a t c g c t g t a t t t t a a c t g t a t t c t c t c
ATAGCAAAGCCATTTTACCATTATAACTGTATTATCGCTGTATTTTAACTGTATTCTCTC
ATAGCAAAGCCATTTTACCATTATAACTGTATTATCGCTGTATTTTAACTGTATTCTCTC
x g G A T l- 20  
x g G A T l- 2 0
S a c 4 - E c o R l -4
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0 8 0 9 _ 1 0 _ 8 0
0 7 2 ;L_4 _ 8 0 0
CONSENSUS
1 2 2 9 _ 5 _ 8 0 0  
0 80  9 _ 1 0 _ 8  0 
0 7 2 1 _ 4 _ 8  0 0 
CONSENSUS
0 9 1 4 _ 1 _ 7 0 0
1 2 2 9 _ 5 _ 8 0 0
0 8 0 9 _ 1 0 _ 8 0
° 7 2 1_ 4 _ 8 0 0
CONSENSUS
0 9 1 4 _ 1 _ 7 0 0
1 2 2 9 _ 5 _ 8 0 0
0 8 0 9 _ 1 0 _ 8 0
0 7 2 1 _ 4 _ 8 0 0
CONSENSUS
0 9 1 4 _ 1 _ 7 0 0  
1 2 2 9 _ 5 _ 8 0 0  
0 8 0 9 _ 1 0 _ 8  0
0721_4_800
CONSENSUS
0 9 1 4 _ 1 _ 7 0 0
1 2 2 9 _ 5 _ 8 0 0
0 8 0 9 _ 1 0 _ 8 0
0721_4_800
CONSENSUS
0 9 1 4 _ 1 _ 8  0 0 
0 9 1 4 _ 4 _ 8  0 0 
0 9 1 4 _ 4 _ 7  0 0 
0 9 1 4 _ 1 _ 7  0 0 
1 2 2 9 _ 5 _ S 0 0  
0 8 0 9 _ 1 0 _ 8 0  
CONSENSUS
0 9 1 4 _ 1 _ 8 0 0
0 9 1 4 _ 4 _ 8 0 0
0 9 1 4 _ _ 4 _ 7 0 0
0 9 1 4 _ 1 _ 7 0 0
1 2 2 9 _ 5 _ 8 ° 0
CONSENSUS
0 9 1 4 _ 1 _ 8 0 0
0 9 1 4 _ 4 _ 8 0 0
0 9 1 4 _ 4 _ 7 00
0 9 1 4 _ 1 _ 7 0 0
1 2 2 9 _ 5 _ 8 00
CONSENSUS
 +  +  +  +  +  +
> TGCAAATTCTCTCTGTGTTTAACATTTTCATCAGATAACTCAACCATAATCTGCATTTTA
> TGCAAATTCTCTCTGTGTTTAACATTTTCATCAGATAACTCAACCATAATCTGCATTTTA
> TGCAAATTCTCTCTGTGTTTAACATTTTCATCAGATAACTCAACCATAATCTGCATTTTA
 +  +  +  +  +  +
< GAAAAGCCTTAGGGM x g G A T l- 1 1
> RATCTCTTTATGGGGTTATTTGAVATCAACTAATGTGTGTAAGTGGAAAAGGCTTAGGGA
> AATCTCTTTATGGGGTTATTTGAAATCAACTAATGTGTGTAAGTGGAAAAGGCTTAGGGA
> AATCTCTTTATGGGGTTATTTGAAATCAACTAATGTGTGTAAGTGGAAAAGGCTTAGGGA
 +..............+ . . . .  +...............+...............+...............+
> CTTCCATTTCAGT G T - S a c 4 - A lu 9
< CCATTAGGTTAACCTTAGAAGGGGGTAAATCTTMCTGAAGGCAAA. GCTTCCATTTCAGT
> CCATTAGGTTAAGCTTAGAAGGGGGTAAATCTTACTGAAGGCAAAAGCTTCCATTTCAGT
> CCATTAGGTTAAGCTTAGAAGGGGGTAAATCTTACTGAAGGCAAAAGCTTCCATTTCAGT
> CCATTAGGTTAAGCTTAGAAGGGGGTAAATCTTACTGAAGGCAAAAGCTTCCATTTCAGT
 +..............+...............+...............+...............+...............+
> CTCATAATGGAACATGTCAGATAATTACAGTGAAATATGTGC CAATGATAAAGAGCATAG
< CTCATAATGGAACATGTCAGATAATTACAGTGAAATATGTGCCAATGATAAAGAGCATAG
> CTCATAATGGAACATGTCAGATAATTACAGTGAAATATGTGCCAATGATAAAGAGCATAG
> CTCATAATGGAACATGTCAGATAATTACAGGGAAATATGTGCCAATGATAAAGRGCATAG
> CTCATAATGGAACATGTCAGATAATTACAGTGAAATATGTGCCAATGATAAAGAGCATAG
 + + + +   . . . + ■ ■ • +
> TTATATATSTCTTCCTAGTCAGAGAAATCATCACATGGTGTTTGATAGAGGAACTTACAG 
< TTATATATGTGTTCCTAGTCAGAGAAATCATCACATGGTGTTTGATAGAGGAACTTACAG
> TTATATATGTGTTCCTAGTCAGAGAAATCATCACATGGTGTTTGATAGAGGAACTTACAG
> TTATATWTGKGTTCCTAGKCAGRGAAAT C A T . MMATGGGGTTTGATAGRGGAAC. TACCG
> TTATATATGTGTTCCTAGTCAGAGAAATCATCACATGGTGTTTGATAGAGGAACTTACAG
 + + + + + +
> ATACGGCTCCTCGTTTTTTTCTGATGGAAGAGGGAAATTATATTACTGTGGTTATTGGTA 
< ATACGGCTCCTCGTTTTTTTCTGATGGAAGAGGGAAATTATATTACTGTGGTTATTGGTW
> ATACGGCTCCTCGTTTTTTTYTTATGGAAGAGGGAAATTATATTACTGTGGTTATTGGTA
> ATACSGCTCCTCGTTTTTTTYTGWKGRARGRGG
> ATACGGCTCCTCGTTTTTTTCTGATGGAAGAGGGAAATTATATTACTGTGGTTATTGGTA
 + + ... + + + +
CATG G T - S a c 4 - A lu 9  
CCCATG G T - S a c 4 - H a e lO  
CCCATG G T - S a c 4 - H a e lO  
CCCAGAGACACATCACAGGGCAACGTTTTGGAAATGCTTCTATTTAATTAATGGCCCATG 
CCCAGAGACACATCACAGGGCAACGTTTTGGAAATGCTTCTATTTAATTAATGGCCCATG 
CCCAGAGACACA
CCCAGAGACACATCACAGGGCAACGTTTTGGAAATGCTTCTATTTAATTAATGGCCCATG
 + + + + . + +
< TCCTTCTCCTTCMAAAAATGGAGAMCGTTTGTTAGAGTGTGCAATATTATGAGATATAAG
> TTC TTC TC C TTC . AAAAATGGAGAACGTTTGTTAGAGTGTGCAATATTATGAGATATAAG
< T TC TTC TC C TTC . AAAAATGGAGAACGTTTGTTAGAGTGTGCAATATTATGAGATATAAG
> TTC TTC TC C TTC. AAAAATGGAGAACGTTTGTCAGAGTGTGCAATATTATGAGATATAAG
< TTC TTC TC C TTC . AAAAATGGAGAACGTTTGTTAGAGTGTGCAATATTATGAGATATAAG
> TTC TTC TC C TTC . AAAAATGGAGAACGTTTGTTAGAGTGTGCAATATTATGAGATATAAG
 + + + + + +
< ATAGATATG. ATTTTATTGACTGTTACTGTGTTATTAAATWAGATGGCAATATAC. AGTA
> ATAGATATG. ATTTTATTGACTGTTACTGTGTTATTAAATTAGATGGCAATATAC. AGTA
< ATAGATATG. ATTTTATTGACTGTTACTGTGTTATTAAATTAGATGGCAATATACGAGTA
> ATAGATATG. ATTTTMTTGACTGTCACTGTGTTATTAAATTAGATGGCAATATAC. AGTA
< ATAGATATGAATTTTATTGACTGTTACTGTGTTATTAAATTAGATGGCAATATAC. AGTA
> ATAGATATG. ATTTTATTGACTGTTACTGTGTTATTAAATTAGATGGCAATATAC. AGTA
192
 + + + + + +
0 8 2 9 _ 3 _ 7 0 0  > CCTGCCCTGGAAT. . . G C . . A . TGTGTCCCAGTCAGAATGCCA
0 9 1 4 _ 1 _ 8 0 0  < TCTGTATATAAGGAGGGCCTGCCCTGGAAT. . . GC . . AATGTGTCCCAGTCAGAATGCCA 
0 9 1 4 _ 4 _ 8 0 0  > TCTGTATATAAGGAGGGCCGAATCCG. AATCCCGCTGAAAATGG 
° 9 1 4 _ 4 _ 7 0 0  < TCTGTATATAAGGAGGGCCGAATCCG. AATCCCGCTGAAAATGG
0 9 1 4 _ 1 _ 7 0 0  > TCTGTATATAAGGAGGGCCTGCCCTGGAAT.. . G C . .AATGTGTCCCAGTCAGAATGCCA 
1 2 2 9 _ 5 _ 8 0  0 < TCTGTATATAAGGAGGGCCTGCCCTGGAAT. . . GC . .AATGTGTCCCAGTCAGAATGCCA
CONSENSUS > TCTGTATATAAGGAGGGCCTGCCCTGGAAT.. . G C . .AATGTGTCCCAGTCAGAATGCCA
G T - S a c 4 - H a e 2
 + .............................+ .............................+ .+  + ............................................................ +
0 8 2 9 _ 3 _ 7 0  0 > AAAAACTCAAAAAAAAGTTTTTTTTTACTAGAAAAACCAAATTTTTAGTGGGAAAAAAAA
0 9 1 4 _ 1 _ 8 0  0 < AAAAACTCAAAAAAAAGTTTTTTTTTACTAGAAAAACCAAATTTTTAGTGGGAAAARAAA 
0 9 1 4 _ 1 _ 7 0 0  > AAAMACTCAAAAAAAAGTTTTTTTTTACTAGAAAAACCAAATTTTTAGTGGGAAAAAAAA 
1 2 2  9 _ 5 _ 8 0  0 < AAAAACTCAAAAAAAAGTTTTTTTTTTCTAGAAAAACCAAATTTTTAGTGGGAAAAAAAA 
CONSENSUS > AAAAACTCAAAAAAAAGTTTTTTTTTACTAGAAAAACCAAATTTTTAGTGGGAAAAAAAA
 + ................................ + ................................ + ................................. + .................................+ ................................. +
0 82 9 _ 3 _ 7 ° 0  > ATTGAATATTTCAAGATTTATTATACCCCTAGGATGGAAAAAGTCTGAATCCGAAAATCC 
0 9 1 4 _ 1 _ 8 0 0  < ATTGAATATTTCAAGATTTATTATACCCCTAGGATGGAAAAAGTCTGAATCCGAAAATCC 
0 9 1 4 _ 1 _ 7 0 0  > ATTGAATATTTCAAGATTTATTATACCCCTAGGATGGAAAAAGTCTGAATCCGAAAATCC 
12  2 9 _ 5 _ 8  00  < ATTGAATATTTCAAGATTTATTATACCCCTAGGATGGAAAAAGTCTGAATCCGAAAATCC
CONSENSUS > ATTGAATATTTCAAGATTTATTATACCCCTAGGATGGAAAAAGTCTGAATCCGAAAATCC
 + .............................+ .............................+ ..............................+ ............................. + ..............................+
0 8 2  9 _ 3 _ 7 00  > AGCATCTCAGACCTGCCGAGGTTGTATATAAGTCATTGGGAAAGGTCCTTATCCTATTTG
0 9 1 4 _ 1 _ 8  0 0  < AGCATCTCAGACCTGCCGAGGTTGTATATAAGTCATTGGGAAAGGTCCTTATCCTATTTG
0 9 1 4 _ 1 _ 7 0 0  > AGCATCTCAGACCTGCCGAGGTTGTATATAAGTCATTGGGAAAGGTCCTTATCCTATTTG
1 2 2 9 _ 5 _ 8 0 0 < AGCATCTCAGACCTGCCGAGGTTGTATATAAGTCATTGGGAAAGGTCCTTATCCTATTTG 
CONSENSUS > AGCATCTCAGACCTGCCGAGGTTGTATATAAGTCATTGGGAAAGGTCCTTATCCTATTTG
 + ............................. + ............ +  + ...............................................+ ..............................+
0 82  9 _ 3 _ 7  0 0 > GAAGTTTCTGTGAATTAGCCCGAAAWTTATGACTATTTCAGCACTTTCTGGCAAAAATGT
0 9 1 4 _ 1 _ 8  0 0 < GAAGTTTCTGTGAATTAGCCCVAAAAATATGACTATKTCAG . ACTGTCTGGCAAAAATGT 
0 9 1 4 _ 1 _ 7 0 0  > GAAGTTTCTGTGAATTAGCCCGAAAAATATGACTATTTCAG. ACTTTCTGGCAAAAATGT
1 22  9 _ 5 _ 8  0 0 < GAAGTTTCTGTGAATTAGCCCGAAAAATATGACTATTTCAG. WCTTTCTGGCAAAAATGT 
CONSENSUS > GAAGTTTCTGTGAATTAGCCCGAAAAATATGACTATTTCAG. ACTTTCTGGCAAAAATGT
0 1 3 1 _ 1 _ 8 0 0
0 8 2 9 _ 3 _ 7 0 0
0 9 1 4 _ 1 _ 8 0 0
0 9 1 4 _ 1 _ 7 0 0
! 2 2 9 _ 5 _ 8 0 0
CONSENSUS
TTTTTTTTTGTTTWGTCCC
AGTAATTCAGGAAAAAATTATTTRATTCGGCTTTTCAATCCTTTTYTTTTGTTT. GTCCC 
AGTAATTCAGGAAAAAATTATTTGATTCGGCTTTTCAATCCTTTTTTTTTGTTT. GTCCC 
AGTAATTCAGGAAAAAATTATTTGATTCGGCTTTTCAATCCTTTTTTTTTGTTT. GTCCC 
AGTAATTCAGGAAAAAAAAAAWTGATTCGCCTTTTCAA. YCTTTT
AGTAATTCAGGAAAAAATTATTTGATTCGGCTTTTCAATCCTTTTTTTTTGTTT. GTCCC
x g G A T l- 2 3
0 1 3 1 _ 1 _ 8 0 0  
0 8 2 9 _ 3 _ 8 0 0  
0 8 2  9 _ 3 _ 7 0 0  
0 9 1 4 _ 1 _ 8 0  0 
0 9 1 4 _ 1 _ 7 0 0  
CONSENSUS
TGATCCAATGAAATTGTGATTTTYTTTTAAAAATAATAAATAAGGTCCAGTCATGGATTT 
A T T T T . TTTTAAAAATAATAAATAAGGTCCAGTCATGGATTT 
TGATCCAATGAAATTGTGATTTT. YTTTAAAAATAATAAATAAGGTCCAGT 
TGATCCAATGAAATTGTGATTTT. TTTTAAAAATAATAAATAAGGTCCAGTCATGGATTT 
TGATCCAATGAAATTGTGATTTT. TTTTAAAAATAATAAATAAGGTCCAGTCATGGATTT 
TGATCCAATGAAATTGTGATTTT. TTTTAAAAATAATAAATAAGGTCCAGTCATGGATTT
 +  +  +  +  +  +
0 1 3 1 _ 1 _ 8  00  < TTGTTTGGTCAGCCTTTTTTGATTAAAATAGTCAGATAATTTCGGAMCTTTGATAAATAA 
0 82 9 _ 3 _ 8  00  < TTGTTTGGTCAGACTTTTTTGATTAAAATAGTCAGATAATTTCGGAACTTTGATAAATAA 
0 9 1 4 _ 1 _ 8  00  < TTGTTTGGTCAGACTTTTTTGATTAAAATAGTCAGATAATTTCGGAACTTTGATAAATAA 
0 9 1 4 _ 1 _ 7  0 0  > TTGTTTGGTCAGACTTTTTTGATTAAAATAGTCAGATAATTTCGGAACTTTGATAAATAA 
CONSENSUS > TTGTTTGGTCAGACTTTTTTGATTAAAATAGTCAGATAATTTCGGAACTTTGATAAATAA
0 1 3 1 _ 1 _ 8 0 0
0 8 2 9 _ 3 _ 8 0 0
0 9 1 4 _ 1 _ 8 0 0
0 9 1 4 _ 1 _ 7 0 0
CONSENSUS
GGCCCTTGGTCTACTACAAGTTGTMCAAATTGTTTTGCTTGAGGMATCTATAGATGTTAT
GGCCGAACTGAATCCGAATCCTAATTTGCATATGTAAATTAGGGGCGGGTAGGAAAATGC
GGCCCTTGGTCTACTACAAGTTGTACAAATTGTTTTGCTTGAGGAATCTATAGATGTTAT
GGCCCTTGGTCTACTACAAGTTGTACAAATTGTTTTGCTTGAGGAATCTATAGATGTTAT
GGCCCTTGGTCTACTACAAGTTGTACAAATTGTTTTGCTTGAGGAATCTATAGATGTTAT
193
0 2 2 7 _ 5 _ 8 0 °  < CCMAAAARAAHCCCAYCCCYSCTGGAGAA x g G A T l-2 3
0 1 3 1 _ 1 _ 8 0 0 < GAATATACAAGTATTATGTGAAGGACAAATTTCCTATAGAATCCCATCCCTGCTGGAGAA
0 8 2 9 _ 3 _ 8 0 0 < ACATGACTTTTCGTCACAAAAGAAGGATTTTTTCCACTTTTTCCTTTTCTACCCCTAATT 
0 9 1 4 _ 1 _ 8  0 0 < GAATATACAAGTATTATGTGAAGGACAAATTTCCTATAGAATCCCATCCCTGCTGGAGAA 
0 9 1 4 _ 1 _ 7 0 0  > GAATATACAAGTATTATGTGAAG
CONSENSUS > GAATATACAAGTATTATGTGAAGGACAAATTTCCTATAGAATCCCATCCCTGCTGGAGAA
 +  +  +  +  +  +
0 22  7_ 5 _ 8  0 0 < CCTACASCGTCGGAAYCTGAAATATTGGSYCTTSYCMASCAGAGAAAGCGACGGAAAGAG 
0 1 3 1 _ 1 _ 8  0 0 < ACTACAGCGTCGGAATCTGAAATATTGGGTCTTGTC . AGCAGAGAAAGCGACGGAAAGAG 
0 8 2 9 _ 3 _ 8 0 0  < TACATATGCAAATTAAGGTTCGGATTTGGTTCGGTATTCGG
0 9 1 4 _ 1_ 8  0 0 < ACTACAGCGTCGGAATCTGAAATATTGGGTCTTGTC .AGCAGAGAAAGCGACGGAAAGAG
CONSENSUS > ACTACAGCGTCGGAATCTGAAATATTGGGTCTTGTC. AGCAGAGAAAGCGACGGAAAGAG
02 2 0 _ 4 _ 8  00  
0 2 2 7 _ 5 _ 8 0 0  
0 1 3 1 _ 1 _ 8 0 0  
0 9 1 4 _ 1 _ 8 0 0  
CONSENSUS
AKGATAGAGATGAGGASGATGAAAAAYTTKGAAG 
CAATTCTGCC. CTTTTAAGG. CAATCATGATAGAGATGAGG. CGATGAAAA. YTTTGAAG 
CAATTCTGACACTTTTAAGGACAATCATGATAGAGATGAGGACGATGAAAM. CTTTGAAG 
CAAKTCTGACACTTTTAAGGACAATCATGATAGAGATGAGGACGATGAAAAACTTTGAAG 
CAATTCTGACACTTTTAAGGACAATCATGATAGAGATGAGGACGATGAAAAACTTTGAAG
x g G A T l- 2 3
02 2 0 _ 4 _ 8  00 
0 2 2 7 _ 5 _ 8 0 0  
0 1 3 1 _ 1 _ 8 0 0  
0 9 1 4 _ 1 _ 8 0 0  
CONSENSUS
< GGAAGTAACAGAGAGACGCTTGGAGAAACCTTAAATAGTCCAATGTTTTCCAGCTTGGC.
< GGAAGTAACAGAGAGM. GCTTGGAGAA. CCTTAAATAGTCCAATGTTTYCCAGCTTGGCC
< GGAAGTAACAGAGAGACGCTTGGAGAAACCTTAAATAGTCCAATGTTTTCCAGCTTGGCA
< GGAAGTAACAGAGAGACGCTTGGAGAAACCTTAAATAGTCCAATGTTTTCCAG
> GGAAGTAACAGAGAGACGCTTGGAGAAACCTTAAATAGTCCAATGTTTTCCAGCTTGGCm
 +  +  +  +  +  +
1 2 2 9 _ 6 _ 8 0 0  > AGASTAATG. . . . YATAGTC. SSGCTCAG
0 1 0 1 _ 3 _ 8  0 0 > ATKATGATTGDTAGAGCTAAATGTCATGAS. SCAGAGGG. TCGGACA.
02 2 0 _ 4 _ 8  00  < CTTCTGGAGGCAATGATGATTGTTAGAGCTAAATGTCATGAGTT. AGAGGGTTCGGACA.
0 2 2 7 _ 5 _ 8 ° 0 < CTTCTGGAGGCAATGATGATTGTTAGAGCTAAATGTCATGAGTTCAGAGGGTTCGGACA. 
0 1 3 1 _ 1 _ 8 0 0  < CTTCTGGAGGCAATGATGATTGTTAGAGCTAAATGTCATGAGTTCAGAGGGTTCGG. C A . 
CONSENSUS > CTTCTGGAGGCAATGATGATTGTTAGAGCTAAATGTCATGAGTTCAGAGGGTTCGGACA.
x g G A T l■ 
x g G A T l-
12
12
 + .............................+ .............................+ ..............................+ .............................+ .............................. +
12  2 9 _ 6 _ 8  0 0 > CGCACAGTCTKACAAAATCTTCTTTTTATGGRGATGTTGGGAT. GCTAAGAGCTTGTTGG
0 1 0 1 _ 3 _ 8  0 0  > C . AACAGTCTGACAAAATCTTCTTTTTATGGGGATGTTGGGTT. GCTAAGAGCTTGTTGG
0 2 2 0 _ 4 _ B 0 0  < C . AACAGTCTGACAAAATCTTCTTTTTATGGGGATGTTGGGTKCTM. . . . MSSCTGTTGG 
0 2 2 7_ 5 _ 8 0 °  < C . AACAGTCTGACAAA. TCTTCTTTTTATGGGGATGTTRAAAAAAAKAAGAGCTTGTTRG 
0 1 3 1 _ 1 _ 8 0 0  < C . AACAGTCTGACAAA. TCTTCTTTTTATGGGGATGTTGSC
CONSENSUS > C . AACAGTCTGACAAAATCTTCTTTTTATGGGGATGTTGGGwT. GCTAAGAGCTTGTTGG
 + .............................+ .............................+ .+  + ............................................................ +
1 2 2  9 _ 6 _ 8 0 0 > GTTGCTAAGAGCTTGTTGGGTTGCTAAGACATTGCTTAGWCCAAGGTATTGTTGGGTAGA 
0 1 0 1 _ 3 _ 8 0 0  > GTTGCTAAGAGCTTGTTGGGTTGCTAAGACATTGCTTAGYCCAAGGTATTGTTGGGTAGA 
0 2 2 0 _ 4 _ 8 0 0  < G TK . CTAAGASCCTGTTGGG. TKCTA
0 2 2 7 _ 5 _ 8 0 0  < G T T . RMAAAAACTTGTTGGG. T
CONSENSUS > GTTGCTAAGAGCTTGTTGGGTTGCTAAGACATTGCTTAGtCCAAGGTATTGTTGGGTAGA
1 2 2 9 _ 6 _ 8 0 0
0 1 0 1 _ 3 _ 8 0 0
CONSENSUS
> TAATTGTCCTTGATTACACATGGTGGAGGATGCAGCAAATTGCAGAACACTTTTTGTATC
> TAATTGTCCTTGATTACACATGGTGGAGGATGCAGCAAATTGCAGAACACTTTTTGTATC
> TAATTGTCCTTGATTACACATGGTGGAGGATGCAGCAAATTGCAGAACACTTTTTGTATC
 +  +  +  +  +  +
1 2 2  9_ 6_ 8 0 0  > TGGAAGAGAAGGACTTGGATTAGTTTGTCATTCTTCCATCCTGAAGAAGACACAGAGAAT 
0 1 0 1_ 3_ 8 0 0  > TGGAAGAGAAGGACTTGGATTAGTTTGTCATTCTTCCATCCTGAAGAAGACACAGAGAAT 
CONSENSUS > TGGAAGAGAAGGACTTGGATTAGTTTGTCATTCTTCCATCCTGAAGAAGACACAGAGAAT
 +  +  +  +  +  +
1 2 2  9 _ 6 _ 8  0 0 > ACACTGAAATGAGAAATACCTTACACCACAGAGAAGACTTTTATTACTTGTATTACTCGA 
0 1 0 1 _ 3 _ 8  0 0 > ACACTGAAATGAGAAATACCTTACACCACAGAGAAGACTTTTATTACTTGTATTACTCGA 
CONSENSUS > ACACTGAAATGAGAAATACCTTACACCACAGAGAAGACTTTTATTACTTGTATTACTCGA
194
 + .............................+ .+  . . . .  + ........................................................... + ..............................+
1 0 2 9 _ 7 _ 8 0 0  < CTTTGGTTTAAATATATGTATTTTTAAMCATTTGCT
0 7 0 6 _ 8 _ 8 0 0  < CYCTYCTTTTTTTTWA. TW TTTTT. TTTTTYMMCATTTTCT
1 2 2  9 _ 6 _ 8  0 0 > AATATAACGTTTACAGTATCACTTCTTTGGTTTAAATATATGTATTTTTAAACATTTGCT
0 1 0 1 _ 3 _ 8 0 0  > AATATAACGTTTACAGTATCACTTCTTTGGWTTAAATATATGTATTTTTAAACATTTGCT
CONSENSUS > AATATAACGTTTACAGTATCACTTCTTTGGTTTAAATATATGTATTTTTAAACATTTGCT
 +.............. +.............. +.............. +.............. +...............+
1 0 2  9 _ 7 _ 8  0 0 < TWTTTATTTATATATATATACAGTATATATATGGTGATATGGATATATGGTCATTTCCCC 
0 7 °  6 _ 8 _ 8  0 0 < TATYTHTTTATATATATATACTGTATATATATGGTGATATGGATATATGGTCATTTCCCC 
1 2 2 9 _ 6 _ 8  00  > TATTTATTTATATATATATACAGTATATATATGGGGATATGGATATATGGRCATTTCCCC
0 1 0 1 _ 3 _ 8  0 0 > TATTTATTTATATATATATACAGTATATATATGGAGATATGGATATATGGTCATTTCCCC
CONSENSUS > TATTTATTTATATATATATACAGTATATATATGGTGATATGGATATATGGTCATTTCCCC
 +.............. +.............. +.............. +.............. +...............+
1 0 2  9 _ 7 _ 8  0 0 < CATA. CATTTCAATATATCTGGGCTTATTTATTCTTGTATATTTAGTTATTTTTTTGAAG 
0 7 0 6 _ 8 _ 8  0 0  < CATA. CATTTCAATATATCTGGGCTTATTTATCCTTGTATATTTAGTTATTTTTTTGAAG 
1 2 2  9_ 6 _ 8 0 0  > CATACCATTTCAATATATCTGGGCTTATTTATTCTTGTATATTTAGTTATTTTTTTGAAG 
0 1 0 1 _ 3 _ 8  0 0  > CATA. CATTTCAATATATCTGGGCTTATTTATTCTTGTATATTTAGTTATTTTTTTGAAG
CONSENSUS > CA TA . CATTTCAATATATCTGGGCTTATTTATTCTTGTATATTTAGTTATTTTTTTGAAG
 + . . . .........+.............. +.............. +.............. +...............+
1 0 2  9 _ 7 _ 8  0 0 < AAATCATTTATAAAAAATATTGTTGACTTCTTTTGCTTTTCTGCTTGAAACGAGCGTGCA 
0 70 6 _ 8 _ 8 0 0 < AAATCATTTATAAAAAATATTGTTGACTTCTTTTGCTTTTCTGCTTGAAACGAGCGTGCA
1 2 2  9_ 6_ 8 0 0  > AAATCATTTATAAAAAATATTGTTGACTTCTTTTGCTTTTCTGCTTGAAACGAGCGTGCA
0 1 0 1 _ 3 _ 8  0 0 > AAATCATTTATAAAAAATATTGTTGACTTCTTTTGCTTTTCTGCTTGAAACGAGCGTGCA
CONSENSUS > AAATCATTTATAAAAAATATTGTTGACTTCTTTTGCTTTTCTGCTTGAAACGAGCGTGCA
1 0 2 9 _ 7 _ 8 0 0  
0 7 0 6 _ 8 _ 8  00  
1 2 2 9 _ 6 _ 8 0 0  
0 1 0 1 _ 3 _ 8  00  
CONSENSUS
TTCTGGGAGTTGGGTGTTCCGGATGTCTGACTTGTCCTAGAACCAGTTTCTAGACCTTAA
TTCTGGGAGTTGGGTGTTCCGGATGTCTGACTTGTCCTAGAACCAGTTTCTAGACCTTAA
TTCTGGGAGTTGGGTGTTCCGGATGTCTGACTTGTCCTAGAACCAGTTTCTAGACCTTAA
TTCTGGGAGTTGGGTGTTCCGGATGTCTGACTTGTCCTAGAACCAGTTTCTAGACCTTAA
TTCTGGGAGTTGGGTGTTCCGGATGTCTGACTTGTCCTAGAACCAGTTTCTAGACCTTAA
 + + + • • ;  + + +
1 0 2  9 _ 7 _ 8  00 < CGACTGCCACCTGCTCCCTGGAACGATCAGTTGGTGCAAGTGAGATCTGACAGTCACAGA 
0 7 0 6 _ 8 _ 8 0 0 < CGACTGCCACCTGCTCCCTGGAAYGATCAGTTGGTGCAAGTGAGATCTGACAGTCACAGA 
1 2 2  9 _ 6 _ 8 00  > CGACTGCCACCTGCTCCCTGGAACGATCAGTTGGTGCAAGWGAGATCTGACAGTCACAGA
0 1 0 1 _ 3 _ 8  0 0 > CGACTGCCACCTGCTCCCTGGAACGATCAGTTGGTGCAAGTGAGATCTGACAGTCACAGA
CONSENSUS > CGACTGCCACCTGCTCCCTGGAAcGATCAGTTGGTGCAAGtGAGATCTGACAGTCACAGA
1 0 2 9 _ 7 _ 8 0 0
0 7 ° 6 _ 8_ 8 0 0
1 2 2 9 _ 6 _ 8 0 0
0 1 0 1 _ 3 _ 8 0 0
CONSENSUS
TGAGTGAGTTGTCTGTAACAAATGATGATAACAAATCTAATAATAATATGTAAATAAAGG
TGAGTGAGTTGTCTGTAACAAATGATGATAACAAATCTAATAATAATATGTAAATAAAGG
TGAGTGAGTTGTCTGTAAGAAATGATGATAAGAAATGTAATAATAATATGTAAATAAAGG
TGAGTGAGTTGTCTGTAACAAATGATGATAACAAATCTAATAATAATATGTAAATAAAGG
TGAGTGAGTTGTCTGTAACAAATGATGATAACAAATCTAATAATAATATGTAAATAAAGG
 +  +  +  . + .   +  +
1 0 2 9 _ 7 _ 8 0 0  < GAAAGAATGCTTGTTATGTTATCCAAACCATTTTTTACTCTTTCTCCCAGGCTATTCCAA 
0 7 0 6 _ 8 _ 8  0 0  < GAAAGAATGCTTGTTATGTTATCCAAACCATTTTTTACTCTTTCTCCCAGGCTATTCCAA 
12  2 9 _ 6 _ 8  0 0 > GAAAGAATG. TTGTTATGTTATGGAAAGGATTTT
0 1 0 1 _ 3 _ 8 0 0  > GAAAGAATGCTTGTTATGTTATCCAAACCATTTTTTACTCTTTCTCCCAGGCTATTCCAA
CONSENSUS > GAAAGAATGCTTGTTATGTTATCCAAACCATTTTTTACTCTTTCTCCCAGGCTATTCCAA
1 0 2 9 _ 7 _ 8 0 0  
0 7 0 6 _ 8 _ 8 0  0 
0 1 0 1 _ 3 _ 8 0 0  
CONSENSUS
TTTCCTGCCCATCTGCAAACTGATTATTGTCTCAGGTTGAAGGTTCATTTGCAGCTCAGT
TTTCCTGCCCATCTGCAAACTGATTATTGTCTCAGGTTGAAGGTTCATTTGCAGCTCAGT
TTTCCTGCCCATCTGCAAACTGATTATTGGC
TTTCCTGCCCATCTGCAAACTGATTATTGtCTCAGGTTGAAGGTTCATTTGCAGCTCAGT
 +  +  +  +  +  +
1 0 2  9 _ 7 _ 8  0 0 < CCAAGAATCGCAGCTGTTCCAGCAAAGAGCAGTTCCTTGTTTTTCCATAAATATTTCTTT 
0 7 0 6 _ 8 _ 8 0 0  < CCAAGAATCGCAGCTGTTCCAGCAAAGAGCAGTTCCTTGTTTTTCCATAAATATTTCTTT 
0 7 0 6 _ 3 _ 8 0  0 > TATCYAGGKBYTCCAGCAATAGMGTTKTTTTTTTTCCATAAATATTTCTTT
CONSENSUS > CCAAGAATCGCAGCTGTTCCAGCAAAGAGCAGTTCCTTGTTTTTCCATAAATATTTCTTT
GABA T r  9 
x g G A T l- 3 3
x g G A T l- 2 4
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c d n a 6
1 0 2 9 _ 7 _ 8 0 0
0 7 0 6 _ 8 _ 8 ° 0
0 7 0 6 _ 3 _ 8 0 0
CONSENSUS
c d n a 6
1 0 2 9 _ 7 _ 8 0 0  
0 7 0 6 _ 8 _ 8 0 0  
0 2 2 0 _ 5 _ 8 0 0  
0 7 0 6 _ 3 _ 8  00 
0 6 2 3 _ 5 _ 8 0 0  
0 7 0 6 _ 7_ 8  0 0 
CONSENSUS
c d n a 6
0706_8_800 
0 2 2 0 _ 5 _ 8 0 0  
0 7 0 6 _ 3_ 8 00 
0 6 2  3 _ 5 _ 8  00 
0 70  6 _ 7 _ 8  0 0 
CONSENSUS
0 7 0 6 _ 8 _ 8 0 0
c d n a 7
0 2 2 0 _ 5 _ 8 0 0  
0 706_3_800 
0 6 2 3 _ 5 _ 8 0 0  
0 7 0 6 _ 7 _ 8 0 0  
CONSENSUS
c d n a 7
0 2 2 0 _ 5 _ 8 0 0  
0 7 0 6 _ 3 _ 8 0 0  
0 6 2 3 _ 5 _ 8 0 0  
0 70  6 _ 7 _ 8  0 0 
CONSENSUS
c d n a 7
0 2 2 0 _ 5 _ 8 0 0  
0 7 0 6 _ 3_ 8  00 
0 6 2 3 _ 5 _ 8 0 0  
0 7 0 6 _ 7 _ 8 0 0  
CONSENSUS
c d n a 7
0 2 2 0 _ 5 _ 8 0 0  
0 7 0 6 _ 3 _ 8  00 
0 6 2  3 _ 5 _ 8  00 
0 7 0 6 _ 7 _ 8 0 0  
CONSENSUS
0 2 2 0 _ 5 _ 8 0 0
0 7 0 6 _ 3 _ 8 0 0
0623_5_800
0 7 0 6 _ 7 _ 8 0 0
CONSENSUS
 +  +  +  +  +  +
> GTGGTCTACTTCTCAGCGACATATCCCTACATCATGCT G . GTCATCTTGTTC x G A T -1
< CTCGGCAGGTGGTCTGCTTCTCAGCGACATATCCCTACATCATGCTG. GTCATCBTGTTC
< CTCGGCAGGTGGTCTACTTCTCAGCGACATATCCCTACATCATGCTGTGTCATCTTGTTC
> C TC G . CAGRTTTTCTACTTCTCAGCTACATATCCCTACATCATGCTG. GTCATCTTGTTC
> CTCGGCAGGTGGTCTACTTCTCAGCGACATATCCCTACATCATGCTG. GTCATCTTGTTC
 +  +  +  +  +  +
> T T C A . G A . GGA. GTGACCTTGCCGGG. AGCCTTGGATGGGATTTTGTTTTATATAACTCC
< T T C A . G A . GGA. GTGATWW
< TTCATGATGGATGTGACCTTGCCGGG. AGYCTTGGATGGGATTTTGTTTTATATAACTCC
< TATATCCCYCC x g G A T l- 2 5
> T T C A . G A T. G A . GTGACCTTTCCGGGNRGCCTTGGATGGGATTTTGTTTTATATAACTCC
> GGGGGGGGTG. GGGAGAGAAC. GC x g G A T l- 3 2
> GGAGWGAGCTG. X g G A T l- 3 2
> T T C A . G A . GGA. GTGACCTTGCCGGG. AGCCTTGGATGGGATTTTGTTTTATATAACTCC
............................+ ............................. + ..............................+ ............................ 4 - ............................. + ............................... +
> TAAATTCAGCAAGCTCTCGGATTCAGAG
< TAAATTCATGCAMGTCTSTGGCTTSCTGCTGTGTCCTGTCGNTCGCGTNTCGSSSTTTTK
< TAAATTCAGCMMSCTCTCGGATTCAGAGKTAATCTCCCGACCCCGTGACAAATMCCCATA
> TAAATTCAGCAAGCTCTCGTATTCRGAGGTAATCTACCCACACCCKTACAAATAACCATA
> GAAA. GGWBS. SGGGSG. NGAKTCAGAG. TAATCTACCGACACCGTGACAAATAACCATA
> . AAA. GGMTSTBBSKCGCGGAKGCAGAGNKAATCTACCGACACCGTGACAAATAACCATA
< TAAATTCAGCAAGCTCTCGGATTCAGAGGTAATCTACCGACACCGTGACAAATAACCATA
 +  +  +  +  +  . . .  +
< GGGGTGGGNGGGTTNTTT
> GTCTG xGAT-1
< ATGAAATAAAGTCMCAAAASYGATCAATTCCAMCGATATCTTCCATKTTGTGCAGTTCTG
> ATTAAATAAAGTCACAAAAACKATCAATTCCAACCATATCTTCCATTTTGKGCAGTTCTG
> ATGAAATAAAGTCACAAAAACGATCAATTCCAACGATATCTTCCATGTTGTGCAGGTCTG
> ATGAAATAAAGTCACAAAAACGATCAATTCCAACGATATCTTCCATGTTGTGCAGGTCTG
< ATGAAATAAAGTCACAAAAACGATCAATTCCAACGATATCTTCCATGTTGTGCAGGTCTG
> GCTGGACGCTGCCA
< GCTGGACGCTGCCM
> KCTGKACGCKGCCA
> GCTGGACGCTGCCA
> GCTGGACGCTGCCA
< GCTGGACGCTGCCA
 + + + + + +
> CTCAGATCTTCTTTTCTTATGGTTTGGGACTTGGCTCCTTAATTGCTTTGGGAAGCTACA
< CTCAGATCTTCTTCTCTTATGTTTTGGGCCTTGSCTCCTTAATTGCTTTGGGAACCTMCA
> CTCRGATCTTCTTCTCTTATGGTTTGGGACTKGGCTCCTTAATKGCTTTGGGAAGCTACA
> CTCAGATCTTCTTCTCTTATGGTTTGGGACTTGGCTCCTTAATTGCTTTGGGAAGCTACA
> CTCAGATCTTCTTCTCTTATGGTTTGGGACTTGGCTCCTTAATTGCTTTGGGAAGCTACA
< CTCAGATCTTCTTCTCTTATGGTTTGGGACTTGGCTCCTTAATTGCTTTGGGAAGCTACA
 . . . .  +  +  . . .  +  +    +  +
> ATCGATTCCACAACAATGTTTACAGG
< ATCGATTCCACAACAATKTTTACAGGCAAGTACAGAGGAAAATTGAATCCTAATAAAAT .
> ATCCATTCCACAACAAKGTTTACAGMCAAGTACAGRGGAAAATKGAATCCTAATAAAATA
> ATCGATTCCACAACAATGTTTACAGGCAAGKACAGAGGAAAATTGAATCCTAATAAAATA
> ATCGATTCCACAACAATGTTTACAGGCAAGGACAGAGGAAAATTGAATCCTAATAAAATA
< ATCGATTCCACAACAATGTTTACAGGCAAGTACAGAGGAAAATTGAATCCTAATAAAATA
 +  +  +  +  +  +
< CATTATGGATTAAACCATCAGGATATGAAAGTATCCTTGAAATWTTAAGGTATAAGAACA
> CATTATGGATTAAAACATCRGGATATGAAAGTATACTGGAAATATTAAGGTATAAGAACA
> CATTATGGATTAAAACATCAGGATATGAAAGTATACTTGAAATATTAAGGTATAAGAACA
> CATTATGGATTAAAACATCAGGATATGAAAGTATACTTGAAATATTAAGGKATAAGAACA
< CATTATGGATTAAAACATCAGGATATGAAAGTATACTTGAAATATTAAGGTATAAGAACA
196
 +  +  +  +  +  +
0 2 2 0 _ 5 _ 8 0 0  < CCTACTATTTTTCTTGACACAAAGGGG . TTATTGTATTTATTAGAGGTCAAACACMAAAA 
0 7 0 6 _ 3 _ 8  0 0 > A CTA C. ATTTTTCTGGACACAAAGGGGNTTATTGTATTTATTAGAGGTCAAACACCAAAA
0 6 2  3 _ 5 _ 8  00  > A CTA C. ATTTTTCTTGACACAAAGGGG. TTATTGTATTTATTAGAGGGCAAACACCAAAA
0 7 0 6 _ 7 _ 8  00  > A CTA C. ATTTTTCTTGACACAAAGGGG. KTATTGTATTTATTAGAGGTCAAACACCAAAA
CONSENSUS < ACTAC. ATTTTTCTTGACACAAAGGGG. TTATTGTATTTATTAGAGGTCAAACACCAAAA
0 2 2 0 _ 5 _ 8 0 0  
0 7 0 6 _ 3 _ 8  00 
0 6 2 3 _ 5 _ 8 0 0  
0 7 0 6 _ 7_ 8 0 0  
0 8 2 2 _ 3 _ 8 0 0  
CONSENSUS
ACTATATTTTTACAATAAAATMTTATTTTTTGTGAAAAAA. C T TK . WATTTTTTCATTAT 
A C TA . ATTTTTACAATAAAATCTCATTTTTTGTGAAAAAAACTTGGAATTTTTTCATGAT 
A C TA . ATTTTTACAATAAAATCTCATTTTTTGTGAAAAAAACTTGGAATTTTTTCATGAT 
A CTA . ATTTTTACAATAAAATCTCATTTTTTGTGAAAAAAACTTGGAATTTTTTCATGAT
ACTTGGAATTTTTTCATGAT 
A C TA . ATTTTTACAATAAAATCTCATTTTTTGTGAAAAAAACTTGGAATTTTTTCATGAT
0 2 2 0 _ 5 _ 8 0 0
0 7 0 6 _ 3 _ 8 0 0
0 6 2 3 _ 5 _ 8 0 0
0 7 0 6 _ 7 _ 8 0 0
0 8 2 2 _ 3 _ 8 0 0
0 8 0 9 _ 1 0 _ 7 0
0 8 0 4 _ 1 _ 8 0 0
CONSENSUS
TTATTAYACC. TGAGGATAGAAAAAGT. AAAATMWRAAAATCCAGA 
TTATTACACCCTGAGGATAGAAAAAGTSAAAATSTGAAAATSCAGCATCTGAGASCTGCC 
TTATTACACCCTGAGGATAGAAAAAGTCAAAATCTGAAAATCCAGCATCTGAGASCTGCC 
TTATTACACCCTGAGGATAGAAAAAGTCAAAATCTGAAAATCCAGCATCTGAGACCTGCC 
TTATTACACCCTGAGGATAGAAAAAGTCAAAATCTGAAAATCCAGCATCTGAGACCTGCC 
ACACCCTGAGGATARAAAAAGTCAAAATCTGAAAATCCAGCATCTGAGACCTGCC
AAATCCAGCATCTGAGRCCTGCC
TTATTACACCCTGAGGATAGAAAAAGTCAAAATCTGAAAATCCAGCATCTGAGACCTGCC
0 7 ° 6 _ 3_ 8 0 0
0 6 2 3 _ 5 _ 8 0 0
0 7 0 6 _ 7_ 8 0 0
0 8 2 2 _ 3 _ 8 0 0
0 8 0 9 _ 1 0 _ 7 0
0 8 0 4 _ 1 _ B 0 0
CONSENSUS
AAGGTTGTATACAAGTCTATGGCAGAAGTCCTGAAGATGTTGCCATCTGCTCTGGGKTTT
AAGGTTGTATACAAGTCTATGGCAGAAGTCCTGAAGATGTTGCCATCTGCTCTGGGTTTT
AAGGTTGTATACAAGTCTATGGCAGAAGTCCTGAAGATGTTGCCATCTGCTCTGGGTTTT
AAGGTTGTATACAAGTCTATGGCAGAAGTCCTGAAGATGTTGCCATCTGCTCTGGGTTTT
AAGGTTGTATACAAGTCTATGGCAGAAGTCCTGAAGATGTTGCCATCTGCTCTGGGTTTT
AAGGTTGTATACAAGTCTATGGCAGAAGTCCTGAAGATGTTRCCATCTGCTCTGGGTTTT
AAGGTTGTATACAAGTCTATGGCAGAAGTCCTGAAGATGTTGCCATCTGCTCTGGGTTTT
0 7 0 6 _ 3 _ 8 0 0  
0 6 2 3 _ 5 _ 8 0 0  
0 7 0 6 _ 7 _ 8  0 0 
0 8 2 2 _ 3 _ 8 0 0  
0 8 0 9 _ 1 0 _ 7 0  
0 8 0 4 _ 1 _ 8 0 0  
CONSENSUS
GKGCAAGAATSAGA. . . . TTTCATGGATTTTGGGGAAAAAATAAAAAAAAKTGGAAAATG 
GTGCAAGAATCAGA . . . .  TTTCATGGATTTTGGGS . AAAAATAAAAAAAAGGGGAAAATC 
GTG C AAGAAT C AG A . . . .  TTTCATGGATTTTGGGC . AAAAAT AAAAAAAAGTGGAAAATC 
GTGCAAGAATCAGA. . . . TTTCATGGATTTTGGGC. AAAAATAAAAAAAAGTGGAAAATC 
GTGCAAGAATCAGA. . . . TTTCATGGATTTTGGGC . AAAAATAAAAAAAAGTGGAAAATC 
GTGCAAGAATCARAAATTTTBCATGGATTTTGGGC . AAAAATAAAAAAAAGTGGAAAATC 
GTGCAAGAATCAGA. . . . TTTCATGGATTTTGGGC . AAAAATAAAAAAAAGTGGAAAATC
..........................................+ ............................. 4 -  +  . ...................................... + .............................................+ ............................................... 4 -
0 7 0 6 _ 3 _ 8 0  0 > TGAATAAAATSTGTASATTTTGAATTTTGTTATGTATTTGAGAGATATTTK
0 6 2 3 _ 5 _ 8 0 0  > TGAATAAAATCTGTACATTTTGAATTTTCTTATGTATTTTACAGATATTTTTTGAGGTTT 
0 7 0 6 _ 7 _ 8 0 0 > TGAATAAAATCTGTACATTTTGAATTTTCTTATGTATTTTACAGATATTTTTTGAGGTTT 
0 8 2 2 _ 3 _ 8 0 0  < TGAATAAAATCTGTACATTTTGAATTKTCTTATGTATTTTACAGATATTTTTTGAGTTTT 
0 80  9 _ 1 0 _ 7 0 < TGAATAAAATCTGTACATTTTGAATTSTCTTATGTATTTTACAGATATTTTTTGAGTTTT 
0 8 0 4 _ 1 _ 8 0 0 < TGAATAAAATCTGTACATTTTGAATTTTCTTATGTATTTTACAGATATTTTTTGAGTKTT 
CONSENSUS < TGAATAAAATCTGTACATTTTGAATTTTCTTATGTATTTTACAGATATTTTTTGAGTTTT
0 6 2 3 _ 5 _ 8 0 0
0 7 0 6 _ 7 _ 8 0 0
0 8 2 2 _ 3 _ 8 0 0
0 8 0 9 _ 1 0 _ 7 0
0 8 0 4 _ 1_ 8 ° 0
CONSENSUS
TTTCCTGCACTGGAATGKGTAGGTATAATGKATTGATAAATAAGGGGAAGAAACCTGTGS
TTTCCTGCACTGGAATGTGTAGGTATAATGTATTGATAAATAAGGGGAAGHAACCTGTGC
TTTCCTGCACTGGAATGTGTAGGTATAATGTATTGATAAATAAGGGGAAGTAACCTGTGC
TTTCCTGCACTGGAATGTGTAGGTATAATGTATTGATAAATAAGGGGAAGTAACCTGTGC
TTTCCTGCACTGGAATGTGTAGGTATAATGTATTGATAAATAAGGGGAAGTAACCTGTGC
TTTCCTGCACTGGAATGTGTAGGTATAATGTATTGATAAATAAGGGGAAGTAACCTGTGC
0 6 2 3 _ 5 _ 8 0 0  
0 7 0 6 _ 7 _ 8  0 0 
0 8 2 2 _ 3 _ 8 0 0  
0 80  9 _ 1 0 _ 7  0 
0 8 0 4_ 1_ 8 0 0  
CONSENSUS
A
AGATTTGGTCAGAGTATATTTCAGAAAATACTGAGATAAATWT . GAATTTTGAWWAAACT 
AGATTTGGTCAGAGTATATTTCAGAAAATACTGAGATAAATTT . GAATTTTGAT . AAACT 
AGATTTGGTCAGAGTATATTTCAGAAAATACTGAGATAAATTT. GAATTTTGAT. AAACT 
AGATTTGGTCAGAGTATATTTCAGAAAATACTGAGATAAATTTTGAATTTTGAT. AAACT 
AGATTTGGTCAGAGTATATTTCAGAAAATACTGAGATAAATTT. GAATTTTGAT. AAACT
0 8 0 8  D e l . T P 3 - 1
S a c 4 - E c o R l - 4
G T -S a c 4
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 + .............................+ ............+  + ...............................................+ ..............................+
0 7 o 6 _ 7 _ 8  0 0  > CCCAAAATACTCTCTTATWAAACTAGTGGTTGCACCGAAWTCAGGGATCSRGWTCGGGGA
0 8 2 2 _ 3 _ 8  0 0  < C C C . AAATACTCTCTTATAAAACTAG. GGATGCACCGAATCCAGG. ATTCGGTTCGGG. A 
08 0 9 _ 1 0 _ 7  0 < C C C . AAATACTCTCTTATAAAACTAG. GGATGCACCGAATCCAGG. ATTCGGTTCGGG. A
08  0 4 _ 1 _ 8  0 0  < CCC CAAATACTCTCTTATAAAACTAG. GGATGCACCGAATCCAGG. ATTCGGTTCGGG. A
CONSENSUS < C C C . AAATACTCTCTTATAAAACTAG. GGATGCACCGAATCCAGG. ATTCGGTTCGGG. A
 + .............................+ ............+  + ...............................................+ ..............................+
0 7 0 6 _ 7 _ 8 0 0  > TTCGGCC
0 8 2  2 _ 3 _ 8 0 0 < TTCGGCCAAGATTCGGCCATTTTCAGCGGGATTCGGATTCGGCCGGATCCTTCTGTCCGG
08  0 9 _ 1 0 _ 7 0  < TTCGGCCAAGATTCGGCCATTTTCAGCGGGATTCGGATTCGGCCGGATCCTTCTGTCCGG
0 8 0 4 _ 1 _ 8 0 0 < TTCGGCCAAGATTCGGCCATTTTCAGCGGGATTCGGATTCGGCCGGATCCTTCTGTCCGG 
CONSENSUS < TTCGGCCAAGATTCGGCCATTTTCAGCGGGATTCGGATTCGGCCGGATCCTTCTGTCCGG
 + .............................+ ............+  + ...............................................+ ..............................+
0 8 2 2 _ 3 _ 8  0 0 < CCGAACCGAATCTGAATCCCAATTTGCATATGAAAATTAGGGACGGAGAGGGAAATTGCA
08  0 9 _ 1 0 _ 7  0 < CCGAACCGAATCTGAATCCCAATTTGCATATSAAAATTAGGGGCGGAGAGGGAAATTGCA 
0 8 0 4 _ 1 _ 8 0 0 < CCGAACCGAATCTGAATCCCAATTTGCATATGAAAATTAGGGGCGGAGAGGGAAATTGCA
CONSENSUS < CCGAACCGAATCTGAATCCCAATTTGCATATGAAAATTAGGGGCGGAGAGGGAAATTGCA
0 8 2 2 _ 3 _ 8 0 0
0 8 0 9 _ 1 0 _ 7 0
0 8 0 4 _ 1_ 8 0 0
CONSENSUS
TGACTTTTTGTCACAAAACAAGGAAGTAAAAAATGTTTTCCCCTTCCCACCCCTAATTTG
TGACTTTTTGTCACAAAACAAGGAAGTMAAAAATGTTTTCCCCTTCCCACCCCTAATTTG
TGACTTTTTGTCACAAAACAAGGAAGTAAAAAATGTTTTCCCCTTCCCACCCCTAATTTG
TGACTTTTTGTCACAAAACAAGGAAGTAAAAAATGTTTTCCCCTTCCCACCCCTAATTTG
0 8 2 2 _ 3 _ 8 0  0 
0 8 0 9 _ 1 0 _ 7 0  
0 8 0 4 _ 1 _ 8 0 0  
CONSENSUS
CATATGCAAATTAGRATTCGGATTCGGTTCGGTATTCGGCCGAATCCTTCGTGATACACA
CATATGCAAATTAGGATTCGGATTCGGTTCGGTATTCGGCCGAATCCTTCGTGATACACA
CATATGCAAATTAGGATTCGGATTCGGTTCGGTATTCGGCCGAATCCTTCGTGATACACA
CATATGCAAATTAGGATTCGGATTCGGTTCGGTATTCGGCCGAATCCTTCGTGATACACA
0 8 2 2 _ 3 _ 8  0 0 
0 8 0 9 _ 1 0 _ 7  0 
0 8 0 4 _ 1 _ 8 0 0  
CONSENSUS
AAATAGTGGATTCGGTGCATSCCTATATAAAACAGAACAATGATTTTGTTTATCACAGTT 
AAATAGTGGATTCGGTGCATCCCTATATAAAACAGAACAATGATTTTGTTTATCACAGTT 
AAATAGTGGATTCGGTGCAKSS CTATATAAAACAGAACAATGATTTTGTTTATCACAGTT 
AAATAGTGGATTCGGTGCATCCCTATATAAAACAGAACAATGATTTTGTTTATCACAGTT
0 8 2 2 _ 3 _ 8 0 0
0 8 0 9 _ 1 0 _ 7 0
0 8 0 4 _ 1 _ 8 0 0
CONSENSUS
0 8 2 2 _ 3 _ 8 0  0 
0 8 0 9 _ 1 0 _ 7 0  
0804_1_80° 
CONSENSUS
TACCTCTCAAGTTTATAAGGTGCTRCCTAAACCAAATGGTTTCTAATTCTATACTGTACA 
TACCTCTCAAGTT. ATAAGGTGCTGCCTAAACCAAATGGTTTCTAATTCTATACTGTACA 
TACCTCTCAAGTTTATAAGGTGCTGCCTAAACCAAATGGTTTCTAATTCTATACTGTACA 
TACCTCTCAAGTTTATAAGGTGCTGCCTAAACCAAATGGTTTCTAATTCTATACTGTACA
 +  +  +  +  +  +
GTCAAGGATCTACCCCTCTATAATATGTAGATCCTC 
GTCAAGGATCTACCCCTCTATAATATGTAGATCCTC 
GTCAAGGATCTACCCCTCTATAATATGTAGAKCCTC 
G T CAAGGAT CTAC C C C T C TATAATATG TAGAT C CT C
198
APPENDIX B-2
PRELIMINARY CONSENSUS SEQUENCE OF xgGAT-1 GENOMIC FRAGMENT
199
1 ACTATAGGGCACGCGTGGTCGACGGCCCGGGCTGGTCTGACACAAGGTCA
51  g  s  CCATTCyGATTAGAAGrAAAGAGGwTC C r  s  CTAAATATTGGGAAGGGG
1 0 1  TTTGTTACAGTGAGAGCTGTGAAkATGTGGAATTGTCTCCCTGAATCAGT
1 5 1  GGTACAGGCTGATACATTAGATAGGTATAAGAAGGGGTTGGATGGTGTTT
2 01  AGCAAGTGAGGGAATACAGGGATATGGGAGATAGCTCATAGTACGAGGAT
2 5 1  CCATGGACTGGTCCCATTGCCATTTTGGAGTCAGGAAGGAATGTTTTCCC < G T -gw 5
3 0 1  CCTCTGAAGCAAATTGGAGAGGCTTCAAATGGGGATTTTTGCCTTCCTCT
3 5 1  GGATCAACTAGTAGTTAGGCAGGTTATATACAGACCTAAAAGGTTGAACT < G T -gw 6
4 01  TGAGGGGTATGTATCTTTTTTCAACCTAACTATGTTACTTTGTTAAGAAC
4 5 1  ATAAACCTGAGTCTTTCGGTAAAGAAGACTTTGAATCTAGCCATAAGTCT
5 0 1  TCTATATATCAACTGAACTTCCCCTGCTTCTCTAAATTCCATTATTCCTA
5 5 1  CACAACTACTACATTCCTGTACTCCATCCCCCCTCTGTACTTCTTCCTAC
6 0 1  TTCACGAACATTTTTCCTGAACTCCCCTTCCTCTCTTACTTGGTTTGAAC
6 5 1  CATACACCCTCCTAATATTTTGATCTCTGTCCTCTCCTGTCTCTCCTAAA
7 01  CTCTAATTTCCCCTAATTCTAATGAAATTAAACCTCCCTGTTGTCTTAGT
7 5 1  TTTCTTACCCCTCCTTATTTCCTTACTCTACTGAACACTAGACTACCCGA
8 0 1  ACTGTAATTTTCTACTTCTCCAGAACCATAGCTTCTCCTACTTCTCATAG
8 5 1  GATTTGTGTCTCTCCAATTACTTAGGGCTTTTTCCTCTCTTGCTGTATCT
9 0 1  GAACTTAAATTCTTACATCTTCTGCATTACAACTTCTACTGATACTTCAG < G T -gw 3
9 5 1  AACCCTCTCATCTCTTACCTGTTTATAGTTATGTTCTCTTCTTGTCCTGA < G T -gw 4
1 0 0 1  ACTCTTTCCTTTACTACTGGTCAGTACCTTCTTGCACCTCCTGCCTCCAT
1 0  51 TATATTATGTCTTCTTCTGCCTCTCTTGAACTCTATCTTCTCTTACTTCT
1 1 0 1  CTGTCATCTCCTATCTCTTTTGAACTATGTTCTCTTCTAAATTCTCAGCA xgG A T - 1 >
1 1 5 1  CCCTCTTCTTCAACCTATATTAAAATCTGTCTTCTTCTGCCTTTGAACTG
1 2  01  CTTGTTCCTACCTTTTATGGGTTCTTTCCTTTCTCTCAACTTGTGAACTT
1 2  51  GTCCTCTACTTCTTTCTTGTATTTGGACTTGTTAAACCCTGTTCTCTCTT
13 01  AGCTGTACTGAATGCTGCCATTTCCCACCCTCCTATTCAATTCCTATGTT
1 3 5 1  TTATGTATTCATAATTTGGGACTAAATAGTGTTTTCAACATTATGTCTTT
1 4 0 1  CAGATCAACATTTAACCTTATAACCAAGCTCTGACCATCATATTCACCAC cDNA (b p  3 2 - 4 4 4 )
1 4  5 1  TCTGCACCCTGGCGAAAGCGTCTTTCTAACCCTAGTTACGTAAGGAAGAG <G A B A T-11
15  01  CCGCGAAGCTGCTGTCCACGTGGACTGGTGCTGAAATCTCTCGTCCGGCT G A B A T-1>
1 5 5 1  GC C AG G CAC TGCCATTC C AAAC C AAGAGAC A T G GC AAC AAAT G GAAC T AA
1 6 0 1  AGTGGCTGATGGGCAAATTTCCACAGAACTTAGTGAGGCCCCCATTATTA
1 6  51  ATGACAAGCCAAAAACCTTGGTGGTGAAGGTTCAGAAGAAGAAAACAGAA < x g G A T l- 3 /
1 7 0 1  GATATGGAAAGAGATACCTGGAAAGGGAGGTTTGACTTCCTTATGTCCTG <GABAT-2
1 7 5 1  TGTTGGTTACGCCATTGGACTGGGAAATGTGTGGAGATTCCCCTATCTCT
1 8 0 1  GCGGCAAGAATGGAGGAGGTAAGCTCTTCATAGAAATTATATTTCCCATG
1 8 5 1  ATGCTTCAATTGCTACAATTTTTTTGTCTGAAATTTGTCAGATTTTATGG
1 9 0 1  TGTTGTTTTTTATTTCTAAATTAGATTGTTTACACTCCAAACTATTCACT
1 9 5 1  CCACCATGTAAAATGTCATTCCAGAACCAACAAGTGTATTTAGTTGTAAT
2 0 0 1  ATTGGTGTGTATCTATGTTGTGTTTAGCACCGTGGTCCTAGAGGAACGTT xgG A T 1 - 4  >
2 0 5 1  GkTTTCGTTTCACTGTGTACTGTACAAACGTATATGGATGAAATGACAAT
2 1 0 1  AAACTCACTCTTGACTCTCTTGACTTGACTCTTGACTAGGTACATCTCAG
2 1 5 1  CTCATTTTGCCTGGTCATGTGATTTCAGAAAGAGCCAGCACTTTAGGATG
2 2 01  GAACTGCTTTCTGGCAGGCTGTTGTTTCTCCTACTCAATGtAACTGAACG
2 2 5 1  TGTGTCAGTGGGACCTGGATTTTTAATATTGAGTGCTGTTCTTAGATCTA
' 2 3 01  CCAGGCAGCTGTTATCTTGTGTTAGGGAGCTGCTATCTGGTTACCTTCCC
23  51  ATTGTTCGGTTGTTAGGCTGCTGGGGGGGAAGGGAGGGGCTAATATCACT
2 4  01  CTAACTTGCAGTACAGCAGTAAAGAGTGACTGAAGTTTATCAGAGCACAA
2 4  5 1  GTCAATGGGGGAACCTGGGAAACTGACAATATGTCTAGCCCCATATTTGT
2 5 0 1  ATTTGTATTAGTATTATTGTTTGTATCCAATTGGkTCATTAATGGCACAA
2 5 5 1  ATAAATCAATGTATCTATCTTTGC CAAAATATGCAATGGATAGTGCTACT
26  01  GGTCTAGTAACCCATAGCATGGTAGCATGTGTTTGTGCCAATAATGATGG
2 6 5 1  AAATAGCTATAAAGCATGAAGGTCATTTAATTAAACAGCAATTAAAGTCT
2 7 0 1  AATATATCCTTCTAATCATGATATAGTTTTATAGGATCTCTCTGTACAGA
2 7 5 1  CTATGAGCAAACTTAGGGGACTGTTCCTGCTGAATTGTGCTTAGtACAGG
28  0 1  GAATACCTATGCTGCCATAGkTTTATGGGATCTCTCTGtACAGACkAtGA
2 8 5 1  GywAAykTAtkkkACTGTTCCTGCTGAATTGTGCTTAGTACAGGGAATAC
29  01  CTATGCTGCCATAGTwTTATGGGATCTCTCTGTACAGACTATGAGCAAAC
2 9 5 1  TTAGGGGACTGTTCCTGCTGAATTGTGCTTAGTACAGGGAATACCTATGT
30  0 1  ACCATAGTTTTATGGGATCTCTCTGTACAGACTATGAGCAAACTTAGGGG
3 0 5 1  ACTGTTCCTGCTGAATTGTGCTTAGTACAGGGAATACCTATGCTGTCATA
3 1 0 1  GTTTTATGGGAT C T CT CTGTACAGACTATGAGCAAACTTAGGGG CTGTTC
3 1 5 1  CTGCTGAATTGTGCTTAGTACAGGGAATACCTATGCTGCCATAGTTTTAT
32  0 1  GGGATCTCTCTGTACAGACTATGAGCAAACTTAGGGACTGTTCCTGCTGA
32  5 1  ATTGTGCTTAGTACAGGGAATACCTATGCTGCCATAGTTTTATGGGATCT
33 01 CTCTGTACAGACTATGAGCAAACTTAGGGGACTGTTCCTGCTGAATTGTG
33  51 CTTAGTACAGGGAATACCTATGCTGCCATAGTTTTATGGGATCTCTCTGT
34 01 ACAGACTATGAGCAAACTTAGGGACTGTTCCTGCTGAATTGTGCTTAGTA
34 51 CAGGGAATAC CTATGTTGCCATAGTTTTATTATAGCTCTTTGTACAGACT
3 5  01 ACAGTATATGTAAATGTAGGTAATGCTCTTTCTGAATTGTGCTTAATACA
3 5 5 1
3 6 0 1
3 6 5 1
3 7 0 1
3 7 5 1
3 8 0 1
3 8 5 1
3 9 0 1
3 9 5 1
4 0 0 1
4 0 5 1
4 1 0 1
4 1 5 1
4 2 0 1
4 2 5 1
4 3 0 1
4 3 5 1
4 4 0 1
4 4 5 1
4 5 0 1
4 5 5 1
4 6 0 1
4 6 5 1
4 7 0 1
4 7 5 1
4 8 0 1
4 8 5 1
4 9 0 1
4 9 5 1
5 0 0 1
5 0 5 1
5 1 0 1
5 1 5 1
5 2 0 1
5 2 5 1
5 3 0 1
5 3 5 1
5 4 0 1
5 4 5 1
5 5 0 1
5 5 5 1
5 6 0 1
5 6 5 1
5 7 0 1
5 7 5 1
5 8 0 1
5 8 5 1
5 9 0 1
5 9 5 1
6 0 0 1
6 0 5 1
6 1 0 1
6 1 5 1
6 2 0 1
6 2 5 1
6 3 0 1
6 3 5 1
6 4 0 1
6 4 5 1
6 5 0 1
6 5 5 1
6 6 0 1
6 6 5 1
6 7 0 1
6 7 5 1
6 8 0 1
6 8 5 1
6 9 0 1
6 9 5 1
7 0 0 1
7 0 5 1
200
GAGTAATACTGTCCTGGCATTGTTTTCTATAGGGTACTATGACCTCAGAT 
GAGTGTTGTCTGCCCCTTATGAATACAGTGCTGCTGAAGGCAACACTGTA 
TTCATGAGTTGTGGGCAAAGTCTTTCAGTCTATGAATTCATTTAGGGGGT 
GATTCTTGGTGGATTGTGCTTAGTACACAGGTAAACCAATGTTGGCATAG 
TTTTTGGTATCTCTCTTAACAGGTTATGACCAAACCTAGAAGATTATTGC 
TGTTAAAAGTATTACGGGTGGGTGCCTATGCTGGCATAGCGGCAGATACA 
ATAAGCGGTGGGTTTCAATAAACATCTCCAATGAGTTCAATGTACATCTC 
ACAGTCTGATAGATCACCCTGTTGGCTTCTTTGTAAAGGGGTTATAGydA 
GAGGTTGATAATTGAACwGnTACAGATAATTTGTCACCAGAAAGAACAAT 
AGAACCTAAAACAGhCAAATGAGCCAGTAGCACTTGCATArAAGCTACAA 
GGAAGAACAAAGCAAGAGGGGTGAATCTTGTTACTATTTCATTATGAAAA 
ATACACTGAAACTAAAAGATGCTGCAGAAGATTTCTAAATTGTGCCTTTG 
ATTGTAACTCGTTGGTGCCTGACTGGCATTGTGCTCTCCTACACCGGTTA 
GAACTTCTAGGTATTTCCAGTCTCTCATCACACAACCTTGAATATATCGT 
GTTTCTGTATTAAGGCATCATCTTCCTTTCAGCTGCACATTCCTCCTTTT 
CTTGGAATAAAtCTGGAGATACTyAATATTCAGwwTwTyTmmATykyywni 
kC Trw G TysC w G C C sTkG ysw C A m kC G TTG G C TTC yw G rsTTsTA G C TA A  
TGAGwTwAAAAAAATAAGGAATGAGSCTCCAACTGAAThGTATCCGCTCC 
ACTTACTGCCTTTGnCCATAAkCyGATATCAGTTTTTCAGCTCAAAGtTT 
AGTGAGTAATAGTCcAGTGGTATCATTGGGAGATGGTAATAGtCCAGTGG 
TATCATTGGGAGATGGTAATAGTCCAGTrwwwTywwyrkGAGGwGGywwy 
m k T sy A rC sk T rT m w w k rrk m k k d rsT m m y A G T m m w G w k k y A w C m y T sk k  
mkGTGGTAATAGTCCAGTdGTATCATTGnGAGGTGrTAATAGTCCAGTGw 
TATCvCTGGGAGGTGGTAATAgwCCAGTGGwATCATTGGrAGrTGGTArT 
AGTCCAGTGGTATCATTGrGAGGTGGTAATagTccaGTGGTATyATTGGG 
AGGTGGtAATAGTmCAGTkGTATCAyTGGGAGGtGGTAATAGTccaGkGG 
t  a T  sA TTGGGAGGTac a G t  G kA agrG T m C aaw T T  s  r T  ry C A c  T g g g A k k G  
s  kG w A yA t s  TC sA c  kw G G cA yCm TTgg rG k rA k G A cm c tw A TG G G G ttA A  
TCA w TgggA A rG  s  rTAmwAGgcywGGGAwAt cA T kG c tG rA rk rT G A C A A  
TATCAGTGmCTTATCAAACGTTGCCTGTCTATAAATGTTTwCTACCTCTG 
ACCCATCTTCCTTGGTCCTAAATCCTCTCCTGGGAAAATATTTCTGGAAT 
TTATCAGCCGATTCTCCGACATCCCATCATTTGTGTATAAAGGCCACAGT 
GAACGATTTTATTGGCCCAAACGTACTGAATTTTATTGTTACTTTGTTTC 
TGTCCAGGGGCTTTTCTCATTCCCTATTTCCTTACGCTCATTTTCGCTGG 
GGTTCCTCTCTTTCTGTTGGAGTGCTCCCTGGGACAATACACTTCCATTG 
GAGGCCTTGGAGTATGGAAACTTGCTCCCATGTTTAAAGG1ACAGATATA 
ACCACATTTTATTATACTCTGTGTTTCTCTGTGTTTTCCTACACCCCTCC 
CCAATTCTTTCTCTGTCATTCACAGACAGTAAGGTCGATGGTTTCATTGT 
CACTGAkGGATGwTAAATATAAGGGtATACATGAGGAGTCCATTCCATAT 
TAAAGaGcAAAGCTGAAAGCGACGATAACTGAGCACTAAGCACCATTTAT 
AAGGATATAGrTTATAGGATATTCATGGCTCCTTTATATTGTATGTACCC 
GGGGGtTCATTTAGGGGGTTAACTTAATAGACTATTGTATTTGTTCAACT 
CAAcATTAACCATGTAcACTGTGTAAGATGCACATAgGaGGtAAATAGaG 
CA TTA G tTA TG G . GtATGTTATGCTACTCgTGTACTGTATCTTCCCTTTG 
grTACGTTTCATGAGCCTGAAAATACATTTTAGCCGTAACTAATGGkCAA 
TATAAGCTGrAGkGGrAAAGAAGgGGCCACATATGACTTGTGCCCCCAAC 
TAACCAACCAACTAGGGACGCACCGAATCCACTATTTGGGATTCGGCCsA 
w T yTC A G vdTvvTTCGGGAhCGrwwmGGCCGAATACCGAACCAAATCCGA 
ACCTTAATTTGCATATGTAAATTAGGGGGwAGAAAAGGAAAAAGTGGAAA 
AAATCCTTCTTTTGTGACGAAAAGTCATGTGATTTTCCTACCCGCCCCTA 
ATT TACATATG CAAAT TAGGATT CGGAT T CAGT TCGGCCdT kkAAT C C dw 
AkCyhdCTGGmAATGGTCCGAAyTCAGTGCTGAAAAATGGCCGAAsaTCC 
tGGCCGAAbTCCCGAACCGAATCCTGGATTCGGTGCATCCCTACAACCAA 
CCAACGTGAAGAACATATGGAAACAATACTATAATATATACATtAAATGG 
TCCTTTGGGGCAmcTGCAGATGAAAGTTCTCCTCAATGTGCTTTGGGAAG 
CCCCAGCTG C AAAT CAT AGG C AG C C C C C ATG TAG AG C AAT CAT ATG G C C C 
C A G G A A TG ssrG yw rC yssC A ttC C T kG G ggC C A G G m T TyskC C A T A T A T  
CAATTCCTCTCCTTTCTCTTGAGTTTCTCCATGTCAAAACTGCACCCCAG 
kCTCTAGTTGAGTCCAAGGCTTTATAAAGGGCAAGAAATCACCATTTAGT 
TCTtCaTTATCAAGGGTTCmCCTTATTAGGTTTGAATGCAGATGTGGAAT 
gTTmCTGCAGACTGATAGGACGAGATCtCTTCTATCTGCAGGTGTTGGAC 
TCGCTGCTGCCATCCTTTCCTTTTGGCTAAATATCTACTACATTGTTATC 
ATCGCCTGGGCTATATATTACCTCTTCAGTTCCTTCACCACTGTGAGTAA 
TAAGTCAAGTTCTTTCCATGTGTAATATTCTCTACTGTGTACAATAAACA 
TGTCCTAAGAAAGGCAGACCCACCCATATCTGTAACATCATTTTACATTT 
TTTATTAATTATATTCTGAGATATGGGGTGGGGCAGTTTTTCATTTTGGC 
ATAATCCAATGGCATTAGTTGTGATAAAAGGCTATTTTGCAGCAAtAAAT 
ACATTTCTTTTCTGTTACAGACCCTCCCTTGGAAAAACTGTGACAACTAT 
TGGAATACTGAACGTTGCTTCTCCAACTACAGTATCCCCAACACCACCAA 
TATGACGAGTGCCGTTTTGGAATTTTGGGAGTAAGTTTTTTTTTCCATTT 
GTGATTGTCACACTTATATGGCTAAAAGTATGTTCTTCTTATTGCTGGAA
x g G A T l-1 5 >  
x g G A T l- 2  > 
< x g G A T l- 1 7
x g G A T l- 2 8 > /  
< x g G A T l-2 9
CDNA (bp 445-577)
x g G A T l- 1 6 >
x g G A T l- 2 6 >  
< x g G A T l-1 0
cDNA (bp 578-678)
<x g G A T l- 1 8
cDNA (bp 679-788)
7 1 0 1
7 1 5 1
7 2 0 1
7 2 5 1
7 3 0 1
7 3 5 1
7 4 0 1
7 4 5 1
7 5 0 1
7 5 5 1
7 6 0 1
7 6 5 1
7 7 0 1
7 7 5 1
7 8 0 1
7 8 5 1
7 9 0 1
7 9 5 1
8 0 0 1
8 0 5 1
8 1 0 1
8 1 5 1
8 2 0 1
8 2 5 1
8 3 0 1
8 3 5 1
8 4 0 1
8 4 5 1
8 5 0 1
8 5 5 1
8 6 0 1
8 6 5 1
8 7 0 1
8 7 5 1
8 8 0 1
8 8 5 1
8 9 0 1
8 9 5 1
9 0 0 1
9 0 5 1
9 1 0 1
9 1 5 1
9 2 0 1
9 2 5 1
9 3 0 1
9 3 5 1
9 4 0 1
9 4 5 1
9 5 0 1
9 5 5 1
9 6 0 1
9 6 5 1
9 7 0 1
9 7 5 1
9 8 0 1
9 8 5 1
9 9 0 1
9 9 5 1
1 0 0 0 1
1 0 0 5 1
1 0 1 0 1
1 0 1 5 1
1 0 2 0 1
1 0 2 5 1
1 0 3 0 1
1 0 3 5 1
1 0 4 0 1
1 0 4 5 1
1 0 5 0 1
1 0 5 5 1
1 0 6 0 1
201
< x g G A T l-9  
x g G A T l- 6 >
x g G A T l - 3 0 > /  
< x g G A T l-3 1  
CDNA ( b p  7 8 9 - 9 2 1 )
< xgG A T 1 - 2 1
TTGGCTATACATCATTGCCAACCCAAGTGCCACCACATCATCCAATGACA 
TTCCTGACAATTCCTACTTCCTACTTAATGGAACAGTTTGGGGGACCCTT 
TCCTGTTTCAGCACAATATTGCCCCCCCCCCATGCACAGAGCCAGGTCCC 
TACAGAATGGGTTTGCTGAGATGGGAAGACCCTGACTGCAGAACCCATCT <x g G A T l- 7 
GAACCCCTGGGGGATGAATTGGAAACCCAACTGTGAGCCTGATCCCCAAC 
ATCAGTGTCCAACCTCAGTAATGCTCTTGTATCTGAATGGAAACAACTCC 
CAGCAACAATGTTCCATCATGGAACCTTCAGAGAAGCACCGGAGCAGTTA 
TAGCAGCAAAGAGGAGGGCAAACCAACGGAAATCCCTGTGGGATGAACTG 
GAACCGCGACTGTGAGCCTGATCCCCAACATCAGTGTCCAACCTCACTCT 
TGTGGCTGAATGGAAGCAACTCCCAGGAACAATGTTCCAACATGGAAACT 
TCAGAGAAGCACCAGGGCAGTTATAGCAGCAAGAGGAGGGCAAACCAACT 
GAACCCCTGTGGGATAAACTGGAACCCCGACTGTGATCCTGATTCCCAAC 
ATCAGTGCCCAACCtCACTCATGTGTTGGCTTAATGGAAGCAACTCCCAG 
CAACAATGTTCCAACATTAAGTGGGAACCTTCCCAGAAGCACCGGGGCAG 
TTATAGCAGCAAAGGGGGGCAACTTCATATTACCCCCTTGGGTTAGGAAT 
GAGATGTTGGGAGGAAGGTGTTCCTATATTTTTGCCATACTGTGTACAAG 
CATGGAAACATTGGCATGGGAAAAAATCAAGATTAGAATGAGTTAGGCAA 
AGCCAACATCAGCAGCAGAGAAGTTCTGCA. TCACAAGAACCCTACAAAA 
TATGGGAAGGCGGATACGAAGGATCGGCAGTGGGATATACAGTAAAGCTG 
ATGGGGTTTCACAGCCCACAGTAAAGCAACACTGGGTCATGTTTAATCCA 
ATTGCAGCAGGGTTATGGATATGATATATAGATATCAGTCTTTGAGCTtA 
AATATCTAGAAAATATGTAGAAATAATATTTTTTGAAATATAAATTCTAT 
GCGTTTTTGAATATTGCACAAACGAAGAAAGAGCAATTGTATGTAGATTA 
TTTTGATACAAGCTCTTTGTATGACAATCATTCAATTCCATTCCAGGCGC 
AATATGCACCAAATGACTGACGGACTGGAAAAACCAGGGCAGATCCGATG 
GCCGTTGGCGATCACACTGGCCATTGCGTGGGTTTTGGTCTATTTCTGCA 
TCTGGAAAGGAGTCGGCTGGACAGGAAAGGTAATGAGGAACTGCCGGGAT 
ATAGAAAAACCTTTATATAGTGTCTTTATTTGCTTTTTTATAATGTCTAC 
TTTTTCTTTACTGCCCTCTTTTCCGTCACTTTCATTGTCACCTGCTGAGT 
AGCTCCTTCCTCCCCCCGCTCTCCAAGwACAATTTTTTCTTCCTCTCAGA 
ATTCACCACCACTCCTCCTTTTTTTCTGTGCCATTCTCTCCTCTATACCC 
ACCTCTACCCATGCAACATTCTCTCCTCTATACCCACCTCTACCCATGCA 
ACATTTTCTCCCCTTTCCCAAGAGTCATTTTCATTTTCCCAGTGTTTTAT 
TCTTTTTTTGCCAGAGTAACCTTCACTTTTCATGGTCCATTCACTTCCCA x g G A T l- 2  0 > 
TACCCATTCACTATGTTCCCCTACTTTCTTTGCCCATTCTGACAGCCAGT 
CCCATTGTCTTTTTAGTTGTTGTTAAATTAAACATGAGGATGTCTGTGCC 
ATCATATATAATATACTATATCAGTCACACATACAG. AAAAGGAATTCCT 
GCTGTTAAGTAGCTGAACTGACTAAATCAATTCATTAATGCTAATACAGG 
TATGGGATCTGTTATTTGGAAACCTGTTATCCAGAAAGCTCTGAATATTG < xgG A T 1 - 1 3  
GAAAAGCAATCTCCCATAGAATCCATTATGATAAAATAATCCACATTTTT 
AAACATTATTCCCTTTTTCTGTGTAATAATAAAACAGTAGGsTGTACTTG 
ATTCAAACCAAGATATAATTAATC sTTATTTTAAATAAAACsAG S CTAAT 
GGGTTCATTTAATGTTTACATGTTTTTCTAGTAGACTTAAGGTATGAAGA 
TCCAAATTATAGAAAGATCCATTATTCGGAAAACCCGAGTCCCAAGCATT 
CTGGATAACAGGTCCCATACCTGTATTGATATCCTCAGTTATGGGACACA 
GAACAGTGGATGAGCTGAACCAAAACATAGCAAAGCCATTTTACCATTAT 
AACTGTATTATCGCTGTATTTTAACTGTATTCTCTCTGCAAATTCTCTCT 
GTGTTTAACATTTTCATCAGATAACTCAACCATAATCTGCATTTTAAATC 
TCTTTATGGGGTTATTTGAAATCAACTAATGTGTGTAAGTGGAAAAGGCT 
TAGGGACCATTAGGTTAAGCTTAGAAGGGGGTAAATCTTACTGAAGGCAA 
AAGCT T C CAT TT C AGTCTC AT AATGG AAC ATGT CAGATAATT AC AGTG AA 
ATATGTGCCAATGATAAAGAGCATAGTTATATATGTGTTCCTAGTCAGAG 
AAATCATCACATGGTGTTTGATAGAGGAACTTACAGATACGGCTCCTCGT 
TTTTTTGTGATGGAAGAGGGAAATTATATTACTGTGGTTATTGGTACCGA 
GAGACACATCACAGGGCAACGTTTTGGAAATGCTTCTATTTAATTAATGG 
CCCATGTTCTTCTCCTTCAAAAATGGAGAACGTTTGTTAGAGTGTGCAAT 
ATTATGAGATATAAGATAGATATGATTTTATTGACTGTTACTGTGTTATT 
AAATTAGATGGCAATATACAGTATCTGTATATAAGGAGGGCCTGCCCTGG 
AATGCAATGTGTCCCAGTCAGAATGCCAAAAAACTCAAAAAAAAGTTTTT 
TTTTACTAGAAAAACCAAATTTTTAGTGGGAAAAAAAAATTGAATATTTC 
AAGATTTATTATACCCCTAGGATGGAAAAAGTCTGAATCCGAAAATCCAG 
CATCTCAGACCTGCCGAGGTTGTATATAAGTCATTGGGAAAGGTCCTTAT 
CCTATTTGGAAGTTTCTGTGAATTAGCCCGAAAAATATGACTATTTCAGA 
CTTTCTGGCAAAAATGTAGTAATTCAGGAAAAAATTATTTGATTCGGCTT 
TTCAATCCTTTTTTTTTGTTTGTCCCTGATCCAATGAAATTGTGATTTTT 
TTTAAAAATAATAAATAAGGTCCAGTCATGGATTTTTGTTTGGTCAGACT <x g G A T l - 1 1  
TTTTTGATTAAAATAGTCAGATAATTTCGGAACTTTGATAAATAAGGCCC 
TTGGTCTACTACAAGTTGTACAAATTGTTTTGCTTGAGGAATCTATAGAT 
GTTATGAATATACAAGTATTATGTGAAGGACAAATTTCCTATAGAATCCC 
ATCCCTGCTGGAGAAACTACAGCGTCGGAATCTGAAATATTGGGTCTTGT 
CAGCAGAGAAAGCGACGGAAAGAGCAATTCTGACACTTTTAAGGACAATC
202
< x g G A T l-  23
1 0 6  51 ATGATAGAGATGAGGACGATGAAAAACTTTGAAGGGAAGTAACAGAGAGA xgG A T 1 - 1 2  >
10  7 01  CGCTTGGAGAAACCTTAAATAGTCCAATGTTTTCCAGCTTGGCmCTTCTG
10 7 5 1  GAGGCAATGATGATTGTTAGAGCTAAATGTCATGAGTTCAGAGGGTTCGG
1 0  8 0 1  ACACAACAGTCTGACAAAATCTTCTTTTTATGGGGATGTTGGGwTGCTAA
10 8 5 1  GAGCTTGTTGGGTTGCTAAGAGCTTGTTGGGTTGCTAAGACATTGCTTAg
10 9 0 1  tCCAAGGTATTGTTGGGTAGATAATTGTCCTTGATTACACATGGTGGAGG
10 9 5 1  ATGCAGCAAATTGCAGAACACTTTTTGTATCTGGAAGAGAAGGACTTGGA
1 1 0 0 1  TTAGTTTGTCATTCTTCCATCCTGAAGAAGACACAGAGAATACACTGAAA 
1 1 0 5 1  TGAGAAATACCTTACACCACAGAGAAGACTTTTATTACTTGTATTACTCG 
1 1 1 0 1  AAATATAACGTTTACAGTATCACTTCTTTGGTTTAAATATATGTATTTTT 
1 1 1 5 1  AAACATTTGCTTATTTATTTATATATATATACAGTATATATATGGTGATA
1 1 2  0 1  TGGATATATGGTCATTTCCCCCATACATTTCAATATATCTGGGCTTATTT 
1 1 2 5 1  ATTCTTGTATATTTAGTTATTTTTTTGAAGAAATCATTTATAAAAAATAT
1 1 3  01  TGTTGACTTCTTTTGCTTTTCTGCTTGAAACGAGCGTGCATTCTGGGAGT
1 1 3  51  TGGGTGTTCCGGATGTCTGACTTGTCCTAGAACCAGTTTCTAGACCTTAA
1 1 4  01  CGACTGCCACCTGCTCCCTGGAAcGATCAGTTGGTGCAAGtGAGATCTGA
1 1 4  51  CAGTCACAGATGAGTGAGTTGTCTGTAACAAATGATGATAACAAATCTAA
1 1 5  0 1  TAATAATATGTAAATAAAGGGAAAGAATGCTTGTTATGTTATCCAAACCA 
1 1 5 5 1  TTTT TTACTCTTT CTCCCAGGCTATTCCAATTTCCTGCCCATCTGCAAAC
1 1 6  01  TGATTATTGtCTCAGGTTGAAGGTTCATTTGCAGCTCAGTCCAAGAATCG 
1 1 6 5 1  CAGCTGTTCCAGCAAAGAGCAGTTCCTTGTTTTTCCATAAATATTTCTTT
1 1 7  01 CTCGGCAGGTGGTCTACTTCTCAGCGACATATCCCTACATCATGCTGGTC
1 1 7  51  ATCTTGTTCTTCAGAGGAGTGACCTTGCCGGGAGCCTTGGATGGGATTTT
1 1 8  01 GTTTTATATAACTCCTAAATTCAGCAAGCTCTCGGATTCAGAGGT7VATCT
1 1 8  51  ACCGACACCGTGACAAATAACCATAATGAAATAAAGTCACAAAAACGATC
1 1 9 0 1  AATTCCAACGATATCTTCCATGTTGTGCAGGTCTGGCTGGACGCTGCCAC 
1 1 9 5 1  TCAGATCTTCTTCTCTTATGGTTTGGGACTTGGCTCCTTAATTGCTTTGG 
12 0 01  GAAGCTACAATCGATTCCACAACAATGTTTACAGGCAAGTACAGAGGAAA 
12 0 51  ATTGAATCCTAATAAAATACATTATGGATTAAAACATCAGGATATGAAAG 
1 2 1 0 1  TATACTTGAAATATTAAGGTATAAGAACAACTACATTTTTCTTGACACAA 
1 2 1 5 1  AGGGGTTATTGTATTTATTAGAGGTCAAACACCAAAAACTAATTTTTACA
1 2 2  0 1  ATAAAATCTCATTTTTTGTGAAAAAAACTTGGAATTTTTTCATGATTTAT
12 2 5 1  TACACCCTGAGGATAGAAAAAGTCAAAATCTGAAAATCCAGCATCTGAGA
1 2 3  01 CCTGCCAAGGTTGTATACAAGTCTATGGCAGAAGTCCTGAAGATGTTGCC 
1 2 3 5 1  ATCTGCTCTGGGTTTTGTGCAAGAATCAGATTTCATGGATTTTGGGCAAA
1 2 4  01  AATAAAAAAAAG TGGAAAAT CTGAATAAAAT CTGTACATT TTGAATTTTC 
12 4 51  TTATGTATTTTACAGATATTTTTTGAGTTTTTTTCCTGCACTGGAATGTG 
12  5 01  TAGGTATAATGTATTGATAAATAAGGGGAAGTAACCTGTGCAGATTTGGT 
1 2 5 5 1  CAGAGTATATTTCAGAAAATACTGAGATAAATTTGAATTTTGATAAACTC 
1 2 6 0 1  CCAAATACTCTCTTATAAAACTAGGGATGCACCGAATCCAGGATTCGGTT 
1 2 6 5 1  CGGGATTCGGCCAAGATTCGGCCATTTTCAGCGGGATTCGGATTCGGCCG 
12  7 01  GATCCTTCTGTCCGGCCGAACCGAATCTGAATCCCAATTTGCATATGAAA 
12  7 51  ATTAGGGGCGGAGAGGGAAATTGCATGACTTTTTGTCACAAAACAAGGAA 
1 2 8  0 1  GTAAAAAATGTTTTCCCCTTCCCACCCCTAATTTGCATATGCAAATTAGG 
1 2 8 5 1  ATTCGGATTCGGTTCGGTATTCGGCCGAATCCTTCGTGATACACAAAATA
12  9 0 1  GTGGATTCGGTGCATCCCTATATAAAACAGAACAATGATTTTGTTTATCA 
1 2 9 5 1  CAGTTTACCTCTCAAGTTTATAAGGTGCTGCCTAAACCAAATGGTTTCTA
13  0 01  ATTCTATACTGTACAGTCAAGGATCTACCCCTCTATAATATGTAGATCCT 
1 3 0 5 1  C
x g G A T l- 2 4 >
x g G A T l - 3 2 >
cDNA (bp 922-1056)
<G A B A T-9
<GABAT- 9 ( c o n t )
< x g G A T l-3 3
CDNA (bp 1057-1161)
< x g G A T l-1 4  
< x g G A T l- 2 5
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